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Abstract 
Transgenic maize MON810 is a maize variety that has been genetically modified to express 
Cry1Ab isolated from the soil bacterium Bacillus thuringiensis (Bt) to produce a natural 
insecticide (Bt toxin) which kills larvae of the European corn borer (ECB), a major pest of 
maize.  The mode of action of Bt toxin in ECB is through binding to specific receptors on the 
epithelial cells of the highly alkaline midgut of the insect, resulting in pore-formation, osmotic 
imbalance, cell lysis and subsequent death of the insect.  In contrast, this Bt toxin is considered 
to be harmless or nontoxic to mammals due to acidified gut pepsinolysis and the lack of Cry 
protein binding-sites on the mammalian gut epithelial cells.  However, to date, no studies have 
investigated the cellular effects of these Cry proteins at the proteome level.  The aim of this 
study was therefor to investigate the in vivo and in vitro effects of MON810 maize expressing 
the δ-insecticidal protein Cry1Ab from Bacillus thuringiensis, on differential gene expression at 
the proteome level in the epithelial cells of the small intestine of the rat as a model for 
mammals.  Proteomic profiling techniques were included for the in vivo and in vitro studies to 
obtain a better understanding of the underlying molecular responses in rat to MON810.  
Transgenic Bt maize (MON810), the corresponding parental non-transgenic maize (MON 
CONV CORN), and 3 other maize varieties, MON Garst 8450, MON Gold HVST H8920 and 
MCert Rod commercial control (used as internal controls), were provided by Monsanto, USA.  
All diets were formulated by TestDiet and contained approximately 33% (w/w) corn grain; 
other diet components were adjusted to provide approximately equal levels of protein, calories 
and nutrients.  Different reference varieties were used in this study to determine whether the 
changes that may occur with the consumption of MON810 maize lay within the expected range 
for several different unmodified reference varieties.  Two rats feeding trials (7-day and 28-day) 
were conducted to assess the safety of MON810 maize using forty immature male Wistar rats 
(rats were between 6 to 7 weeks of age at the beginning of the study).  Rats were assigned to the 
above 5 experimental groups based on body weight means.  No adverse behavioural effects on 
rats were observed and there were no significant differences in absolute body weights, body 
weight gains, food consumption and feed conversion efficiency between rats fed MON810 in 
the diet when compared to rats fed diets containing grain from the other maize varieties.  Thus 
the transgenic variety MON810 had no adverse effects on these parameters.  Following these 
feeding studies, rats were sacrificed and the total proteins extracted from the small intestinal 
epithelial cells were separated by 2D gel electrophoresis.  Differentially expressed proteins were 
identified using SameSpot Progenesis software followed by liquid chromatography–mass 
spectrometry (LC-MS/MS); the mass spectrometry data were analysed by Global Proteome 
Machine (GPM) search engine for protein identification.  The same proteomic profiling 
techniques were used for the in vitro approaches for MON810 maize safety evaluation where 
primary intestinal epithelial cells and HCT116 cell line were used.  In vivo effects of these 
different maize varieties on the proteome of the epithelial cells of the small intestine when all 
five groups were compared showed that there were 5, 4, 3, 0, 0, differentially expresed protein 
spots for Mcert, Mon Conv Corn, MON810, Mon Garst and MON Gold, respectively for the 7-
day trial.  Two stress-related proteins (LDLR chaperone MESD precursor and peroxiredoxin-6) 
were up-regulated (2.4 fold) in the MON810 group and 1 stress-related protein (thioredoxin-
dependent peroxide reductase) was up-regulated (2.6 fold) in the Mcert group.  For the 28-day 
trial, only 2 proteins spots (representing 6 proteins) were up-regulated in the small intestinal 
epithelial cells of rats fed MON810, one of which was a stress-related protein (stress-induced 
phosphoprotein 1; 3.1 fold).  In vitro effects of MON810 and its near isogenic line on the 
proteome of the epithelial cell lines were negligible, with only 4 protein spots (5 stress-related 
protein) being up-regulated in the small intestinal primary epithelial cells (IE cells) when 
exposed to Bt maize extracts and 2 protein spots (1 stress-related protein) being up-regulated 
when exposed to non-Bt maize extracts.  There were no differentially expressed spots between 
the HCT116 cell lines.  The findings from the in vivo and in vitro studies both suggest that 
MON810 has negligible effects on rats at the cellular level.  They also confirm the lack of 
mammalian toxicity when using rats as a model system. 
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1 General Introduction 
     Global interest surrounding the use of genetically modified (GM or transgenic) crops 
is continuously increasing because of the possibility of the food produced being more 
nutritious and agronomic productivity being higher, both being affected without the use 
of pesticides (Shintani and DellaPenna, 1998; Ye et al., 2000).  However, concerns 
relating to their safety for human consumption are widespread and need to be fully 
addressed before their acceptance into the market. Although several studies have been 
conducted to evaluate the safety of GM crops, there is still a debate on the potential risk 
of GM derived food products and there exists widespread and vocal demand for 
additional evidence of GM food safety (Haslberger, 2006; Hug, 2007). 
1.1 Genetically modified crops 
     According to the World Health Organization (WHO), Genetically Modified 
Organisms (GMOs) are those organisms in which the genetic material (DNA) has been 
altered in a way that does not occur naturally (Domingo, 2007). 
     Crops developed through biotechnology have been marketed and used by farmers 
since the mid-1990s.  Biotechnology was used in the first generation of so-called GM 
crops to provide growers with complementary and sometimes alternative crop 
management solutions to the use of pesticides. Genes identified from other plants or 
non-plant sources or selected host genes are modified and transferred to a crop plant.  
The altered or new protein expression resulting from these modifications confer on the 
plant a desired physiological trait, such as resistance to particularinsect pests or 
herbicides. Second generation modifications provide traits such as enhanced nutritional 
or health-promoting characteristics that are of (claimed) benefit to consumers 
(Malarkey, 2003). 
     The technology used allows selected individual genes to be transferred from an 
organism into another, and also between non-related species.  Such methods are used to 
create GM plants, which are then used to grow GM food crops.  The GM crops 
currently on the market are mainly aimed at achieving an increased level of crop 
protection through the introduction of resistance against plant pest diseases and through 
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increased tolerance towards herbicides.  Taking into account that different GMOs 
include different genes inserted in different ways, the WHO indicates that individual 
foods and their safety should be assessed on a case-by-case basis, and that it is not 
possible to make general statements on the safety of all GM foods.  In general, the 
safety assessmentof GM foods should investigate: a) toxicity, b) allergenicity, c) 
specific components thought to have nutritional or toxic properties, d) stability of the 
inserted gene, e) nutritional effects associated with genetic modification, and f) any 
unintended effects which could result from the gene insertion (Cellini et al., 2004; 
Domingo, 2007). 
     A record 175.2 million hectares of biotech crops were grown globally in 2013, at an 
annual growth rate of 3%, up 5 million from 170 million hectares in 2012 (Figures 1.1, 
1.2 and 1.3). The year 2013, was the 18th year of commercialization, of the period 
1996-2013, when the overall growth volume continued to be seen after a remarkable 
previous 17 consecutive years of increases; notably 12 of the 17 years witnessed 
double-digit growth rates.  The global hectarage of biotech crops has increased more 
than 100-fold from 1.7 million hectares in 1996 to over 175 million hectares in 2013 – 
this makes biotech crops the fastest adopted crop technology in recent history.  This 
adoption rate speaks for itself in terms of its benefits in its delivery to farmers and 
consumers alike (James, 2013). 
1.1.1 Types of GM crops 
     There are many different types of GM crops that are currently being developed that 
are able to enhance the quality of life in agricultural communities (Cohen, 2005).   
     GM crops can reduce the use of conventional pesticides, which has quantifiable 
environmental and human health benefits, as well as reducing application costs per acre.  
Of the transformation events reported in many studies, 35 confer insect-resistant traits to 
crops, reflecting the perceived importance of action on the effect of pests on crops and 
thus on regional economies (Table 1.1).  In addition, GM crops can reduce the use of 
other agrochemicals which are widely used to fight virus, fungus or other diseases.  
Eighty-four transformation events target this area, which if brought to the market 
successfully, can target reduced costs and increased production.  Also, genetic 
modification can improve abiotic stress crop tolerance, such as drought and salinity that 
place limitations on poor farmers located in less favoured regions.  Of the 201 events, 
11 are being developed in this area.  The GM crops can produce better product quality, 
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such as prolonged shelf life or enhanced product characteristics (foods delivering 
alternative carbohydrate or fat composition) that would improve transportation and 
consumer appeal.  Of 15 transformation events being developed for product qualities, 5 
are in the area of nutritional enhancement and 6 are to prolong shelf life. The other 4 are 
for product characteristics, such as increased sucrose.  There are also major public 
initiatives, such as HarvestPlus, that seeks to reduce micronutrient malnutrition to breed 
nutrient-dense staple foods.  Furthermore, GM crops can produce alternative and more 
efficient provision of essential vitamins and vaccines.  Nine transformation events are 
being developed for plant-based vaccine deployment as seen in Table 1.1 (Cohen, 
2005). 
1.1.2 Commercially growing GM crops 
     In 2013, 27 countries planted biotech crops.  Of the 27 countries which planted these 
in 2013 (Table 1.2 and Figure 1.4), 19 were developing and 8 were industrial countries. 
Each of the top 10 countries, of which 8 were developing, grew more than 1 million 
hectares providing a broad-based worldwide foundation for continued and diversified 
growth in the future.  More than half the world’s population, 60% or ~4 billion people, 
live in the 27countries planting biotech crops (James, 2013). 
     In 2013, five EU countries planted a record 148,013 hectares of Bt maize, up 18,942 
hectares or 15% from 2012. Spain led the EU with a record 136,962 hectares of Bt 
maize, up 18%.  Portugal was lower by approximately 1,000 hectares, caused by a seed 
shortage, and Romania’s figure was the same as in 2012.  The other countries, Slovakia  
and Czechia, planted lower and small hectarages attributed to onerous and over-
demanding EU reporting procedures for farmers (James, 2013). 
1.1.3 Advantages of GM-derived foods 
Pest resistance 
     The loss of crops from insect pests can be staggering, resulting in devastating 
financial loss for farmers and starvation in developing countries. Farmers typically use 
many tons of pesticides annually.  However, consumers would prefer not to consume 
foods that have been treated with pesticides because of the potential health hazards, and 
run-off of agricultural wastes from excessive use of pesticides and fertilizers which 
contaminate the water supply and adversely affect the environment.  Therefore, it is 
widely held in sections of the scientific and lay community that growing GM foods such 
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as Bt maize can help eliminate the application of chemical pesticides and reduce the cost 
of bringing a crop to market (Baum et al., 2001; Moellenbeck et al., 2001). 
     Insects not only cause direct yield losses by damaging and consuming plants, but 
also act as vectors for many viral diseases and the damage they inflict often facilitates 
secondary microbial infections (Ferry and Gatehouse, 2009). 
Herbicide tolerance 
     Weeds compete with crops for resources, in some cases by parasitism.  The cost of 
weeds, measured in terms of reduced yields, the application of herbicides and the 
mechanical and manual labour required to remove them, is probably the largest single 
input into agriculture (Ferry and Gatehouse, 2009). 
     Removing weeds from crop plants by physical means such as tilling is not cost-
effective, so farmers often spray large quantities of different herbicides (weed-killer) as 
a means of weed control. This is an expensive and a time-consuming process which 
requires care to ensure that the herbicide does not harm the crop plant or the 
environment.  The genetically-engineered crop plants which are resistant to herbicides 
can help prevent environmental damage by reducing the amount of herbicides needed 
(Whitman, 2000).  
     For this reason, weed control has been identified as the primary target for first-
generation genetically modified technology and most of the transgenic plants grown in 
the world today have been modified for herbicide tolerance, allowing the use of a safe, 
broad spectrum of herbicides such as glyphosate.  Glyphosate, for example, is active 
against a wide range of plants but has a very low toxicity to wildlife, farm animals and 
humans; in soil, it is rapidly bound to soil particles and inactivated by bacteria (Ferry 
and Gatehouse, 2009). 
     Furthermore, Monsanto which is an agriculture biotechnology company based in 
USA has created a strain of soybeans genetically modified so as not to be affected by 
their herbicide product under the trade name Roundup.  Growing these soybeans 
requires only one application of weed-killer instead of multiple applications and this 
will reduce the production cost and limiting the dangers of agricultural waste run-off 
(Whitman, 2000). 
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Figure 1.1: Global area of biotech crops. 
A record 18 million farmers, in 27 countries, planted 175.2 million hectares (433 million acres) in 2013, a 
sustained increase of 3% or 5 million hectares (12 million acres) over 2012. 
Source: James, 2013. 
 
Figure 1.2: Global area of biotech crops, 1996 to 2013: by crop (million hectares, million acres). 
Source:  James, 2013. 
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Figure 1.3: Global area of biotech crops, 1996 to 2013: by trait (million hectares, million acres). 
Source:  James, 2013. 
 
 
Table 1.1: Transformation events created at public research institutions related to quality-of-life 
categories. 
Source: Cohen, 2005. 
Trait No. of events 
Insect resistance  35 
Lepidoptera  35 
Disease resistance  82 
Bacteria  8 
Fungi  21 
Viruses  53 
Abiotic stress tolerance  11 
Drought  7 
Salinity  4 
Quality improvement  15 
Nutritional and other  9 
Enhancing shelf-life  6 
Other  9 
Vaccines  9 
Total in this table  152 
Total number of reported events 201 
Percentage of all events related to quality-of-life traits 75.6% 
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Table 1.2: Global area of biotech crops in 2013: by country (million hectares). 
Source: James, 2013. 
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Figure 1.4: Global map of biotech crop countries and mega-countries in 2013. 
Source: James, 2013. 
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Disease resistance 
     There are many nematodes, fungi, bacteria and viruses that can cause disease to 
plants.  Therefore, plant biologists are working to create plants with genetically-
engineered resistance to such diseases (Dahleen et al., 2001; Scorza et al., 2001). 
     In Africa, the major cause of disease in lowland rice ecosystems is rice yellow mottle 
virus (RYMV).  The only naturally occurring resistance genes to RYMV are found in 
African landraces, which are difficult to cross with the cultivated varieties. Therefore, 
transgenes were constructed from the RNA polymerase gene of RYMV, which encodes 
a highly conserved component of the virus replicative machinery. The gene was 
transferred to three West African cultivated rice varieties that are grown in regions with 
the worst records of viral disease and where the yield gaps are the highest. All three 
varieties were shown to be resistant to RYMV, and one of the varieties was resistant to 
isolates of the virus from several different locations in Africa. In the best performing 
lines, viral replication was completely blocked over several generations (Ferry and 
Gatehouse, 2009). 
Cold tolerance 
     Cold stress is one of the major environmental factors limiting the agricultural 
productivity of crop plants.  Plants vary greatly in their abilities to survive freezing 
temperatures (Zhang et al., 2011).  Frost, for example, can destroy sensitive seedlings.  
Therefore, an antifreeze gene from cold water fish has been introduced into plants such 
as tobacco and potato.  With this antifreeze gene, these plants are able to tolerate cold 
temperatures that may normally kill unmodified seedlings (Kenward et al., 1999). 
Drought tolerance/salinity tolerance 
     As the world population grows and more land is utilized for housing instead of food 
production, farmers are increasingly needing need to grow crop plants in places 
unsuited for plant cultivation.  Therefore, creating plants that can withstand high salt 
content in soil and groundwater or long periods of drought is necessitated to enable the 
cultivation of crops in formerly inhospitable places (Tang, 2000; Zhang and Blumwald, 
2001). 
     Conventional breeding has helped to create varieties with increased tolerance to 
drought, but progress in introducing new genes through genetic manipulation has been 
slow.  Despite decades of research, only one drought-tolerant genetically modified crop 
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has been approved in the United States: Monsanto’s DroughtGard maize, which 
expresses a stress-response gene from bacteria (Jones, 2013). 
Nutrition 
     Malnutrition is a common problem in the third world countries where impoverished 
peoples rely on a single crop such as rice for the main staple of their diet.  In this case 
and other instances of reliance on single crops, sufficient amounts of all necessary 
nutrients are absent and thus malnutrition often results.  If rice, as but one example, 
could be genetically engineered to contain additional vitamins and minerals, nutrient 
deficiencies could be alleviated.  For example, blindness due to vitamin A deficiency is 
a common problem in third world countries.  Researchers at the Swiss Federal Institute 
of Technology Institute for Plant Sciences have created a variety of golden rice 
containing an unusually high content of beta-carotene (vitamin A).  Since this rice was 
funded by the Rockefeller Foundation, a non-profit organization, the Institute hopes to 
offer the golden rice seed free to any third world country that requests it. Plans were 
also underway to develop golden rice that also has increased iron content. However, the 
grant that funded the creation of these two rice strains was not renewed, perhaps 
because of the vigorous anti-GM food protest movement in Europe, and so this 
nutritionally-enhanced rice may not come to market (Whitman, 2000). 
     The creation of ‘Golden Rice’ with enhanced vitamin A content is an example of the 
metabolic engineering approach to nutritional improvement.  Vitamin A deficiency is 
prevalent in the developing world, and is probably responsible for the death of 2 million 
children every year.  Humans can synthesize vitamin A if provided with the precursor 
molecule β-carotene (also known as pro-vitamin A), a pigment found in many plants but 
not cereal grains.  Therefore, a strategy was devised to introduce the correct metabolic 
steps into rice endosperm to facilitate β-carotene synthesis (Ferry and Gatehouse, 2009).  
Although developed primarily for animal feed, maize has been genetically engineered to 
express enhanced levels of β-carotene, ascorbate and folate (Naqvi et al., 2009).  Mice 
fed on a diet enriched with this genetically engineered multivitamin corn showed no 
sub-acute effects and no sub-chronic toxicity (Arjó et al., 2012).  
     There are also many examples of transgenic technology being employed to increase 
the nutritional value of plants, either through direct interference with nutrient 
accumulation or through the modification of primary or secondary metabolism.  An 
example of the former strategy is the expression of seed storage proteins or 
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developmental regulators to increase the protein content of food.  Specific reports 
include the expression of the AmA1 seed albumin gene from Amaranthus 
hypochondriacus in potato, which has been shown to double protein content and 
increase the content of essential amino acids, and the expression of the Gpc-B1 gene in 
wheat, which improved grain protein, zinc and iron content (Ferry and Gatehouse, 
2009). 
Pharmaceuticals 
     Vaccines and medicines are often costly to produce and may require special storage 
conditions not readily available in third world countries.  Researchers are working to 
develop edible vaccines in potatoes and tomatoes and these vaccines will be much 
easier to store, ship and administer than traditional injectable vaccines (Daniell et al., 
2001; Kong et al., 2001). 
     Clinical trials showed that an oral vaccine expressed in plants gives protection 
against a virulent viral pathogen in livestock. One of these trials was conducted on 
swine using an edible form of avaccine for transmissible gastroenteritis virus (Ferry and 
Gatehouse, 2009).   
     There have been several human clinical trials involving plant-derived, oral vaccines.  
Yusibov et al. (2002) conducted a trial involving 14 volunteers given spinach infected 
with alfalfa mosaic virus vectors expressing the rabies virus glycoprotein and 
nucleoprotein.  Five of these individuals had previously received a conventional rabies 
vaccine.  Three of the five and all nine of the initially naive subjects produced 
antibodies against the rabies virus while no such response was seen in those given 
normal spinach. 
Phytoremediation 
     Not all GM plants are grown as crops.  Soil and ground water pollution continues to 
be a problem in all parts of the world. Plants such as poplar trees have been genetically 
engineered to clean up heavy metal pollution from contaminated soil (Bizily et al., 
2000). 
     Hyper-accumulators are model plants for phytoremediation as they are tolerant to 
heavy metals.  The hyper-accumulation of heavy metals in some plants has been 
recorded by many researchers in the last few decades emphasising the importance of 
further advanced research into the molecular basis of phytoremediation technology.  In 
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metal biology, it is experimentally proved that even some metals that are essential for 
normal plant growth (such as iron and copper) may become toxic, depending on 
the dose and mode of exposure.  Therefore, remediation of metal-contaminated soils has 
become a goal for many research laboratories in the world (Sarma, 2011). 
1.1.4 Concerns regarding GM foods for human use 
Allergenicity 
     Many children in the Europe and US have developed allergies to certain foods. An 
allergic reaction to nuts is an example of an ordinary familiar food that has become 
allergenic to some people which can be serious and even fatal.  There is a possibility 
that introducing a gene into a plant may create a new allergen or cause an allergic 
reaction in susceptible individuals (Nordlee et al., 1996). 
     The insertion of novel genes into crops, such as a gene from the Brazil nut to 
enhance the nutritional content of the soybean, can create health problems in people 
who are allergic to various plant proteins, including those of nuts.  Several investigators 
have documented how, when genetically engineered soybeans were fed to mice and 
rabbits, their cells and enzymatic activities were altered.  These studies emphasize the 
need for careful consideration of what traits are to be expressed and what the 
consequences may be, if any, for human health (Ferry and Gatehouse, 2009). 
Unknown effects on human health 
     There is a concern that introducing foreign genes into food plants may have an 
unexpected and negative impacts on human health.  On the whole, with the exception of 
possible allergenicity, scientists believe that GM foods do not present a risk to human 
health (Whitman, 2000). 
     Genetic engineers have experimentally produced drugs and other chemicals by 
manipulating the genetic make-up of various plants. There areseveral risks associated 
with this technology including contaminating the food supply. The best approach would 
be to produce these possibly hazardous materialsin secured greenhouses where insects 
and pollen cannot invade or escape (Ferry and Gatehouse, 2009). 
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1.1.5 Environmental concerns 
Pesticide resistant crops could be toxic to non-target organisms 
     Transgenic crops that express insecticidal transgenes to control agricultural pests 
may also affect non-target organisms.  The ecological risks of releasing transgenic Bt 
plants could be toxic effects on organisms that are not pests of the crop itself but are 
predators and parasites of the pests and, therefore, of benefit to agriculture.  However, 
these problems may be directly related to the application of Bt toxin and not due to 
cultivation of crops carrying the Bt gene, as is evident from the studies on the effects of 
spraying of Bt-toxin on non-target organisms or pests (Singh et al., 2006). 
     In addition, the Bt toxin could be harmful to insects related to the European corn 
borer, including moths and butterflies.  In 1999, a group of Cornell scientists expressed 
concern specifically regarding the monarch butterfly. In 2001, the Environmental 
Protection Agency (EPA) announced its findings: that Bt does not harm monarch 
butterflies.  Furthermore, the roots of Bt plants have been found to release the toxin into 
the soil and following harvest, decaying plants still contain trace amounts (Hanten, 
2002).  
Reduced effectiveness of pesticides 
     The release and wide spread cultivation of GM crops with pest or disease resistance 
has raised concerns that this may impose intense selection pressure on pest and 
pathogen populations to adopt to the resistance mechanism (Singh et al., 2006). 
     Bt crops expose insects to the toxins whether or not there is a major infestation.  
Many people are concerned that insects may become resistant to Bt or other crops that 
have been genetically-modified to produce their own pesticides (Whitman, 2000).  
Thus, to delay the onset of resistance in pest population it is mandatory in many 
countries growing Bt crops, including USA, that at least 20% of the crops is non-
transgenic, thus providing a refugia. 
All of these environmental hazards are compounded by genetic pollution 
     Many crop plants disperse pollen which may be carried by wind or insect pollinators 
so that genetically engineered plants may cross pollinate non-engineered plants, 
introducing new genes into wild plant populations and the ecosystem, thus affecting the 
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whole food chain.  This may result in some organic farmers, whose fields are near GM 
crops, not being able to certify their crops as organic (Hanten, 2002).   
     Another concern is that crop plants engineered for herbicide tolerance and weeds 
will cross-breed, resulting in the transfer of the herbicide resistance genes from the 
crops into the weeds and these super-weeds would then be herbicide tolerant as well 
(Whitman, 2000). 
1.1.6 Genetically modified maize/corn 
     The use of biotech crops has been rising since their commercialization in 1996.       
Maize is the world’s third leading cereal crop, following wheat and rice.  It is grown as 
a commercial crop in over 25 countries worldwide. In 1995–1997, 66% of all the maize 
produced worldwide was used for animal feed and 17% for human consumption.  In 
developing countries, 30% of the maize produced was used for human consumption and 
57% for animal feed, whereas in Western Europe, North America and other high 
income countries, 4% was used for human consumption and 76% for animal feed during 
the same period.  GM maize is one of the most extensively cultivated genetically 
modified crops, with traits introduced in these lines being, basically, resistance to 
herbicides and increased tolerance to insects and pests.  Genetically modified maize 
expressing gene encoding Bacillus thuringiensis (Bt) occupying 37.3 million hectares, 
was the second most frequently cultivated GM plant after the GM soybean (Liu et al., 
2012).  
     The first-commercial-scale plantings of insect-protected field corn hybrids, 
commonly referred to as Bt corn, occurred in 1996, following regulatory approval by 
USA and Canadian authorities.  These first field corn hybrids derived from a genetic 
modification designated Event 176, express a gene that enables the plants to produce an 
insecticidal protein, Cry1Ab, similar to that produced in nature by certain subspecies of 
the common soil bacterium Bacillus thuringiensis (Domingo, 2007). 
Definition of MON 810 
     MON810 is a variety of maize that has been genetically modified in order to produce 
a natural insecticide (Bt toxin) which kills the larvae of the European corn borer 
(Ostrinia nubilalis).  Scientists have developed Bt corn by transferring the genetic 
information of the Bacillus thuringiensis bacterium, responsible for the production of a 
toxin, to corn (VIB, 2010). 
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     MON 810 maize contains a truncated cry1Ab transgene originated from Bacillus 
thuringiensis (Bt) and inherited in its several subspecies.  The full length coding 
sequence of the Bacillus thuringiensis ssp. kurstaki cry1Ab gene produces a 131 kDa 
Cry1 protoxin, while MON 810 cry1Ab transgene expresses a 91 kDa N-terminal 
fragment of it—a so called pre-activated toxin form, as documented in the official 
registration and reassessment documents of Bt plants of genetic event MON 810, listed 
in the database of AGBIOS, which is a Canadian company dedicated to providing 
public policy, regulatory, and risk assessment expertise for products of biotechnology.  
Cry pro-toxins of Bacillus thuringiensis act as trypsin-activated toxins in sensitive 
insect larval groups.  However, to become active and exert their insecticidal activity, 
pro-toxin molecules have to be processed in the insect midgut by trypsin-like and other 
proteases.  Proteolytic activation usually leads to rapid removal of the highly conserved 
C-terminal pro-toxin tail.  Various cysteine residues in this part are involved in 
intramolecular disulfide bridges that cross-link the different pro-toxin molecules in the 
unsolubilized crystal.  At the N-terminal end, a few residues are cleaved off more 
slowly resulting in a final toxic fragment of molecular size between 60 and 70 kDa.  
Smaller pro-toxins lacking the conserved C-terminal region are minimally trimmed at 
both ends upon proteolytic activation.  Although MON 810 cultivars (Agrigold, 
Asgrow, DeKalb, Garst, Golden Harvest, Monsanto, Pioneer) were registered in the 
USA and Europe as early as 1996 and 1998, respectively, Cry1A toxin production of 
the cultivars has to date not been fully explored with extremely variable levels being 
reported.  For example, in Monsanto’s documents registered in the databases of 
AGBIOS, the U.S. Environmental Protection Agency and the U.S. Department of 
Agriculture, mostly the same, non-published measurements are cited, referring to 
Cry1Ab toxin content of 7.93 to 10.61, 0.09, and 0.19 to 0.91 mg Cry1Ab/g fresh 
weight in leaf, pollen, and grain, respectively, in the U.S. documentation, and 7.59 to 
15.06 and 0.35 to 0.69 mg Cry1Ab/g fresh weight in leaf and grain, respectively, in 
European Union documentation.  Furthermore, these studies also mention levels of 
Cry1Ab toxin expressed in the first-, second-, and third-leaf levels in pooled over 
season samples from four-leaf to pollination stage, that is, 9.78, 8.43, and 4.91 mg 
Cry1Ab/g fresh weight, respectively.  These reports thus suggest that expression levels 
are spatially and temporarily variable, and dependent upon the regions in which they are 
grown (Székács et al., 2010). 
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     Protein expression levels – whether transgenic or endogenous – can be quite 
variable in planta and can be affected by a number of factors. In fact, Monsanto 
regularly acknowledges year of cultivation, geographical location, and environmental 
conditions as potential sources of this variability in the expression levels of Cry1Ab 
protein in MON810 (Michael Koch, 2014, pers.comm.).  The expression levels of 
Cry1Ab protein were derived from grain produced from field trials conducted according 
to international guidance. These studies are very well controlled and take extensive 
steps to account for numerous sources of variability that can skew results and are 
considered the most reliable expression values for the Cry1Ab protein in 
MON810.  The expression values which are of specific interest to the present study are 
those in grain; the fraction consumed by humans.  The range of mean expression levels 
for Cry1Ab in MON 810 grain from four separate field trials was 0.31-0.57 µg/g (Safety 
Assessment of YieldGard®Insect-Protected Corn Event MON 810, 2002). Of note, this 
range of mean values of the expression level of Cry1Ab protein is consistent with the 
information in the technical assessment from Brazil (National Technical Biosafety 
Commission-CTNBio, 2006), which indicates an expression level in the grain of 
0.31µg/g.  Therefore, the more conservative (i.e., high) estimate of intake for Cry1Ab in 
MON810 grain is 0.57 µg/g. 
History of MON 810 
   Maize is one of the most widely grown crops for both feed and fodder, producing 
high-fructose corn syrup, dextrose, glycose, starch, oil, flour and meal.  By means of 
transferring an insecticidal trait to maize (Bt corn), it is possible to control damaging 
pests that cause 7% loss of maize products (Kılıç and Akay, 2008). 
     In 1988, MON810 maize was one of the first genetically modified plants to be 
allowed for cultivation in the European Community, where it currently takes place 
mainly in Spain.  This corn variety, developed by Monsanto, produces its own 
insecticide, which is specifically directed against the European corn borer, a 
lepidopteran pest that can seriously damage the corn harvest.  The most important 
advantage of MON810 is the increased harvest certainty for farmers.  They pay a 
slightly higher premium for the seed, but in exchange they have a higher certainty that 
the harvest will be successful. Moreover, farmers need to use fewer insecticides keeping 
costs down and further lowering the environmental impact of the crop.  Millions of tons 
of MON810 are harvested and consumed worldwide every year.  Scientific research 
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shows that MON810 does not have any harmful consequences on human health or on 
the environment.  However, various European Union (EU) member states have blocked 
its cultivation in their countries.  Public opinion in some member states is still actively 
opposed to the introduction of genetically modified crops (VIB, 2010). 
MON810 is a group of tens of varieties 
     Monsanto developed the MON810 corn variety in the 1990s.  Once such a variety is 
created, an intensive refinement program starts with the goal of deriving as many 
different varieties as possible from it.  Each region needs its own variety adapted to the 
local soil and climatic circumstances.  Thus, there are MON810 varieties that grow well 
close to the Canadian border and others that flourish in warmer climates. Therefore, 
MON810 is not a single corn variety: it is the name for tens of corn varieties, derived 
from the MON810 line.  In Spain today, there are more than 100 MON810 corn 
varieties on the market. The majority of these are included not only in the Spanish but 
also in the European list of crop varieties (European Commission, 2009). 
     Monsanto was not alone in bringing MON810 varieties onto the market: around ten 
other seed companies also adopted Monsanto’s technology under license (VIB, 2010). 
The European stalk borer 
     The European corn borer (Ostrinia nubilalis) is a lepidopteran insect whose larvae 
eat the corn stems and cobs.  The European corn borer appears mainly in Southern and 
Eastern Europe and in large parts of the USA and Canada.  In the years that the moth 
appears in large quantities, it can damage up to 30% of the corn harvest (Bohn et al., 
1999).  
     In the United States, Germany, Canada, France, Italy and many other countries, the 
corn borer constitutes an important pest for the cultivators of corn.  Consequently, 
despite its name, the European corn borer was originally a problem in America with 
regard to corn cultivation.  Since the larvae of the moth live inside the stem, they are 
hard to reach with insecticides that are sprayed on the crop.  The development of 
corn/maize varieties with resistance to this insect pest, such as Bt expressing maize, thus 
provides a viable means of controlling this pest (VIB, 2010). 
     Plants affected by the corn borer lose their vigour and as a consequence are easily 
levelled during exposure to gusting winds.  In addition, the tissues where the corn has 
been eaten by the larvae are an ideal point of growth for moulds, in particular Fusarium 
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species.  These moulds produce mycotoxins. In affected plants, a much higher 
concentration of these mycotoxins is found, some of which are carcinogenic to 
mammals (Magg et al., 2002). 
Mode of action of Bt Cry toxins 
     The most successful insect pathogen used for insect control is the bacterium Bacillus 
thuringiensis (Bt), which presently occupies ~2% of the total insecticidal market.  Bt is 
almost exclusively active against larval stages of specific insects and kills the insect by 
disruption of the mid-gut tissue followed by septicemia (Bravo et al., 2011). 
     Bacillus thuringiensis toxin is a collective term for a family of toxins produced in 
nature by the soil bacterium Bacillus thuringiensis (the full version of the abbreviation 
Bt).  This bacterium is present throughout the world in various strains, each of which 
produces another form of Bt toxin.  Each of these forms has a specific effect on certain 
types of insects.  The Cry1 form is toxic for the larvae of specific lepidoptera and Cry3 
for certain types of coleopteran (beetles).  In contrast to many chemical pesticides, Bt is 
not toxic to humans and other mammals, since the activated toxin requires the presence 
of specific receptors that are unique for these insects and with which the toxin can bind, 
since binding is a prerequisite for toxicity (VIB, 2010). 
     Cry proteins show highly species-specific toxicity against certain insects and only a 
few insect species are affected by each of the Cry proteins.  The mode of action in the 
insect is through specific receptors in the gut, which is highly alkaline, with binding of 
the toxin resulting in pore-formation, osmotic imbalance, cell lysis and subsequent 
death of the insect as illustrated in Figure 1.5 (Schrøder et al., 2007).  
     The transformation of Cry proteins from a relatively inert crystalline protoxin to a 
cytotoxic form is a multistep process.  Following ingestion of inclusion body proteins 
by a susceptible larva, the Cry1 proteins (lepidopteran specific) are solubilised in the 
insect mid-gut to release 130 kDa pro-toxins, which are then activated by proteases in 
the insect mid-gut to form the active truncated 65 kDa toxin molecules that 
subsequently bind to specific receptors on the mid-gut epithelium.  Several mechanisms 
of toxicity have been proposed.  Toxin sub units oligomerize to form pore structures 
capable of insertion into the membrane.  These pores allow ions and water to pass freely 
into the cells, resulting in swelling, lysis, and the eventual death of the host.  More 
recently, an alternative hypothesis has been proposed that suggests Cry toxicity is 
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independent of toxin oligomerization and that pore formation may be a secondary effect 
of the toxic events triggered by toxin binding to the receptor.  Cry toxin binding to 
insect mid gut epithelial receptors is an important determinant of specificity.  The 
correlation between binding and toxicity was first demonstrated using brush border 
membrane vesicles (BBMV) prepared from microvilli by a technique developed by 
Wolfersberger (1984).  In lepidopterans, the optimum characterized receptors are the 
aminopeptidase N (APN) receptors and the cadherin-like receptors. 
     Recent work by Arenas et al. (2010) suggests that the GPI-anchored proteins, 
aminopeptidase (APN) and alkaline phosphatase (ALP) are important for Bt toxicity, 
first as initial receptors promoting the localization of toxin monomers in the midgut 
microvilli before interaction with cadherin, and then as secondary receptors mediating 
oligomer insertion into the membrane.  Work with the non-toxic Domain III Cry1Ab 
toxin (L511A mutant) suggests that ALP (which is preferentially present in neonate 
larvae) may have a predominant role in toxin action, as this mutant did not bind ALP 
but retained APN binding suggesting that the initial interaction with ALP is critical for 
toxicity.  Thus ALP may have a predominant role in toxin action since Cry toxins are 
highly effective against neonate larvae that are the target for pest control programmes 
(Xu et al., 2013). 
     The Cry proteins are regarded as harmless or nontoxic to mammals, including 
humans, probably due to acidified gut pepsinolysis and the lack of Cry protein binding-
sites on mammalian gut epithelial cells.  Numerous data from toxicity studies show no 
significant adverse effects of the Cry proteins on body weight gain or clinical 
observations.  Furthermore, no signs of pathogenicity to mammals, including humans, 
have been reported (Schrøder et al., 2007). 
Yield advantages for the cultivation of the MON810 crop 
     Insect pests, weeds or weather circumstances can ruin farmer's harvests.  Therefore, 
farmers look for methods of increasing harvest certainty and for this reason most would 
be willing to pay an additional fee for Bt seeds as some form of assurance (VIB, 2010).  
     In places where the European corn borer is a pest for corn growers (such as the USA, 
Canada, Spain, Southern Germany or Italy), farmers can ensure a good yield by 
replacing conventional corn varieties with MON810 plants.  This is the most important 
motive for farmers to sow it, as by doing so, they improve their chances of having a 
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good harvest.  In the European Union, Spain is the country with the longest experience 
in cultivating Bt corn. Scientific research shows that, under normal circumstances, 
farmer's income increases by 15% with Bt corn.  This is mainly due to the fact that 
farmers use half of the amount of pesticides with Bt corn as with conventional corn 
because the plant produces its own pesticide and farmers can save on spraying (Gomez-
Barbero et al., 2008).  
     Furthermore, the quality of MON810 corn can offer advantages. Since the plants are 
less damaged by the corn borers, there is a reduced likelihood of moulds infecting corn 
plants.  On average, Bt plants contain lower levels of mycotoxins, leading to forage that 
contains fewer harmful substances.  In addition, when using corn for conversion into 
biofuel, Bt corn is better than normal corn because of the low quantities of mycotoxins, 
since those molecules are also harmful for the microorganisms that must convert the 
starch in the corn into ethanol (VIB, 2010). 
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Figure 1.5: Mechanism of toxicity of Bt. 
The mode of action of Bt can be summarised in the following stages: 1) ingestion of
sporulated Bt and specific insecticidal crystalline protein (ICP) by an insect larva; 2)
solubilization of the crystalline ICP in the midgut; 3) activation of the ICP by proteases;
4) binding of the activated ICP to specific receptors in the midgut cell membrane; 5)
insertion of the toxin in the cell membrane and formation of pores and channels in the
gut cell membrane, followed by destruction of the epithelial cells and 6) subsequent Bt
spore germination and septicaemia may enhance mortality. 
Source: World Health Organization, 1999. 
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1.2 Omic based technologies in food safety 
     Omic technologies can, in principle, allow visualization of all of the changes that 
take place when the genetics, nutrition or environment of an organism is altered. 
Targeted compositional analysis is today a key component of the food safety assessment 
paradigm in which known nutrients, anti-nutrients, toxicants, allergens, and other 
molecules of potential biological importance to humans or animals are quantitatively 
analysed.  In recent years new transgenic crop varieties possessing a variety of useful 
agronomic traits have been developed using modern biotechnology.  An important 
characteristic of transgenic plants is that well-defined genes that encode specific 
desirable traits are inserted into crop plants in vitro to produce new varieties. Plant 
varieties developed using conventional methods of plant breeding are typically not 
subject to pre-market regulatory review; however, transgenic crops are required to pass 
a pre-market review before they can be widely cultivated.  One component of safety 
assessment is the evaluation of safety for transgenic crops as food or feed.  The safety 
review seeks to establish that foods and feeds produced using modern molecular 
methods of in vitro gene insertion are as safe as any other in the market; in particular, 
that a new variety is as safe as a conventional counterpart, often called a comparator.  
Since safety is a relative concept, the degree of safety sought must be defined.              
A cornerstone of the food safety assessment is the Substantial Equivalence paradigm 
that asserts that differences in safety between a new variety and its conventional 
comparator can arise only from differences observed between them.  The comparator 
selected is usually a variety that is very similar to the parental strain from which the 
transgenic was developed, although in the case of crop varieties in which the 
composition has been intentionally altered, it is conceivable that alternative comparators 
could be selected.  A primary focus of comparative assessment has been a thorough 
evaluation of the composition of a given crop.  Typically, 50–100 or more individual 
components are determined for each crop variety; the selection of analytes follows 
recommendations of the OECD Consensus Documents that describe key nutrients, anti-
nutrients, and other compounds of biological interest for many crops.  This evaluation 
of crop composition is sometimes referred to as targeted analysis; it should be noted that 
the target of the analysis typically comprises greater than 95% of the crop composition.   
The emergence of omic technologies over the last two decades has contributed powerful 
discovery tools for medical, pharmaceutical and biological research.  Transciptomic, 
proteomic and metabolomics analysis of crops plants have been described.  To date, 
Chapter 1-Introduction 
23 
 
omic technologies have not been formally applied to the food safety assessment of 
transgenic crops (Chassy, 2010).  
1.2.1 Assessing the safety of whole foods 
     No food or feed poses zero risk or is absolutely safe.  It is also difficult to evaluate 
the safety of a plant-derived food since the food can be a mixture of 100s or even 1000s 
of compounds.  The mycoprotein food Quorn is a good example of the difficulty of 
assessing the safety of a wholly novel food.  Quorn is a single-cell protein product that 
can be formed into cheese, meat or poultry-like foods. Researchers performed extensive 
compositional studies, fed the material to animals, rubbed it on their skin, injected it 
under their skin, and fed it to human volunteers without ill effect being observed.  The 
Food and Drug Administration (FDA) approved the product even though there was no 
specific test that definitively demonstrated the product was safe to consume; what could 
be demonstrated was that its composition was similar to other high quality protein foods 
and that it was apparently innocuous when consumed by living subjects.  The FDA did 
not object to the developers claim that Quorn should be considered generally as safe 
(GRAS) in spite of the fact that about one in every 100,000 people that consume it 
experience an adverse reaction (Miller and Dwyer, 2001).   
     Although transgenic crops are categorized as novel foods, the safety assessment 
process applied to transgenic crops, foods and feeds should in principle be much more 
straightforward than that described for Quorn since only one, or at most a few genes, are 
inserted and the changes that are introduced are small, well-defined and usually 
predictable.  Transgenic crops are not wholly novel foods as was the case with Quorn.  
In the production of a transgenic crop, the crop composition usually remains largely 
unchanged, except for the presence of a few well-defined additions.  When a gene is 
inserted into a plant, three questions are appropriate about safety for consumption: Is the 
inserted DNA safe to consume? Is the protein product(s) of the gene, if applicable, safe 
to consume? Are the intended, and any unintended changes, safe to consume? (Chassy, 
2010). 
     Since DNA, including antibiotic resistance makers used in the development of the 
transgenic plant, is considered safe to consume, the safety assessment focuses primarily 
on the safety of any newly synthesized proteins, any newly introduced compounds, and 
any changes in composition that may have occurred during plant breeding.  It is 
noteworthy in this regard that conventional plant breeding produces genetic and 
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compositional changes of a similar or greater magnitude than transgenic breeding but 
resulting cultivars are not required to undergo pre-market safety assessment (Cellini et 
al., 2004; Parrott, 2005; Herman et al., 2009; Chassy, 2010). 
     Prior to selection of a gene to insert into a plant, a bioinformatics analysis is 
performed to ensure that the gene product bears no resemblance (similarity) to 
potentially toxic or allergenic proteins (Delaney et al., 2008; Goodman et al., 2008). 
     The safety of inserted proteins is also assessed through evaluation of the digestibility 
of the protein, and by toxicological evaluation of the protein in laboratory animals 
exposed by an oral route of administration. Since the great majority of proteins are safe 
for humans to consume, digestible proteins that do not have a structural resemblance to 
known allergens or toxins, and which produce no adverse reactions in animal tests, are 
regarded as safe to consume (Chassy, 2010). 
     As noted previously, extensive targeted compositional analysis is a key element of 
the safety assessment paradigm.  Compositional analysis provides direct evidence that 
intended changes have occurred as well as revealing if any unintended changes in 
composition have occurred.  The safety and nutritional value of a food or feed can be 
deduced from the composition.  Moreover, the absence of large unexpected changes and 
the presence of intended changes in composition are also interpreted as an indicator that 
no adverse unintended effects have occurred in the breeding process (Chassy, 2010). 
     Although animal studies are exceedingly difficult to perform and may bear only 
limited  influence when completed (ILSI, 2003; Chassy et al., 2004; Hartnell et al., 
2007; ILSI, 2008), over two-hundred animal studies on whole transgenic foods and 
feeds have also been conducted in order to provide an additional level of assurance that 
a new crop variety is safe (EFSA, 2008).  While a number of reports, beginning with 
Ewen and Pusztai (1999)  flawed experiments using transgenic potato, have claimed 
adverse effects resulting from feeding transgenic crops to laboratory animals, none of 
these studies has been proven to have revealed any negative effect(s) that was the result 
of the transgenic breeding process nor have these studies been repeatable.  Studies that 
make claims of adverse effects of consumption of GM crops are often poorly designed, 
inadequately documented and conducted, suffer from experimenter bias, and make 
conclusions that are not rooted in any meaningful biological differences (Chassy et al., 
2004; EFSA, 2008). 
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     The safety of the inserted gene and its products, taken along with the compositional 
analysis are the keystones of an effective safety evaluation.  It should also be noted that 
the rigorous screening for absence of changes in a long list of key phenotypes that is 
performed throughout the development process, as well as the extensive back-crossing 
into elite varieties that is required to produce a commercial cultivar, doubtless serve as 
an effective screen against unintended and undetected changes being present in a new 
transgenic variety.  More importantly, change in and of itself does not increase risk 
since changes can be beneficial, neutral or deleterious. This is evidenced by fact in that 
the crop varieties in use today differ significantly in composition from historical stock 
(Chassy, 2010). 
1.2.2 Can–omics of novel food/feed inform a safety assessment? 
     As discussed previously, the Omic technologies are powerful analytical tools for 
discovery research.  The potential applicability of Omics to safety assessment remains 
under review.  Furthermore, it must be remembered that they only represent a 'snap shot' 
in time.  
Transcriptomics 
     The current status of transcriptomic analysis of food crops has been reviewed.  
Transcriptome profiling tools allows the identification of differences in the transcription 
of genes representing a significant portion of the genome between two or more samples 
of a plant to be made.  The research reported to date demonstrates that reproducibility is 
a major challenge for transcriptomic analyses.  Duplicate analysis of a sample can 
produce different differential gene expression patterns, and it is clear that variables such 
as time of sampling, method of mRNA isolation, and differences in soil and weather 
during cultivation, can profoundly impact expression patterns observed. Perhaps more 
important is that different varieties of the same crop can display very different gene 
expression patterns when cultured side-by-side in the same field.  It is not immediately 
apparent how differences in the expression of genes observed in two varieties of the 
same food or feed crop can be interpreted from a safety perspective.  For a variety of 
reasons, differences in transcription do not necessarily translate into differences in the 
proteome or metabolome.  The transcriptome is therefore not necessarily predictive of 
the composition of the final food or feed that will be consumed.  Catalogues of gene 
expression patterns that correlate with ‘‘safe” and ‘unsafe” samples of a crop plant do 
not exist since: (1) to date, virtually all examples of commonly eaten crops are equally 
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safe when consumed as intended, and (2) no extensive databases of ‘‘normal 
transcriptome” patterns have been compiled as has been done for compositional analysis 
of crops.  If a plant is known to produce an anti-nutrient or an allergen, using expression 
analysis to evaluate expression of the genes associated with biosynthesis of these 
components would not be predictive for the quantitative measure of anti-nutrient 
content.  Transcription analysis targeted in this way would also be simply an alternative, 
and likely an inferior alternative, to a direct analysis of a constituent, such as a protein, 
that is currently analysed through composition studies.  An underlying motivation for 
the suggestion that transcriptomics could be useful in safety assessment arises from 
concerns that unintended changes may have occurred as a result of transgene insertion 
(Chassy, 2010). 
     The hypothesis to be evaluated here is that transcriptomics could be a tool for 
revealing unintended effects.  The comparatively few studies reported to date indicate 
that transgene insertion is less likely to elicit major changes in the transcriptome than 
other modalities of crop breeding as, for example, radiation mutagenesis (Baudo et al., 
2006; Batista et al., 2008). 
Proteomics 
     Proteomics is the large-scale study of proteins, particularly their structures and 
functions (Anderson and Anderson, 1998; Blackstock and Weir, 1999).  Proteins are 
vital parts of living organisms, as they are the main components of the physiological 
metabolic pathways of cells.  The term "proteomics" was first coined in 1997 to make 
an analogy with genomics, the study of the genes (James, 1997).  The word "proteome" 
is a blend of "protein" and "genome", and was coined by Marc Wilkins in 1994 while 
working on the concept as a PhD student.  The proteome is the entire complement of 
proteins, including the modifications made to a particular set of proteins, produced by 
an organism or system (Wilkins et al., 1996).  
     The proteome has also been defined as the protein complements expressed by the 
genome of an organism or cell type.  The most common implementation of proteome 
analysis is the separation of proteins extracted from the cell or tissue by high-resolution 
two-dimensional (2-D) gel electrophoresis, and identification of separated proteins by 
sensitive mass spectrometric techniques (Anderson and Anderson, 1998).  
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     Proteome analysis is technically complex compared to genomic and transcriptomic 
profiling techniques.  It is however essential for the comprehensive analysis of 
biological systems, as protein expression levels are not predictable from the messenger 
RNA (mRNA) expression levels, proteins are dynamically modified and processed in 
ways, which are not necessarily apparent from the gene sequence.  In their biologically 
active form, many proteins are post-translationally modified by glycosylation, 
phosphorylation, acylation or other modifications.  Many proteins are only functional if 
associated with other molecules, including DNA, RNA, proteins, and organic and 
inorganic cofactors.  These modifications are dynamic and reversible and may alter the 
three dimensional structure and the state of protein activity.  Collectively, the type of 
protein modification and the sites modified cannot be determined from the gene 
sequence alone.  Therefore, it is expected that proteomics will be able to provide the 
most precise and detailed molecular description of the state of a cell or tissue (Haynes et 
al., 1998). 
     There are a number of difficulties in protein analysis, which complicate the task.  
Proteins cannot be amplified (like DNA/RNA) from a template found in the sample.  
They cannot even be expressed in large amounts in the form in which they finally 
function in the biological system, due to post-translational modifications.  In addition, 
proteins vary dramatically with respect to their solubility in commonly used solvents.  
There are no solvents in which all proteins are soluble and which would also be 
compatible with protein analysis.  Detergents, in particular sodium dodecyl sulphate 
(SDS), are frequently added to aqueous solvents to maintain protein solubility.  The 
compatibility of SDS is a big advantage of SDS polyacrylamide gel electrophoresis 
(SDS-PAGE) and 2-D gel electrophoresis, which are the most preferred methods for the 
separation of small amounts of proteins.  However, the use of salts and detergents is 
limited by their incompatibility with mass spectrometric analyses (Haynes et al., 1998). 
     The most commonly used technique in proteome analysis is based upon the 
separation of proteins by 2-D gel electrophoresis (2DE) and their subsequent 
identification by mass spectrometry (MS) or tandem mass spectrometry (MS/MS).  In 2-
D gel electrophoresis, proteins are first separated by isoelectric focusing (IEF) and then 
by SDS-PAGE in the second perpendicular dimension.  Separated proteins are 
visualized with high sensitivity by staining or autoradiography, producing 2-D arrays 
that contain thousands of proteins.  The technique is widely used due to its compatibility 
with high concentrations of detergents, protein denaturants and other additives 
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promoting protein solubility.  However, other separation techniques, such as liquid 
chromatography (LC), are replacing 2DE (Haynes and Yates, 2000). 
     Ideally, all expressed proteins should be present in the 2-D gel, but in practice at 
least 10-15% of proteins cannot be included in the gel.  Very basic proteins (pI>11) are 
not easy to analyse with 2-D gel electrophoresis due to the lack of suitable conditions 
for IEF in this pH range.  Also some hydrophobic proteins (example transmembrane 
proteins) and high molecular weight proteins (>200 KDa) resist entry into 2-D gel.  
Many regulatory proteins are expressed in low copy numbers and hence cannot be 
visualised by the applied detection methods (Westermeier, 2006).   
     The identification of individual proteins from polyacrylamide gels has traditionally 
been carried out using N-terminal sequencing, internal peptide sequencing, 
immunoblotting or comigration with known proteins.  The dramatic growth of large-
scale proteomic, genomic and expressed sequence tag (EST) sequence databases have 
resulted in a fundamental change in the way proteins are identified.  The current method 
relies on excising spots from gels, proteolytically digesting them and then extracting the 
peptides.  The final stage is the analysis of these peptides by MS or tandem mass 
spectrometry MS/MS and the correlation of the mass spectral data derived from the 
peptides with information contained in databases (Haynes and Yates, 2000). 
     Proteomic applications in the safety assessment of transgenic crops have been 
recently reviewed.  Research has focused primarily on the use of modern protein 
analytical techniques—the techniques used in proteomics—for the analysis of changes 
in the abundance of a few well characterized proteins of interest in a particular crop 
(e.g. soybean allergens).  However, it should be noted here that the application of 
modern protein chemistry techniques to measure the concentration of multiple allergens 
is not proteomic profiling, rather it is a very sophisticated and useful form of targeted 
analysis.  As it is generally understood, proteomic profiling is an attempt to provide a 
rough estimate of the concentration of all of the proteins that are expressed in an 
organism.  Although the relative concentration of dozens of major proteins can be 
estimated using 2D-gel electrophoresis, and the presence or absence of hundreds more 
can be detected, proteomic technology is only able to detect about 1000 of potentially 
10,000–30,000 proteins that could be encoded in the plant genome.  Proteomic analysis 
is also not typically quantitative, is time consuming and expensive, and requires 
specialized equipment and software.  The lack of laboratory-to-laboratory 
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reproducibility and lack of standards for methodology, data handling and analysis all 
present challenges to an industry-standard approach (Chassy, 2010). 
     From a food safety assessment perspective, the proteome is not likely to be a good 
predictor of the metabolome and if it is, it is as yet unknown how the prediction made 
by differences observed between two proteomic displays may be deciphered. An 
additional complication is that repeat analyses are highly variable, difficult to 
reproduce, and there is a total absence of accumulated knowledge about what would be 
a safe display and what should raise a red flag of caution (noting of course that food is 
inherently safe).  Although proteomic analysis can reveal that differences exist between 
two or more samples, it is not yet clear that differences in the protein context are 
relevant to food safety risk since it is not likely that the proteome composition rigidly 
controls the metabolome.  From a food safety perspective, it is the composition of a 
crop that determines the safety and nutritional value.  Metabolic and cellular regulatory 
circuits, differences in substrate availability and product utilization, as well as 
differential rates of protein turnover and differences in the external environment, all 
work to disconnect the proteome from having a predictive value for the composition of 
the metabolome.  Proteomic analysis does not appear to be useful for the detection of 
unintended effects either since conventional varieties with long histories of safe 
consumption appear to have larger proteomic differences compared with varieties 
developed through transgene insertion.  There is much ongoing research directed at 
developing a system with which the concentration of allergens that are present in 
specific samples of a food crop can be rapidly measured.  This targeted application of 
proteomic techniques is likely to be successful in the near future in defining a system 
for profiling and estimation of allergenic protein content.  There is no published 
evidence that differences between varieties in allergen concentration materially change 
the degree of clinically relevant allergenicity of any crop.  There is little quantitative 
information and even less agreement among allergists on the amount of any specific 
protein allergen that is required for sensitization and subsequent elicitation.  Since food 
allergens are generally abundant proteins, it may well be that they are always present in 
ample amounts to participate in the allergy process.  Food allergy is an inappropriate 
response by an individual to a protein, or proteins present in a food, that are innocuous 
to more than 99% of human subjects under similar conditions of exposure.  The adverse 
reaction appears to be caused by (1) host genetics, (2) the food matrix and environment 
of the exposure, (3) the physiological and nutritional state of the host, and (4) repeated 
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exposure to an allergen.  A key observation is that patients who are allergic to various 
foods can have IgE molecules in their serum that react with different, and sometimes 
totally unrelated, proteins and combinations of proteins in the food.  This formation of 
IgE antibodies points to a failure of the immune system to ignore or become tolerant to 
a protein more than it does to the allergic potential of specific proteins.  At present no 
regulatory decision about safety could be justified on the basis of proteomic displays of 
foods as a way to categorize foods to which people already are or may become allergic 
(Chassy, 2010). 
Metabolomics 
     The potential for application of metabolomic analysis to food and agricultural 
research have been reviewed.  It has been suggested that the primary value of 
metabolomic analysis is in support of plant breeding and selection.  However, it has also 
been suggested that metabolomic analysis can be used in support of the food safety 
assessment of transgenic crops (Chassy et al., 2004; Dixon et al., 2006).  
     Although an extensive compositional data set is required, information derived 
directly from metabolomic analysis is not one of the tests currently required by food 
safety assessment or in support of applications for the approval of new transgenic crops.  
Comparative compositional analysis provides a direct insight into any compositional 
changes that have occurred in the plant breeding process.  The metabolomic analysis 
offers the possibility of analyzing a significantly greater number of metabolites in a 
short period of time than is possible with conventional analysis.  Metabolomic analysis 
also offers the prospect of reducing the cost of analysis for each analyte.  It has also 
been suggested that analysis targeted at specific compounds might overlook an 
unintended and unexpected change in an unanalysed component of the crop that could 
be of significance to health or nutrition.  Unintended changes can and do occur in all 
forms of plant breeding and it is for this reason that changes in nutrients and potentially 
deleterious compounds are evaluated in the safety assessment.  More importantly, since 
intracellular pathways and metabolic pools are tightly interconnected, targeted analysis 
of 50–100 or more analytes that are major components of the food (which can represent 
more than 95% of the composition) provides significant additional information about 
the metabolome.  One potential outcome of research using metabolomic techniques, 
however, may be the identification of a small set of key indicator metabolites whose 
concentration can be used to predict the plant metabolome.  Metabolite profiling 
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techniques have been applied to potato, wheat, rice, tomato, arabidopsis, and gerbera.  
These studies have demonstrated that profiling can provide a quick snapshot that is 
useful in comparing varieties and evaluating changes in metabolic pools.  There exist 
some significant hurdles to be crossed before metabolomics profiling can be applied to 
food safety assessment.  The cost of analytical equipment is high and few laboratories 
are prepared to perform the analysis.  Owing to methodological differences, as well as 
differences in data analysis, statistical analysis and reporting, results obtained in 
different laboratories are difficult to compare thus limiting the ability to compare data 
over many years across the food industry.  The data that are generated are often 
expressed as relative concentrations.  Most metabolomic profiles include a significant 
number of unidentified metabolites.  The absolute concentrations of most metabolites 
are reported with poor run-to-run and sample-to-sample reproducibility, and 
unacceptably poor accuracy and precision.  Databases with which to compare results 
with normal concentrations do not exist.  The findings that transgenic plants 
composition closely resembles that of parental varieties, and that the range of 
concentrations observed in transgenic varieties falls within the normal ranges for those 
constituents found in conventional varieties, parallels the observations made using 
targeted analysis (Chassy, 2010).   
     It is concluded that while metabolomic profiling is a powerful research tool that can 
be used effectively by plant breeders, it does not at present offer advantages for food 
safety assessment.  It is not clear that metabolome profiling will ever meet currently 
applicable standards for compositional analysis.  Safety assessment requires 
internationally validated and standardized measurement techniques and robust databases 
that establish norms and safety intervals (Chassy, 2010). 
1.2.3 Use of proteomic based technologies to study toxicology and animal response 
to stress 
     Toxicology is likely to prove one of the most important applications of proteomics.   
2DE is a highly sensitive means of screening for toxicity and probing toxic 
mechanisms.  By comparing proteins expressed following treatment with a given drug 
with those present under untreated conditions, it is possible to identify changes in 
biochemical pathways via observed alterations in sets of proteins that may be related to 
the drugs efficacy or toxicity.  When a large enough library of proteomic signatures has 
been compiled for compounds of known toxicity, it will be possible to use it to assess 
the toxicity of novel compounds.  Many large-scale proteomics studies in toxicology 
Chapter 1-Introduction 
32 
 
have entered the public domain.   A group at Imperial College London/SmithKline 
Beecham reported a 2DE- and NMR-based study of glomerular nephrotoxicity in an 
experimental rat following exposure to puramycin aminonucleoside.  By monitoring the 
proteins in urine, the study has permitted a more detailed understanding of the nature 
and progression of the proteinuria associated with glomerular nephrotoxicity than has 
previously been possible.  In a second example, a study of lead toxicity in a rabbit 
model identified a number of proteins that change expression following increased lead 
exposure, of which several molecules, provisionally identified as glutathione-S 
transferase variants, may be developed into valuable markers of lead toxicity in humans.  
Other notable reports to emerge recently in proteomic toxicology include an analysis of 
cyclosporin A toxicity, which revealed a novel toxic mechanism involving the calcium 
binding protein calbindin-D, and the ongoing studies of liver protein changes following 
exposure of rodents to peroxisome proliferators being conducted by Argonne National 
Laboratories and Large Scale Proteomics Corporation.  However, although numerous 
other toxicological studies have used proteomics tools such as 2DE and MS, the 
potential of proteomics in routine toxicology has yet to be realized (Anderson et al., 
2000). 
     Carboni et al. (2006) identified the molecular changes in protein levels induced in rat 
hippocampus by repeated exposure to psychosocial stress with a proteomic technique.  
In the social defeat model, the experimental animal was defeated by a dominant male 
eight times. Additional groups of rats were submitted to a single defeat or placed in an 
empty cage (controls).  The open field test was carried out on parallel animal groups.  
The day after the last exposure, levels of hippocampal proteins were compared between 
groups after separation by 2-D gel electrophoresis and image analysis.  Spots showing 
significantly altered levels were submitted to peptide fingerprinting mass spectrometry 
for protein identification.  The pattern of changes induced by repeated stress was 
quantitatively and qualitatively different from that observed after a single exposure.  
From their study, they found that several changed proteins have already been associated 
with stress-related responses; some of them are described for the first time in relation to 
stress. 
     In addition, Mairesse et al. (2012)  investigated the exposure of rats to early life 
stress.  Rats exposed to early life stress are considered to be a valuable model for the 
study of epigenetic programming leading to mood disorders and anxiety in the adult 
life.  They found that rats submitted to prenatal restraint stress (PRS) are characterized 
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by an anxious/depressive phenotype associated with neuro-adaptive changes in the 
hippocampus.  They used this PRS model to identify proteins that are specifically 
affected by early life stress.  Therefore, they performed a proteomic analysis in the 
hippocampus of adult male PRS rats.  Pregnant females were randomly assigned to 
stressed or control groups (n= 12 per group).  From day 11 of pregnancy until delivery, 
pregnant female rats were subjected to three stress sessions daily (45 min each), during 
which they were placed in transparent plastic cylinders and exposed to bright light.  
Mairesse and his colleagues found that PRS induced changes in the expression profile 
of a number of proteins, involved in the regulation of signal transduction, synaptic 
vesicles, protein synthesis, cytoskeleton dynamics, and energetic metabolism.  
Immunoblot analysis showed significant changes in the expression of proteins, such as 
LASP-1, fascin, and prohibitin, which may lie at the core of the developmental 
programming triggered by early life stress (Mairesse et al., 2012). 
     The epithelial cells of the small intestine were selected as the target tissue for 
studying changes in the proteome profile because the small intestine is the main organ 
for the absorption of nutrients and water in mammals.  Further more, early studies 
showed weak or nonspecific binding of Cry1Ab to the small intestinal epithelial cells of 
mammalian cells, specifically bovine and porcine cells (Shimada et al., 2006).   
 
1.3 Aims of the project 
The overall project aim is to: 
 Study the effects of a commercial GM crop, insect resistant maize expressing Bt 
Cry 1Ab, on both feed conversion efficiency and differential gene expression in 
the epithelial cells of the small intestine of the rat as a non-target model system. 
This will be achieved through the following specific objectives: 
 To study the In vivo effects of transgenic maize (MON810) expressing the δ-
insecticidal protein Cry 1Ab from Bacillus thuringiensis, on weight gain and 
food consumption in rat as a non-target species.  Rat will serve as a model 
system for both humans and livestock (Chapter 3). 
 To study the In vivo effects of transgenic maize (MON810) expressing the δ-
insecticidal protein Cry 1Ab on differential gene expression at the proteome 
level in the epithelial cells of the small intestine of the rat (Chapter 4).   
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 To conduct comparative in vitro studies of Cry 1Ab on mammalian epithelial 
cells as a possible alternative to animal studies.  In these studies both rat small 
intestinal primary epithelial cells and one human epithelial cell line will be 
investigated (Chapter 5). 
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Chapter 2 
2 Materials and Methods 
2.1 Materials 
     The following reagents were purchased from Sigma-Aldrich, USA: Dulbecco's 
modified eagle media high glucose with 4500 mg/L glucose, L-glutamine, and sodium 
pyruvate, without sodium bicarbonate, powder, suitable for cell culture  (Catalogue # 
D7777); Hydrochloric acid, Molecular biology grade (Catalogue #  H1758); Dimethyl 
sulfoxide (DMSO) for molecular biology 99.9% (Catalogue #  D8418); Urea (Ultra 
pure) for electrophoresis (Catalogue # U6504); Tris (Ultra Pure)or  
(Tris(hydroxymethyl)aminomethane) (Catalogue # 93362); Thiazolyl Blue Tetrazolium 
Bromide Powder (MTT) (Catalogue # M5655); Glacial acetic acid ≥99.99% (Catalogue 
# 338826); Trypan Blue powder, cell culture tested (Catalogue #  T6146); Methanol, 
BioReagent, suitable for protein sequencing (Catalogue # M1770), Mineral oil, light 
(Catalogue # 330779); Bromophenol blue for electrophoresis (Catalogue # B5525); 
Coomassie Brilliant Blue G250 (Catalogue # 27815), Acrylamide, for electrophoresis 
≥99% (Catalogue #  A8887); Agarose, Ultra pure, for electrophoresis (Catalogue # 
05070); Concentrated phosphoric acid approx. 85% H3PO4 (aqueous) (Catalogue # 
438081); Sodium Hydroxide, reagent grade, ≥98% (Catalogue # S5881); Ammonium 
persulfate (APS), ACS reagent grade (Catalogue # 248614), N,N-Methylene-
Bisacrylamide (Catalogue #  M7256); 2-Mercaptoethanol (99%) for electrophoresis 
(Catalogue # M7154); Sodium pyruvate (Catalogue # 15990); Fetal Bovine Serum 
(FBS) for cell culture (Catalogue # 12106C); L-Glutamine, cell culture tested, from 
non-animal source (Catalogue #  G8540); Penicillin-Streptomycin solution stabilized, 
with 10,000 units penicillin and 10 mg streptomycin/mL, sterile-filtered, BioReagent, 
suitable for cell culture (Catalogue #P4333); Ethylenediaminetetraacetic acid (EDTA) 
(Catalogue # E6758); Ammonium sulfate for molecular biology (Catalogue # A4418); 
Ammonium bicarbonate (Catalogue # 09830);MEM Vitamin Solution (100×) 
(Catalogue # M6895); Sodium bicarbonate, cell culture tested (Catalogue#S5761), 
Thiourea, very pure (Catalogue # T7875), Phenylmethanesulphonyl fluoride (PMSF) 
(Catalogue # P7626); Sodium carbonate (Catalogue # S7795); Sodium azide (Catalogue 
# S2002); Trypsin from porcine pancreas (Catalogue # T4799); Phenol Red, powder, 
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BioReagent, cell culture tested (Catalogue # P3532); n-Butanol for molecular biology, 
≥99% (Catalogue # B7906); Diethyl ether (Catalogue # 309966); and HEPES buffer 
solution, 1M in H2O (Catalogue # 83264). 
     Glycine for molecular biology (Catalogue # 17-1323-01); Gycerol, 87% for 
molecular biology (Catalogue # 17-1325-01); immobilized pH-gradient (IPG) Strips 
with pH 3-10L, 18 cm long (Catalogue # 17-1234-01);Sodium Dodecyl Sulfate (SDS) 
for electrophoresis (Catalogue # 17-1313-01);N,N,N,N-Tetramethylethylendiamine 
(TEMED) (Catalogue # 17-1312-01);IPG Buffer pH 3-10 (Catalogue # 17-6000-87);3-
[(3-Chloamidopropyl)dimethylammonio]-1-propane-sulfonate (CHAPS) (Catalogue # 
17-1314-01); 2-D Quant Kit, 500 assay (Catalogue # 80-6483-56);2-D Clean up kit 
(Catalogue # 80-6484-51); Dithiothreitol (DTT) (Catalogue # 17-1318-
01);Iodoacetamide, proteomic-grade (Catalogue # RPN6302); andProtease Inhibitor 
Mix (Catalogue # 80-6501-23) were all purchased from GE healthcare, Sweden. 
     SDS-PAGE Molecular weight standard, broad range (Catalogue # 161-0317) was 
purchased from Bio-Rad, USA. 
     Sequencing Grade Modified Trypsin (Catalogue # V5111) was purchased from 
Promega, UK. 
     Petri dishes and sterile 96/24 well clear flat bottom polysterene Tissue Culture (TC.) 
treated micro plates with lids were obtained from BD Falcon, as were 25 cm2 and 75 
cm2 cell culture flasks.  Sterile pipette tips were purchased from Eppendoeff, USA. 
     Cryogenic tubes with cap for Storage of Biological Material in low temperature 
liquid nitrogen were purchased from Corning, USA. 
     Syringe filter units, Diameter 25mm, pore size 0.2µl were obtained from Nalgene, 
USA. 
2.2 Methods 
2.2.1 Effects of different maize lines on weight gain and food consumption of male 
Wistar rats 
Test materials 
     Transgenic Bt maize MON 810, its corresponding parental non-transgenic (near 
isogenic) maize (MON Conv Corn), and two different maize varieties, MON Garst 8450 
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as reference 1, and MON Gold HVST H8920 as reference 2 were kindly provided by 
Monsanto, St Louis, USA.  In addition, commercial Purina rodent chow (MCert Rod 
control), was provided by Purina Mills.  All diets were shipped to the Institute for 
Research on Environment and Sustainability (IRES), School of Biology, University of 
Newcastle, Newcastle upon Tyne, UK before it was shipped to King Abdulaziz 
University, King Fahad Research Centre, Jeddah, Saudi Arabia.  All shipping and 
handling was conducted so as to protect the quality and freshness of the maize grains. 
Diet formulation for rat feeding trials 
     All control, test, reference diets and the commercial rodent chow were formulated by 
Purina Mills (St. Louis, Missouri) using corn grains supplied by Monsanto Company 
(St. Louis, Missouri).  Approximately 6.0 kg of each rodent diet were prepared.  The 
diets were formulated according to the specifications of Purina Mills International, LLC 
(PMI) Certified Rodent LabDiet 5002.  Approximately 33% (w/w) corn grains were 
used for all diets, adjusting other components of the diet to provide approximately equal 
levels of protein, calories and nutrients in all diets as detailed in Table 3.1 (Chapter 3). 
The basal diet used for all treatments is a proprietary formula developed by Purina. 
Further details of diet components, other than as shown in Table 3.1 are therefore not 
available as it is marketed under and protected by a registered trade name.  For the four 
different experimental diets, the standard corn variety used by Purina was substituted 
with either MON810, its near isogenic line, MON Garst 8450 or MON Gold HVST 
H8920.  All diets were shipped under ambient conditions by all laboratories and were 
storied at ambient temperature upon receipt. Corn-based diets prepared by Purina Mills 
are known to be stable for at least 6 months under these conditions. 
Compositional analyses of rat diets 
     Rats in Group I were fed only with diet containing approximately 33% corn from Bt 
parental non-transgenic variety, those in Group II with test diet containing 33% 
transgenic Bt corn grain and those in Groups III and IV with diet containing 33% 
reference corn varieties (as described above). Rats in Group V were fed commercial 
Purina rodent chow containing approximately 33% standard corn.  These percentages 
were chosen in order to maintain a balanced rodent diet for both the 7-day and 28-day 
feeding study.  The mixing ratios of experimental diets are provided in Table 2.1.  All 
diets were mixed by Purina to ensure homogeneity. 
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     To quantify levels of Bt Cry1Ab in the MON810 diet (fed to rats in Group II) a 50g 
sample was collected by Purina TestDiet (Richmond, IN) on the day of diet preparation 
and sent frozen to Monsanto Company where Cry1Ab protein analysis was carried out; 
the diet containing the parental non-transgenic maize (fed to rats in Group I) was used 
as the control for these analyses.  The Cry1Ab protein served as marker to confirm that 
the appropriate grains were used to prepare the test and control diets. 
Analysis for nutritional composition and environmental contaminants 
     Approximately 100 gram samples of each formulated diet were shipped from Purina 
TestDiet to Covance Laboratories (Madison, WI) for analysis of nutritional components 
and environmental contaminants.  
Animals and housing 
     Forty locally bred immature male Wistar rats, obtained from the Faculty of 
Pharmacy, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia were between 
6 to 7 weeks of age at the beginning of the study.  The study conforms to the National 
Research Council guidelines for animal experimentation (National Research Council, 
1996). The Wistar rats were allowed to acclimate to the housing conditions for 1 week 
during which they kept on basal diet.  Rats had free access to food and water and all rats 
were provided with tap water ad libitum through the study and were housed singly in 
polycarbonate cages with a stainless steel cover.  The Laboratory conditions were 
maintained 12 h light/dark cycle, at temperature of 23 ± 3 0C and a relative humidity of 
47 ± 5.  Animals were observed two times daily for general wellbeing and care. 
Experimental design: 7-day and 28-day Rat Feeding Trials 
     Two animal feeding studies were conducted in one laboratory at King Fahad 
Research Center, King Abdulaziz University, Jeddah, Saudi Arabia under conditions 
described above.  The study design is an adaptation of the Organization for Economic 
Cooperation and Development (OECD) guideline No. 407 (OECD, 2008) for a repeated 
dose 28-day oral toxicity study in rodents.  Rats were randomly assigned to five 
experimental groups based on body weight means.  However, the different groups were 
not randomly assigned within the cage rack for logistical reasons.  The rats were fed 
with the different experimental diets for either 7 or 28 days.  Four rats per group were 
used for both 7 and 28 days feeding trials (Table 2.2).   In line with requirements 
governing the use of animals for experimentation (The three Rs), four rats per group is 
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considered to be the minimum, but acceptable, number used by the industry in such 
studies (Cockburn, pers. comm.).  The animals were observed twice daily; body weight 
and food consumption were measured once daily.  All animals were fed at 08:00 am 
daily and water was freely available throughout the study.  The cumulative food 
consumption for each cage was recorded daily and casual observations were made of 
animal development and behavior. 
     Before the above studies were undertaken a preliminary study using commercial 
rodent diet was carried out following the conditions stated above. This provided a 
growth curve for the basal diet under the proposed experimental conditions, and 
importantly highlighted any potential problems that needed to be addressed before the 
actual experiments were carried out. 
2.2.2 Isolation of small intestine epithelial cells 
     Intestinal epithelial cells (IECs) were isolated from the rat small intestine according 
to the method described by Bjerknes and Cheng (Bjerknes and Cheng, 1981) with minor 
modifications. At the end of each trial the animals were anesthetized with diethyl ether 
for 3 minutes and killed by cervical dislocation.  The abdomen of each rat was opened 
and the small intestine was removed.  The lumen of the small intestine was perfused 
with cold phosphate-buffered saline (PBS), pH 7.4 and gently everted using a 4-mm-
diameter glass rod and flushed with PBS with its two ends enveloped.  The swollen 
intestine was transferred to a clean flask, and immersed into 20 ml of warm PBSPE 
solution (PBS containing 1mM PMSF and 1 mM EDTA), and shaken at 150 cycles per 
min for 5 minutes.  Shaking procedures was carried out on an orbital shaking platform.  
After shaking, the intestine was transferred to another clean flask containing 20 ml of 
warm PBSPE solution, and vibrated for another 5 min.  The vibrating procedure was 
carried out on a vortexer.   The shed intestinal epithelial cells were centrifuged at 500×g 
for 10 minutes.  The cell pellets harvested as described above were then washed in ice-
cold PBS three times.  Cell counts of the isolated viable epithelial cells were performed 
by using viable cells analyzer (BECKMAN Coulter Counter, U.S.A) and ViCellXR 
2.03 software.  The isolated cells were stored at -800C until further use. 
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Table2.1: Ratios of experimental diets (%). 
Approximately 33% (w/w) corn grains were used for all diets 
Groups 
Diets (%) 
Control Maize 
(MON Conv Corn) 
Transgenic Maize 
(MON810) 
Reference Maize 1 Reference Maize 2 
Commercial Purina 
rodent chow 
Group I 33 0 0 0 0 
Group II 0 33 0 0 0 
Group III 0 0 33 0 0 
Group IV 0 0 0 33 0 
Group V 0 0 0 0 33 
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2.2.3 Protein separation and identification 
     All solutions were prepared using double de-ionised water (Ultra Pure Water) with 
resistance of higher than 18 Ohm (18.2 Ω), prepared on a MilliQ system from Millipore 
(Direct-Q® 3 UV Water Purification system, U.S.A). 
Protein extraction from isolated rat intestinal epithelial cells 
     Sample preparation is of the utmost importance and very critical to acquisition of 
highquality data from proteome analysis based on 2-DE. The solubilisation process 
includes denaturation of the protein to break non-covalent bindings within and among 
the proteins, while maintaining the native charge and molecular weight of soluble 
proteins (Rabilloud, 1999).  Addition of protease inhibitor cocktails have extensively 
been used in order to prevent degradation of proteins that otherwise would result in 
artefactual spots on the 2-D gel and loss of high molecular weighted proteins (Kim and 
Kim, 2007).  In addition, it has been shown that urea, thiourea and CHAPS in 
combination are very effective inhibitors of proteolytic activity (Castellanos‐Serra and 
Paz‐Lago, 2002); furthermore, detergents such as CHAPS are commonly included in the 
solubilisation mixture due to its efficiency for solubilising hydrophobic proteins (Görg 
et al., 2004). 
     Total proteins were extracted from the isolated epithelial cells with an appropriate 
volume (200 µl) of lysis buffer (sample buffer) containing 7 M urea, 2 M thiourea, 65 
mM DTT, 2% CHAPS, 2 mM PMSF, 0.5 % IPG buffer, and protease inhibitor mixture 
(GE healthcare).  The extraction mixture was sonicated using Sonic Dismembrator 
model 100 (Fisher Scientific), and then centrifuged at 12000×g at 40C for 20 minutes, 
for removal of particulate materials.  After the protein solution was collected and 
transferred to a clean tube, the supernatant was then directly applied to 2D gel 
electrophoresis or stored at -20 0C as aliquots until use. 
Determination of  protein concentration 
     Total soluble protein concentrations were determined using the 2-D Quant kit (GE 
healthcare, Sweden) to ensure that appropriate and accurate amounts of protein were 
loaded, following the Manufacture's instructions.  Samples prepared for electrophoresis 
(including SDS-PAGE and IEF) are often difficult to quantify due to the presence of 
detergent and reductant.  2-D electrophoresis samples represent a particularly difficult 
quantification challenge due to the possible presence of interfering carrier ampholyte 
Chapter 2-Materials and Methods 
 
42 
 
and thiourea in addition to the detergents and reductants typically used in sample 
preparation for electrophoresis.  The 2-D Quant Kit circumvents these limitations and 
can be used to accurately quantify protein samples prepared for 2-D electrophoresis.  A 
calibration curve was prepared according to Table 2.3 using a stock solution of 2 mg/ml 
bovine serum albumin (BSA) provided with the kit, over the range 0 – 50μg.  Following 
the manufacture's instructions, precipitant (500 μl) were added to 5μl of each sample to 
be analysed, including to the BSA samples required to construct the calibration curve.  
The tubes were vortexed briefly and incubated for 2 to 3 minutes at room temperature.  
Co-precipitant (500 μl) were then added to each sample, mixed briefly by vortexing or 
inversion and centrifuged at a minimum of 10 000xg for 5 min to pellet the proteins. 
The supernatants were decanted and the tubes were re-centrifuged to remove the 
remaining supernatant.  Copper solution (100 μl) and distilled or de-ionized water (400 
μl) were added to each tube.  The tubes were vortexed briefly to dissolve the 
precipitated protein.  Working color reagent (1ml) was added to each tube (color reagent 
was prepared by mixing 100 parts of color reagent A with 1 part color reagent B to 
prepare the color reagent used to measure unbound copper ion as described in the 
manufacture's instructions).  The tubes were mixed by inversion and incubated at room 
temperature for 15-20 minutes.  The absorbance of each sample and standard was read 
at 480 nm and water was used as a reference.  The absorbance was read within 40 
minutes of the addition of the working color reagent.  Unlike most protein assays, the 
absorbance of the assay solution decreases with increasing protein concentration.  
Therefore, the blank reading was not subtracted from the sample reading or used the 
assay blank as the reference.  A calibration curve was plotted using the absorbance 
readings of the standards against the quantity of the protein.  Unknown protein 
concentrations of the samples were then determined from the standard curve. 
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Table  2.2: Organisation of the study groups. 
Group Number Treatment Group diet Identification 
MON 810 
(% in Diet) 
Control or reference 
(% in Diet) 
7 day Feeding 
Males 
28 day Feeding 
Males 
1 Conventional Control 0 33 4 4 
2 MON 810 Test 33 0 4 4 
3 Garst 8450 Reference 1 0 33 4 4 
4 Golden Harvest H8920 Reference 2 0 33 4 4 
5 PMI Commercial diet Commercial 0 33 4 4 
 
 
 
Table 2.3: Construction of standard calibration curve for protein concentration using bovine serum 
albumin (BSA) as a standard protein. 
Tube number 1 2 3 4 5 6 
Volume of 2mg/ml BSA standard solution 0µl 5µl 10µl 15µl 20 µl 25 µl 
Protein quantity 0 µg 10µg 20µg 30µg 40µg 50µg 
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Cleaning up and preparing the samples for 2-D electrophoresis 
     The protein samples were cleaned using 2-D Clean-Up kit (GE Healthcare, Sweden). 
The ability to analyze a sample effectively by 2-D electrophoresis is often limited by the 
presence of non-protein impurities in the sample.  For example excess salts and buffers 
from sample preparation can render the solution too conductive for effective first 
dimension isoelectric focusing (IEF).  Charged detergents, lipids, phenolics and nucleic 
acids can also interfere both with first dimension IEF separation and visualization of the 
2-D result.  Protein precipitation is therefore often employed to selectively separate 
proteins in the sample from contaminating substances as well as for concentrating 
samples.  Recovery is generally above 90%.  The procedure does not result in spot gain 
or loss, or changes in spot position relative to untreated samples.  The precipitated 
proteins are easily resuspended in 2-D sample solution.  Protein samples (1300 to 1500 
µg of total protein) were cleaned using the 2-D Clean up kit.  The protein samples were 
transferred into microcentrifuge tubes and centrifuged at 8000g for 10 mins.  For each 
volume of sample, 3 volumes of precipitant were added and mixed well by vortexing 
and incubated on ice (4-5 0C) for 15 minutes.  This process was repeated, the 
supernatant discarded and the pellet retained.  Co-precipitant was added 3-4x times the 
size of the pellet.  Samples were again centrifuged at 8000 xg for 5 minutes.  The wash 
was discarded.  De-ionised distilled water was pipetted on top of the pellet to cover the 
pellet and the tube was vortexed for several seconds to disperse the pellet.  Wash buffer 
(1 ml), pre-chilled for at least 1 h at -20°C was added to the protein sample.  Wash 
additive (5 μl) were added to the protein sample and vortexed until the pellet was fully 
dispersed.  Samples were incubated at -20oC for at least 30 minutes, being vortexed for 
20-30 seconds once every 10 minutes, followed by centrifugation at 8000 xg for 10 
minutes.  Then, the supernatant was carefully discarded and the pellet was allowed to air 
dry briefly (no more than 5 min) because if it becomes too dry, it will be difficult to 
resuspend in rehydration solution for first dimension IEF.  Pellets were resuspend in 
350 µl of the rehydration solution (8M urea, 2% CHAPS, 0.5% IPG buffer, 0.002% 
bromophenol blue, 0.3% DTT) and vortexed for 30 seconds to fully dissolve the pellets.  
Finally, samples were centrifuged at 8000 xg for 10 minutes to remove any insoluble 
material and to reduce any foam.  The supernatant may be loaded directly onto first 
dimension IEF or transferred to another tube and stored at -80°C for later analysis. 
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Two-dimensional gel electrophoresis (2-DE) 
     Two-dimensional gel electrophoresis was performed according to Görg et al. (1988), 
with modifications introduced by Bjellqvist et al. (1993). 
First dimensional electrophoresis (Isoelectric Focusing (IEF)) 
     The first dimension of 2-DE consists of isoelectric focusing, where proteins are 
separated on basis of their charge.  The isoelectric point (pI) of a protein is the pH value 
of the proteins surroundings at which the protein has a zero net charge.  In order to 
overcome the limitations of the presence of Carrier ampholytes (CA), the use of  
immobilised pH gradients (IPG) was developed by Bjellqvist et al. (1982) and further 
improved by Gorg and colleagues (Görg et al., 1988) and now represents the method of 
choice (Görg et al., 2009).  The IPG can be cast in different ranges between pH 2.5-pH 
12 in both narrow or wide ranges (Görg et al., 2004) and the choice of range is 
dependent on sample complexity and scientific purpose. Temperature during IEF has a 
significant effect on the 2-DE pattern, since the position of protein spots on the gel vary 
along the pH gradient, when different temperatures are applied. Thus, to achieve high 
levels of reproducibility of 2-DE gels, it is very important that IEF is conducted under a 
defined temperature, where 200C has been shown to provide optimal conditions (Görg 
et al., 1991). 
     Isoelectric focusing dry polyacrylamide gel strips with immobilised pH-gradients                 
(IPG dry strips; GE healthcare) were applied for IEF.  Wide range immobiline dry strips 
with pH 3-10, 18 cm long (IPG pH 3-10, 18 cm, linear) were used.  The IPG strips were 
rehydrated overnight in 350 µl of urea rehydration buffer (8M urea, 2% CHAPS and 
0.3% DTT) supplemented with 0.5% IPG buffer (GE healthcare) and 0.002% 
bromophenol blue.  The recommended rehydration time is 12 hours.  Preparative 
sample loads was used.  The protein samples were loaded in the rehydration step 
(rehydration loading).  Proteins (1300µg to 1500µg) were treated with the 2-D Clean Up 
Kit (GE Healthcare, Sweden) as previously described above and loaded per strip; 
focusing was performed under light mineral oil (paraffin oil) to avoid drying of the 
strips during the focusing process.  Active rehydration was applied using 50V to the 
IPG strips during rehydration to facilitate uptake of the sample into the IPG strip.  The 
current limit was set to 50 μA per strip to prevent overheating or burning of the IPG 
strips.  The rehydrated IPG strips were focused on an Ettan IPGphor 3 isoelectric 
focusing unit (GE Healthcare, Sweden).  The running conditions for the samples were 
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optimised and determined according to the standard protocol of the 2-D Electrophoresis 
Handbook (GE Healthcare, Sweden) with the following modifications:  Initially, the 
samples were run in a step mode for 2h at 250 volts (V) followed by one step in 
gradient mode for 3h at 10000 V.  Finally, the samples were left in step mode at 10000 
V for 4h (Table 2.4) or until the steady state was reached; this was achieved using Ettan 
IPGphor 3 Control Software, which allows easy programming and viewing of run data 
on a PC (Figure 2.1).  The current for each strip remained stable at 50 µA and 
isoelectric focusing was run at 200C.  During the run, the damp electrode wicks were 
changed 2 times to remove high amounts of salts and nucleic acids.  After IEF 
separation, the IPG strips were rinsed with double deionised water, to remove the excess 
mineral oil, and either frozen or directly transferred into 10 ml of freshly prepared first 
equilibration buffer (reducing buffer; 50 mM Tris-HCl, pH8.8, 6 M urea, 30 % glycerol, 
2 % SDS, and 0.002% of bromophenol blue) for 15 min.  The DTT (1%) was added in 
the first equilibration buffer.  This solution was replaced after 15 min by 10 ml of 
freshly prepared second equilibration buffer (alkylation buffer; 50 mM Tris-HCl, pH8.8, 
6 M urea, 30 % glycerol, 2 % SDS, and 0.002% of bromophenol blue) for another 15 
min at room temperature.  Iodoacetamide (2.5%) was added in the second equilibration 
buffer.  The equilibration processes were carried on a rocker at room temperature before 
the strips were rinsed again with SDS-electrophoresis buffer (25mM Tris-HCL, pH 8.3, 
192mM glycine, 0.1% SDS in 5L sterile double deionised water) and placed on top of 
SDS polyacrylamide gels for the second stage of electrophoresis. 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
     Following the separation of proteins by first dimensional IEF, the second dimension 
was carried out by SDS-PAGE in an electric field, where proteins are separated 
according to their molecular weights. 
     Gels were cast using PROTEAN® II xi gel casting stands recommended by the 
manufacturer (BIO-RAD, U.S.A).  To achieve a smooth surface water saturated with n-
butanol was added to the top of the gels and then the gels were left for about an hour to 
set and used immediately.  The gels were prepared according to the standard protocol of 
the 2-D Electrophoresis Handbook (GE healthcare, Sweden) (Table 2.5). 
     IEF Strips were loaded on 12.5% SDS-polyacrylamide gels (20 cm x 20 cm, 0.1 cm 
thick) and run over night at 1W at 15 °C until the bromophenol blue dye had reached 
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the bottom of the gel using PROTEAN® II xi Cell, PROTEAN® II xi Cell IPG 
conversion kit (BIO-RAD, U.S.A) with a chiller circulator (JULABO, U.S.A).  A broad 
range molecular weight standard was run on the same gel to determine the relative 
molecular masses of the proteins.  Powder-free nitrile gloves were worn when handling 
the gels to avoid contamination with keratin.  Following electrophoresis gels were then 
stained to enable visualisation of protein spots. 
SDS-PAGE molecular weight standards, broad range 
     Broad range molecular weight standards, as shown in Figure 2.2 (BIO-RAD, U.S.A), 
were applied to the second dimension; prior to use they were diluted 1:20 in SDS 
reducing sample bufferas detailed in the manufacturer’s guidelines (BIO-RAD, U.S.A).  
These were heated for five minutes at 950C, then cooled and 10 µl/well loaded for full 
length (16-20 cm) gels (Table 2.6 and 2.7). 
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Table 2.4: Running conditions of the isoelectric focusing for the protein samples. 
 
Step Voltage (V) Step mode Time (h) Voltage hour (Vh) 
1 250 Step 2 500 
2 10000 Gradient 3 15375 
3 10000 Step 4 40000 
Total 9 55875 
 
 
 
 
 
 
Figure 2.1: Ettan IPGphor 3 control software which allows easy programming and viewing of run data on 
a computer. 
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Table 2.5: Gel Composition. 
 
30%/0.8% Acrylamide/Bisacrylamide 20.85ml 
1.5M Tris-HCl, pH 8.8 12.5 ml 
10% SDS 500 µl 
Double distilled water 15.9 ml 
*10% Ammonium persulfate (APS) 500 µl 
*TEMED 20 µl 
*APS and TEMED were added immediately after degasing before casting. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.6: Stock sample buffer (stored at room temperature). 
 
 Amount 
Distilled water 4.8 ml 
0.5M tris-HCl pH 6.8 1.2 ml 
Glycerol 1 ml 
10% (w/v) SDS 2 ml 
0.1% (w/v) Brompphenol blue 0.5 ml 
Total volume 9.5 ml 
 
Table 2.7: SDS reducing sample buffer 
 (Prepared immediately before use). 
 
 
 Amount 
2-Mercaptoethanol or  ß-Mercaptoethanol 25 µl 
Stock Sample buffer 475 µl 
Total volume 500 µl 
Figure 2.2: Broad molecular weight standards run on 12.5% gel, as supplied by BIO-RAD. 
Chapter 2-Materials and Methods 
 
50 
 
Visualisation of proteins 
     Following 2-DE, the separated proteins were visualised with Colloidal Coomassie 
Brilliant Blue G-250 stain (stock solution: 10% ammonium sulfate, 1% (w/v) 
phosphoric acid, 0.1% Coomassie Blue G-250 in 500 ml sterile deionized water).  
Staining with Colloidal Coomassie Brilliant Blue G-250 is about ten times more 
sensitive (about 10-40 ng of protein) than conventional staining with Coomassie R-250 
and fully compatible with mass spectrometry.  The staining method used in this study 
has been modified from Neuhoff et al. (1988).  Briefly, the peptides in the gels were 
fixed for at least 30 min in fixing solution composed of 10% (v/v) acetic acid and 40% 
(v/v) ethanol.  After that, the fixing solution was decanted and the gels were washed 
with deionized water then stained overnight with Colloidal Coomassie Brilliant Blue G-
250 (working concentration: 8% (w/v) ammonium sulfate, 0.8% (w/v) phosphoric acid, 
0.08% (w/v) coomassie blue G-250, 20% (v/v)  methanol in 500 ml of sterile deionized 
water).  To remove the residual stain, gels were rinsed repeatedly with sterile deionized 
water (Neuhoff et al., 1988). 
Image acquisition and analysis 
     After protein staining, it is of vital importance that proteins spots are aligned 
accurately to ensure high quality data from proteome experiments.  PDQuest version 
8.0.1 was used for image acquisition and Progenesis SameSpot software version 4.1 was 
used for image analysis.  Since slight variations in protein load per gel and staining 
efficiency can have a considerable impact on the spot volumes, spot volume 
normalisation, a necessary step in 2-DE data acquisition to minimize the analytical 
variation caused by gel-to-gel variations, is very important for quantification of spot 
volumes. 
     The polyacrylamide gels were scanned in reflective mode (600 dots per inch (dpi)) 
using a GS-800™ Calibrated Imaging Densitometer (BIO-RAD, U.S.A), saved as a 
gray-scale TIFF file, and analysed by the image analysis software Progenesis SameSpot.  
Parameters of intensity and contrast were chosen so that the protein spots were 
calculated.  All other parameters were set as proposed by the manufacturer. 
Chapter 2-Materials and Methods 
 
51 
 
Mass spectrometry based identification of proteins of interest 
     The classical 2-DE based approach coupled with identification by mass spectrometry 
has become the most widely used approach in proteomics to effectively identifying the 
proteins of tissues, cells and bio-fluids (Fuchs et al., 2005). 
Tryptic in gel digestion for liquid chromatography-mass spectrometry (LC-MS/MS) 
     Trypsin (Sequencing Grade Modified Trypsin, Promega) stock solution was prepared 
according to the manufacturer protocol.  All washing and digestion steps were 
performed in a laminar flow hood.  Protein spots were excised from the gel manually 
using specialised spot pickers (Harris UNI-CORETM, Sigma- Aldrich) and transferred 
into 1.5 ml microcentrifuge tubes (Eppendorf).  Gel pieces were washed with 500μl of 
100mM ammonium bicarbonate for 30 mins on a shaker.  The gels were subsequently 
washed twice with 500μl of 50% acetonitrile/100mM ammonium bicarbonate for 30 
mins at 370C on a shaker, and the liquids were discarded.  After discarding the wash, 
50μl of acetonitrile was added to shrink the gel pieces.  After 10 minutes, the solvent 
was removed and the gel pieces were completely dried under vacuum (Concentrator 
5301, Eppendorf).  Then, 20μl of 12.5 ng μl-1 of trypsin was added to each sample 
followed by addition of sufficient 25mM ammonium bicarbonate to just cover the gel 
piece.  Protein samples were allowed to digest overnight at 37˚C. After digestion, the 
tubes were briefly centrifuged to pellet the gel pieces. All liquids were transferred to 
fresh labelled 0.5 ml Eppendorf tubes. Then 20μl 5% formic acid was added to each 
sample and the tubes were incubated for 20mins. Subsequently, 40μl acetonitrile was 
added to each tube containing the protein sample and the tubes were incubated for 20 
mins at room temperature.  The tubes were briefly centrifuged to pellet any remaining 
gel pieces.  All liquids were transferred to the same labelled tubes.  The volume of the 
pooled samples were reduced to about 2-3 μl in a Speed vac, then 10μl of 0.1% formic 
acid was added to each sample prior to analysis by mass spectrometer.    
Nanoflow HPLC electrospray tandem mass spectrometry (nLC-ESI-MS/MS) 
     An ion-trap mass spectrometer (amaZon ETD, Bruker Daltonics, Bremen, Germany) 
equipped with an on-line nanospray source was used for mass spectrometry data 
acquisition.  Briefly, solubilised peptides were fractionated on a nanoflow HPLC system 
(Thermo RSLCnano) before online analysis by electrospray ionisation (ESI) mass 
spectrometry on an amaZon speed ion ETD trap (Bruker Daltonics).  Peptide separation 
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was performed on a Pepmap C18 reversed phase column (LC Packings), using a 5 - 
85% v/v acetonitrile gradient (in 0.5% v/v formic acid) run over 45 min. at a flow rate 
of 0.2 µl/min.  Mass spectrometric (MS) analysis was performed using a continuous 
duty cycle of survey.  The mobile phase consisted of 0.1% v/v formic acid/H2O and the 
peptides were eluted at 200 nl/min.  A survey scan was conducted in standard enhanced 
mode from m/z 400 to m/z 1600MS scan, followed by up to ten MS/MS analyses of the 
most abundant peptides, choosing the most intense multiply charged ions with dynamic 
exclusion for 120 s. 
     LC-MS/MS is a powerful analytical chemistry technique that combines the physical 
separation capabilities of liquid chromatography (or HPLC) with those of mass 
spectrometry.  It therefore enhances sensitivity and facilitates precise detection of 
biomolecules.  The spectra that were obtained through the Bruker DataAnalysis 3.4 
software from the MS/MS experiments were subsequently used for the confident 
identification of the proteins present in the mixture. 
Database search for protein identification 
     For the analysis of mass spectrometry data, different search programs are available 
on the Internet.  Protein identifications were assigned using the Global Proteome 
Machine (GPM) search engine (www.thegpm.org) to interrogate protein sequences in 
the ENSEMBL Rattus Norvegicus database.  The following settings were applied: 
method, ion trap (4 Da); cleavage site, trypsin [RK]|{P}; may missed cleavage, 1; 
complete modifications, carbamidomethyl (CU); variable modification, oxidation (M); 
fragment mass error, 0.4 Da; parent mass error, ±0.3 Da; fragment type, monoisotopic; 
maximum parent charge, 4.  Only identification with log(e) values ≤ -3 were regarded as 
significant hits regardless of the number of peptides. 
2.2.4 In vitro effects of transgenic maize (Bt maize MON810) expressing Cry1Ab 
protein (Bacillus thuringiensis toxin) on mammalian epithelial cells 
Test material 
     The transgenic Bt maize (Product safety summary for MON 810 corn) and the 
corresponding parental non-transgenic maize were kindly provided by Monsanto, St 
Louis, USA and shipped to the Institute for Research on Environment and Sustainability 
(IRES), School of Biology, University of Newcastle, Newcastle upon Tyne, UK.  All 
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shipping and handling was conducted to protect the quality and freshness of the maize 
grains. 
Protein extraction of maize (MEB307Bt) Cry1Ab MON810 
     The seed coat was removed and seeds ground to a fine powder and extracted at 
100mg/ml over night at 4°C using 1X TBS (0.1M Tris, 150 mM NaCl) and 1% SDS 
extraction buffer.  Extracts were centrifuged at 13000 xg, and the supernatant dialyzed 
against dH2O at 4°C.  Buffer was changed 4X in 24 hours.  Finally, the dialysed extracts 
were flash frozen and freeze dried. 
Immunoassy by Western blotting of test material 
     The presence of the Cry1Ab protein in seeds of the transgenic maize line MON810 
and its absence in the parental control maize was verified by immunological assay 
(Western blotting after analysis of total protein by SDS-PAGE). Ten mg of lyophilized 
protein was dissolved in 1 ml of 1xTBS (0.1 M tris, 150 mM NaCl) + 0.1% SDS buffer 
and 20 μl from this solution was then mixed with 5 μl 6x SDS + ME (mercaptoethanol) 
loading dye. The mixture was boiled for 10 minutes and then loaded onto 12.5% 
polyacrylamide gel (200 μg of proteins were loaded onto the gel and electrophoresed).  
The marker used was Mark 12 Unstained Standard (Invitrogen) and the gel was run at 
80 V for first 30 minutes and then at 150 V for 1 h 45 min. The proteins were then 
transferred onto a nitrocellulose membrane in a transfer unit running at 0.2 A for 2 hrs.  
The membrane was incubated on a shaker for 1 h in blocking solution (20% w/v dried 
milk powder, 0.15 tween20 in 1x PBS) followed by washes in 30 ml double distilled 
water.  The washed membranes were incubated on a shaker for 2 h with Cry1Ab 
antibody (primary antibody) followed by incubation with goat anti-rabbit-HRP 
conjugate (secondary antibody) for 1 h.  Both the antibodies were diluted 1:5000 in 
PBS-T before use.  Membranes were then washed thrice with PBS-T, 5 min each wash, 
and finally subjected to ECL (chemiluminescence) detection (Amersham) and 
quantified by densitometric scanning using Bio-Rad Molecular Analyst software. 
Cell culture methods 
     Phosphate Buffered Saline (PBS) was used to wash the cells.  It was prepared by 
dissolving 9 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.2 g KH2PO4 and 1 g NaHCO3 in 
800 ml double de-ionised water (d.d. H2O) with a resistance of higher than 18 Ohm, 
prepared on a MiliQ system from Millipore.  The PBS pH was adjusted to 7.4 and the 
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volume was completed to 1000 ml with d.d. H2O.   Trypsin/EDTA solution was used to 
detach the cells from the tissue culture flasks and plates (Table 2.8).  All solutions were 
sterile filtered using 0.2 µm vacuum filters (Millipore) and were of cell culture grade.  
All media preparation and other cell culture work were performed in a safety cabinet.  
All surfaces were surface sterilised with 70% ethanol before beginning the work.  
Sterile pipettes and disposable test tubes were used for cell culture.  Pipette tips were 
autoclaved prior to use.  All cell culture vessels, test tubes, centrifuge tubes and pipette 
tips boxes were opened in the laminar flow hood to avoid contamination.   
     All cell lines were incubated in DMEM medium in a humidified cell culture 
incubator (SANYO) at 360C, 5% CO2.   All cell lines were cultured in optimised 
medium at pH 7.4.  All procedures were performed under the restricted sterile 
conditions in a laminar flow hood.  If medium contamination was suspected, the 
medium was discarded and fresh medium prepared. 
Isolation of epithelial cells from rat small intestine 
     The isolation of small intestinal epithelial cells was carried out as described in 
section 2.2.2 above. 
Establishment in culture of epithelial cells isolated from rat small intestine and the 
commercial human epithelial cell line HCT116 
     Intestinal epithelial cells which were isolated from rat small intestine, as described 
above, and human colon cancer cell line HCT-116 which, was obtained from National 
Cancer Institute, Cairo, Egypt, as frozen ampoules were cultured in Dulbecco’s 
Modified Eagle’s Medium-high glucose (with 4500 mg/L glucose, 0.584 g/L L-
glutamine, and 110 mg/L sodium pyruvate (Sigma) supplemented with 10% Heat-
Inactivated Fetal Calf Serum (HIFCS) (Sigma),  3.7 g sodium bicarbonate (Sigma),    2 
mM glutamine (Sigma), 26.18 mM NaHCO3 (Sigma), 10 ml of 1M HEPES (Sigma), 10 
ml of Minimum Essential Medium vitamin solution (MEM vitamin solution 100x) 
(Sigma) and 1 % Penicillin/Streptomycin  solution with 10,000 units penicillin and 10 
mg streptomycin/mL (Sigma)) at 37oC in a humidified atmosphere with 5% CO2 until 
monolayer (complete sheet) was observed.  
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Cell count and viability count 
     Determination of viable cell numbers for appropriate cell seeding was performed by 
using a viable cells analyzer (BECKMAN Coulter Counter, U.S.A) together with 
ViCellXR 2.03 software.  The tissue culture flask was transfered from the cell culture 
incubator to a laminar flow hood.  Medium was removed from the tissue culture flask.  
Trypsin/EDTA solution (2 ml) was added and removed directly after 5 seconds and 
another 2ml of Trypsin/EDTA solution was added and incubated for 2 minutes at 360C.  
The tissue culture flask was jarred against the palm of the hand to complete cell 
detachment and fresh medium was added to inactivate trypsin.  To 25 cm2 tissue culture 
flask, cells were resuspended in 10 ml medium and to 75 cm2 tissue culture flask, cells 
were resuspended in 25 ml medium.  Cell number and viability were assessed as 
proposed by the BECKMAN Coulter Counter manufacture. 
     A cryogenic vial (approximately 1x 106 cells per vial) was removed from gas phase 
liquid nitrogen storage and allowed to stand at room temperature for 1 minute, after 
which the vial was then transferred to a 370C water bath and left for 10 minutes until 
thawed.  The vial was first cleaned using a cloth impregnated with 70% ethanol and the 
content was transferred to a 25 cm2 tissue culture flask with a vented cap containing 9 
ml of pre-warmed medium at 370C.  The tissue culture flask neck was sterilized with 
70% ethanol and transferred to the cell culture incubator at 360C containing 5% CO2.  
All procedures were performed under sterile conditions in a laminar flow hood.  Cells 
were incubated overnight and inspected 24 hours later.  Medium was removed and new 
medium (10 ml) was added.  Cells were allowed to proliferate and subcultured again 
when confluent. 
     Cells were inspected every two days, followed by replacement of old medium with 
fresh medium.  Cells were examined under an inverted microscope for signs of 
metabolic stress, which was typically characterized by blabbing of cells membranes and 
rounding-up of cells followed by detachment from the tissue culture flask surface.  
When detachments become excessive, the tissue culture flask and its contents were 
discarded.  If fungal or yeast infection was evident or suspected, the tissue culture flask 
content and stock medium were discarded. 
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Subculturing of cells 
     Medium was removed from the tissue culture flask.  Trypsin/EDTA solution (2 ml) 
was added and removed directly after 5 seconds and another 2ml of Trypsin/EDTA 
solution was added and incubated for 2 minutes at 360C.  The tissue culture flask was 
jarred against the palm of the hand to complete cells detachment and fresh medium was 
added to inactivate trypsin.  To 25 cm2 tissue culture flask, cells were resuspended in 10 
ml medium and to 75 cm2 tissue culture flask, cells were resuspended in 25 ml medium.  
Cells number and viability were also assessed.  Medium was changed 24 hours later and 
subsequently every two days until confluent. 
Cell staining 
     Cells were washed three times with 1x PBS.  After that, the cells were fixed in 4% 
formaldehyde for 5 minutes at room temperature.  Then, the cells were stained with 
Coomassie Brilliant Blue for 3 minutes followed by repeated washing with distilled 
water.   The stained cells were allowed to dry at room temperature for one day before 
visualization under an inverted microscope (OLYMPUS 1x71) using the software 
OLYMPUSDP2-BSW, 2006. 
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Table 2.8: Recipe of trypsin/EDTA solution 
 Amount 
Phosphate Buffer Saline 350 ml 
Trypsin 1.25  g 
Ethylenedinitrilotetraacetic acid, EDTA (F.W 292.24) 0.1 g 
Sodium Bicarbonate (NaHCO3)  (F.W 84.01) 0.75 g  
Phenol red (0.5%) (F.W 354.38) 0.5 ml 
Phosphate Buffer Saline To 500 ml 
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Cryopreservation 
     For long-term storage, the medium was removed from a confluent tissue culture 
flask.  Cells were trypsinised and centrifuged and the pellets were resuspended in ice 
cold frozen medium containing 10% DMSO in 30% FBS and 60% medium followed by 
quick and gentle mixing.  Aliquots (1.5 ml) were transferred into cryovials which were 
labeled with cell name, passage number and date and frozen at -800C for one day before 
being transferred to liquid nitrogen at -1920C for long-term storage.  For re-cultivation, 
cells were thawed in 370C water bath and resuspended in the Dulbecco’s Modified 
Eagle’s Medium-high glucose (with 4500 mg/L glucose, 0.584 g/L L-glutamine, and 
110 mg/L sodium pyruvate (Sigma) supplemented with 10% Heat-Inactivated Fetal Calf 
Serum (HIFCS) (Sigma), 3.7 g sodium bicarbonate (Sigma), 2 mM glutamine (Sigma), 
26.18 mM NaHCO3 (Sigma), 10 ml of 1M HEPES (Sigma), 10 ml of Minimum 
Essential Medium vitamin solution (MEM vitamin solution 100x) (Sigma) and 1 % 
Penicillin/Streptomycin solution with 10,000 units penicillin and 10 mg 
streptomycin/mL (Sigma)) then incubated at 37oC in a humidified atmosphere with 5% 
CO2 until monolayer was observed.  
Cell viability assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) assay) 
     To determine the effects of the transgenic Bt maize ( MON 810 ) and the 
corresponding parental non-transgenic maize extracts on both IECs and HCT 116 cell 
line, a [3-(4,5-dimethyl thiazole-2-yl)]-2,5-diphenyl tetrazolium bromide (MTT) assay 
was performed.  For cell viability assay, 1 × 105 cells (HCT 116 and IECs)/well were 
plated in 100 μl of DMEM media into a 96-well plate.  The cells were allowed to attach 
and grow for 24 h at 37°C in humidified atmosphere of 5% CO2.  After that the old 
medium was replaced with fresh medium containing the maize extracts at various 
concentrations for determining the effect on cells growth.  The transgenic Bt maize 
(MON 810) and the corresponding parental non-transgenic maize extracts were added at 
various concentrations ranging from 0, 6.25, 12.5, 25, 50, 100 and 200µg/ml after 24 h 
incubation.  After 48 h incubation in a humidified CO2 incubator at 37˚C, 20 µl of MTT 
solution (2 mg/ml) was added to all wells of the plate at the final concentration of 0.5 
mg/ml.  Then, 200 µl of isopropanol was added under dark to each well.  The resulting 
MTT-products were determined by measuring the absorbance at 550 nm using an 
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ELISA plate reader (Molecular Devices, U.S.A).  The optical density obtained is 
directly related to the viability of cells. 
%	ݒܾ݈݅ܽ݅݅ݐݕ ൌ ܱ݌ݐ݈݅ܿܽ	݀݁݊ݏ݅ݐݕ	݋݂	ݏܽ݉݌݈ܱ݁݌ݐ݈݅ܿܽ	݀݁݊ݏ݅ݐݕ	݋݂	ܿ݋݊ݐݎ݋݈ ൈ 100 
 
Calibration of growth curve through the Growth Cell Cycle 
     Cells were trypsinised and the cells number and viability were determined.  After 
appropriate dilution they were seeded at 5000 cells/well in 24 well plate (BD Falcon) 
containing 1.5 ml growth medium with 10% FBS and incubated at 360C, 5% CO2.  
Quadruplicate wells were taken at daily intervals for determining cell numbers per well 
as described in section above. 
Determination of exposure time of Bt and non-Bt maize extracts for both IE cells and 
HCT116 cell line 
     To determine the optimal exposure time of IE cells and HCT116 cell line to maize 
extracts, growth curves were constructed using the control medium (without any maize 
extracts) and medium with non-cytotoxic concentrations of both Bt and non-B tmaize 
extract.  For the both the control plate and the experimental plate, 5000 cells/well were 
seeded at day 0 in 24-well plate (BD Falcon) containing medium supplemented with 
10% FBS and incubated at 360C, 5% CO2 for 24 hours.  After this duration, for the 
controls the medium was removed and new medium was added to each well, whereas 
for the experimental plates the medium was removed and new medium containing non-
cytotoxic concentrations of either Bt maize extract or non-Bt maize extract (based on 
results from the MTT assay) was added to each well.  All plates were incubated at 360C, 
5% CO2 for another 24 hours.  At day 1, the cells of 5 wells were trypsinised and the 
cells number and viability were determined.  This was repeated for days 2, 3 and 4.  All 
experiments were done triplicate for each treatment. 
Protein separation and identification 
     All solutions were prepared using double de-ionised water (Ultra Pure Water) with 
resistance of higher than 18 Ohm (18.2 Ω), prepared on a MilliQ system from Millipore. 
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Protein extraction from cultured cells 
     Cells were seeded in 75-cm2 tissue culture flasks, grown for 1day prior to exposure 
to Bt or non-Bt maize extracts or medium only (negative control) as above. The cells 
were harvested 48 h after treatment, rinsed with PBS, and trypsinized with a solution of 
2.5 g/L trypsin and 0.2 g/L EDTA. After 1 min, media containing FBS were added to 
terminate the action of trypsin. The resulting suspension was centrifuged at 12000×g for 
10 min at 4 0C.  After the supernatant was discarded, the cells were resuspended in ice-
cold 1× PBS and centrifuged at 12000×g for 10 min at 4 0C and the supernatant was 
removed.  This wash-step was repeated thrice.  Cells were resuspended in cold PBS and 
counted.  The pelleted cells were stored at -80 0C until further use.  Cells, previously 
treated with Bt maize extract and cells treated with isogenic maize extract were 
resuspended in lysis buffer (containing 7 M urea, 2 M thiourea, 65 mM DTT, 2% 
CHAPS, 2 mM PMSF, 0.5 % IPG buffer, and protease inhibitor mixture (GE 
healthcare)). The extraction mixture was sonicated using Sonic Dismembrator model 
100 (Fisher Scientific), and then centrifuged at 12000×g at 4 0C for 20 minutes, for 
removal of particulate materials.  After the protein solution was collected and 
transferred to a clean tube, the supernatant was then directly applied to 2D gel 
electrophoresis or stored at -20 0C as aliquots until use.  Subsequent details for protein 
separation and identification are as described above for the in vivo studies. 
2.2.5 Statistical analysis 
     The significance of the differences was tested using the parametric analysis of 
variance (one-way ANOVA) and the nonparametric analysis of variance (Kruskal wallis 
test). The IBM SPSS statistics 20 and Minitab 16 programs were used to perform 
statistical analyses.  Differences were considered to be statistically significant when the 
p-value was <0.05 and highly significant when the p-value was <0.001. 
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Chapter 3  
3 In Vivo Effects of Transgenic Maize Expressing the δ-Insecticidal 
Protein Cry 1Ab from Bacillus thuringiensis on Weight Gain and 
Food Consumption of Young Adults Male Wistar Rats 
3.1 Effects of different maize lines, including MON810, on weight gain and food 
consumption of male Wistar rats 
3.1.1 Diet formulation for rat feeding trials 
     All control, test and reference diets were formulated by Purina Mills International 
(PMI) using corn (maize) grain supplied by Monsanto Company.  Approximately 33% 
(w/w) corn grain was used for all diets, adjusting other components of the diet to 
provide approximately equal levels of protein, calories and nutrients in all diets as 
detailed in Table 3.1.  Compositional, contaminant, and nutritional content of the 
experimental diets met the specifications for Certified Rodent LabDiet 5002 established 
by PMI.  PCR analysis confirmed that the test diet contained MON 810 as it tested 
positive for the Cry1Ab transformation event.  The control and reference diets did not 
test positive for the Cry1Ab transformation event and therefore was considered to be 
free from contamination by the transgenic line. 
3.1.2 Mortality 
     Feeding trials were carried out over both 7 days and 28 days to investigate the effects 
of the different maize lines on both rat performance and differential gene expression in 
the epithelial cells of the small intestine.  During these periods no mortality occured. 
3.1.3 Behavioural observations 
     The rats were observed twice daily for well-being.  There were no changes noted 
during the duration of the study in behaviour (no aggressive behaviour or biting), 
activity, posture, gait, or external appearance for any of the different treatments and all 
of the 40 animals were healthy and appeared normal during the course of the study. 
3.1.4 Absolute body weight measurements for the 7-day rat feeding trial 
     There was an increase in the absolute body weight for the entire five groups from 
day 1 to day 8 (Table 3.2 and Figure 3.1).  Changes in body weight were noted after 1 
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week.  The average body weight of the rats in the control (MON Conv Corn) and test 
(MON 810) group were 283.5 g and 266.5 g respectively.  In rats belonging to the 
control group the body weight was greater (283.5 g) as compared to the other four 
groups, but this showed no significant differences (p =0.603). 
3.1.5 Body weight gain for the 7-day rat feeding trial 
     The data presented in Figure 3.2 show changes in body weight gain of rats fed the 
five different diets over a period of 7 days.  The growth rate was highest with the Purina 
rodent chow followed by control, reference 2, test and reference 1 diets.  Therefore, rats 
fed on the commercial Purina rodent chow and diet containing approximately 33% 
control corn grain gained more body weight than rats fed on diet containing 33% 
transgenic Bt corn grain or the ones fed on diet containing 33% reference corns.  The 
body weight gain of the test group compared with the control is 9.9% less than the 
control where as body weight gain of Reference 1 and Reference 2 groups compared 
with the control are 10.6% and 7.1% less than the control respectively.  In addition, the 
body weight gain of the commercial rodent diet group compared with the control is 
9.2% greater than the control.  However, no significant differences in body weight gain 
between the five diets (p =0.859) (Table 3.3). 
3.1.6 Food consumption for the 7-day rat feeding trial 
     Food intake was calculated on a weekly basis for the rats by group over the treatment 
period as shown in Table 3.4 and Figure 3.3.  The food consumption of the control and 
test group was 283 g and 267.75 g, respectively.  The weekly food intake for the control 
diet group was higher than in the other groups during the whole treatment period (283 
g), but this showed no significant differences between the five diets (p =0.695).  
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3.1.7 Feed conversion efficiency (FCE) for the 7-day rat feeding trial 
     Feed conversion efficiency (food intake/Weight gain), which is a measure of an 
animal's efficiency in converting feed mass into increased body mass, was measured as 
illustrated below (Table 3.5): 
Group mean food intake in week/Group mean weight gain in week  
     Animals that have a low FCE are considered efficient users of feed.  Therefore, the 
rats fed on the commercial rodent diet are considered efficient users of feed and they 
have the highest body weight gain (Figure 3.4), but this also showed no significant 
differences between the five diets (p =0.600). 
3.1.8 Absolute body weight measurements for the 28-day rat feeding trial 
     There was an increase in the absolute body weight for the entire five groups from 
day 1 to day 29 (Table 3.6 and Figure 3.5).  Changes in body weight were noted after 
four week.  The average body weight of the rats in the control and test groups were 
325.5 g and 335.25 g respectively, after four weeks.  In rats belonging to the test group 
the body weight was greater (335.25 g) as compared to the other four groups.  
     There was no significant differences in absolute body weight of rats from the various 
feed groups after 28 days (F4,15=0.33, p=0.852 after week 1, F4,15=1.26, p=0.333 after 
week 2, F4,15=0.88, p=0.498 after week 3, F4,15=0.78, p=0.558 after week 4).  The 
residuals were not significantly different to a normal distribution (p=0.810).  The 
residual of an observed value is the difference between the observed value and the 
estimated function value.  It can also be stated that the highest mean absolute body 
weight was attained by rats fed on test diet followed by the control, and the least was for 
the reference 1 group.  
3.1.9 Body weight gain for the 28-day rat feeding trial 
     There was no significant differences in body weight gain of rats from the various 
feed groups after 28 days (F4,15=1.35, p=0.297 after four weeks).  The residuals were 
not significantly different to a normal distribution (p=0.682).  It can also be stated that 
the highest mean body weight gain was attained by rats fed on diet containing 
approximately 33% transgenic Bt corn grain followed by the commercial diet and the 
lowest was for the reference 1 group (Figure 3.6).  
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     The body weight gain of the test group compared with the control is 35.7% greater 
than the control where as body weight gain of Reference 1 and Reference 2 groups 
compared with the control are 13.6% and 0.23% lower than the control, respectively.  In 
addition, the body weight gain of the commercial rodent diet group compared with the 
control is 21.6% greater than the control (Table 3.7). 
3.1.10 Food consumption for the 28-day rat feeding trial 
     Food intake was calculated on a weekly basis for the rats by group over the treatment 
period, as shown in Table 3.8 and Figure 3.7.  The food consumption of the control and 
test group was 332.5 g and 294.75 g respectively, after 28 days.  The weekly food 
intake for the control diet group was higher than in the other groups during the whole 
treatment period (332.5 g), but this showed no significant differences between the five 
diets (p =0.450). 
3.1.11 Feed conversion efficiency (FCE) for the 28-day rat feeding trial 
     Feed conversion efficiency (food intake/weight gain), which is a measure of an 
animal's efficiency in converting feed mass into increased body mass, was measured as 
shown in section 3.1.7 above (Table 3.9). 
     Animals that have a low FCE are considered efficient users of feed. Therefore, the 
rats fed on diet containing approximately 33% transgenic Bt corn grain are considered 
efficient users of feed and they have the highest body weight gain (Figure 3.8), but there 
was no significant differences in FCE between the five diets (p =0.270).  
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Table 3.1: Composition of experimental diets for rats (%). 
 
ingredients Test 
(MON810) 
MON Garst 
(reference 1) 
MON Gold 
(reference 2) 
Control 
 (MON Conv Corn) 
Cereal products (ground Corn, Ground Oats, Wheat Germ, Ground Wheat, Wheat Middlings) 61 59.4 58.3 58.1 
Vegetable Proteins (Dehydrated Alfalfa Meal, Dried Beet Pulp, Ground Soybean Hulls, Dehulled 
Soybean Meal, Dried Brewers Yeast) 
26.6 27.8 30.3 29.7 
Animal Proteins (fish Meal, Acid Casein, Dried Whey) 6.1 6.4 5.0 6.0 
Energy Sources (Animal Origin) 0.0 0.0 0.0 0.0 
Energy Sources-All other (Soybean Oil, Cane Molasses) 4.2 4.3 4.2 4.1 
Supplementation (vitamins, Major Minerals, Trace Minerals, Amino Acids) 2.1 2.1 2.2 2.1 
*All of these diets and the commercial chow (not shown) are based very tightly on Certified Rodent LabDiet 5002 which is a 
proprietary formula so PMI would not be able to provide us with the ingredient percentages for any of the diets. Control and 
reference grain are from conventional varieties that arenot biotechnology-derived. Only the test (MON810) is biotechnology-
derived. 
 
 
 
 
 
 
Table 3.2: Change in absolute body weight (grams) using group means ± SD after 1 week for the 7-day 
rat feeding trial. 
 
Groups of rats (n=4) 
Body Weight 
Day1 Day 8 
Commercial 224.25±6.94 262.75±10.65 
Control 248.25±21.02 283.5±29.69 
Test 234.75±10.99 266.5±18.64 
Reference 1 243.25±11.78 274.75±21.04 
Reference 2 247.25±25.36 280±20.33 
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Figure 3.1: Change in absolute body weight (grams) for 7-day rat feeding studies using group means 
after 1 week.  Values are means ± SD. 
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Figure 3.2: Change in body weight gain (grams) for 7-day rat feeding studies using group means after 1 
week (on day 8).  Values are means ± SD. 
 
 
Table 3.3: Differences in body weight gain on D8 compared with the control for the 7-day rat feeding 
studies. Values are means ± SD. 
 
Group (n=4) Body weight Gain on D8 Difference with control (%) 
Commercial 38.5±5.19 9.2 
Control 35.25±10.30  --- 
Test  31.75±12.06 -9.9 
Reference1 31.5±12.39 -10.6 
Reference2  32.75±10.37 -7.1 
 
Table 3.4: Weekly food consumption (g) for 7-day rat feeding studies using group means of weekly food 
intake. 
 
Group (n=4) week 1 
Commercial 260.25±7.58 
Control 283±23.35 
Test 267.75±13.02 
Reference 1 274.75±16.09 
Reference 2 279.75±23.92 
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Figure 3.3: Weekly food consumption (in grams) for 7-day rat feeding studies using group means of 
weekly food intake.  The values represented are means ± SD. 
 
Table 3.5: Feed conversion efficiency (FCE) for the 7-day rat feeding trial 
Group (n=4) Group mean food intake in week 1 Group mean weight gain in week 1 Feed conversion efficiency 
Commercial 260.25 38.5 6.831±0.72 
Control 283 35.25 8.4375±1.89 
Test 267.75 31.75 9.28625±3.20 
Reference 1 274.75 31.5 9.656±3.35 
Reference 2 279.75 32.75 9.278±3.28 
 
 
 
Figure 3.4: Feed conversion efficiency (FCE) for the 7-day rat feeding trial.  The values represented are 
means ± SD. 
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Table 3.6: Change in absolute body weight (grams) using group means ± SD after 1 week, 2 weeks, 3 
weeks and 4 weeks for the 28-day rat feeding trial. 
 
Groups of rats (n=4) 
Body weight 
Day1 Day 8 Day 15 Day 22 Day 29 
Commercial 190.25±11.32 228.75±6.84 271±12.80 293.5±22.05 322.25±27.70 
Control 217±21.83 252.25±24.30279.25±29.07304.75±35.01 325.5±37.56 
Test 188±31.05 220.25±34.82 251±37.46 263.5±38.85 335.25±31.43 
Reference 1 202.25±21.23 232.5±27.34 257±29.24 276.75±31.82 296±38.68 
Reference 2 214.75±14.63249.75±16.72 276±23.25 303.5±32.41 323±37.37 
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Figure 3.5: Change in absolute body weight (grams) using group means for the 28-day rat feeding trial.  
Values are means ± SD. 
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Figure 3.6: Change in body weight gain (grams) using group means for week 1, 2, 3 and 4 for the 28-day 
rat feeding trial.  Values are means ± SD. 
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Table 3.7: Differences in body weight gain on day 29 (after 4 weeks) compared with the control diet for 
the 28-day rat feeding trial. Values are means ± SD. 
 
Groups 
(n=4) 
Body weight 
gain on week1 
Body weight 
gain on week2
Body weight 
gain on week3 
Body weight 
gain on week4 
Difference with 
control (%) 
Commercial 38.5±11.90 80.75±20.02 103.25±30.73 132±35.91 21.6 
Control 35.25±14.22 62.25±23.22 87.75±30.31 108.5±35.51 --- 
Test 32.25±4.99 63±8.28 75.5±14.73 147.25±54.10 35.7 
Reference1 30.25±8.18 54.75±10.14 74.5±13.67 93.75±20.43 -13.6 
Reference2 35±11.16 61.25±16.15 88.75±25.31 108.25±29.34 -0.23 
 
Table 3.8: Weekly food consumption (g) for the 28-day rat feeding trial using group means of weekly 
food intake. 
 
Groups (n=4) week 1 week 2 week 3 week 4 
Commercial 226.75±8.05 268±10.09 301.5±18.57 330±27.94 
Control 251.25±22.94 286.5±27.95 313.5±34.21 332.5±36.23 
Test 220.25±35.34 251±36.76 272.25±39.85 294.75±31.85 
Reference 1 232±27.01 263.25±32.38 286.75±32.71 303.75±37.16 
Reference 2 251.25±17.05 283±21.83 310.5±31.11 329±35.13 
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Figure 3.7: Weekly food consumption for the 28-day rat feeding trial using group means of weekly food 
intake. 
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Table 3.9: Feed conversion efficiency (FCE) for the 28-day rat feeding trial. 
 
 
 
 
 
 
 
 
 
  
Group (n=4) week 1 week 2 week 3 week 4 
Commercial 6.37875±2.14 3.473456±0.83 3.0987563±0.80 2.611311±0.54 
Control  8.836±5.66 5.2908617±2.50 3.9635924±1.53 3.322774±1.07 
Test 6.856134±0.76 3.9916667±0.38 3.6703348±0.61 2.2794306±1.01 
Reference 1 9.6563497±3.35 4.8603603±0.49 3.8945799±0.42 3.2969066±0.39 
Reference 2 9.2781944±3.28 4.798677±0.90 3.6562076±0.73 3.1581234±0.58 
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Figure 3.8: Feed conversion efficiency (FCE) for the 28-day rat feeding trial. 
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Chapter 4 
4 In vivo Effects of Transgenic Maize Expressing the δ-Insecticidal 
Protein Cry 1Ab from Bacillus thuringiensis on Differential Gene 
Expression at the Proteome Level in the Epithelial Cells of the 
Small Intestine of Male Wistar Rats.   
4.1 Separation of protein by 2-D gel electrophoresis 
     For 2-DE it is critical that equal amounts of protein are loaded on the gels.  Thus 
total protein concentrations of the isolated rat small intestinal epithelial cells were 
determined using the 2-D Quant kit (GE healthcare, Sweden) as illustrated in Figure 4.1 
and 4.2 and Appendix 25 and 26 (see Appendices to chapter 4). 
     All rat samples were initially separated in the first dimension by isoelectric focusing 
(IEF).  Samples were focused successfully until they reached the steady state.  The 
steady state of IEF was indicated by two conditions: 1) Final high voltage (10000V) 
was reached; 2) current decreased and reached steady state (Figure 4.3).  
     Following IEF all protein samples were then separated successfully by SDS-PAGE 
(Figure 4.4 and 4.5). 
4.2 2D gel image analysis and spot picking gels 
     Initial identification of differentially expressed proteins was carried out by Nonlinear 
Dynamics Ltd (UK).  However, before cutting the protein spots from the relevant gels 
for identification, further analysis was required. 
The objectives for refining the analysis were: 
1- To confirm the results of the detection of differentially expressed proteins. 
2- To exclude false positives from the analysis. 
3- To provide required information for picking the protein spots for identification by 
mass spectroscopy. 
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Figure 4.1: Standard calibration curve for protein concentration of the isolated rat small intestinal 
epithelial cells for the 7-day trial using bovine serum albumin (BSA) as a standard protein.. 
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Figure 4.2: Standard calibration curve for protein concentration of the isolated rat small intestinal
epithelial cells for the 28-day trial using bovine serum albumin (BSA) as a standard protein. 
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Figure 4.3: IEF run for rat samples showing recorded data for current, voltage and volt-hours (Vh). 
The first red arrow indicated the IPG buffer movement, the yellow arrow indicated the salt movement and 
the blue arrow indicated the protein movement.  The green arrow indicated that all proteins were focussed 
and steady state was reached.      
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2D gels were used to separate small intestinal epithelial cells proteins extracted from rats from the 7-day 
trial.  The first dimension was performed using immobilized pH 3-10 gradients gel strips, followed by 
SDS-PAGE using 12.5% acrylamide gels. 
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2D gels were used to separate small intestinal epithelial cells proteins extracted from rats from the 28-day 
trial.  The first dimension was performed using immobilized pH 3-10 gradients gel strips, followed by 
SDS-PAGE using 12.5% acrylamide gels. 
Figure 4.4: Representative image of the colloidal coomassie brilliant blue G-250 stained 2D gel (7-
day trial). 
Figure 4.5: Representative image of the colloidal coomassie brilliant blue G-250 stained 2D gel (28-
day trial). 
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     Progenesis Samespot software version 4.1 was used for refining the analysis.  
Average normalized volume of 200,000 was selected. In general, the experimental 
design was not changed from the original analysis which was carried out by Nonlinear 
Dynamics Ltd (UK); several artefacts and false positives were removed. There were 
also some spots that were detected as differentially expressed proteins, however they 
were quite faint on the actual gels and were classified as "unpickable" spots.  Some 
protein spots were considered not to have a sufficiently high protein content for 
identification by mass spectroscopy.  Examples of such proteins are presented in Figure 
4.6.  Because of the high resolution of the images and magnifying tools in Progenesis 
software, the number of the observed protein spots by using the software might be 
higher than the pickable protein spots in actual gels. 
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Figure 4.6: Examples of the protein spots that are detected as differentially expressed protein by
Progenesis software, but are false positives or not practically pickable.   
These spots are indicated in red zones. 
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4.2.1 7 Day rat feeding trial: gel image analysis 
     Spots were filtered by an average normalised volume (pixel intensity over spot area) 
of 200,000.  This removed 276 spots, leaving 1226 to be taken forward for analysis. The 
number of spots to pick for protein identification reduced from 136 to 52.  In ‘View 
Results’, all filters were removed and all groups selected.  The entire complement of 
1226 spots were ranked by p-value (low to high) then viewed individually to highlight 
their relevance.  From the initial work, there were many spots shown to be significant, 
yet were actually anomalous results.  Spots were discounted from subsequent analysis 
according to the following: 
1-Too close to edge of gel, out of the gel (Figure 4.6). 
2- Contained streaks (Figure 4.7). 
3- Spots within the area of high protein concentration, acidic, high Mw, problematic 
separation (Figure 4.8). 
     With the original experimental design and the original filters in place, the refined 
data set was placed into the same groupings to show the differentially expressed spots.  
Whilst the original data gave 136 spots as differentially expressed, the refined data 
reduced them to 52 spots (Table 4.1).  Spot picking gels are illustrated in Appendix 1 to 
10 (see Appendices to chapter 4). 
4.2.2 28 Day rat feeding trial: gel image analysis 
     There were 1722 spots in the filtering step.  A filter by average normalised volume 
of 200,000 removed 225 spots.  A further 50 spots were removed from the size standard 
of the gel, thus leaving 1447 (Appendix 11).  From the initial work, there were again 
many spots shown to be significant, yet were actually anomalous results. Spots were 
removed according to the following: 
1- Contained streaks. 
2- De-staining issues leading to higher background signal, realising a false positive.  
3- Too close to edge of gel, problematic separation.  
4- Extra care was taken when assessing spots within the area of high protein 
concentration; acidic, high Mw. 
5- Issues with alignment (Appendix 12). 
     The original data gave 73 spots as being differentially expressed, however the 
refined data reduced them to 38 spots (Table 4.2 and Figure 4.9). 
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    Spot picking gels are illustrated in Appendix 13 to 20 (see Appendices to chapter 4).  
Protein spots that were selected and picked for both 7 and 28-day rat feeding trials are 
illustrated in Table 4.3. 
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Figure 4.7: Example of Spot streaking at edge of gel. 
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Figure 4.8: Area of high protein concentration, acidic side of gel, high MW. 
 
 
Table 4.1: Summary of results of the original number of protein spots and the number of spots after 
refining for the 7-day rat feeding trial. 
Treatment Original number of spots Spots after refining 
MCert V Mon 810 09 04 
MCert V Mon Garst 23 07 
MCert V Mon Conv Corn 30 12 
MCert V Mon Gold 13 01 
Mon 810 V Mon Garst 15 07 
Mon 810 V Mon Conv Corn 23 10 
Mon810 V Mon Gold 03 01 
Mon Garst V Mon Conv Corn 16 06 
Mon Garst V Mon Gold 01 01 
Mon Conv Corn V Mon Gold 03 03 
Total 136 52 
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Table 4.2: Summary of results of the original number of protein spots and the number of spots after 
refining for the 28-day rat feeding trial. 
 
Treatment Original number of spots Spots after refining 
MCert V Mon 810 00 00 (20*) 
MCert V Mon Garst 02 01 
MCert V Mon Conv Corn 10 07 
MCert V Mon Gold 03 02 
Mon 810 V Mon Garst 15 09 
Mon 810 V Mon Conv Corn 21 12 
Mon810 V Mon Gold 16 05 
Mon Garst V Mon Conv Corn 05 01 
Mon Garst V Mon Gold 00 00 
Mon Conv Corn V Mon Gold 01 01 
Total 73 38 
*According to P and Q values there were zero significant spots. By switching from Q-value to fold change of >1.5 these 20 spots 
were detected and this shows how the software can alter the results by changing some parameters. 
Figure 4.9: According to P and Q values there were zero significant spots when comparing between
MCert and MON810 groups for the 28-day rats feeding trial.   
By switching from Q-value to fold change of >1.5 the following list of spots was obtained. 
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                                                                            Table 4.3: Protein spots numbers that were picked for both 7 and 28-day rat feeding trials. 
  
28-Day rats feeding trial (25 spots) 7-Day rats feeding trial (29 Spots) 
M
o
n
C
o
n
v
C
o
r
n
 
v
s
 
M
o
n
G
o
l
d
 
M
o
n
C
o
n
v
C
o
r
n
 
v
s
 
M
o
n
 
G
a
r
s
t
 
M
o
n
8
1
0
 
v
s
 
M
o
n
G
o
l
d
 
M
o
n
8
1
0
v
s
M
o
n
G
a
r
s
t
 
M
o
n
8
1
0
v
s
M
o
n
C
o
n
v
C
o
r
n
 
M
C
e
r
t
v
s
M
o
n
G
o
l
d
 
M
C
e
r
t
v
s
M
o
n
G
a
r
s
t
 
M
C
e
r
t
v
s
M
o
n
C
o
n
v
C
o
r
n
 
M
o
n
C
o
n
v
C
o
r
n
V
M
o
n
 
G
o
l
d
 
M
o
n
G
a
r
s
t
V
M
o
n
G
o
l
d
 
M
o
n
G
a
r
s
t
V
M
o
n
C
o
n
v
 
C
o
r
n
 
M
o
n
8
1
0
V
M
o
n
G
o
l
d
 
M
o
n
8
1
0
V
M
o
n
C
o
n
v
 
C
o
r
n
 
M
o
n
8
1
0
V
M
o
n
G
a
r
s
t
 
M
C
e
r
t
V
M
o
n
G
o
l
d
 
M
C
e
r
t
V
M
o
n
C
o
n
v
C
o
r
n
 
M
C
e
r
t
V
M
o
n
G
a
r
s
t
 
M
C
e
r
t
V
M
o
n
8
1
0
 
2149 1972 1485 
1564 
2149 
2232 
3305 
1485 
1960 
1972 
2209 
2912 
2893 
2965 
4082 
4101 
1485 
1707 
2179 
2232 
2222 
2442 
2550 
3123 
3190 
3320 
3255 
3506 
2149 
3305 
 
2912 
 
2550 
2762 
3123 
3190 
3305 
3320 
3506 
 
2249 
2443 
2883 
14441257 
1777 
2249 
2400 
2443 
2883 
26261328 
1777 
1950 
2004 
2045 
2212 
2249 
2400 
2443 
2883 
1950 
2048 
2212 
2279 
2626 
3243 
3248 
2249 1146 
1580 
1976 
1950 
2016 
2021 
2212 
2045 
2249 
2400 
2511 
2883 
1222 
1516 
1976 
2212 
2608 
3243 
3248 
1146 
1630 
2306 
3258 
 
Chapter 4-In vivo results of the effects of Bt maize on differential gene expression at the 
proteme level in the epithelial cells of the small intestine of the rat.  
 
87 
 
4.3 Protein identification using the global proteome machine (GPM) search engine 
     Protein IDs were done at the Burchmore lab, Glasgow Polyomics, University of 
Glasgow.  For protein identifications, the analysis of mass spectrometry data were assigned 
using the Global Proteome Machine (GPM) search engine (www.thegpm.org) to interrogate 
protein sequences in the ENSEMBL Rattus Norvegicus database as illustrated in Appendix 
21 to 23.   The common Repository of Adventitious Proteins, cRAP, is an attempt to create 
a list of proteins commonly found in proteomics experiments that are present either by 
accident or through unavoidable contamination of protein samples.  The types of proteins 
included fall into three general classes: 
1. common laboratory proteins; 
2. proteins added by accident through dust or physical contact; and 
3. proteins used as molecular weight or mass spectrometry quantitation standards. 
     A list of contaminants can be found at both GPM and Mascot sites, they call it cRAP.  
The GPM link which was used in this study is:  http://www.thegpm.org/crap/ 
GPM database with over 100 junk proteins is already linked to other databases including 
rat.  That is why human keratin is in the list of identified proteins (Appendix 24). 
     Most of the proteins from the rat small intestine (s.i.) epithelial cells from both the 7-day 
and 28-day study were successfully identified as illustrated in Appendix 27 and 28.  The 
LC–MS/MS analysis of 29 colloidal comassie brilliant blue-stained 2-D gel spots for the 7-
day rats feeding trial generated a total of 69 protein identifications.  Of these 29 spots, 20 
were a mixture of two or more proteins, and 9 generated single protein identification for 
each spot. Some proteins were identified from multiple spots.  For example, in the 7-day rat 
feeding trial, catalase was identified from three spots.  Catalase was identified in spots 
1146, 1257, and 1328.  Similarly, protein disulfide-isomerase A3 was identified from four 
spots.  Protein disulfide-isomerase A3 was identified in spots 1444, 1516, 1580, and 1630 
(Table 4.4).  LC–MS/MS analysis of 25 colloidal comassie brilliant blue-stained 2-D gel 
spots for the 28-day rat feeding trial generated a total of 39 protein identifications.  Of these 
25 spots, 18 were a mixture of two or more proteins, and 7 generated single protein 
identification for each spot.  Some proteins were identified from multiple spots.  For 
example, in the 28-days rat feeding trial, stress-induced-phosphoprotein 1 was identified 
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from two spots.  Stress-induced-phosphoprotein 1 was identified in spots 1485 and 1564 
(Table 4.5). 
4.3.1 Comparison of differentially expressed proteins from rat small intestine 
epithelial cells: 7-day study 
     The venn diagrams illustrated in Figure 4.10 and 4.11 show the number of 2D gel 
protein spots identified by Progenesis SameSpots software (Nonlinear Dynamics Ltd, 
Newcastle upon Tyne, UK) between two diet groups (Figure 4.10) and all the five diet 
groups (Figure 4.11) that were differentially expressed and up-regulated when rats were fed 
for 7 day on conventional diet or the parental control for MON810 corn diet (Mon Conv 
Corn) which was formulated to contain approximately 33% control corn grain; test diet 
(MON 810 group) which was formulated to contain the test corn grain at approximately 
33%; reference diets (Mon Garst and Mon Gold Groups) which were formulated to contain 
the references corn grain at approximately 33% and commercial Purina rodent chow 
(Mcert) which was purchased from Purina Mills Inc and normally contains approximately 
33% corn.  The threshold used to qualify differentially expressed spots was a Student t test 
P value less than 0.05 and the false discovery rate (FDR, from q-values). 
Comparison of differentially expressed proteins between MON810 and Mon Conv Corn 
diet groups  
     The venn diagram illustrated in Figure 4.10 a summarizes the significantly regulated 
spots between MON810 and Mon Conv Corn groups.  One thousand two hundred and 
sixteen protein spots were identified to be commonly expressed in both MON810 and Mon 
Conv Corn, whereas 4 up-regulated spots were identified for MON810 fed rats (Spot No. 
1950, 2212, 1328, 2045) and 6 up-regulated spots were identified for Mon Conv Corn fed 
rats (Spot No. 2883, 2443, 2400, 2004, 1777, 2249).   
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mon Conv Corn showed that 2 stress-related proteins (catalase and 60 kDa heat shock 
protein) were up-regulated (2.4 fold) in the former group but no stress related proteins were 
up-regulated in Mon Conv Corn group.   
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Comparison of differentially expressed proteins between MON810 and Mcert diet groups       
     The Venn diagram (Figure.4.10 b) summarizes the significantly regulated spots between 
Mcert and MON810 groups.  One thousand two hundred and twenty two spots were 
identified to be commonly expressed in both Mcert and MON810, whereas only 2 up-
regulated protein spots were identified for Mcert fed rats (Spot No. 2306 and 3258) and 2 
up-regulated spots were identified for MON810 fed rats (Spot No. 1146 and 1630).   
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mcert showed that 3 stress-related proteins (catalase, 60 kDa heat shock protein and stress-
induced phosphoprotein 1) were up-regulated (between 2.2-2.5 fold) in the former group 
but no stress related proteins were up-regulated in Mcert group.  
Comparison of differentially expressed proteins between Mcert and Mon Garst diet 
groups  
     The venn diagram illustrated in Figure 4.10 c summarizes the significantly regulated 
spots between Mcert and Mon Garst groups.  One thousand two hundred and nineteen spots 
were identified to be commonly expressed in both Mcert and Mon Garst, whereas 7 up-
regulated spots were identified for Mcert fed rats (Spot No. 3248, 1222, 2212, 3243, 2608, 
1976, 1516).   
     Comparison between differentially expressed proteins between rats fed Mcert and Mon 
Garst showed that 2 stress-related proteins (thioredoxin-dependent peroxide reductase and 
protein DJ-1) were up-regulated (between 1.4-2.6 fold) in the former group but no stress 
related proteins were up-regulated in Mon Garst group.   
Comparison of differentially expressed proteins between Mcert and Mon Conv Corn diet 
groups  
     The venn diagram illustrated in Figure 4.10 d summarizes the significantly regulated 
spots between Mcert and Mon Conv Corn groups.  One thousand two hundred and fourteen 
spots were identified to be commonly expressed in both Mcert and Mon Conv Corn, 
whereas 7 up-regulated spots were identified for Mcert fed rats (Spot No. 1580, 2511, 2016, 
Chapter 4-In vivo results of the effects of Bt maize on differential gene expression at the 
proteme level in the epithelial cells of the small intestine of the rat.  
 
90 
 
2212, 2045, 1976, 1950) and 5 up-regulated spots were identified for Mon Conv corn fed 
rats (Spot No. 2883, 2021, 2249, 1146, 2400).   
     Comparison between differentially expressed proteins between rats fed Mcert and Mon 
Conv Corn showed that 1 stress-related protein (60 kDa heat shock protein) was up-
regulated (3 fold) in the former group and 1 stress related protein (stress-induced 
phosphoprotein 1) was up-regulated in Mon Conv Corn group.   
Comparison of differentially expressed proteins between Mcert and Mon Gold diet 
groups  
     The venn diagram illustrated in Figure 4.10 e summarizes the significantly regulated 
spots between Mcert and Mon Gold groups.  One thousand two hundred and twenty five 
spots were identified to be commonly expressed in both Mcert and Mon Gold, whereas 
only 1 up-regulated spot was identified for Mcert fed rats (Spot No. 2249).   
     Comparison between differentially expressed proteins between rats fed Mcert and Mon 
Gold showed that no stress-related proteins were up-regulated.   
Comparison of differentially expressed proteins between MON810 and Mon Garst diet 
groups  
     The venn diagram illustrated in Figure 4.10 f summarizes the significantly regulated 
spots between MON810 and Mon Garst groups.  One thousand two hundred and nineteen 
spots were identified to be commonly expressed in both MON810 and Mon Garst, whereas 
7 up-regulated spots were identified for MON810 fed rats (Spot No. 2212, 3248, 2279, 
3243, 1950, 2626, 2048).   
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mon Garst showed that 3 stress-related proteins (thioredoxin-dependent peroxide reductase, 
peroxiredoxin-6 and LDLR chaperone MESD precursor) were up-regulated (1.8-2.5 fold) 
in the former group.   
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Comparison of differentially expressed proteins between MON810 and Mon Gold diet 
groups  
     The venn diagram illustrated in Figure 4.10 g summarizes the significantly regulated 
spots between MON810 and Mon Gold groups.  One thousand two hundred and twenty five 
spots were identified to be commonly expressed in both MON810 and Mon Gold, whereas 
only 1 up-regulated spotwas identified for MON810 fed rats (Spot No. 2626).   
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mon Gold showed that 2 stress-related proteins (peroxiredoxin-6 and LDLR chaperone 
MESD precursor) were up-regulated (1.2 fold) in the former group.   
Comparison of differentially expressed proteins between Mon Garst and Mon Conv Corn 
diet groups  
     The venn diagram illustrated in Figure 4.10 h summarizes the significantly regulated 
spots between Mon Garst and Mon Conv Corn groups.  One thousand two hundred and 
twenty spots were identified to be commonly expressed in both Mon Garst and Mon Conv 
Corn, whereas 6 up-regulated spots were identified for Mon Conv Corn fed rats (Spot No. 
2249, 1257, 1777, 2400, 2883, 2443).   
     Comparison between differentially expressed proteins between rats fed Mon Conv Corn 
and Mon Garst showed that 1 stress-related protein (catalase) was up-regulated (2.6 fold) in 
the former group.   
Comparison of differentially expressed proteins between Mon Garst and Mon Gold diet 
groups  
     The venn diagram illustrated in Figure 4.10 i summarizes the significantly regulated 
protein spots between Mon Garst and Mon Gold groups.  One thousand two hundred and 
twenty five spots were identified to be commonly expressed in both Mon Garst and Mon 
Gold, whereas only 1 up-regulated spot was identified for Mon Garst fed rats (Spot 
No.1444).   
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     Comparison between differentially expressed proteins between rats fed Mon Garst and 
Mon Gold showed that 1 stress-related protein (T-complex protein 1 subunit beta) was up-
regulated (1.5 fold) in the former group.   
Comparison of differentially expressed proteins between Mon Conv Corn and Mon Gold 
diet groups  
     The venn diagram illustrated in Figure 4.10 j summarizes the significantly regulated 
spots between Mon Conv Corn and Mon Gold groups.  One thousand two hundred and 
twenty three spots were identified to be commonly expressed in both Mon Conv Corn and 
Mon Gold, whereas 3 up-regulated spots were identified for Mon Conv Corn fed rats (Spot 
No. 2883, 2249, and 2443).   
     Comparison between differentially expressed proteins between rats fed Mon Conv Corn 
and Mon Gold showed that no stress-related proteins were up-regulated. 
Comparison of differentially expressed proteins between all 5 diet groups: 7-day study 
     When all five groups were compared there were 5, 4, 3, 0, 0, differentially expressed 
protein spots for Mcert, Mon Conv Corn, MON810, Mon Garst and MON Gold, 
respectively (Figure 4.11).   
     Comparison between differentially expressed proteins between rats fed Mcert, Mon 
Conv Corn, MON810, Mon Garst and MON Gold showed that only 2 stress-related 
proteins (LDLR chaperone MESD precursor and peroxiredoxin-6) were up-regulated (2.4 
fold) in the MON810 group and 1 stress-related protein (thioredoxin-dependent peroxide 
reductase) was up-regulated (2.6 fold) in the Mcert group. 
4.3.2 Comparison of differentially expressed proteins from rat small intestine 
epithelial cells: 28-day study 
     The venn diagrams illustrated in Figure 4.12 and 4.13 show the number of 2D gel 
protein spots identified by Progenesis SameSpots software (Nonlinear Dynamics Ltd, 
Newcastle upon Tyne, UK) between two groups (Figure 4.12) and all the five groups 
(Figure 4.13) that were differentially expressed and up-regulated when rats were fed for 28-
days on conventional diet or the parental control for MON810 corn diet (Mon Conv Corn) 
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which was formulated to contain approximately 33% control corn grain; test diet (MON 
810 group) which was formulated to contain the test corn grain at approximately 33%; 
reference diets (Mon Garst and Mon Gold Groups) which were formulated to contain the 
references corn grain at approximately 33% and commercial Purina rodent chow (Mcert) 
which was purchased from Purina Mills Inc and normally contains approximately 33% 
corn.  The threshold used to qualify differentially expressed spots was a Student t test P 
value less than 0.05 and the false discovery rate (FDR, from q-values).   
Comparison of differentially expressed proteins between MON810 and Mon Conv Corn 
diet groups 
     The venn diagram illustrated in Figure 4.12 a summarizes the significantly regulated 
spots between MON810 and Mon Conv Corn groups.  One thousand four hundred and 
thirty five spots were identified to be commonly expressed in MON810 and Mon Conv 
Corn, whereas 9 up-regulated spots were identified for MON810 fed rats (Spot No. 3320, 
1485, 2550, 2222, 3190, 2179, 1707, 2232, 2442) and 3 up-regulated spots were identified 
for Mon Conv Corn fed rats (Spot No. 3123, 3506, 3255).   
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mon Conv Corn showed that 2 stress-related proteins (stress-induced phosphoprotein 1 and 
peroxiredoxin-1) were up-regulated (between 2.5-3.1 fold) in the former group and 1 stress 
related protein (superoxide dismutase) was up-regulated (1.5 fold) in Mon Conv Corn 
group.   
Comparison of differentially expressed proteins between MON810 and Mcert diet groups 
     The Venn diagram (Figure 4.12 b) shows that there were no differentially expressed 
spots between Mcert and MON810 groups.  One thousand four hundred and forty seven 
spots were identified to be commonly expressed in both Mcert and MON810 groups.   
Comparison of differentially expressed proteins between Mcert and Mon Garst diet 
groups 
     The venn diagram illustrated in Figure 4.12 c summarizes the significantly regulated 
spots between Mcert and Mon Garst groups.  One thousand four hundred and forty six 
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spots were identified to be commonly expressed in both Mcert and Mon Garst, whereas 
only 1 up-regulated spot was identified for Mcert fed rats (Spot No. 2912).   
     Comparison between differentially expressed proteins between rats fed Mcert and Mon 
Garst showed that no stress-related proteins were up-regulated.   
Comparison of differentially expressed proteins between Mcert and Mon Conv Corn diet 
groups 
     The venn diagram illustrated in Figure 4.12 d summarizes the significantly regulated 
spots between Mcert and Mon Conv Corn groups.  One thousand four hundred and forty 
spots were identified to be commonly expressed in both Mcert and Mon Conv Corn, 
whereas 4 up-regulated spots were identified for Mcert fed rats (Spot No. 3190, 3320, 2550, 
2762) and 3 up-regulated spots were identified for Mon Conv corn fed rats (Spot No. 3123, 
3506, 3305).   
     Comparison between differentially expressed proteins between rats fed Mcert and Mon 
Conv Corn showed that 1 stress-related protein (peroxiredoxin-1) was up-regulated (2.8 
fold) in the former group.   
Comparison of differentially expressed proteins between Mcert and Mon Gold diet 
groups 
     The venn diagram illustrated in Figure 4.12 e summarizes the significantly regulated 
spots between Mcert and Mon Gold groups.  One thousand four hundred and forty five 
spots were identified to be commonly expressed in both Mcert and Mon Gold, whereas 
only 1 up-regulated spot was identified for Mcer fed rats (Spot No. 2149) and 1 up-
regulated spot was identified for Mon Gold fed rats (Spot No. 3305).   
     Comparison between differentially expressed proteins between rats fed Mcert and Mon 
Gold showed that no stress-related proteins were up-regulated.   
Comparison of differentially expressed proteins between MON810 and Mon Garst diet 
groups 
     The venn diagram illustrated in Figure 4.12 f summarizes the significantly regulated 
spots between MON810 and Mon Garst groups.  One thousand four hundred and thirty 
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eight spots were identified to be commonly expressed in both MON810 and Mon Garst, 
whereas 7 up-regulated spots were identified for MON810 fed rats (Spot No. 2209, 1485, 
1960, 1972, 2912, 4082, 4101) and 2 up-regulated spots were identified for Mon Garst fed 
rats (Spot No. 2893, 2965).   
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mon Garst showed that 2 stress-related proteins (stress-induced phosphoprotein 1 and 60 
kDa heat shock protein) were up-regulated (between 2.2-2.4 fold) in the former group and 1 
stress related protein (T-complex protein 1 subunit beta) was up-regulated (3.1 fold) in Mon 
Garst group.   
Comparison of differentially expressed proteins between MON810 and Mon Gold diet 
groups 
     The venn diagram illustrated in Figure 4.12 g summarizes the significantly regulated 
spots between MON810 and Mon Gold groups.  One thousand four hundred and forty two 
spots were identified to be commonly expressed in both MON810 and Mon Gold, whereas 
4 up-regulated spots were identified for MON810 fed rats (Spot No. 2232, 2149, 1564, 
1485) and 1 up-regulated spot was identified for Mon Gold fed rats (Spot No. 3305). 
     Comparison between differentially expressed proteins between rats fed MON810 and 
Mon Gold showed that 2 stress-related proteins (2 stress-induced phosphoprotein 1) were 
up-regulated (between 1.8-2.4 fold) in the former group.   
Comparison of differentially expressed proteins between Mon Garst and Mon Conv Corn 
diet groups 
     The venn diagram illustrated in Figure 4.12 h summarizes the significantly regulated 
spots between Mon Garst and Mon Conv Corn groups.  One thousand four hundred and 
forty six spots were identified to be commonly expressed in both Mon Garst and Mon Conv 
Corn, whereas only 1 up-regulated spot was identified for Mon Conv Corn fed rats (Spot 
No. 1972).   
     Comparison between differentially expressed proteins between rats fed Mon Garst and 
Mon Conv Corn showed that no stress-related proteins were up-regulated.   
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Comparison of differentially expressed proteins between Mon Garst and Mon Gold diet 
groups 
     The venn diagram illustrated in Figure 4.12 i summarizes the significantly regulated 
spots between Mon Garst and Mon Gold groups.  One thousand four hundred and forty 
seven spots were identified to be commonly expressed in both Mon Garst and Mon Gold, 
whereas no differentially expressed spots between Mon Garst and Mon Gold groups were 
found.   
Comparison of differentially expressed proteins between Mon Conv Corn and Mon Gold 
diet groups 
     The venn diagram illustrated in Figure 4.12 j summarizes the significantly regulated 
spots between Mon Conv Corn and Mon Gold groups.  One thousand four hundred and 
forty six spots were identified to be commonly expressed in both Mon Conv Corn and Mon 
Gold groups, whereas only 1 up-regulated spot was identified for Mon Conv Corn fed rats 
(Spot No. 2149).   
     Comparison between differentially expressed proteins between rats fed Mon Conv Corn 
and Mon Gold showed that no stress-related proteins were up-regulated. 
Comparison of differentially expressed proteins between all 5 diet groups: 28-day study 
     When all five groups were compared, only two spots were differentially expressed, these 
being in the rats fed MON810 (Figure 4.13).  Comparison between differentially expressed 
proteins between rats fed Mcert, Mon Conv Corn, MON810, Mon Garst and MON Gold 
showed that 1 stress-related protein (stress-induced phosphoprotein 1) was up-regulated 
(3.1 fold) in the MON 810 group. 
     In order to assess functional relevance of changes in the identified differentially 
expressed proteins, the proteins were aligned into 28 groups according to their molecular 
functions for the 7-day rat feeding trial and into 21 groups for the 28-day rat feeding trial 
(Table 4.4 and 4.5; Figure 4.14, 4.15 and 4.16).  Categorizations were based on information 
provided by the online resource UniProt classification system.  Some proteins were 
annotated manually, based on literature searches and closely related homologues. 
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Figure 4.10: Two-set venn diagrams comparing the changes in the differentially expressed protein spots and 
up-regulated spot number when rats were fed for 7 days on conventional diet (Mon Conv Corn group) which 
was formulated to contain approximately 33% control corn grain; test diet (MON810 group) which was 
formulated to contain the test corn grain at approximately 33%; reference diets (Mon Garst and Mon Gold 
groups) which were formulated to contain the references corn grain at approximately 33% and commercial 
Purina rodent chow (Mcert group) which was purchased from Purina Mills Inc and normally contains 
approximately 33% corn. 
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Figure 4.11: Five-set venn diagram analysis of the differentially expressed protein spots showing
the up-regulated spots between the five groups for the 7-day rat feeding trial. 
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Figure 4.12: Two-set venn diagrams comparing the changes in the differentially expressed protein spots and
up-regulated spot number when rats were fed for 28 days on conventional diet (Mon Conv Corn group) which
was formulated to contain approximately 33% control corn grain; test diet (MON 810 group) which was
formulated to contain the test corn grain at approximately 33%; reference diets (Mon Garst and Mon Gold
groups) which were formulated to contain the references corn grain at approximately 33% and commercial
Purina rodent chow (Mcert group) which was purchased from Purina Mills Inc and normally contains
approximately 33% corn. 
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Figure 4.13: Five-set venn diagram analysis of the differentially expressed protein spots showing the
up-regulated spots between the five groups for the 28-day rat feeding trial. 
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Figure 4.14: Functional classifications of differentially expressed intestinal epithelial cells proteins for the 7-
day rat feeding trial. 
A total of 88 proteins were identified and these proteins fall within 28 major functional categories. 19 (22%) 
contain oxidoreductase activity, 9 (10%) are chaperones, 8 (9%) contained transferase activity, 6 (7%) 
contained structural molecule activity and 6 (7%) are ribonucleoproteins.
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Figure 4.15: Functional classifications of differentially expressed intestinal epithelial cells proteins for the 28-day rat
feeding trial. 
A total of 47 proteins were identified and these proteins fall within 21 major functional categories. 9 (19%) contain
oxidoreductase activity, 2 (4%) are chaperones, 3 (6%) contained transferase activity, 2 (4%) contained structural
molecule activity and 3 (6%) are ribonucleoproteins. 
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Figure 4.16: Summary of proteins identified by LC-MS/MS from small intestinal epithelial cells for both 7
and 28 day rat feeding trials, representing molecular functions. 
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Table 4.4: Functional classification of the identified protein spots of the 7-day rat feeding trial. 
Molecular 
function number of proteins name of protein Spot No. Groups 
structural 
molecule activity 
2 prelamin-A/C 1146, 1630, Mcert Vs MON810 
2 Actin, cytoplasmic 1 Actin, cytoplasmic 1 2016, 2021 
Mcert Vs Mon Conv 
Corn 
1 Actin, gamma-enteric smooth muscle 2021 Mcert Vs Mon Conv Corn 
1 beta-actin-like protein 2 2021 Mcert Vs Mon Conv Corn 
chaperones 
3 60 kDa heat shock protein, mitochondrial 1630, 1580, 1328 
Mcert Vs MON810, 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn 
1 Calnexin Precursor 1222 Mcert Vs Mon Garst 
1 Calreticulin Precursor 1976 
Mcert Vs Mon Garst, 
Mcert Vs Mon Conv 
Corn 
1 T-complex protein 1 subunit zeta 1146 
Mcert Vs MON810, 
Mcert Vs Mon Conv 
Corn 
1 T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) 1444 Mon Garst Vs Mon Gold 
1 
LDLR chaperone MESD Precursor 
(Mesoderm development candidate 2) 
(Mesoderm development protein) 
2626 MON810 Vs Mon Garst, MON810 Vs Mon Gold 
1 Protein DJ-1 (Parkinson disease protein 7 homolog) 2608 Mcert Vs Mon Garst 
Growth factor 1 
Mesencephalic astrocyte-derived 
neurotrophic factor Precursor (Protein 
ARMET) (Arginine-rich protein) 
2883 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn, 
Mon Conv Corn Vs Mon 
Gold 
Oxidoreductase 
1 aldehyde dehydrogenase X, mitochondrial precursor 1516 Mcert Vs Mon Garst 
1 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial 2249 
Mcert Vs Mon Conv 
Corn, Mcert Vs Mon 
Gold, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn, 
Mon Conv Corn Vs Mon 
Gold 
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Molecular 
function number of proteins name of protein Spot No. Groups 
1 
D-beta-hydroxybutyrate dehydrogenase, 
mitochondrial Precursor (BDH) (EC 
1.1.1.30) (3-hydroxybutyrate 
dehydrogenase) 
2249 
Mcert Vs Mon Conv 
Corn, Mcert Vs Mon 
Gold, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn, 
Mon Conv Corn Vs Mon 
Gold 
1 Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial 1146 
Mcert Vs MON810, 
Mcert Vs Mon Conv 
Corn 
2 Glyceraldehyde-3-phosphate dehydrogenase 2045, 2048 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn, MON810 
Vs Mon Garst 
1 Malate dehydrogenase, mitochondrial 2004 Mon810 Vs MonConvCorn 
2 
Dihydrolipoyl dehydrogenase, 
mitochondrial Precursor (EC 1.8.1.4) 
(Dihydrolipoamide dehydrogenase) 
1328, 1444 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Gold 
2 
UDP-glucose 6-dehydrogenase (UDP-
Glc dehydrogenase) (UDP-GlcDH) 
(UDPGDH) (EC 1.1.1.22) 
1328, 1444 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Gold 
1 Methylmalonate-semialdehyde dehydrogenase , mitochondrial 1328 
MON810 Vs Mon Conv 
Corn 
1 
Pyridine nucleotide-disulfide 
oxidoreductase domain-containing 
protein 2 
1257 Mon Garst Vs Mon Conv Corn 
1 
Succinate dehydrogenase iron-sulfur 
subunit, mitochondrial Precursor (EC 
1.3.5.1) (Iron-sulfur subunit of complex 
II) 
2443 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn, Mon 
Conv Corn Vs Mon 
Gold 
1 Glutamate dehydrogenase 1, mitochondrial 1444 Mon Garst Vs Mon Gold 
1 aldehyde dehydrogenase X, mitochondrial precursor 1516 Mcert Vs Mon Garst 
1 
4-trimethylaminobutyraldehyde 
dehydrogenase (TMABADH) (EC 
1.2.1.47) 
1516 Mcert Vs Mon Garst 
Chapter 4-In vivo results of the effects of Bt maize on differential gene expression at the 
proteme level in the epithelial cells of the small intestine of the rat.  
 
106 
 
Molecular 
function number of proteins name of protein Spot No. Groups 
2 
Aldehyde dehydrogenase, mitochondrial 
Precursor (EC 1.2.1.3) (ALDH class 2) 
(ALDH1) (ALDH-E2) 
1516, 1580 
Mcert Vs Mon Garst, 
Mcert Vs Mon Conv 
Corn 
Antioxidant 
1 
Thioredoxin-dependent peroxide 
reductase, mitochondrial Precursor (EC 
1.11.1.15) (Peroxiredoxin-3) (PRX-3) 
(PRx III) 
3243 Mcert Vs Mon Garst 
1 
Peroxiredoxin-6 (EC 1.11.1.15) 
(Antioxidant protein 2) (1-Cys 
peroxiredoxin) (1-Cys PRX) 
2626 MON810 Vs Mon Garst, MON810 Vs Mon Gold 
Electron transport 
1 
Cytochrome b-c1 complex subunit 2, 
mitochondrial Precursor (Ubiquinol-
cytochrome-c reductase complex core 
protein 2) (Core protein II) (Complex III 
subunit 2) 
1777 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn 
1 Electron transfer flavoprotein subunit beta (Beta-ETF) 2608 Mcert Vs Mon Garst 
1 
Electron transfer flavoprotein subunit 
alpha, mitochondrial Precursor (Alpha-
ETF) 
2279 MON810 Vs Mon Garst 
Protein disulfide 
isomerase activity 4 Protein disulfide-isomerase A3 
1444, 1516, 
1580, 1630 
Mon Garst Vs Mon 
Gold, Mcert Vs Mon 
Garst, Mcert Vs Mon 
Conv Corn, Mcert Vs 
MON810 
Kinase 1 UMP-CMP kinase (EC 2.7.4.14) (Cytidylate kinase) 2608 Mcert Vs Mon Garst 
Initiation factor in 
Protein 
biosynthesis 
1 
Eukaryotic translation initiation factor 3 
subunit I (eIF3i) (Eukaryotic translation 
initiation factor 3 subunit 2) (eIF-3-beta) 
2016 Mcert Vs Mon Conv Corn 
chloride channel 
regulator activity 1 
Na(+)/H(+) exchange regulatory cofactor 
NHE-RF1 2016 
Mcert Vs Mon Conv 
Corn 
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Molecular 
function number of proteins name of protein Spot No. Groups 
Transferase 
1 
N-acetyl-D-glucosamine kinase (N-
acetylglucosamine kinase) (EC 2.7.1.59) 
(GlcNAc kinase) 
2016 Mcert Vs Mon Conv Corn 
2 3-ketoacyl-CoA thiolase, mitochondrial 1777, 3248 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn, Mcert 
Vs Mon Garst, MON810 
Vs Mon Garst 
1 Phosphoglycerate kinase 1 1777 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn 
1 Creatine kinase U-type, mitochondrial 1777 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn 
1 
Succinyl-CoA:3-ketoacid-coenzyme A 
transferase 1, mitochondrial Precursor 
(EC 2.8.3.5) 
1328 MON810 Vs Mon Conv Corn 
1 Pyruvate kinase isozymes M1/M2 1257 Mon Garst Vs Mon Conv Corn 
1 
Dihydrolipoyllysine-residue 
succinyltransferase component of 2-
oxoglutarate dehydrogenase complex, 
mitochondrial 
2443 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn, Mon 
Conv Corn Vs Mon 
Gold 
Porin 
2 
Voltage-dependent anion-selective 
channel protein 2 (VDAC-2) (Outer 
mitochondrial membrane protein porin 2) 
(B36-VDAC) 
2212, 2279 
Mcert Vs Mon Garst, 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Garst, MON810 Vs Mon 
Conv Corn 
1 Voltage-dependent anion-selective channel protein 1 2249 
Mcert Vs Mon Conv 
Corn, Mcert Vs Mon 
Gold, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn, 
Mon Conv Corn Vs Mon 
Gold 
Response to stress   
(co-chaperone ) 1 Stress-induced-phosphoprotein 1 1146 
Mcert Vs MON810, 
Mcert Vs Mon Conv 
Corn 
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Molecular 
function number of proteins name of protein Spot No. Groups 
Ribonucleoprotein 
1 heterogeneous nuclear ribonucleoprotein L isoform b 1146 
Mcert Vs MON810, 
Mcert Vs Mon Conv 
Corn 
2 
Heterogeneous nuclear 
ribonucleoproteins A2/B1 (hnRNP 
A2/B1) 
2279, 2400 
MON810 Vs Mon Garst, 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn 
1 Heterogeneous nuclear ribonucleoprotein H 1580 
Mcert Vs Mon Conv 
Corn 
1 Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) 1580 
Mcert Vs Mon Conv 
Corn 
1 ErbB3-binding protein 1 1630 Mcert Vs MON810 
Peroxidase 3 Catalase 1146, 1257, 1328 
Mcert Vs MON810, 
Mcert Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn, 
MON810 Vs Mon Conv 
Corn 
Repressor 1 coiled-coil-helix-coiled-coil-helix domain containing protein 3 2400 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn 
Muscle protein 
1 Tropomyosin beta chain 1976 
Mcert Vs Mon Garst, 
Mcert Vs Mon Conv 
Corn 
3 Tropomyosin alpha-1 chain 1976, 2021, 3258 
Mcert Vs Mon Garst, 
Mcert Vs Mon Conv 
Corn, Mcert Vs 
MON810 
1 Tropomyosin alpha-3 chain 2306 Mcert Vs MON810 
serine-type 
endopeptidase 
inhibitor activity 
and Tumor 
suppressor 
1 Serpin B5 (Peptidase inhibitor 5) (PI-5) (Maspin) 1950 
Mcert Vs Mon Conv 
Corn 
Hydrolase 1 3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) 1950 
Mcert Vs Mon Conv 
Corn 
translation 
elongation factor 
activity 
1 Elongation factor 2 1950 Mcert Vs Mon Conv Corn 
Developmental 
protein 1 THO complex subunit 6 homolog 2048 MON810 Vs Mon Garst 
Ligase 1 UPF0027 protein C22 or f28 homolog (p55) 1328 
MON810 Vs Mon Conv 
Corn 
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Molecular 
function number of proteins name of protein Spot No. Groups 
Mitosis 1 Centrosomal protein of 55 kDa. 1328 MON810 Vs Mon Conv Corn 
Protease 
1 Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) 2443 
MON810 Vs Mon Conv 
Corn, Mon Garst Vs 
Mon Conv Corn, Mon 
Conv Corn Vs Mon 
Gold 
1 
Cytosol aminopeptidase (EC 3.4.11.1) 
(Leucine aminopeptidase 3) (LAP-3) 
(Leucyl aminopeptidase) (Proline 
aminopeptidase) (EC 3.4.11.5) (Prolyl 
aminopeptidase) 
1444 Mon Garst Vs Mon Gold 
ATP binding 2 ATP synthase subunit alpha, mitochondrial 1444, 2443 
Mon Garst Vs Mon 
Gold, MON810 Vs Mon 
Conv Corn, Mon Garst 
Vs Mon Conv Corn, 
Mon Conv Corn Vs Mon 
Gold 
calcium ion 
binding/Transfer, 
Carrier protein 
1 annexin A11 1444 Mon Garst Vs Mon Gold 
1 Annexin A2 2045 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn 
DNA repair 1 PAX interacting (with transcription-activation domain) protein 1 2511 
Mcert Vs Mon Conv 
Corn 
epidermal growth 
factor receptor 
binding 
1 Growth factor receptor-bound protein 2 2626 MON810 Vs Mon Garst, MON810 Vs Mon Gold 
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Table 4.5: Functional classification of the identified protein spots of the 28-day rat feeding trial. 
Molecular function number of proteins name of protein Spot No. Groups 
structural molecule 
activity 2 Lamin-A 1485, 1564 
MON810 Vs Mon Conv 
Corn, MON810 Vs Mon 
Gold 
chaperones 
1 60 kDa heat shock protein, mitochondrial 1960 MON810 Vs Mon Garst 
1 T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) 2893 MON810 Vs Mon Garst 
Oxidoreductase 
1 
Isocitrate dehydrogenase subunit 
alpha, mitochondrial Precursor 
(EC 1.1.1.41) 
3190 Mcert Vs Mon Conv Corn 
1 Isocitrate dehydrogenase , mitochondrial 2222 
MON810 Vs Mon Conv 
Corn 
2 Isocitrate dehydrogenase cytoplasmic 2209, 4101 MON810 Vs Mon Garst 
1 Glyceraldehyde-3-phosphate dehydrogenase 4082 MON810 Vs Mon Garst 
1 Malate dehydrogenase, mitochondrial 4082 MON810 Vs Mon Garst 
1 
Dihydrolipoyl dehydrogenase, 
mitochondrial Precursor (EC 
1.8.1.4) (Dihydrolipoamide 
dehydrogenase) 
1707 MON810 Vs Mon Conv Corn 
1 
Superoxide dismutase , 
mitochondrial Precursor (EC 
1.15.1.1) 
3255 MON810 Vs Mon Conv Corn 
1 
Alcohol dehydrogenase (EC 
1.1.1.2) (Aldehyde reductase) 
(Aldo-keto reductase family 1 
member A1) (3-DG-reducing 
enzyme) 
2442 MON810 Vs Mon Conv Corn 
Antioxidant/ Peroxidase 1 
Peroxiredoxin-1 (EC 1.11.1.15) 
(Thioredoxin peroxidase 2) 
(Thioredoxin-dependent 
peroxide reductase 2) 
3190 Mcert Vs Mon Conv Corn 
Electron transport 1 
Cytochrome b-c1 complex 
subunit 2, mitochondrial 
Precursor (Ubiquinol-
cytochrome-c reductase complex 
core protein 2) (Core protein II) 
2232 MON810 Vs Mon Conv Corn 
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Molecular function number of proteins name of protein Spot No. Groups 
1 Electron transfer flavoprotein subunit beta (Beta-ETF) 2912 Mcert Vs Mon Garst 
Protein disulfide 
isomerase activity 4 Protein disulfide-isomerase A3 
2149, 1707, 
1960, 1972 
Mcert Vs Mon Gold, 
MON810 Vs Mon Conv 
Corn, MON810 Vs Mon 
Garst 
Kinase 
1 
Adenylate kinase 2, 
mitochondrial (AK 2) (EC 
2.7.4.3) (ATP-AMP 
transphosphorylase 2) 
2912 Mcert Vs Mon Garst 
1 Phosphoglycerate kinase 1 2232 MON810 Vs Mon Conv Corn 
Transferase 
2 
Ornithine aminotransferase, 
mitochondrial Precursor (EC 
2.6.1.13) (Ornithine--oxo-acid 
aminotransferase) 
2550, 2179 
Mcert Vs Mon Conv 
Corn, MON810 Vs Mon 
Conv Corn 
1 3-ketoacyl-CoA thiolase, mitochondrial 2222 
MON810 Vs Mon Conv 
Corn 
Response to stress         
(co-chaperone ) 2 Stress-induced-phosphoprotein 1 1485, 1564 
MON810 Vs Mon Conv 
Corn, MON810 Vs Mon 
Gold 
Ribonucleoprotein 
1 
Heterogeneous nuclear 
ribonucleoprotein A3 (hnRNP 
A3) 
4082 MON810 Vs Mon Garst 
1 heterogeneous nuclear ribonucleoprotein U 2550 Mcert Vs Mon Conv Corn 
1 40S ribosomal protein S3 2762 Mcert Vs Mon Conv Corn 
Repressor 1 chromobox homolog 3 3305 
Mcert Vs Mon Conv 
Corn, Mcert Vs Mon 
Gold 
Muscle protein 
1 Actin, gamma-enteric smooth muscle 3506 Mcert Vs Mon Conv Corn 
1 
Actin, cytoplasmic 1 Actin, 
cytoplasmic 1, N-terminally 
processed 
3506 Mcert Vs Mon Conv Corn 
Hydrolase 
1 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31) 2965 MON810 Vs Mon Garst 
1 Acyl-coenzyme A thioesterase 2, mitochondrial 4101 MON810 Vs Mon Garst 
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Molecular function number of proteins name of protein Spot No. Groups 
Protease 
1 
Proteasome subunit alpha type-4 
(EC 3.4.25.1) (Proteasome 
component C9) 
2912 Mcert Vs Mon Garst 
1 
Cytosol aminopeptidase (EC 
3.4.11.1) (Leucine 
aminopeptidase 3) (LAP-3) 
(Leucyl aminopeptidase)(Proline 
aminopeptidase) (EC 3.4.11.5) 
(Prolyl aminopeptidase) 
2442 MON810 Vs Mon Conv Corn 
1 Lactotransferrin; Lactoferrin; EC 3.4.21. 2893 MON810 Vs Mon Garst 
NADH dehydrogenase 
(ubiquinone) activity 
2 
NADH dehydrogenase 
(ubiquinone) 1 beta subcomplex, 
10 
3190, 3123 Mcert Vs Mon Conv Corn 
1 
NADH dehydrogenase 
(ubiquinone) 1 beta subcomplex, 
9 
3320 Mcert Vs Mon Conv Corn 
regulation of 
microtubule-based 
process 
1 Protein MEMO1 2762 Mcert Vs Mon Conv Corn 
Protein binding 1 Calcyclin-binding protein 2912 Mcert Vs Mon Garst 
Ligase 1 
Tyrosyl-tRNA synthetase, 
cytoplasmic (EC 6.1.1.1) 
(Tyrosyl--tRNA ligase) (TyrRS) 
1707 MON810 Vs Mon Conv Corn 
Actin capping 1 
Gelsolin Precursor (Actin-
depolymerizing factor) (ADF) 
(Brevin) 
2209 MON810 Vs Mon Garst 
Lyase 1 
Alpha-enolase (EC 4.2.1.11) (2-
phospho-D-glycerate hydro-
lyase) (Non-neural enolase) 
(NNE) (Enolase 1) 
1960 MON810 Vs Mon Garst 
DNA binding 1 
DNA-directed RNA polymerases 
I, II, and III subunit RPABC1 
(RNA polymerases I, II, and III 
subunit ABC1) (DNA-directed 
RNA polymerase II subunit E) 
2965 MON810 Vs Mon Garst 
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Chapter 5 
5 In vitro Effects of Transgenic Maize (Bt Maize MON810) Expressing 
Cry1Ab Protein (Bacillus Thuringiensis Toxin) on Mammalian 
Epithelial Cells. 
5.1 Characterization of test material 
     Western blot analyses of the grain extracts from MON810 revealed a band 
corresponding to the predicted molecular weight of Cry1Ab (65 KDa protein), confirming 
the presence of Cry1Ab in Bt maize.  This was absent from its corresponding parental non-
transgenic maize (Figure 5.1).  
5.2 Establishment in culture of epithelial cells isolated from rat small intestine and 
the commercial human epithelial cell line HCT116 
     Rat gut epithelial cells were successfully established in culture.  Examination of the 
morphology suggests that these cells were derived from progenitor cells and have the 
ability to rapidly proliferate in culture.  They do provide a good in vitro model for rat small 
intestine, particularly since they are derived from non-tumour cells.  In summary, these 
cells must be considered to be 'epithelial-like' (IE cells; Figure 5.2).  Human epithelial cell 
line HCT116 was sourced and successfully established in culture (Figure 5.3). 
5.3 Calibration of growth curve through the growth cell cycle 
     A growth curve was plotted when fresh medium was inoculated with a given number of 
cells   (5000 cells), and the growth monitored over a period of time (10 days).   Plotting the 
data yielded a typical growth curve for the normal epithelial-like cells and tumor cells 
(Figure 5.4 and 5.5; Table 5.1 and 5.2). 
     When the IE cells were grown in 24-well plates, starting with 5000 cells/well, the cells 
initially adjusted to the new medium (lag phase) and then started dividing regularly 
(exponential phase).  When their growth became limited, the cells stopt dividing (plateau 
phase or stationary phase), until eventually they showed loss of viability (death phase).  
When HCT116 cells were grown in 24-well plate (starting with 5000 cells/well) the cells 
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initially adjusted to the new medium showing a slow initial phase or lag phase followed by 
a middle phase characterized by rapid growth (exponential phase).  When their growth 
became limited the cells stopt dividing and showed loss of viability (death phase).  
However, unlike IECs, no plateau phase or stationary phase was observed.  
5.4 Cytotoxicity assessment (MTT assay) 
     MTT assays were conducted to evaluate the cytotoxicity of Bt maize extracts on IE cells 
and HCT116 cells (Table 5.3 and 5.4). 
     A non-toxic dose of extracts from both Bt maize and its near isogenic line at 
concentrations that are biologically meaningful but still present an effect, were used on the 
above cells.  The MTT data for the IE cells and HCT cells showed that IE cells are more 
sensitive than HCT116 cells to the toxicity of Bt maize and non-transgenic maize, 
indicating that these different cells have different sensitivities to Bt toxicity.  For IE cells, 
only 6.25 µg/ml produced acceptable low levels of toxicity, i.e. non-cytotoxic dose (<20% 
toxicity) from exposure to Bt maize and non-transgenic maize, with the higher 
concentrations tested showing unacceptable levels of cytotoxicity.  For HCT116 cells, 
doses of 50 µg/ml (the highest non-cytotoxic dose) were required to cause an acceptable 
toxic effect.   
     In vitro toxicological studies with IE cells in the presence of extracts from Bt maize and 
its near isogenic line indicates that there was no significant difference between the 
transgenic and parental lines and that the isolated gut epithelial cells are a suitable model 
for in vivo studies (Figure 5.6).  Similarly, In vitro toxicological studies with HCT116 cells 
in the presence of extracts from Bt maize and its near isogenic line indicates that there was 
no significant differences (Figure 5.7).  Statistical analyses suggest that the transgenic line 
expressing Bt in these single dose experiments is not toxic to these cells. 
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Figure 5.1: Immunoassay by western blot showing the presence of Cry1Ab in protein extracts from the seeds
of maize MON810.  Cry1Ab was absent in seed extracts of the near-isogenic parental line. 
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Figure 5.2: Rats small intestinal epithelial-like cells stained with coomassie brilliant blue
G-250 (X10). 
Figure 5.3: HCT116 cells stained with coomassie brilliant blue G-250 (X10). 
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Table 5.1: Viability of IE cells over a period of 10 days. 
Day No. of viable cells/ml x 106 
(Mean ±SE) 
0 0.005±0.000 
2 0.02875±0.002 
4 0.2175±0.015 
6 0.4625±0.107 
8 0.4875±0.050 
10 0.15±0.010 
 
Figure 5.4: Typical growth curve for IE cells showing the different phases. 
When IE cells were grown in 24 well plate starting with 5000 cells/well the cells initially
adjusted to the new medium (lag phase) until they can start dividing regularly (exponential 
phase).  When their growth becomes limited, the cells stop dividing (plateau phase or
stationary phase), until eventually they show loss of viability (death phase).  Growth was
expressed as change in the number viable cells vs time.  Each value represents the   mean
±SE.  
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Table 5.2: Viability of HCT116 over a period of 10 days. 
Day No. of viable cells/ml x 106 
(Mean ±SE) 
0 0.005±0.000   
2 0.0138±0.004   
4 0.0538±0.006   
6 0.316±0.027   
8 0.662±0.076   
10 0.514±0.062   
 
Figure 5.5: Typical growth curve for HCT116 cell line showing the different phases. 
When HCT116 cells were grown in 24 well plate starting with 5000 cells/well the cells initially
adjusted to the new medium showing a slow initial phase or lag phase until they can start
dividing rapidly (exponential phase).  When their growth becomes limited the cells stop
dividing and they show loss of viability (death phase). Unlike IECs, no plateau phase or
stationary phase was observed.  Growth was expressed as change in the number viable cells vs
time.  Each value represents the   mean ±SE.    
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Table 5.3: MTT assay results for evaluation of IE cell viability. 
Cells were exposed to the indicated concentration of non-Bt maize extract and Bt maize extract (6.25-
200µg/ml).  A dose of 6.25µg/ml of non-transgenic maize and Bt maize extract produced acceptable levels of 
toxicity (<20% toxicity). 
 
IE Cells 
Non-transgenic maize extract (control) Bt maize extract 
Concentration  µg/ml Viability % Concentration  µg/ml Viability % 
0 100 0 100 
6.25 79.16 6.25 77.07 
12.5 75.2 12.5 67.28 
25 76.26 25 63.88 
50 70.85 50 67.81 
100 63.16 100 58.77 
200 63.16 200 61.46 
 
Table 5.4: MTT assay results for evaluation of HCT116 cell viability. 
Cells were exposed to the indicated concentration of non-Bt maize extract and Bt maize extract (6.25-
200µg/ml).  A dose of 50ug/ml and less of non-transgenic maize and Bt maize extract produced acceptable 
levels of toxicity (<20% toxicity).  
  
HCT116 
Non-transgenic maize extract (control) Bt maize extract 
Concentration  µg/ml Viability % Concentration  µg/ml Viability % 
0 100 0 100 
6.25 83.39 6.25 84.35 
12.5 74.22 12.5 79.87 
25 82.53 25 78.98 
50 85.54 50 83.24 
100 73.28 100 76.63 
200 66.49 200 71.74 
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Figure 5.7:  Cytotoxic effects of extracts from Bt maize and its corresponding parental non-transgenic maize 
on human epithelial cell line HCT116. 
Cells were exposed to the indicated concentration of non-Bt maize extract and Bt maize extract (6.25-
200µg/ml).  As shown in this diagram, doses of 50µg/ml and less of non-transgenic maize and Bt maize 
produced acceptable levels of toxicity (<20% toxicity).  Statistical analyses indicate that there was no 
significant difference (p-value ˃0.05) between Bt and non-Bt maize.  Each value represents the mean ±SE.
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Figure 5.6: Cytotoxic effects of extracts from Bt maize and its corresponding parental non-transgenic maize on
epithelial cells isolated from rat small intestine. 
Cells were exposed to the indicated concentration of non-Bt maize extract and Bt maize extract (6.25-200µg/ml).  As
shown in this diagram, doses of 6.25µg/ml of non-transgenic maize and Bt maize produced acceptable levels of
toxicity (<20% toxicity).  Statistical analyses indicate that there was no significant difference (p-value ˃0.05)
between Bt and non-Bt maize.  Each value represents the mean ±SE. 
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5.5 Determination of exposure time of Bt and non-Bt maize extracts for both rat IE 
cells and the HCT116 cell line 
     To determine the optimal exposure time of IE cells and the HCT116 cell line to maize 
extracts, growth curves were constructed using the control medium (without any maize 
extracts) and medium with non-cytotoxic concentrations of both Bt and non-Bt maize 
extracts.  For both the control assay and the experimental assay, 5000 cells/well were 
seeded at day 0 in 24-well plates containing medium supplemented with 10% FBS and 
incubated for 24 hours.  After this duration, for the controls the medium was removed and 
new medium was added to each well, whereas for the experimental plates the medium was 
removed and new medium containing non-cytotoxic concentrations of either Bt maize 
extract or non-Bt maize extract (based on results from the MTT assay dose of 6.25µg/ml for 
IECs and dose of 50µg/ml for HCT116 cell line) was added to each well.  All plates were 
incubated for another 24 hours.  On day 2, the cells of 5 wells were trypsinised and cell 
numbers and viability were determined.  This was repeated for days 3, 4 and 5 (Table 5.5 
and Table 5.6).  All experiments were done in triplicate for each treatment (Figure 5.8 and 
Figure 5.9). 
     The results suggest that both Bt-maize and non-Bt maize affect growth of the IE cells (or 
possibly more cells have died in the treatment groups) as both treatments cause a slight 
reduction in cell numbers (Table 5.5).  However, neither of these maize seed extracts 
appeared to affect growth of the HCT116 cell line (Table 5.6).  However, statistical 
analyses indicate that there was no significant difference (p-value ˃0.05) between Bt and 
non-Bt maize extract on IE cells and HCT116 cell line.  Regarding to the observed results, 
the cells were incubated with the maize extracts for 4 days after seeding for the protein 
samples and not more than that period to avoid the cells from entering in a lag phase after 4 
days.  
5.6 Determination of protein concentration 
     Total protein concentrations of the IE cells and HCT116 cell line were determined using 
the 2-D Quant kit (GE healthcare, Sweden) as illustrated in Figure 5.10 and 5.11 and Table 
5.7 and 5.8. 
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Table 5.5: Growth curves for IE cells using control medium (without any maize extracts) and medium 
containing non-cytotoxic concentration (6.25µg/ml) of either Bt maize extract or non-Bt maize extract. 
Values show mean± standard error. 
 
Treatment 
(n=5) 
No. of viable cells/ml x 106 (Mean ±SE) 
Day 0 Day 2 Day 3 Day 4 Day 5 
Control 0.005±0.00 0.03±0.00 0.06±0.02 0.12±0.04 0.27±0.08 
Non-Bt maize 0.005±0.00 0.02±0.00 0.05±0.01 0.12±0.02 0.21±0.07 
Bt maize 0.005±0.00 0.03±0.01 0.04±0.01 0.09±0.03 0.21±0.05 
 
 
 
Figure 5.8: Growth curves for rat intestinal epithelial (IE) cells using control medium (without any maize 
extracts) and medium containing non-cytotoxic concentration of either Bt maize extract or non-Bt maize 
extract.  Statistical analyses indicate that there was no significant difference (p-value ˃0.05) between Bt, non-
Bt maize and the control. 
Values show mean± standard error. 
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Table 5.6: Growth curves for HCT116 cell line using control medium (without any maize extracts) and 
medium containing non-cytotoxic concentration (50µg/ml) of either Bt maize extract or non-Bt maize extract. 
Values show mean± standard error. 
 
Treatment 
(n=5) 
No. of viable cells/ml x 106 (Mean ±SE) 
Day 0 Day 2 Day 3 Day 4 Day 5 
Control 0.005±0.00 0.02±0.00 0.04±0.01 0.13±0.05 0.26±0.07 
Non-Bt maize 0.005±0.00 0.02±0.00 0.05±0.01 0.12±0.03 0.28±0.05 
Bt maize 0.005±0.00 0.02±0.00 0.05±0.01 0.13±0.05 0.28±0.07 
 
 
Figure 5.9: Growth curves for HCT116 cell line using control medium (without any maize extracts) and 
medium containing non-cytotoxic concentration of either Bt maize extract or non-Bt maize extract.  Statistical 
analyses indicate that there was no significant difference (p-value ˃0.05) between Bt, non-Bt maize and the 
control. 
Values show mean± standard error. 
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5.7 First dimensional electrophoresis (Isoelectric Focusing (IEF)) 
     Protein samples were focused successfully until they reached the steady state.  The 
steady state of IEF was indicated by two conditions: 1) Final high voltage (10000V) was 
reached; 2) current decreased and reached steady state (Figure 5.12).  
5.8 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
     Proteins samples were separated successfully by SDS-PAGE (Figure 5.13 and 5.14). 
5.9 2D gel image analysis and spot picking gels 
     Initial identification of differentially expressed proteins was carried out by Nonlinear 
Dynamics Ltd (UK).  However, before cutting the protein spots from the relevant gels for 
identification, further analysis was required as detailed in chapter 4. 
     Progenesis Samespot software version 4.1 was used for refining the analysis.  Average 
normalized volume of 200,000 was selected.  In general, the experimental design was not 
changed; several artefacts and false positives were removed.  There are also some spots that 
are readily detected as differentially expressed proteins, however they are quite faint on the 
actual gels and can be classified as "unpickable" spots or spots with low protein contents 
that may not contain enough protein for identification by mass spectroscopy.  Because of 
high resolution of the images and magnifying tools in Progenesis software, the number of 
the observed protein spots by using the software might be higher than the pickable protein 
spots in actual gels.  In the Filtering step there were 1627 spots. These were filtered by 
average normalised volume of 200,000.  This removed 273 features, leaving 1354 for 
further analysis.  The number of protein spots to pick for subsequent analysis was reduced 
from 90 to 48 (Table 5.9).  
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Figure 
5.10: 
Standar
d 
calibrati
on 
curve 
for protein concentration of the rat IE cells using bovine serum albumin (BSA) as a standard protein. 
 
Table 5.7: Protein concentrations of the rat IE cells. 
 1 2 mean x µg/5µl µg/µl µl/500ug µl/1300ug µl/1500ug 
IECs Bt maize 0.334 0.353 0.3435 60.785 12.157 41.128568 106.934277 123.385704 
IECs non-Bt maize 0.296 0.311 0.3035 66.5 13.3 37.593985 97.7443609 112.781955 
 
 
Figure 5.11: Standard calibration curve for protein concentration of the HCT116 cell line using bovine serum 
albumin (BSA) as a standard protein. 
 
Table 5.8: Protein concentrations of the HCT116 cell line. 
 1 2 mean x µg/5µl µg/µl µl/500ug µl/1300ug µl/1500 
HCT116  Bt maize 0.277 0.267 0.272 67.5 13.5 37.037037 96.2962963 111.111111 
HCT116 non Bt maize 0.295 0.286 0.2905 65.1875 13.0375 38.3509108 99.7123682 115.052733 
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Figure 5.12: A typical IEF run for protein sample of the rat IE cells with recorded
data of current, voltage and Vh. 
The first red arrow indicated the IPG buffer movement, the yellow arrow indicated
the salt movement and the blue arrow indicated the protein movement.  The green
arrow indicated that all proteins were focussed and steady state was reached. 
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Figure 5.13: Representative image of the colloidal coomassie brilliant blue G-250 stained 2D gel.  2D gel was used
to separate small intestinal epithelial-like cells (IE cells) proteins extracted from cultured IE cells exposed to Bt
maize extract. 
The first dimension was performed using immobilized pH 3-10 gradient gel strips, and followed by SDS-PAGE. 
Figure 5.14: Representative image of the colloidal coomassie brilliant blue G-250 stained 2D gel.  2D gel was used
to separate proteins extracted from HCT116 cell line exposed to Bt maize extract. 
The first dimension was performed using immobilized pH 3-10 gradient gel strips, and followed by SDS-PAGE. 
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     In ‘View Results’, all Filters were removed and all groups selected.  The entire 
complement of features were ranked by p-value (low to high), and then viewed individually 
to highlight their relevance.  Spots were removed according to the following:  
 Contained a streak.  
 De-staining issues leading to higher background signal, realising a false positive. 
 Very close to edge of gel, problematic separation.  
 Extra care was taken when assessing spots within the area of high protein 
concentration; acidic, high Mw.  
 Issues with alignment.  
     Spot picking gels are illustrated in Appendix 29 to 31 (see appendices to chapter 5).  
Protein spots that were picked are illustrated in Table 5.10. 
 
5.10 Protein identification using the global proteome machine (GPM) search engine 
     Protein IDs were done at the Burchmore lab, Glasgow Polyomics, University of 
Glasgow.  For protein identifications, the analysis of mass spectrometry data were assigned 
using the Global Proteome Machine (GPM) search engine (www.thegpm.org) to interrogate 
protein sequences in the ENSEMBL Rattus Norvegicus database.   The common Repository 
of Adventitious Proteins, cRAP (pronounced "cee-RAP"), is an attempt to create a list of 
proteins commonly found in proteomics experiments that are present either by accident or 
through unavoidable contamination of protein samples.  The types of proteins included fall 
into three general classes as detailed in chapter 4. 
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Table 5.9: Results summary for both IE cells and HCT116 cell line of the original number of spots and the 
Spots after refining. 
Treatment Original number of spots Spots after refining 
HCT116 Vs IEC for Bt samples. 56 30 
HCT116 Vs IEC for non-Bt samples. 24 12 
Bt Vs non-Bt for the IECs 09 06 
Bt Vs non-Bt for the HCT116 01 00 
Total 90 48 
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Table 5.10: Protein spots that have been picked from the 2D gels (43 spots). 
Bt Vs non Bt-maize for IECs 
samples 
HCT116 Vs IECs for Bt-maize 
samples 
HCT116 Vs IECs for non-Bt-maize 
samples 
1627 
1687 
2204 
2547 
2601 
2882 
814 
914 
1561 
1650 
1615 
1043 
3634 
1706 
1954 
1891 
2098 
2170 
2262 
2370 
2393 
2401 
2550 
2547 
2590 
2597 
3657 
2648 
2786 
2817 
2987 
3653 
3137 
3391 
3436 
3524 
 
 
914 
1687 
1895 
2370 
2600 
3663 
2817 
2877 
3667 
3360 
3120 
3309 
There were no differentially expressed protein spots between the HCT116 cell lines when cells were exposed 
to Bt maize and non-Bt maize extracts.   
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     Most of the proteins were successfully identified as illustrated in Appendix 32 
(Appendices to chapter 5).  In general, LC–MS/MS analysis of the 43 colloidal comassie 
brilliant blue stained 2-D gel protein spots representing all the differentially expressed 
protein spots between treatments (Table 5.10), generated a total of 152 protein 
identifications. Of the 43 spots, 36 spots were a mixture of two or more proteins, and 7 
spots generated single protein identification for each spot. 
5.10.1 Comparison of differentially expressed protein spots from IE cells and 
HCT116 cell line after exposure to Bt-maize extract 
     When comparing between HCT116 cell line and IE cells following exposure to Bt-maize 
extracts, 30 differentially expressed protein spots were analysed by LC-MS/MS.  LC–MS-
MS analysis of 30 colloidal comassie brilliant blue stained 2-D gel spots generated a total 
of 108 protein identifications.   Of the 30 spots, 25 spots were a mixture of two or more 
proteins, whilst only 5 spots generated single protein identification for each spot.  The 
threshold used to qualify differentially expressed spots was a Student t test, P value less 
than 0.05 and the false discovery rate (FDR, from q-values).   One thousand three hundred 
and twenty four spots were identified to be commonly expressed in both HCT116 cell line 
and IE cells whereas 10 up-regulated spots were identified for HCT116 (Spot No. 2393, 
2401, 3436, 1954, 1043, 2648, 2098, 2370, 1650, 3524) and 20 up-regulated spots were 
identified for IECs (Spot No. 2597, 814, 2547, 3634, 1561, 3653, 1891, 2262, 1615, 914, 
3391, 3137,2170, 2817, 2550, 2590, 2987, 3657, 2786, 1706) (Figure 5.15 a).   
     Comparison between differentially expressed proteins between HCT116 cell line and IE 
cells exposed to Bt maize (MON810) extracts showed that 5 stress-related proteins (3 
Stress-70 protein, 60 KDa heat shock protein and peroxiredoxin-1) were up-regulated 
(between 1.5-2.6 fold) in the former cell line and 19 stress related proteins (5 heat shock 
protein HSP 90-beta, 4 heat shock protein HSP 90-alpha, 4 stress-70 protein, heat shock 
protein 90 KDa beta member 1, T-complex protein 1 subunit epsilon, 2 60 KDa heat shock 
protein, T-complex protein 1 subunit alpha and peroxiredoxin-4) were up-regulated 
(between 1.5-4.4 fold) in IE cells.   
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5.10.2 Comparison of differentially expressed protein spots from IE cells and 
HCT116 cell line after exposure to non-transgenic near isogenic maize line extract 
     The venn diagram illustrated in Figure 5.15 (b) shows the number of 2D gel protein 
spots identified when comparing between HCT116 cell line and IE cells that were 
differentially expressed and up-regulated when cells were exposed to non-Bt maize extract.  
One thousand three hundred and forty two spots were identified to be commonly expressed 
in both HCT116 cell line and IE cells, whereas 5 up-regulated protein spots were identified 
for HCT116 (Spot No. 2600, 2877, 3309, 3360, 2370) and 7 up-regulated protein spots 
were identified for IE cells (Spot No. 914, 3663, 3667, 2817, 1895, 3120, 1687).  
Comparison between differentially expressed proteins between HCT116 cell line and IE 
cells exposed to non-Bt near isogenic maize extract showed that 8 stress-related proteins (2 
Stress-70 protein, heat shock protein 4 like, heat shock protein HSP 90-beta, peroxiredoxin-
1, thioredoxin peroxidase 2, 60 KDa heat shock protein and peroxiredoxin-4) were up-
regulated (between 1.3-1.9 fold) in the former cell line and 4 stress related proteins (heat 
shock protein HSP 90-alpha, heat shock protein HSP 90-beta, 60 KDa heat shock protein 
and heat shock-related 70 KDa protein 2) were up-regulated (between 1.2-1.9 fold) in IE 
cells.  
5.10.3 Comparison of differentially expressed protein spots from IE cells after 
exposure to Bt-maize and non-transgenic near isogenic maize line extract  
     The venn diagram illustrated in Figure 5.15 (c) shows the number of 2D gel protein 
spots identified when comparing between IE cells that were differentially expressed and up-
regulated when cells were exposed to Bt maize and non-Bt maize extract.  One thousand 
three hundred and forty eight spots were identified to be commonly expressed in both IE 
cells exposed to Bt maize extract and IE cells exposed to non-Bt maize extract whereas 4 
up-regulated spots were identified for IE cells exposed to Bt maize extract (Spot No. 2547, 
1627, 2601, 2882) and 2 up-regulated spots were identified for IE cells exposed to non-Bt 
maize extract (Spot No. 1687, 2204).  Comparison between differentially expressed 
proteins between IE cells exposed to Bt maize extract and IE cells exposed to non-Bt maize 
extract showed that 8 stress-related proteins (2 Stress-70 protein, heat shock protein HSP 
90-alpha, 2 heat shock protein HSP 90-beta, 2 T-complex protein 1 subunit epsilon and 60 
KDa heat shock protein) were up-regulated (between 2.1-3.7 fold) in the IE cells exposed to 
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Bt maize extract and 1 stress related proteins (heat shock-related 70 KDa protein 2) was up-
regulated (2.2 fold) in IE cells exposed to non-Bt maize extract.   
5.10.4 Comparison of differentially expressed protein spots from HCT116 cell line 
after exposure to Bt-maize and non-transgenic near isogenic maize line extract  
     The venn diagram illustrated in Figure 5.15 (d) shows the number of 2D gel protein 
spots identified when comparing between HCT116 cell lines that were differentially 
expressed and up-regulated when cells were exposed to Bt maize and non-Bt maize extract.  
One thousand three hundred and fifty four spots were identified to be commonly expressed 
in both HCT116 cell line exposed to Bt maize extract and HCT116 cell line exposed to non-
Bt maize extract and shows that there were no differentially expressed protein spots 
between the cells.   
     In order to assess functional relevance of changes in the identified differentially 
expressed proteins of IECs and HCT116, the proteins were aligned into 27 groups 
according to their molecular functions (Appendix 33 and 34).  Categorizations were based 
on information provided by the online resource UniProt classification system.  Some 
proteins were annotated manually, based on literature searches and closely related 
homologues.  For IECs, proteins were aligned into 14 groups according to their molecular 
functions (Table 5.11; Figure 5.16).   
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Figure 5.15: Two sets venn diagrams comparing the changes in the differentially expressed and up
regulated spot number when cells were exposed to Bt and non-Bt maize extracts. 
a) Venn diagram summarises the number of protein spots with differential expression and up-regulation
between HCT116 cell line and IE cells when exposed to dose of 50µg/ml of Bt maize extract for 
HCT116 cell line and 6.25µg/ml of Bt maize extract for IECs. b) Venn diagram summarises the number
of protein spots with differential expression and up-regulation between HCT116 cell line and IE cells
when exposed to dose of 50µg/ml of non-Bt maize extract for HCT116 cell line and 6.25µg/ml of non-
Bt maize extract for IE cells. c) Venn diagram summarises the number of protein spots with differential
expression and up-regulation when IE cells were exposed to dose of 6.25µg/ml of Bt and non-Bt maize 
extracts. d) Venn diagram summarises the number of protein spots with differential expression and up-
regulation when HCT116 cell line was exposed to dose of 50µg/ml of Bt and non-Bt maize extracts. 
Overlap between the two sets indicates those protein spots that were identified to be commonly
expressed in both treatments.   
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Table 5.11: Functional classification of the identified protein spots for IE cells. 
Spot No. 2547, 1627, 2601, 2882, 1687, 2204. 
 
 
 
Molecular 
function 
number of 
proteins name of protein Spot No. Groups 
structural 
molecule activity 
1 Actin, cytoplasmic 1 Actin, cytoplasmic 1 2601 IECs Bt vs IECs non-Bt 
1 Lamin-B1 2547 IECs Bt vs IECs non-Bt 
1 Nuclear migration protein nudC  2547 IECs Bt vs IECs non-Bt 
1 Tubulin beta-5 chain  2547 IECs Bt vs IECs non-Bt 
2 Moesin  2547, 2601 IECs Bt vs IECs non-Bt 
1 Vimentin  1687 IECs Bt vs IECs non-Bt 
chaperones 
1 Endoplasmin Precursor (Heat shock protein 90 kDa beta member 1) 2547 IECs Bt vs IECs non-Bt 
2 Heat shock protein HSP 90-beta  2547, 2601 IECs Bt vs IECs non-Bt 
1 Heat shock protein HSP 90-alpha  2547 IECs Bt vs IECs non-Bt 
2 T-complex protein 1 subunit epsilon  2547, 1627 IECs Bt vs IECs non-Bt 
1 60 kDa heat shock protein, mitochondrial  1627 IECs Bt vs IECs non-Bt 
1 Heat shock-related 70 kDa protein 2 1687 IECs Bt vs IECs non-Bt 
2 Stress-70 protein, mitochondrial Precursor  2547, 1627 IECs Bt vs IECs non-Bt 
Oxidoreductase 
1 L-lactate dehydrogenase B chain  2547 IECs Bt vs IECs non-Bt 
1 Aldose reductase  2547 IECs Bt vs IECs non-Bt 
1 aldo-keto reductase family 1, member B8 2547 IECs Bt vs IECs non-Bt 
Protein disulfide 
isomerase activity 1 Protein disulfide-isomerase  1687 IECs Bt vs IECs non-Bt 
Kinase 1 Pyruvate kinase isozymes M1/M2 2547 IECs Bt vs IECs non-Bt 
Transferase 1 S-adenosylmethionine synthetase isoform type-2  2547 IECs Bt vs IECs non-Bt 
Hydrolase 1 Transitional endoplasmic reticulum ATPase  2601 IECs Bt vs IECs non-Bt 
ATP binding 1 78 kDa glucose-regulated protein  1687 IECs Bt vs IECs non-Bt 
calcium ion 
binding 1 Annexin A2  2204 IECs Bt vs IECs non-Bt 
mitochondrial 
calcium ion 
homeostasis 
1 inner membrane protein, mitochondrial 1627 IECs Bt vs IECs non-Bt 
nucleotide 
binding 1 Nucleolin-like protein  2601 IECs Bt vs IECs non-Bt 
protein domain 
specific binding 
1 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) 2882 IECs Bt vs IECs non-Bt  
1 14-3-3 protein theta  2882 IECs Bt vs IECs non-Bt 
actin binding 1 14-3-3 protein gamma  2882 IECs Bt vs IECs non-Bt 
sodium channel 
regulator activity 1 14-3-3 protein eta  2882 IECs Bt vs IECs non-Bt 
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Figure 5.16: Functional classifications of differentially expressed intestinal epithelial cells proteins (IECs
Bt and IECs non-Bt). 
A total of 32 proteins were identified and these proteins fall within 14 major functional categories. 3 (9%)
contain oxidoreductase activity, 10 (31%) are chaperones, 1 (3%) contained transferase activity and 7
(22%) contained structural molecule activity. 
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Chapter 6 
6 Discussion 
     The present study investigated the effects of MON810, a commercial insect-resistant 
GM maize line expressing the δ-insecticidal protein Cry1Ab from Bacillus 
thuringiensis, on both the feed conversion efficiency and differential gene expression at 
the proteome level in the epithelial cells of the small intestine of rat as a non-target 
model system.  In addition, comparative in vitro studies of Cry1Ab on mammalian 
epithelial cells were conducted as a possible alternative to animal studies.  The potential 
cellular effects of Cry1Ab on mammalian epithelial cells are unknown.  Therefore, these 
cellular effects were investigated via changes in the proteome as a first stage, to look for 
possible changes in major metabolic/biosynthetic pathways.  Molecular proteomic 
profiling techniques were included for both the in vivo and in vitro approaches for the 
safety evaluation of MON810. For this study the maize lines used were grown 
simultaneously in neighbouring fields, using the same agricultural techniques and had 
therefore the same external climatic conditions, which eliminates or at least reduces 
environmental variables.  Three reference lines were used to determine whether the 
changes that may occur with the consumption of MON810 maize lay within the 
expected range for several different unmodified reference varieties or whether the 
change lies outside of it.  In addition, the compositional analysis indicated that both the 
transgenic and non-transgenic maize had similar nutritional composition, and thus the 
diets given to the animals were similarly balanced. 
6.1 Physiological effects of MON 810 in rats 
     In the present study potential effects of expression of Cry1Ab protein were limited to 
the measurements of the absolute body weight, body weight gain, food consumption 
and feed conversion efficiency. Monitoring body weight gain and food consumption in 
feeding studies with rats, ruminants, pigs and poultry can be a sensitive indicator of 
overall animal health.  The absence of any meaningful differences in these measured 
parameters across a variety of animal species provides further support for the 
comparability of MON810 to conventional corn varieties (Borzelleca, 1996).  However, 
other studies have also investigated the effects of Cry1Ab on blood chemistry, 
hematology, urine chemistry, organ weights, gross and microscopic appearance of 
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tissues, peripheral immune response and digestive fate of the Cry1Ab gene as discussed 
by below.  This was because previous extensive studies had already been carried out 
and was outside the scope of the present study.  Although it was necessary to verify the 
lack of toxicity of Cry1Ab protein in rats, the focus of the present study was to 
investigate the effects of MON810 at the subcellular level by evaluating the effects on 
the proteome of the epithelial cells from the small intestine of young male rates. 
     During the course of the 7 and 28-day rat feeding studies, no adverse behavioural 
effects on rats were observed and there were no significant differences in absolute body 
weights, body weight gains, food consumption and feed conversion efficiency between 
animals fed MON 810 in the diet when compared to animals fed diets containing grain 
from conventional control, reference varieties and the commercial rodent control.  
Whilst a small number of animals may affect the statistical power regarding the 
detection of subtle differences, in line with requirements governing the use of animals 
for experimentation (The three Rs, Balls and Fentem, 2008), four rats per group is 
considered to be the minimum, but acceptable, number used by the industry in such 
studies (Cockburn, pers. comm.). 
      The comparable responses of rats fed MON810 to rats fed control grain supports the 
absence of untoward pleiotropic effects in MON810 corn as confirmed in 
comprehensive composition studies as well as feeding studies in swine, poultry and 
ruminants with MON 810 and related Bt corn varieties that produce Cry1Ab protein in 
planta (Weber et al., 2000; Hammond et al., 2002; Donkin et al., 2003; Taylor et al., 
2003). 
     Hammond et al. (2006) have carried out a 90-day rat feeding study with grain from 
MON 810 corn (YieldGard®Cornborer – YieldGard Cornborer is a registered 
trademark of Monsanto Technology, LLC) that is protected against feeding damage 
from Corn borer insects.  Corn borer protection was accomplished through the 
introduction of Cry1Ab coding sequences into the corn genome for in planta production 
of a bioactive form of Cry1Ab protein.  In the study by Hammond et al. (2006), grain 
from MON810 and its near-isogenic control were separately formulated into rodent 
diets at levels of 11% and 33% (w/w) by Purina Mills, Inc. (PMI).  A total of 400 rats 
were used, these being divided into 10 groups of 20 rats/sex/group.  The responses of 
rats fed diets containing MON810 grain were compared to those of rats fed grain from 
conventional corn varieties.  Overall health, body weight, food consumption, clinical 
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pathology parameters (blood chemistry, hematology, and urine chemistry), organ 
weights, and gross and microscopic appearance of tissues were comparable between 
groups fed diets containing MON810 and conventional corn varieties.  The ‘‘no 
observed effect level’’ is equal to the highest dietary level of MON810 (33%) fed to 
rats.  From their studies, these authors hypothesized that substantial safety margins exist 
for human consumption of MON810 grain based on the rat feeding study and are 
supported by a lack of adverse effects in numerous farm animal feeding studies.  
Consistent with agronomic, compositional and farm animal feeding studies, the 90-day 
rat feeding study did not detect detrimental effects in the MON810 grain.  Thus, 
MON810 is considered to be substantially equivalent to, and as safe and nutritious as, 
conventional corn varieties (Hammond et al., 2006). 
     In agreement with these findings, a study was done by Kılıç and Akay (2008) on 
Wistar albino rats that were fed through three generations with either 20% Bt corn or its 
conventional counterpart corn (below the safety margin 33%) containing diets in order 
to maintain a balanced rodent diet in this long-term feeding study.  The Bt corn and its 
reference line that were used by Kılıç and Akay were obtained from the agency of 
Turkish Ministry of Agriculture and Rural Affairs.  No statistically significant 
differences were found in final body weights and relative organ weights (Liver and 
kidney) of rats within groups but there were some minimal histopathological changes in 
the liver and kidney.  They concluded that although the results obtained from their study 
showed minor histopathological effects in rats fed with Bt corn, long-term consumption 
of transgenic Bt corn throughout three generations did not cause severe health concerns 
on rats. 
     In addition, Onose et al. (2008) have evaluated the sub-chronic toxicity of dietary 
administered Cry1Ab protein from Bacillus thuringiensis in male rats with chemically 
induced gastrointestinal impairment.  They investigated the possible toxicity of Bt 
proteins under conditions of small intestinal damage and/or reduced gastricacid 
secretion.  Gastrointestinal impairment (GI) alone and GI with a purified Bt protein 
Cry1Ab fed (GI + Bt) groups were given intra-peritoneal injections of famotidine to 
decrease gastric acid secretion twice a day at 30 mg/kg body weight in weeks two and 
four. GI and GI + Bt groups were additionally fed diets containing 80 ppm 
indomethacin for chemical induction of intestinal damage during weeks one and three.    
Bt alone and GI + Bt groups were also fed diet containing Bt protein Cry1Ab at a 
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concentration of 10 ppm in weeks two and four.  A no treatment control group was also 
included in their study.  At the end of week four, all rats were euthanized under ether 
anesthesia and blood samples were collected for serum biochemistry and hematology 
and a complete necropsy was performed.  No significant changes indicative of toxicity 
of the Bt protein Cry1Ab were found with any of the parameters investigated.  From 
their study, they concluded that no significant toxicological effects were detected in this 
sub-chronic gastrointestinal impairment rat model. 
     The summary prepared by the GMO Panel of the European Food Safety Authority 
(EFSA) also supports the conclusion that Cry1Ab is not toxic to mammals.  Their 
conducted 90-day sub-chronic rodent studies and the analysis was performed on feed 
consumption, body weight, clinically observable adverse effects, clinical pathology 
during life, as well as organ weights and histopathology after study termination.  
Following their review of MON810 rat feeding studies for 90-day, they concluded that 
the results of that study do not indicate adverse effects from consumption of maize line 
MON810 (EFSA, 2004). 
     It is noteworthy that similar studies with pigs, as a human model, failed to 
demonstrate any toxic effects on either growth or the intestinal flora as a consequence of 
feeding on MON810 in either short-term or long-term studies (Walsh et al., 2011; 
Buzoianu et al., 2012a).  Furthermore, this group also showed that feeding sows 
MON810 did not cause any inflammation or allergy or effects on the peripheral immune 
response (Walsh et al., 2012; Buzoianu et al., 2012b).  Interestingly it would appear that 
Cry 1Ab is readily digested.     
     In addition to the effects of Bt maize, several studies have been carried out to 
investigate the effects of other Bt crops in rats.  One of these studies was a 90 day 
feeding trial on Wistar rats to assess the safety of Bt rice consumption.  Blood samples 
collected one week prior to sacrifice were analyzed and compared for biochemical and 
standard haematological parameters and the results showed that only a few parameters 
were significantly different, but all within the normal reference intervals for rats of this 
breed and age and not in relation to any other findings, thus these differences were not 
considered treatment related.  Upon sacrifice a large number of organs were weighed, 
histopathological and macroscopic examinations were carried out; the results showed no 
adverse or toxic effects of Bt rice in rats (Schrøder et al., 2007).  Another study 
performed by Kroghsbo et al. (2008) to examine the immunmodulating effect of Bt rice 
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expressing Cry1Ab protein from Bacillus thuringiensis (Bt) in 28- and 90-day Wistar 
rats feeding studies.  Similarly, no detrimental effects of Cry1Ab protein were found.  
Also Yuan et al. (2013) constructed a study to verify the safety of the consumption of Bt 
rice on gastrointestinal (GI) health of rats after 90 days by measuring a range of 
parameters including intestinal immunity, intestinal permeability, bacterial activity, 
fecal enzymes, epithelial structure, and microflora composition; again, no significant 
differences were found between genetically modified and non-genetically modified 
groups and no detrimental effects were found on GI health resulting from exposure to 
genetically modified Bt rice.  From their study, these authors hypothesized that this 
study may offer a systematic safety assessment model for GM crops with respect to the 
effects on GI health. 
6.1.1      Effects of consumption of MON810 on gene expression in rat small 
intestinal epithelial cells at the proteome level:  In vivo effects 
     To the best of our knowledge, this study is the first to evaluate the potential effects 
of transgenic maize (MON810) expressing Cry1Ab on differential gene expression in 
the epithelial cells of the small intestine (s.i.) of rats at the level of the proteome.  Thus, 
there are no direct comparative studies investigating effects of Bt Cry proteins on small 
intestine proteome.  The present study shows that many of the differentially expressed 
proteins are defense/stress-related proteins.  The focus of this study was on expression 
of stress-related proteins because these proteins act as indicators that the cells are 
exposed to different kinds of stress conditions, such as infection, inflammation, 
exercise, exposure of the cell to toxins, starvation, hypoxia, or water deprivation.  
Initially the study was conducted for 7 days to see if there is an acute effect and then for 
28 days to see if there is a sub-chronic effect of MON810 maize.  The time points 
selected in the present study, i.e. 7 days and 28 days, were selected on the basis of the 
OECD guidelines in respect of oral toxicity studies in rodents.  Whilst it is 
acknowledged that changes in the proteome are dynamic and will therefore change with 
time, what is important is to make a direct correlation between the proteome profile 
with potential toxicity at the same given time point.  Whilst changes to the epithelial 
small intestinal cells are likely to be detected within a much shorter time frame, 
physiological effects will take much longer to be detectable.  No positive control was 
used in this study, because, to the best of my knowledge, there are no appropriate 
molecules that could be used which exhibit an identical mode of action to that of 
Cry1Ab. 
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7-Day rat feeding trial: Acute effects 
     As mentioned above, rat body weights were similar in all animals during the whole 
experiment.  At sacrifice, body weight gain for the five different groups varied from 
31.5 to 38.5 g. However, there were no significant differences between control and GM 
maize-fed animals as well as to the other rats fed on reference maize diets and 
commercial rodent diet. 
Comparison between MON810 and Mon Conv Corn fed rats 
     Proteome analysis demonstrated that in MON810 maize-fed rats there were a number 
of differentially expressed proteins, mostly related to metabolic pathways (i.e. protein 
biosynthesis, lipid and carbohydrate metabolism) when compared to its parental control 
maize-fed rats (Mon Conv Corn group).  Interestingly, similar results were found with 
rats fed other maize varieties.   
     Comparison between differentially expressed proteins between rats fed MON810 
maize diet and its parental control diet (Mon Conv Corn group) showed that 2 stress-
related proteins (catalase and 60 kDa heat shock protein) were up-regulated in rats fed 
MON810 maize diet but no stress related proteins were up-regulated in Mon Conv Corn 
group. 
     This 60 kDa heat shock protein is known to be expressed in response to a wide 
variety of physiologicaland environmental insults, acting as molecular chaperones for 
nascent and stress-accumulated misfolded proteins, or mediating immunological 
functions, thus exerting a protective function.  Cells from virtually all organisms 
respond to a variety of stresses by the rapid synthesis of a highly conserved set of 
polypeptides termed heat shock proteins (HSPs).  The precise functions of HSPs are 
unknown, but there is considerable evidence that these stress proteins are essential for 
survival at both normal and elevated temperatures.  HSPs also appear to play a critical 
role in the development of thermotolerance and protection from cellular damage 
associated with stresses such as ischemia, cytokines, and energy depletion.  These 
observations suggest that HSPs play an important role in both normal cellular 
homeostasis and the stress response suggesting that the HSPs may be important 
modifying factors in cellular responses to a variety of physiologically relevant 
conditions such as hyperthermia, exercise, oxidative stress, metabolic challenge, and 
aging (Kregel, 2002).  Expression of HSPs occurs contributing to the higher capability 
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of young rats to cope against xenobiotics and stress conditions (Malatesta et al., 2008).  
Previous studies have shown that heat shock proteins (HSPs) are involved in 
cytoprotection mediated by their function as a molecular chaperone (Nakamura et al., 
1991; Schoeniger et al., 1994; Otaka et al., 1997).    Takada et al. (2010) have examined 
the effect of HSP60 or HSP70 over expression on hydrogen peroxide induced (H2O2) 
cell damage in the small intestinal epithelial cells.  They have established HSP60- or 
HSP70-overexpressing small intestinal epithelial cells by transfecting full length of 
human HSP60 or HSP70 cDNA to rat small intestinal (IEC-6) cells, and investigated 
the cytoprotective ability of these cells to withstand hydrogen peroxide-induced small 
intestinal epithelial cell injury.  These cells were treated with H2O2 (0–0.14 mM) and 
the viability of these cells was determined by MTT-assay, whilst cell necrosis was 
evaluated by LDH-release assay.  Furthermore, they evaluate apoptosis by caspases-3/7 
activity assay.  They found that the viability was significantly higher in both HSP60-
overexpressing cells and HSP70-overexpressing cells compared with that in control 
cells after H2O2 treatment; they also found that the apoptotic cells were also reduced in 
HSP60-overexpressing.  From their study, they concluded that HSP60 plays an 
important role in protecting small intestinal epithelialcells from H2O2-induced cell 
injury.  However, they found that HSP70-overexpressing cells did not show anti-
apoptotic ability.  From their findings, they suggested that the function of each HSP is 
different in the small intestine. Therefore, they suggested that for the therapy of small 
intestinal mucosal lesion, HSP60-induction therapy could be a new therapeutic strategy.  
     The other stress-related protein which was up regulated in rats fed MON810 maize 
diet is catalase.  Tissues are normally protected from oxidative damage by the presence 
of enzymes such as catalase, which is an oxidative stress response protein which occurs 
in almost all aerobically respiring organisms and serves to remove the hydrogen 
peroxide formed in the cells to protect them from the toxic effects of the hydrogen 
peroxide (Takeuchi et al., 1995).   
Comparison between MON810 and Mcert maize fed rats 
     Proteome analysis revealed an up-regulation of three stress-related proteins in 
MON810 maize-fed rats when compared to Mcert maize-fed rats, whereas no stress 
related proteins were up-regulated in Mcert maize-fed rats.  These stress-related proteins 
were catalase, 60 kDa heat shock protein and stress-induced phosphoprotein 1.  Stress-
induced phosphoprotein 1 (STIP1) is a 62.6 kDa protein, also known as heat shock 
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protein (HSP)-organizing protein (HOP).  STIP1 acts primarily as an adapter that directs 
HSP 90 to HSP 70-client protein complexes in the cytoplasm, but recent evidence 
suggests that STIP1 can also modulate the chaperone activities of these HSPs (Odunuga 
et al., 2004).  Overexpression of this protein may confer protective reactions or mediate 
anti-apoptosis signaling in the epithelial cells (Zhang et al., 2006). 
Comparison between MON810 and Mon Garst maize fed rats 
     Again, proteome analysis revealed an up-regulation of three stress-related proteins in 
MON810 maize-fed rats when compared to Mon Garst maize-fed rats, whereas no stress 
related proteins were up-regulated in Mon Garst maize-fed rats.  These stress-related 
proteins were thioredoxin-dependent peroxide reductase, peroxiredoxin-6 and LDLR 
chaperone MESD precursor.  Thioredoxin-dependent peroxide reductase enzyme 
protects radical-sensitive enzymes from oxidative damage by a radical-generating 
system (Masaki et al., 2003).  The antioxidant enzyme peroxiredoxin 6 (Prdx6) is a key 
regulator of the cellular redox balance, particularly under stress conditions and 
overexpressed Prdx6 reduced oxidative stress as reflected by the lower levels of 
oxidized phospholipids in the protumorigenic skin of Prdx6 transgenic mice (Rolfs et 
al., 2013).  In addition, there is increasing evidence that the peroxiredoxin plays a role 
in cell signaling, by controlling and/or sensing hydrogen peroxide and peroxynitrite 
levels (Bertoletto et al., 2012).  Prdx6 has important roles in both antioxidant defense 
based on its ability to reduce peroxidized membrane phospholipids and in phospholipid 
homeostasis based on its ability to generate lysophospholipid substrate for the 
remodeling pathway of phospholipid synthesis (Fisher, 2011).  LDLR chaperone MESD 
(Mesoderm development protein) precursor is a chaperone specifically assisting the 
folding of beta-propeller/EGF (epidermal growth factor) modules within the family of 
low-density lipoprotein receptors (LDLRs).  Members of the low-density lipoprotein 
receptor (LDLR) family require the chaperone called Mesoderm development, in the 
mouse. All LDLRs have at least one six-bladed beta-propeller domain, which is 
immediately followed by an epidermal growth factor (EGF) repeat (Koduri and 
Blacklow, 2007).  In the present study, the LDLR chaperone MESD precursor and 
peroxiredoxin-6 were uniquely differentially expressed in MON810 maize fed rats.  
Comparison between MON810 and Mon Gold maize fed rats 
     In addition, proteome analysis revealed an up-regulation of two stress-related 
proteins in MON810 maize-fed rats when compared to Mon Gold maize-fed rats, 
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whereas no stress related proteins were up-regulated in Mon Gold maize-fed rats.  These 
two stress-related proteins were peroxiredoxin-6 and LDLR chaperone MESD 
precursor, as discussed above. 
     Furthermore, comparison between differentially expressed proteins between rats fed 
Mcert maize, Mon Conv Corn, MON810 maize, Mon Garst maize and MON Gold 
maize showed that 2 stress-related proteins (LDLR chaperone MESD precursor and 
peroxiredoxin-6) were up-regulated in MON810 maize-fed rats and 1 stress-related 
protein (thioredoxin-dependent peroxide reductase) was up-regulated in the Mcert 
maize-fed rats.  These results highlight the importance of including other conventional 
varieties when evaluating the effects of a GM ingredient. 
Comparison between rats fed non-transgenic maize lines 
     Expression of HSPs and other stress-related proteins have been found with other 
maize varieties.  Comparison between differentially expressed proteins between rats fed 
Mcert maize diet and Mon Garst maize diet showed that 2 stress-related proteins 
(Thioredoxin-dependent peroxide reductase and protein DJ-1) were up-regulated in the 
Mcert maize-fed rats, but no stress related proteins were up-regulated in Mon Garst 
maize-fed rats.  DJ-1 is an antioxidant protein that participates in anti-oxidative stress 
reactions to protect cells against oxidative stress and cell death (Ariga et al., 2013).  
Comparison between differentially expressed proteins between Mcert maize-fed rats 
and Mon Conv Corn-fed rats showed that 1 stress-related protein (60 kDa heat shock 
protein) was up-regulated in the Mcert maize-fed rats and 1 stress related protein 
(stress-induced phosphoprotein 1) was up-regulated in Mon Conv Corn-fed rats.  
Comparison between differentially expressed proteins between Mon Conv Corn-fed rats 
and Mon Garst maize-fed rats showed that 1 stress-related protein (catalase) was up-
regulated in the Mon Conv Corn-fed rats.  Comparison between differentially expressed 
proteins between Mon Garst maize-fed rats and Mon Gold maize-fed maize showed that 
1 stress-related protein (T-complex protein 1 subunit beta) was up-regulated in the Mon 
Garst maize-fed rats.  T-complex protein 1 subunit beta is a molecular chaperone which 
assists the folding of proteins upon ATP hydrolysis (UniProtKB, 2013). 
     Importantly, the 7-day rat feeding trial data confirmed the up-regulation of a few 
stress-related proteins not only in MON810 maize-fed rats but also in its parental 
control maize-fed rats, reference maize variety-fed rats (Mon Garst group) and 
Chapter 6-Discussion 
 
146 
 
commercial maize-fed rats.  Thus, the subsequent up-regulation of these stress-related 
proteins in the rat small intestine is not unique to the GM maize diet, but was also 
shown to occur in the non-transgenic maize lines.  Thus, in vivo effects of these 
different maize varieties on the proteome of the epithelial cells of the small intestine 
were negligible, with only 2 stress-related proteins were up-regulated in MON810 
maize-fed rats and 1 stress-related protein was up-regulated in the Mcert maize-fed rats 
when the five different groups were compared to each other.  The difference in the 
number of these stress-related proteins is likely to be due to the physiological 
differences between rats.  However, there were no other studies to support this 
observation.  The only other study to have used proteomics to investigate the stress 
response in rodents was that of Zhang et al. (2003), who studied the differentially 
expressed proteins of gamma-ray irradiated mouse intestinal epithelial cells.  They 
compared the proteomics of mouse intestinal epithelial cells with its irradiated 
counterparts in vivo to provide an efficient resolution to analyze radiation related 
proteins directly at the protein level.  The intestinal epithelia were isolated from mice 
grouped as sham-irradiation, 3 h and 72 h irradiation and the mice were exposed to 9.0 
Gy single dose of γ-irradiation.  The irradiated mice were then killed 3 h and 72 h post-
radiation, and intestines were removed.  A series of methods, including two dimensional 
electrophoresis, PDQuest 2-DE software analysis, peptide mass fingerprinting based on 
matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-
TOF-MS) and SWISS-PROT database searching, were used to separate and identify the 
differential proteins.  They also used western blotting and RT-PCR to validate the 
differentially expressed proteins.  From their study, they found that the mouse intestine 
was severely damaged by 9.0 Gy γ-irradiation.  A total of 19 spots matched known 
proteins after database searching.  These proteins were mainly involved in metabolism, 
anti-oxidation, protein post-translational processes, and signal transduction.  They found 
that among the 19 preliminarily identified proteins, three spots belonged to oxidative 
stress response proteins, i.e., peroxiredoxin I, glutathione S-transferase P2, and 
antioxidant protein 2.  From their study, they concluded that these differentially 
expressed proteins might play important roles when mouse intestine was severely 
injured by γ-irradiation and they suggested that differential proteomic analysis may be a 
useful tool to study the proteins involved in radiation damage of mouse intestinal 
epithelia. 
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     In conclusion, the observed differences in the number of stress-related proteins 
identified in the 7-day feeding study are consistent with normal physiological variation 
between rats and are not related to the consumption of MON810 maize.  Therefore, the 
results of this study do not indicate adverse effects on the proteome of the small 
intestinal epithelial cells of rats from the consumption of the transgenic variety MON 
810 maize.   
28-Day rat feeding trial: Sub-chronic effects 
     The study design is an adaptation of the Organization for Economic Cooperation and 
Development (OECD) guideline No. 407 for a repeated dose 28-day oral toxicity study 
in rodents (OECD, 2008).  In the present study, rats were fed diets containing 33% 
(w/w, high dose) maize.  Rats were fed diets formulated with either MON810 maize or 
the parental control for MON810 corn (Mon Conv Corn group) or commercially 
available maize based rodent diet (Mcert group).  Two reference control groups (Mon 
Garst and Mon Gold groups) were included to establish a normal range of values for all 
the parameters measured.  The rats in these reference groups were fed on diets 
containing non-genetically modified maize varieties. 
     It is important to note that the study, while based on the protocol for a sub-chronic 
toxicity study, is a comparative feeding study, with different varieties of maize.  In this 
particular study, the highest level of incorporation in the diet of MON810 maize was 
33%.  The ability of feeding studies to detect adverse effects from a constituent present 
in a food product will be largely dependent on the intrinsic toxicity of any such 
constituent and whether it is present in the food in a sufficient amount to induce toxicity 
under the conditions of the study.  The study has been well designed and executed and 
the absence of any adverse effects in this study may however provide additional 
assurances of safety. 
     No treatment-related deaths or adverse effects were observed during the study; body 
weight gain, food consumption, feed conversion efficiency were similar across all 
groups.  At sacrifice, the body weight gain varied from 93.75 to 147.25 g.  As seen in 
the 7-day study, there were no significant differences between control and GM maize-
fed animals, or indeed between rats fed on reference maize diets and commercial rodent 
diet. 
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Comparison between MON810 and Mon Conv Corn fed rats 
     Proteome analysis demonstrated that in MON810 maize-fed rats the majority of the 
differentially expressed proteins were related to metabolic pathways when compared to 
its parental control maize-fed rats (Mon Conv Corn group).  Interestingly, the same 
results were found with the other maize varieties fed rats.   
     As with the 7-day study, proteome analysis revealed the up-regulation of several 
stress-related proteins in MON810 maize-fed rats when compared to its parental control 
maize-fed rats. Comparison between differentially expressed proteins between rats fed 
MON810 maize diet and its parental control diet (Mon Conv Corn group) showed that 2 
stress-related proteins (stress-induced phosphoprotein 1 and peroxiredoxin-1) were up-
regulated in rats fed MON810 maize diet and 1 stress related protein (superoxide 
dismutase) was up-regulated in Mon Conv Corn group.  Peroxiredoxin-1 and 
superoxide dismutase are antioxidant defense enzymes.  Peroxiredoxin-1 is involved in 
the redox regulation of cells, such as reducing peroxides with reducing equivalents 
throughthe thioredoxin system (Zhang et al., 2003).  The peroxiredoxin proteins have 
conserved cysteine residues that participate in oxidoreductive reactions and protect 
macromolecules from the oxidative damage.  Therefore, peroxiredoxin I is known to 
protect the cells from apoptosis by reducing oxidative damage (Ishii et al., 2000).  Ishii 
et al. (2000) investigated the induction of murine intestinal peroxiredoxin I by the 
dietary butylated hydroxyanisole (BHA), which is a synthetic phenolic antioxidant that 
is widely used as a food preservative.  The mice were fed a diet containing 0.7% (w/w) 
BHA for 7 days and they have found that dietary BHA induces intestinal peroxiredoxin 
I.  From their study, they found that the induction of peroxiredoxin I may be important 
to protect the cells and tissues against toxic electrophiles and reactive oxygen species.  
Superoxide dismutase destroys radicals which are normally produced within the cells 
and which are toxic to biological systems (MacMillan-Crow and Thompson, 1999). 
Comparison between MON810 and Mon Garst maize fed rats 
     Comparison between differentially expressed proteins between rats fed MON810 
maize and rats fed Mon Garst maize showed that 2 stress-related protein (stress-induced 
phosphoprotein 1 and 60 kDa heat shock protein) were up-regulated  in rats fed 
MON810 maize and 1 stress related protein (T-complex protein 1 subunit beta) was up-
regulated in rats fed Mon Garst maize. 
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Comparison between MON810 and Mon Gold maize fed rats 
     Similarly, comparison between differentially expressed proteins between rats fed 
MON810 maize and rats fed Mon Gold maize showed that 2 stress-related proteins (2 
stress-induced phosphoprotein 1) were up-regulated in rats fed MON 810 maize.  
Furthermore, comparison between differentially expressed proteins between all five 
groups (rats fed Mcert, Mon Conv Corn, MON810, Mon Garst and MON Gold maize) 
showed that 1 stress-related protein (stress-induced phosphoprotein 1) was up-regulated 
in rats fed MON810 maize. 
Comparison between rats fed non-transgenic maize lines 
     In the present study, expression of a stress-related protein was also found in rats fed 
the commercial maize based rodent diet (Mcert group).  Comparison between 
differentially expressed proteins between rats fed Mcert maize and Mon Conv Corn 
showed that 1 stress-related protein (peroxiredoxin-1) was up-regulated in rats fed 
Mcert maize. 
     Importantly, our 28-day rat feeding trial data confirmed the up-regulation of stress-
related proteins both in rats fed the GM (MON810) maize and those fed the non-
transgenic maize varieties.  These results highlight the importance of including other 
conventional varieties when evaluating the effects of a GM ingredient and these data 
suggest that these stress-related proteins found in MON810 maize-fed rats are not 
directly related to the consumption of MON810 maize diet, but are due to normal 
physiological variation.  Thus, in vivo effects of these different maize varieties on the 
proteome of the epithelial cells of the small intestine were negligible, with only 1 stress-
related protein being up-regulated in MON810 maize-fed rats when the five different 
groups were compared to each other. 
     Psychological stress is a common event in normal daily life and a mild stress can be 
beneficial because it improves physiological functions in the body, such as a mild 
increase in noradrenalin in the blood improves circulation; a little more secretions of 
thyrotrophic releasing hormone helps basic metabolism in the body (Gardner Jr, 2001). 
     The intestine is one of the common targets of stress.  The intestinal barrier consists 
of a single layer of epithelial cells and the tight junctions connect the epithelial cells to 
each other so as to form a barrier between the external environment and the internal 
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environment.  The intestinal epithelial barrier allows nutrients and water to be absorbed 
and prevents noxious substances from absorption (Nagler-Anderson, 2001).   
     As previously discussed, heat shock proteins (HSPs), also called stress proteins, are a 
group of proteins that are present in all cells and are induced when a cell undergoes 
various types of environmental stresses like heat, cold and oxygen deprivation 
(Trautinger, 2001).  HSPs are also present in cells under perfectly normal conditions 
acting like ‘chaperones,’ to make sure that the cell’s proteins are in the right shape and 
in the right place at the right time.  For example, HSPs help new or distorted proteins 
fold into shape, which is essential for their function.  They also shuttle proteins from 
one compartment to another inside the cell, and transport old proteins to ‘garbage 
disposals’ inside the cell.  Heat shock proteins are also believed to play a role in the 
trafficking of peptides to the cell surface to help the immune system recognize diseased 
cells (Fehrenbach and Northoff, 2000; Latchman, 2001).  Based on the information 
above, we suggest that HSPs in the intestinal epithelium can be affected by 
psychological stress and normal rat intestinal epithelial cells express HSPs.  Therefore, 
the expression of these stress-related proteins in the epithelial cells of the rat small 
intestine does not indicate any adverse effects, which can be directly related to 
MON810 maize.  The most compelling evidence for this is the comparison of results for 
test group individuals against those for the parental, references and commercial 
controls.  This clearly demonstrates that the observed differences in the number of 
stress-related proteins represent normal biological variability. 
     Similarly, Yang et al. (2009) have indicated that the normal rat intestinal epithelial 
cells express HSPs.  The rats in the Yang et al. study were subjected to chronic water 
deficient stress.  They found that the intestinal epithelial heat shock protein (HSP) 70 
was detected in normal intestinal epithelial cells and the chronic stress inhibited 
intestinal epithelial cell HSP70 expression at both mRNA and protein levels that 
correlated with the stress-induced intestinal epithelial hyperpermeability. Also, they 
found that the pretreatment with HSP70 abrogated stress-induced intestinal barrier 
dysfunction.  They suggest that these findings provide evidence in support of the 
concept that chronic stress is involved in many chronic disorders such as inflammatory 
bowel diseases.  Furthermore, that HSP70 inhibited chronic stress induced intestinal 
barrier dysfunction may prevent stress induced intestinal epithelial cell apoptosis. 
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     Wang et al. (2013) assessed the safety of transgenic Bt rice expressing Cry1Ab 
protein by establishing 30 and 90 day safety studies on female Swiss rats.  Their studies 
revealed that Bt rice had no significant effect on hematological indicators, calcium ion 
concentration of blood lymphocytes and apoptosis rate of blood lymphocytes, indicating 
that Cry1Ab protein could not affect the blood lymph of Swiss rat.  Similarly, Bt rice 
had no effect on enzyme activities including catalase (CAT), acetylcholine esterase 
(AChE), superoxide dismutase (SOD) and glutathione (GSH) in heart, liver, spleen, 
brain, kidney and ovary of Swiss rat.  These particular enzymes were selected for study 
as they are known to be involved in the stress response.  In addition to thses enzyme 
studies quantitative real-time PCR (qPCR) was used to analyze the transcript levels of 6 
genes encoding for these major detoxification enzymes in liver (AchE, CAT, SOD, 
alkaline phosphatase (ALP), glutamic oxalacetictransaminase (AST) and alanine 
aminotransferase (ALT).  QPCR analysis of these genes revealed that Cry1Ab rice 
exerted no influences on the levels of these transcripts in liver of Swiss rat.  No 
comparable studies with Bt maize appeare to have been carried out with rats.  Several 
studies have been carried out to investigate the effects of Cry1Ab protein on gene 
expression at the transcriptome level.  Guertler et al. (2012) carried out a long-term 
study with 36 lactating dairy cows fed GM maize (N = 18, MON810) or the near-
isogenic counterpart (N = 18) for a time period of 25 months to study the effect of 
feeding MON810 to cows and to investigate the fate of both the recombinant DNA and 
protein.  After a period of 25 months, tissues of the gastrointestinal tract (small 
intestine, large intestine and appendix) and samples from liver were used for gene 
expression analysis of major genes of the inflammation, cell cycle and apoptosis 
pathways.  These tissues were chosen due to the fact that immunactive Cry1Ab protein 
and its fragments are detectable in the gastrointestinal tract and therefore get in contact 
with the epithelial cells of the gastrointestinal tract.  The results indicate, that feeding 
GM maize (event MON810), compared to feeding the near-isogenic maize variety, does 
not influence the gene expression of biomarkers for apoptosis, inflammation and cell 
cycle in liver and in the gastrointestinal tract of cows.  Statistical analysis of the 
examined gene expression pattern revealed no significant difference in the gene 
expression profile of cows fed transgenic or near-isogenic feed ration.  Therefore, 
Guertler et al. (2012) assumed that compared to near-isogenic feed, GM maize 
MON810 does not have any effect on major genes involved in apoptosis, inflammation 
and cell cycle in the gastrointestinal tract and in the liver of dairy cows.  
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     In conclusion, the observed differences in the differentially expressed proteins are 
consistent with normal physiological variation and are not related to the consumption of 
MON810 maize per se.  The observed proteomic changes are similarly unremarkable 
for rats of this strain and age.  Therefore, the results of this study do not indicate adverse 
effects on the proteome of the small intestinal epithelial cells of rats from the 
consumption of the transgenic variety MON810 maize.  The differences observed are 
not believed to be of major biological importance and were not associated with any 
adverse health effects.  These data can potentially be extrapolated to the humans, 
considering the suitability of rats as a model for humans. 
6.2 Effect of Bt-maize extracts on cultured epithelial cells at the proteome level: 
In vitro effects 
     The increasing presence of GM food and feed on the market has provoked a strong 
demand for a comprehensive risk assessment by use of rat feeding studies.  Currently, 
there is an emphasis on reducing the number of animal experimentations.  The present 
study follows the OECD guidance document in terms of the recognition, assessment and 
use of clinical signs as humane endpoints for experimental animals used in safety 
evaluation (OECD, 2002).  The purpose of this guidance document was to apply the 
principles of the Three Rs (Replacement, Reduction, Refinement) to the use of animals 
in toxicity tests.  The principles of the 3Rs, Replacement, Reduction, Refinement, were 
defined as: 
• Replacement – Using non-animals methods which avoid or replace the use of animals 
such as cell culture. 
• Reduction – Minimising the numbers of animals used by improving the experimental 
design and statistical analysis used in a study. 
• Refinement – improving experimental procedures and other factors affecting animals 
such as their housing and care, to reduce suffering and improve welfare throughout the 
animals’ lives.  Alternative in vitro cell culture assays may contribute to risk 
assessment, yielding supplementary information on cellular physiological and 
biochemical modes of action of novel feed and food compounds (Bondzio et al., 2013). 
     The present study presents an in vitro model system that is useful as a supplementary 
tool in toxicity screening to study the effects of the insect-specific Bt-toxin Cry1Ab on 
the rat intestinal epithelial cells before testing substances on animals in vivo. 
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     The present study was performed to investigate the effects of transgenic maize 
(MON810) expressing Cry1Ab on the viability of rat intestinal epithelial cells (IECs) 
extracted from male Wistar rats and its potential impact on the proteome.  In addition, 
we investigated whether MON810 maize has any effect on the viability of the human 
transformed colon cancer cell line (HCT116) and its potential impact on the proteome.  
This is, to the best of our knowledge, only the second proteomic study performed on 
mammalian epithelial cells exposed to commercially available GMO.  The first study 
was done by Bondzio et al. (2013), as detailed below. 
     The Intestinal epithelial primary cells (IECs) used in the present study is a non-
transformed intestinal cell line originally derived from the small intestine, isolated from 
immature male Wistar rats.  IECs were selected for this study because these primary 
cells maintain differentiated characteristics and exhibit strong similarities to primary 
intestinal epithelial cells used in the rats feeding trial.  Therefore, these cells represent a 
potentially more suitable model than most commonly used transformed cell lines. 
     The MTT assay was conducted to evaluate the cytotoxicity of Bt maize extracts on 
IECs and HCT116 cells.  Extracts from both Bt maize and its near isogenic line (non-
transgenic maize), at non-toxic doses that are biologically meaningful but still see an 
effect, were used one the above cells.   For IECs, only the lowest concentration, 
6.25µg/ml, produced acceptable levels of toxicity (<20% toxicity) following exposure 
to Bt maize and non-transgenic maize.  For HCT116 cells, doses of 50µg/ml (the 
highest non-cytotoxic dose) and less, produced acceptable toxicity (<20% toxicity) 
following exposure to Bt maize and non-transgenic maize.  The MTT data for IEC cells 
and HCT cells showed that IECs are more sensitive than HCT116 cells to the toxicity of 
Bt maize and non-transgenic maize because different cells have different sensitivity to 
toxicity.  However, in vitro toxicological studies with IECs in the presence of extracts 
from Bt maize and its near isogenic line indicates that there was no significant 
differences.  Similarly, in vitro toxicological studies with HCT116 cells in the presence 
of extracts from Bt maize and its near isogenic line indicates that there was no 
significant differences.  Based on the statistical results of MTT assays of cell viability, 
we were able to suggest that the transgenic line expressing Bt in this single dose 
experiments is not toxic to these cells. 
     Similarly, Bondzio et al. (2013)  investigated the effects of Cry1Ab on porcine 
intestinal cells (IPEC-J2 cell line).  Different endpoint assays were performed.  Based 
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on three different assays (WST-1 conversion using the Cell Proliferation Reagent WST-
1 (Roche); the measurement of ATP content which indicates the energy metabolism of 
the cells; and the measurement of LDH release, which reflects the membrane integrity 
of the cells) a more comprehensive picture of the impact of Cry1Ab on IPEC J2 cells 
was obtained.  Moreover, Bondzio and colleagues used transepithelial electrical 
resistance (TEER) as a functional parameter on differentiated IPEC-J2 cells grown on 
collagen-coated membranes in order to characterize the barrier function.  Based on the 
results of these different parameters of cell viability they were able to exclude a short-
term toxic effect of Cry1Ab on cultured IPEC-J2 cells.  Furthermore, a novel electronic 
cell sensor array technology, the real-time cell analysis (RTCA) system, was used for 
dynamic monitoring of cellular events of the Cry1Ab response.  No cytotoxic effects 
were found, either from the use of the endpoint assays or by real-time monitoring.   
     Furthermore, Bondzio et al. (2008) have also introduced a new sheep rumen 
epithelial cell culture as an in vitro cell system to evaluate cytotoxicity of Cry1Ab, 
using lactate dehydrogenase (LDH) release, WST-1 conversion, ATP content and 
caspase 3/7 activity to evaluate cytotoxicity of Cry1Ab.  Neither cytotoxic effects nor 
signs of apoptosis were detected in rumen epithelial cells and no evidence for Cry1Ab 
mediated cytotoxicity was found. 
     However, Mesnage et al. (2013) have recently performed a study on the non-target 
effects of natural Bt toxins.  The mechanisms of action of insect resistance of natural Bt 
toxins are not fully understood and the metabolism of these proteins in mammals is 
currently unknown.  Mesnage et al. exposed human embryonic kidney 293 cell line to 
Cry1Ab.  Mitochondrial respiration assay (MTT) through the succinate dehydrogenase 
activity measurement and other cytotoxicity tests were used.  Mesnage et al. (2013) 
found that Cry1Ab led to respiration inhibition and plasma membrane alterations.  This 
could be consistent with the fact that the consumption of MON810 maize producing 
Cry1Ab (in the ppm range) induced signs of hepatorenal alterations in a subchronic 
feeding study on rats (De Vendômois et al., 2009).  This occurred at relatively high 
concentrations (100 ppm) in comparison to the concentrations normally produced in 
GM plants (1–20 ppm) (Székács et al., 2010).  However, the content can differ greatly 
according to the GM variety and environmental conditions under which the plants are 
grown (Then and Lorch, 2008). 
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     In an earlier study carried out by Shimada et al. (2003), primary cultured bovine 
hapatocytes were used as a model system to determine if Cry1Ab protein affects 
mammalian cells.  There were no significant changes in the secretion of albumin or the 
morphology of the Cry1Ab-treated cells.  The LDH release method showed a tendency 
to increase after the administration of Cry1Ab, but not significantly. Shimada et al. 
(2003) have taken these results on bovine hepatocytes into consideration suggesting that 
Cry1Ab has little acute toxicity on mammalian cells. 
     The similarity of amino acid sequence of novel protein with proteins that could have 
potential safety concerns, i.e., known toxins or allergens, is one of the key endpoints for 
assessing the safety of a novel protein.  For this reason, an amino acid sequence 
comparison was done on Cry1Ab/Ac protein.  The immunoglobulin E (IgE) cross-
reactivity between a newly expressed novel protein and a known allergen should be 
considered a possibility when there is more than 35% identity in a segment of 80 or 
more amino acids and it is reasonable to assume that only matches of eight contiguous 
and identical amino acids have relevance for identifying potential allergens.  The recent 
results of the in silico analysis showed no evidence for any similarity between the 
Cry1Ab protein and any known allergenic or toxic proteins, i.e., less than 35% identity 
with known allergens or toxins across a length of 80 amino acids and no continuous 
eight amino acids identity with known allergens.  However, theoretically the 
bioinformatics analysis of the Cry1Ab protein show that it is safe but the in silico 
analysis had to be verified by in vitro assays (Xu et al., 2009).  The bioinformatics 
analysis of the Cry1Ab protein shows no amino acid sequence similarity to known 
protein toxins or allergens (Delaney et al., 2008). 
     In the present in vitro approach, molecular proteomic techniques (2-DE) for 
investigating the effects of MON810 extracts were included.  Comparison between 
differentially expressed proteins between IECs exposed to Bt maize extract and IECs 
exposed to non-Bt maize extracts showed that 8 stress-related proteins (2 Stress-70 
protein, heat shock protein HSP 90-alpha, 2 heat shock protein HSP 90-beta, 2 T-
complex protein 1 subunit epsilon and 60 KDa heat shock protein) were up-regulated in 
the IECs exposed to Bt maize extract and 1 stress related protein (heat shock-related 70 
KDa protein 2) was up-regulatedin IECs exposed to the non-Bt maize extract.  
However, the majority of differentially expressed proteins were related to metabolic 
pathways.  Comparison between differentially expressed proteins between HCT116 cell 
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lines exposed to Bt maize and non-Bt maize extract showed that there were no 
differentially expressed protein spots between the cells.  Interestingly, we observed 
from the proteomic analyses that IECs are more sensitive than HCT116 cell line to the 
Bt maize extract and these results support the MTT assay results.  The identified stress 
proteins are multifunctional and involved in important cellular processes as discussed in 
the following section. 
     One protein which was up-regulated in the IECs exposed to Bt maize extracts is the 
stress-70 protein, which is implicated in the control of cell proliferation and cellular 
aging.  It also acts as a chaperone that is required for essential cellular functions, such 
as, protein folding and assembly or reassembly (UniProtKB, 2014e).  Two other 
proteins that were up-regulated are the heat shock protein HSP 90-alpha and heat shock 
protein HSP 90-beta.  These are both molecular chaperones that promote the maturation, 
structural maintenance and proper regulation of specific target proteins involved in cell 
cycle control and signal transduction.  These two molecular chaperones undergo a 
functional cycle that is linked to their ATPase activity.  This cycle probably induces 
conformational changes in the client proteins, thereby causing their activation.  They 
also are known to interact dynamically with various co-chaperones that modulate their 
substrate recognition, the ATPase cycle and the function of other chaperones  
(UniProtKB, 2014c; UniProtKB, 2014d).  A third protein that was found to be up-
regulated is T-complex protein 1 subunit epsilon which is a molecular chaperone that 
assists the folding of proteins upon ATP hydrolysis.  It is also known to play a role, in 
vitro, in the folding of actin and tubulin (Seo et al., 2010).  A 60 KDa heat shock 
protein was also identified, which is implicated in mitochondrial protein import and 
macromolecular assembly.  It is thought that this protein may facilitate the correct 
folding of imported proteins and also prevent misfolding.  Furthermore, it may promote 
the refolding and proper assembly of unfolded polypeptides generated under stress 
conditions in the mitochondrial matrix (UniProtKB, 2014a). 
     The only stress related protein which was up-regulated in the IECs exposed to the 
non-Bt maize extract is heat shock-related 70 KDa protein 2; Hsp70s is known to 
stabilize preexistent proteins against aggregation and mediate the folding of newly 
translated polypeptides in the cytosol as well as within organelles.  The Hsp70s 
participate in all these processes through their ability to recognize nonnative 
conformations of other proteins.  They bind extended peptide segments with a net 
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hydrophobic character exposed by polypeptides during translation and membrane 
translocation, or following stress-induced damage (UniProtKB, 2014b). 
     Similarly, Bondzio et al. (2013)  included a molecular proteomic profiling study 
based on 2-DE to evaluate the in vitro effects of Cry1Ab on porcine intestinal cells 
(IPEC-J2 cell line).  Only three proteins were differentially expressed in Bondzio's 
study.  Whilst these three proteins are multifunctional and involved in important cellular 
processes they are also associated with responses to stress.  They were identified as heat 
shock 70 kD protein, type II Keratin cytoskeletal 8 and heterogeneous nuclear 
ribonucleoprotein (HnRNP) H2-like.  This Hsp70 stress protein has been used to 
monitor the impact of environmental factors on various animal species, including pig as 
well as in in-vitro models (Bondzio et al., 2013).   
     There were no other proteomic studies on mammalian intestinal cells for comparison 
with the present study results as far as I am aware. 
     In the present study, heat shock proteins were found to be up-regulated in IE cells 
following exposure to Bt maize extracts.  This finding suggests that they may have a 
protective function and may represent an adaptive response for the maintaining of 
cellular homeostasis under stress.  By comparing the in vitro study with the in vivo 
study, we found that the 60 kDa heat shock protein was expressed in IECs exposed to Bt 
maize extracts as well as in rats fed MON810 maize in both 7-day and 28-day rat 
feeding trials and in rats fed commercial rodent diet for 7-day rat feeding trial. 
     These findings suggest that the combination of in vitro testing and proteomic 
analysis may serve as a promising tool for mechanism based safety assessment because 
the MTT cytotoxicity assay results agreed with the results obtained from the proteomic 
analysis of IECs and HCT116 cell line.  Further studies, particularly long-term 
investigations are needed to determine whether increased expression of heat shock 
proteins is only a transient short-term adaptive response to Cry1Ab or may be the cause 
of further unintended side effects of this protein. 
     Finally, the reason for doing the in vitro study was to see whether there is a viable 
alternative for animal studies by comparing the in vitro study with the results obtained 
from in the in vivo study.  In this particular system the effects both in the cytotoxicity 
assay and the proteomic results are in broad agreement.  Therefore, in my opinion this 
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particular system has potential to be a viable alternative for animal studies because the 
same epithelial cells were used in both the in vitro and in vivo studies.  However, we are 
a long way from being able to substitute animal studies.  
Conclusions 
 The results clearly demonstrated that there were no adverse behavioural effects 
on rats and no significant differences between any of the maize varieties tested 
on rat weight gain or food consumption in either 7-day or 28-day feeding 
studies.  Thus the transgenic variety MON810 had no adverse effects on these 
parameters. 
 The in vivo effects of these different maize varieties on the proteome of the 
epithelial cells of the small intestine were negligible, with only 3 proteins spots 
being up regulated in the small intestinal epithelial cells of rats fed MON810 for 
7 days and only 2 proteins spots being up regulated in the small intestinal 
epithelial cells of rats fed MON810 for 28 days, when compared to other maize 
varieties and to the commercial rodent diet. 
 The in vitro effects of MON810 and its near isogenic line on the proteome of the 
epithelial cell lines were negligible, with only 4 protein spots being up regulated 
in the small intestinal primary epithelial cells (IECs) when exposed to Bt maize 
extracts and 2 protein spots being up regulated when exposed to non-Bt maize 
extracts.  There were no differentially expressed spots in the HCT116 cell lines 
when exposed to either the Bt or non-Bt maize extracts. 
 The findings from the in vivo and in vitro studies were moderately similar and 
the studies reveal the absence of toxicity, with no adverse effects.  Considering 
the low concentrations of Cry1Ab protein in maize, it is highly unlikely to result 
in any toxic effects.  Digestibility of Cry1Ab expressed protein was 
demonstrated by the rapid degradation in simulated gastric or enteric juices.  
This is an additional guarantee of lack of absorption of the whole protein and 
absence of systemic absorption and is already an indication of the low allergenic 
potential of the protein.  Thus, MON810 is considered to be substantially 
equivalent to, and as safe and nutritious as, conventional corn varieties. 
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Future studies 
 Further studies to investigate the in vivo effects of the commercial GM crop 
(MON810), an insect resistant maize variety expressing the δ-insecticidal 
protein Cry1Ab from Bacillus thuringiensis, on differential gene expression at 
the proteome level in the liver of rat as a non-target model system using 
molecular proteomic profiling techniques (2-DE) will be useful in confirming 
the safety of MON810 maize.  The liver will be a suitable organ to choose 
because of the detoxification function of the liver. 
 Conducting comparative in vitro studies of Cry1Ab on liver cells may also be 
useful as a possible alternative to animal studies to assess the safety of MON810 
maize.
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Appendices 
Appendices to chapter 4 
Note: Supplementary information of the respective chapters. The first numeral in the 
caption indicates the chapter, where as the second numeral represents the increasing 
number of the Figure/Table within the same chapter. 
 
 
 
 
 
Appendix 1: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mcert diet
for 7 days. Protein spots from this gel were compared to those from comparator gels where rats were
feds on MON810 diet for 7 days. 
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1146, 1630, 2306, and 3258 (as
indicated on the proteome map). 
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Appendix 2: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mcert diet
for 7 days. Protein spots from this gel were compared to those from comparator gels where rats were
feds on Mon Garst diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1222, 1516, 1976, 2212, 2608,
3243, and 3248 (as indicated on the proteome map). 
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Appendix 3: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mcert diet
for 7 days. Protein spots from this gel were compared to those from comparator gels where rats were
feds on Mon Conv Corn diet for 7 days. 
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1146, 1580, 1976, 1950, 2016,
2021, 2045, 2212, 2249, 2400, 2511, and 2883 (as indicated on the proteome map). 
 
Appendices 
172 
 
 
 
 
 
 
Appendix 4: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mcert diet
for 7 days. Protein spots from this gel were compared to those from comparator gels where rats were
feds on Mon Gold diet for 7 days. 
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spot
that was picked for subsequent identification by LC-MS/MS was 2249 (as indicated on the proteome
map). 
Appendix 5: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MON810
diet for 7 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Garst diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1950, 2048, 2212, 2279, 2626, 
3243, and 3248 (as indicated on the proteome map). 
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Appendix 6: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MON810
diet for 7 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Conv Corn diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1328, 1777, 1950, 2004, 2045, 
2212, 2249, 2443, 2400, and 2883 (as indicated on the proteome map). 
Appendix 7: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MON810
diet for 7 days. Protein spots from this gel were compared to those from comparator gels where rats 
were feds on Mon Gold diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spot
that was picked for subsequent identification by LC-MS/MS was 2626 (as indicated on the proteome 
map). 
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Appendix 8: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mon Garst
diet for 7 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Conv Corn diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1257, 1777, 2249, 2443, 2400, and
2883 (as indicated on the proteome map). 
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Appendix 10: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mon
Garst diet for 7 days. Protein spots from this gel were compared to those from comparator gels where
rats were feds on Mon Gold diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spot
that was picked for subsequent identification by LC-MS/MS was 1444 (as indicated on the proteome
map). 
Appendix 9: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mon Conv
Corn diet for 7 days. Protein spots from this gel were compared to those from comparator gels where
rats were feds on Mon Gold diet for 7 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 2249, 2443, and 2883 (as indicated
on the proteome map). 
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Appendix 11: Removal of 50 features from the size standard of the aggregate gel image (28-day rat 
feeding trial). 
 
 
 
Appendix 12: Example of alignment issue.  
This spot was removed as the incorrect spot had been aligned in Mon Garst replicate 2 (28-day rat 
feeding trial). 
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Appendix 13: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MCert
diet for 28 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Conv Corn diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 2550, 2762, 3123, 3190, 3305,
3320, and 3506 (as indicated on the proteome map). 
Appendix 14: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MCert
diet for 28 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Garst diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spot
that was picked for subsequent identification by LC-MS/MS was 2912 (as indicated on the proteome
map). 
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Appendix 15: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MCert
diet for 28 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Gold diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 2149, and 3305 (as indicated on the
proteome map). 
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Appendix 17: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MON810 
diet for 28 days. Protein spots from this gel were compared to those from comparator gels where rats were 
feds on Mon Garst diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots 
that were picked for subsequent identification by LC-MS/MS were 1485, 1960, 1972, 2209, 2912, 2893, 
2965, 4082, and 4101(as indicated on the proteome map). 
 
Appendix 16: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MON810
diet for 28 days. Protein spots from this gel were compared to those from comparator gels where rats
were feds on Mon Conv Corn diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots
that were picked for subsequent identification by LC-MS/MS were 1485, 1707, 2179, 2232, 2222,
2442, 2550, 3123, 3190, 3255, 3320, and 3506 (as indicated on the proteome map). 
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Appendix 18: 2DE of the proteome of the epithelial cells from the small intestine of rats fed MON810 diet 
for 28 days. Protein spots from this gel were compared to those from comparator gels where rats were feds on 
Mon Gold diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots that 
were picked for subsequent identification by LC-MS/MS were 1485, 1564, 2149, 2232, and 3305 (as 
indicated on the proteome map). 
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Appendix 19: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mon 
Conv Corn diet for 28 days. Protein spots from this gel were compared to those from comparator gels
where rats were feds on Mon Garst diet for 28 days.  
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spot
that was picked for subsequent identification by LC-MS/MS was 1972 (as indicated on the proteome 
map). 
Appendix 20: 2DE of the proteome of the epithelial cells from the small intestine of rats fed Mon
Conv Corn diet for 28 days. Protein spots from this gel were compared to those from comparator
gels where rats were feds on Mon Gold diet for 28 days. 
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein
spot that was picked for subsequent identification by LC-MS/MS was 2149 (as indicated on the
proteome map). 
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Appendix 21: The Global Proteome Machine (GPM) search engine. 
Any rat database (e.g. UniProt or ENSEMBL) or all of them can be selected.  The following settings were applied:
method, ion trap (4Da); complete modifications, carbamidomethyl (CU); variable modification, oxidation (M). 
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Appendix 22: The search engine Global Proteome Machine (GPM) was used to putatively identify differentially
expressed proteins. The following settings were also applied: fragment mass error, 0.4 Da; parent mass error, ±0.3
Da; fragment type, monoisotopic; maximum parent charge, 4. 
Only identification with log(e) values ≤ -3 were regarded as significant hits regardless of the number of peptides.  
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Appendix 23: Clicking on table tab gave the list of identified proteins in one 2D gel spot. 
The lower the log(e) value means more confidence in protein ID. rl indicates the number of peptides involved 
in ID of that protein. 
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Appendix 24: Some of the list of proteins commonly found in proteomics experiments that
are present either by accident or through unavoidable contamination of protein samples. 
Human keratin is in the list of identified proteins as contaminants. 
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Appendix 25: Protein concentrations of the rats epithelial cells for the 7-day trial.  
Replicate 
1 
Replicate 
2 mean x µg/5µl µg/µl µl/1300µg 
Mcert R1 0.675 0.702 0.6885 28.071 5.6142 231.555698 
Mcert R2 0.687 0.641 0.664 31.571 6.3142 205.885148 
Mcert R3 0.616 0.619 0.6175 38.214 7.6428 170.09473 
Mcert R4 0.536 0.561 0.5485 48.071 9.6142 135.216659 
Mon810R1 0.484 0.488 0.486 57 11.4 114.035088 
Mon810R2 0.656 0.571 0.6135 38.785 7.757 167.590563 
Mon810R3 0.579 0.585 0.582 43.285 8.657 150.167495 
Mon810R4 0.499 0.543 0.521 52 10.4 125 
MonGarstR1 0.61 0.623 0.6165 38.357 7.6714 169.460594 
MonGarstR2 0.544 0.521 0.5325 50.357 10.0714 129.07838 
MonGarstR3 0.541 0.505 0.523 51.714 10.3428 125.691302 
MonGarstR4 0.652 0.699 0.6755 29.928 5.9856 217.187918 
MonGoldR1 0.556 0.547 0.5515 47.642 9.5284 136.434239 
MonGoldR2 0.599 0.597 0.598 41 8.2 158.536585 
MonGoldR3 0.596 0.554 0.575 44.285 8.857 146.776561 
MonGoldR4 0.514 0.52 0.517 52.571 10.5142 123.642312 
ConvCornR1 0.492 0.481 0.4865 56.928 11.3856 114.179314 
ConvCornR2 0.479 0.514 0.4965 55.5 11.1 117.117117 
ConvCornR3 0.554 0.558 0.556 47 9.4 138.297872 
ConvCornR4 0.669 0.635 0.652 33.285 6.657 195.283161 
 
 
 
 
 
 
 
 
Appendices 
187 
 
 
 
 
Appendix 26: Protein concentrations of the rats epithelial cells for the 28-day trial. 
Replicate 
1 
Replicate 
2 mean x µg/5µl µg/µl µl/1300ug 
Mcert R1 0.337 0.348 0.3425 60.928 12.1856 106.683298 
Mcert R2 0.435 0.398 0.4165 50.214 10.0428 129.445971 
Mcert R3 0.485 0.507 0.496 39 7.8 166.666667 
Mcert R4 0.413 0.422 0.4175 50.214 10.0428 129.445971 
Mon810R1 0.509 0.506 0.5075 37.357 7.4714 173.996841 
Mon810R2 0.501 0.508 0.5045 37.785 7.557 172.025936 
Mon810R3 0.455 0.361 0.408 51.571 10.3142 126.039829 
Mon810R4 0.397 0.408 0.4025 52.357 10.4714 124.147678 
MonGarstR1 0.595 0.597 0.596 24.714 4.9428 263.008821 
MonGarstR2 0.538 0.531 0.5345 33.5 6.7 194.029851 
MonGarstR3 0.482 0.51 0.496 39 7.8 166.666667 
MonGarstR4 0.45 0.437 0.4435 46.5 9.3 139.784946 
MonGoldR1 0.402 0.365 0.3835 55.071 11.0142 118.029453 
MonGoldR2 0.502 0.501 0.5015 38.214 7.6428 170.09473 
MonGoldR3 0.386 0.356 0.371 56.857 11.3714 114.321895 
MonGoldR4 0.437 0.437 0.437 47.428 9.4856 137.049844 
ConvCornR1 0.319 0.309 0.314 65 13 100 
ConvCornR2 0.307 0.39 0.3485 60.071 12.0142 108.20529 
ConvCornR3 0.455 0.437 0.446 46.142 9.2284 140.86949 
ConvCornR4 0.399 0.417 0.408 51.571 10.3142 126.039829 
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Appendix 27: Identification of differentially expressed proteins from the epithelial cells of the small intestine of rats fed different maize based diets for 7-day. 
The data represent two way comparisons as follows (Mcert vs Mon810, Mcert vs Mon Garst, Mcert vs Mon Conv Corn, Mcert vs Mon Gold, Mon810 vs Mon Garst, Mon810 vs 
Mon Conv Corn, Mon Garst vs Mon Conv Corn, Mon810 vs Mon Gold, Mon Garst vs Mon Gold, Mon Conv Corn vs Mon Gold) and five way comparisons. 
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Mcert Mon 810 
1146 2.5 7.44 63,795 
prelamin‐A/C  isoform 
C2 
Lamins are components of the nuclear lamina, a 
fibrous layer on the nucleoplasmic side of the inner 
nuclear membrane, which is thought to provide a 
framework for the nuclear envelope and may also 
interact with chromatin. Lamin A and C are present in 
equal amounts in the lamina of mammals. Plays an 
important role in nuclear assembly, chromatin 
organization, nuclear membrane and telomere 
dynamics.  Prelamin-A/C can accelerate smooth 
muscle cell senescence. It acts to disrupt mitosis and 
induce DNA damage in vascular smooth muscle cells 
(VSMCs), leading to mitotic failure, genomic 
instability, and premature senescence 
37  ‐165 6.5 74.3 
6.29E+05 1.59E+06 
Stress‐induced‐
phosphoprotein 1  
Mediates the association of the molecular chaperones 
HSC70 and HSP90 (HSPCA and HSPCB). 
11  ‐62.9  6.4 62.5 
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Mcert Mon 810 
heterogeneous  nuclear 
ribonucleoprotein  L 
isoform b  
This protein is a component of the heterogeneous 
nuclear ribonucleoprotein (hnRNP) complexes which 
provide the substrate for the processing events that pre-
mRNAs undergo before becoming functional, 
translatable mRNAs in the cytoplasm. Is associated 
with most nascent transcripts including those of the 
landmark giant loops of amphibian lampbrush 
chromosomes. Associates, together with APEX1, to 
the negative calcium responsive element (nCaRE) B2 
of the APEX2 promoter (Homo sapiens (Human)). 
10  ‐38.2  7.9 64.3 
T‐complex  protein  1 
subunit zeta  
Protein which is transiently involved in the 
noncovalent folding, assembly and/or disassembly of 
other polypeptides or RNA molecules, including any 
transport and oligomerisation processes they may 
undergo, and the refolding and reassembly of protein 
and RNA molecules denatured by stress. Though 
involved in these processes, chaperones are not an 
integral part of these functioning molecules. Also used 
for metallochaperones, which function to provide a 
metal directly to target proteins while protecting this 
metal from scavengers. 
5  ‐31.7  6.6 58 
Catalase   Occurs in almost all aerobically respiring organisms 
and serves to protect cells from the toxic effects of 
hydrogen peroxide. Promotes growth of cells. 
5  ‐31.4  7.1 59.7 
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Mcert Mon 810 
Electron  transfer 
flavoprotein‐ubiquinone 
oxidoreductase, 
mitochondrial  
Accepts electrons from ETF and reduces ubiquinone  3  ‐14.6  7.3 68.1 
1630 2.2 6.83 47,989 
ErbB3‐binding protein 
1  
May play a role in a ERBB3-regulated signal 
transduction pathway. Seems be involved in growth 
regulation. Acts a corepressor of the androgen receptor  
and is regulated by the ERBB3 ligand neuregulin-
1/heregulin (HRG). Inhibits transcription of some 
E2F1-regulated promoters, probably by recruiting 
histone acetylase (HAT) activity. Binds RNA. 
Associates with 28S, 18S and 5.8S mature rRNAs, 
several rRNA precursors and probably U3 small 
nucleolar RNA. May be involved in regulation of 
intermediate and late steps of rRNA processing. May 
be involved in ribosome assembly. Mediates cap-
independent translation of specific viral IRESs 
(internal ribosomal entry site) (Human) 
30  ‐101  6.4 43.6 
5.69E+05 1.24E+06 
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Mcert Mon 810 
prelamin‐A/C  isoform 
C2  
Lamins are components of the nuclear lamina, a 
fibrous layer on the nucleoplasmic side of the inner 
nuclear membrane, which is thought to provide a 
framework for the nuclear envelope and may also 
interact with chromatin. Lamin A and C are present in 
equal amounts in the lamina of mammals. Plays an 
important role in nuclear assembly, chromatin 
organization, nuclear membrane and telomere 
dynamics. Prelamin-A/C can accelerate smooth muscle 
cell senescence. It acts to disrupt mitosis and induce 
DNA damage in vascular smooth muscle cells 
(VSMCs), leading to mitotic failure, genomic 
instability, and premature senescence  
6  ‐40.8  6.5 74.3 
60  kDa  heat  shock 
protein, 
mitochondrial  
Implicated in mitochondrial protein import and 
macromolecular assembly. May facilitate the correct 
folding of imported proteins. May also prevent 
misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under 
stress conditions in the mitochondrial matrix. 
4  ‐23.2  5.9 60.9 
Protein  disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in 
proteins. 
3  ‐14  5.9 56.6 
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Mcert Mon 810 
2306 1.7 4.34 33,859 
Tropomyosin  alpha‐3 
chain  
Binds to actin filaments in muscle and non-
muscle cells. Plays a central role, in association 
with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle 
contraction. Smooth muscle contraction is 
regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing 
cytoskeleton actin filaments. 
63  ‐170  4.7 29 
5.65E+07 3.25E+07 
3258 1.6 4.35 32,615 
Tropomyosin  alpha‐1 
chain  (Tropomyosin‐
1)(Alpha‐tropomyosin)  
Binds to actin filaments in muscle and non-
muscle cells. Plays a central role, in association 
with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle 
contraction. Smooth muscle contraction is 
regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing 
cytoskeleton actin filaments.  
51  ‐109  4.7 28.5 
2.22E+07 1.36E+07 
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3248 6 9.22 43,593 3‐ketoacyl‐CoA  thiolase, mitochondrial   Pathway: Lipid metabolism; fatty acid metabolism.   
4  ‐19.5  8.4  41.9  3.93E+06 6.58E+05 
1222 2.4 4.1 63,450 
Calnexin Precursor   Calcium-binding protein that interacts with newly 
synthesized glycoproteins in the endoplasmic reticulum. It 
may act in assisting protein assembly and/or in the retention 
within the ER of unassembled protein subunits. It seems to 
play a major role in the quality control apparatus of the ER 
by the retention of incorrectly folded proteins. Associated 
with partial T-cell antigen receptor complexes that escape the 
ER of immature thymocytes, it may function as a signaling 
complex regulating thymocyte maturation. Additionally it 
may play a role in receptor-mediated endocytosis at the 
synapse. Calnexin is a chaperone, characterized by assisting 
protein folding and quality control, ensuring that only 
properly folded and assembled proteins proceed further along 
the secretory pathway.
Calnexin acts to retain unfolded or unassembled N-linked 
glycoproteins in the ER. 
4  ‐17.6  4.6  67.4 
4.45E+06 1.83E+06 
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2212 1.9 7.18 35,193 
Voltage‐dependent 
anion‐selective 
channel  protein  2 
(VDAC‐2)(Outer 
mitochondrial 
membrane  protein 
porin 2)(B36‐VDAC)  
Forms a channel through the mitochondrial outer 
membrane that allows diffusion of small hydrophilic 
molecules. The channel adopts an open conformation 
at low or zero membrane potential and a closed 
conformation at potentials above 30-40 mV. The open 
state has a weak anion selectivity whereas the closed 
state is cation-selective  
17  ‐72.9  7.4  31.8 
7.26E+06 3.77E+06 
3243 2.6 6.34 28,275 
Thioredoxin‐dependent 
peroxide  reductase, 
mitochondrial Precursor 
(EC 
1.11.1.15)(Peroxiredoxi
n‐3)(PRX‐3)(PRx III)  
Involved in redox regulation of the cell. Protects 
radical-sensitive enzymes from oxidative damage by a 
radical-generating system. Acts synergistically with 
MAP3K13 to regulate the activation of NF-kappa-B in 
the cytosol. (Human) 
9  ‐15.7  7.1  28.3 
2.86E+06 1.12E+06 
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2608 1.4 5.91 27,277 
UMP‐CMP  kinase  (EC 
2.7.4.14)(Cytidylate 
kinase) 
Catalyzes the phosphorylation of pyrimidine 
nucleoside monophosphates at the expense of ATP. 
Plays an important role in de novo pyrimidine 
nucleotide biosynthesis. Has preference for UMP and 
CMP as phosphate acceptors. (Human) 
10  ‐27.7  8.2  25.8 
5.28E+06 3.80E+06 
Electron  transfer 
flavoprotein  subunit 
beta (Beta‐ETF)  
The electron transfer flavoprotein serves as a specific 
electron acceptor for several dehydrogenases, including 
five acyl-CoA dehydrogenases, glutaryl-CoA and 
sarcosine dehydrogenase. It transfers the electrons to 
the main mitochondrial respiratory chain via ETF-
ubiquinone oxidoreductase (ETF dehydrogenase). 
(Human) 
3  ‐9  7.6  27.7 
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Protein  DJ‐1 
(Parkinson  disease 
protein 7 homolog)I 
Protects cells against oxidative stress and cell death. Plays a 
role in regulating expression or stability of the mitochondrial 
uncoupling proteins SLC25A14 and SLC25A27 in 
dopaminergic neurons of the substantia nigra pars compacta 
and attenuates the oxidative stress induced by calcium entry 
into the neurons via L-type channels during pacemaking. 
Eliminates hydrogen peroxide and protects cells against 
hydrogen peroxide-induced cell death. May act as an atypical 
peroxiredoxin-like peroxidase that scavenges hydrogen 
peroxide. Following removal of a C-terminal peptide, displays 
protease activity and enhanced cytoprotective action against 
oxidative stress-induced apoptosis. Stabilizes NFE2L2 by 
preventing its association with KEAP1 and its subsequent 
ubiquitination. Binds to OTUD7B and inhibits its 
deubiquitinating activity. Enhances RELA nuclear 
translocation. Binds to a number of mRNAs containing multiple 
copies of GG or CC motifs and partially inhibits their translation 
but dissociates following oxidative stress. Required for correct 
mitochondrial morphology and function and for autophagy of 
dysfunctional mitochondria. Regulates astrocyte inflammatory 
responses. Acts as a positive regulator of androgen receptor-
dependent transcription. Prevents aggregation of SNCA. Plays 
a role in fertilization. Has no proteolytic activity. Has cell-
growth promoting activity and transforming activity. May 
function as a redox-sensitive chaperone  
4  ‐7.2  6.3  20 
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1976 2.7 4.14 41,109 
Tropomyosin beta chain  Binds to actin filaments in muscle and non-muscle 
cells. Plays a central role, in association with the 
troponin complex, in the calcium dependent regulation 
of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with 
caldesmon. In non-muscle cells is implicated in 
stabilizing cytoskeleton actin filaments. The non-
muscle isoform may have a role in agonist-mediated 
receptor internalization  
23  ‐81.9  4.5  28.6 
1.22E+07 4.54E+06 
Tropomyosin  alpha‐1 
chain  
Binds to actin filaments in muscle and non-muscle 
cells. Plays a central role, in association with the 
troponin complex, in the calcium dependent regulation 
of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with 
caldesmon. In non-muscle cells is implicated in 
stabilizing cytoskeleton actin filaments. 
12  ‐48.8  4.7  32.7 
Calreticulin  Precursor 
(CRP55)(Calregulin)(HAC
BP)(Endoplasmic 
reticulum  resident 
protein 60)(ERp60) 
Calcium-binding chaperone that promotes folding, 
oligomeric assembly and quality control in the 
endoplasmic reticulum (ER) via the 
calreticulin/calnexin cycle. This lectin interacts 
transiently with almost all of the monoglucosylated 
glycoproteins that are synthesized in the ER. Interacts 
with the DNA-binding domain of NR3C1 and mediates 
its nuclear export. Involved in maternal gene 
expression regulation. May participate in oocyte 
maturation via the regulation of calcium homeostasis  
17  ‐39.2  4.3  48 
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1516 1.8 6.51 51,934 
aldehyde 
dehydrogenase  X, 
mitochondrial 
precursor  
ALDHs play a major role in the detoxification of 
alcohol-derived acetaldehyde. They are involved in the 
metabolism of corticosteroids, biogenic amines, 
neurotransmitters, and lipid peroxidation  
66  ‐288  6.6  57.6 
1.09E+07 5.95E+06 
4‐
trimethylaminobutyra
ldehyde 
dehydrogenase 
(TMABADH)(EC 
1.2.1.47)(Aldehyde 
dehydrogenase  family 
9  member  A1)(EC 
1.2.1.3)  
Converts  gamma‐trimethylaminobutyraldehyde  into 
gamma‐butyrobetaine. 
14  ‐73.9  6.9  56.4 
Aldehyde 
dehydrogenase, 
mitochondrial 
Precursor  (EC 
1.2.1.3)(ALDH  class 
2)(ALDH1)(ALDH‐E2)  
catalytic  activity:  An  aldehyde  +  NAD+  +  H2O  =  a  carboxylate  + 
NADH.  12  ‐67.2  7  56.4 
Protein  disulfide‐
isomerase A3  
Catalyzes  the  rearrangement  of  ‐S‐S‐  bonds  in 
proteins. 
4  ‐26.4  5.9  56.6 
  
 
199
 
S
p
o
t
 
N
o
.
 
F
o
l
d
 
E
x
p
e
r
i
m
e
n
t
a
l
 
p
I
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
W
 
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
r
I
 
l
o
g
(
e
)
 
T
h
e
o
r
i
t
i
c
a
l
 
p
I
 
T
h
e
o
r
i
t
i
c
a
l
 
M
W
 
(
K
i
l
o
D
a
l
t
o
n
s
)
 Average Normalised 
Volumes 
Mcert 
Mon 
Conv 
Corn 
2883 6.9 8.89 21,929 
Mesencephalic 
astrocyte‐derived 
neurotrophic  factor 
Precursor  (Protein 
ARMET)(Arginine‐rich 
protein) 
Selectively promotes the survival of dopaminergic 
neurons of the ventral mid-brain. Modulates 
GABAergic transmission to the dopaminergic neurons 
of the substantia nigra. Enhances spontaneous, as well 
as evoked, GABAergic inhibitory postsynaptic currents 
in dopaminergic neurons. Inhibits cell proliferation and 
endoplasmic reticulum (ER) stress-induced cell death. 
4  ‐18.3  8.5  20.4 
1.41E+06 9.70E+06 
1580 3 6.27 49,144 
Aldehyde 
dehydrogenase, 
mitochondrial 
Precursor (EC 1.2.1.3) 
Catalytic acyivity: An aldehyde + NAD+ + H2O = a 
carboxylate + NADH. 
20  ‐118  7  56.4 
1.18E+06 3.96E+05 
60  kDa  heat  shock 
protein, 
mitochondrial 
Implicated in mitochondrial protein import and 
macromolecular assembly. May facilitate the correct 
folding of imported proteins. May also prevent 
misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under 
stress conditions in the mitochondrial matrix. 
21  ‐110  5.9  60.9 
Protein  disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 8  ‐62.2  5.9  56.6 
  
 
200
S
p
o
t
 
N
o
.
 
F
o
l
d
 
E
x
p
e
r
i
m
e
n
t
a
l
 
p
I
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
W
 
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
r
I
 
l
o
g
(
e
)
 
T
h
e
o
r
i
t
i
c
a
l
 
p
I
 
T
h
e
o
r
i
t
i
c
a
l
 
M
W
 
(
K
i
l
o
D
a
l
t
o
n
s
)
 Average Normalised 
Volumes 
Mcert 
Mon 
Conv 
Corn 
Heterogeneous 
nuclear 
ribonucleoprotein 
HHeterogeneous 
nuclear 
ribonucleoprotein  H, 
N‐terminally 
processed  
This protein is a component of the heterogeneous 
nuclear ribonucleoprotein (hnRNP) complexes which 
provide the substrate for the processing events that pre-
mRNAs undergo before becoming functional, 
translatable mRNAs in the cytoplasm. Mediates pre-
mRNA alternative splicing regulation. Inhibits, 
together with CUGBP1, insulin receptor  pre-mRNA 
exon 11 inclusion in myoblast. Binds to the IR RNA. 
Binds poly(RG) 
5  ‐36.5  6.2  51.2 
Heterogeneous 
nuclear 
ribonucleoprotein  H2 
(hnRNP 
H2)(Heterogeneous 
nuclear 
ribonucleoprotein 
H')(hnRNP H')  
This protein is a component of the heterogeneous 
nuclear ribonucleoprotein (hnRNP) complexes which 
provide the substrate for the processing events that pre-
mRNAs undergo before becoming functional, 
translatable mRNAs in the cytoplasm. Binds poly(RG) 
4  ‐15.9  5.9  49.3 
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2511 3.2 6.09 29,404 
PAX  interacting  (with 
transcription‐activation 
domain) protein 1  
Involved in DNA damage response and in transcriptional 
regulation through histone methyltransferase (HMT) 
complexes. Plays a role in early development. In DNA 
damage response is required for cell survival after ionizing 
radiation. In vitro shown to be involved in the homologous 
recombination mechanism for the repair of double-strand 
breaks (DSBs). Its localization to DNA damage foci requires 
RNF8 and UBE2N. Recruits TP53BP1 to DNA damage foci 
and, at least in particular repair processes, effective DNA 
damage response appears to require the association with 
TP53BP1 phosphorylated by ATM at 'Ser-25'. Together with 
TP53BP1 regulates ATM association. Recruits PAGR1 to 
sites of DNA damage and the PAGR1:PAXIP1 complex is 
required for cell survival in response to DNA damage; the 
function is probbaly independent of MLL-containing histone 
methyltransferase (HMT) complexes. Promotes 
ubiquitination of PCNA following UV irradiation and may 
regulate recruitment of polymerase eta and RAD51 to 
chromatin after DNA damage. Proposed to be involved in 
transcriptional regulation by linking MLL-containing histone 
methyltransferase (HMT) complexes to gene promoters by 
interacting with promoter-bound transcription factors such as 
PAX2. Associates with gene promoters that are known to be 
regulated by MLL2. During immunoglobulin class switching 
in activated B-cells is involved in trimethylation of histone 
H3 at 'Lys-4' and in transcription initiation of downstream 
switch regions at the immunoglobulin heavy-chain  locus; 
this function appears to involve the recruitment of MLL-
containing HMT complexes. (Human) 
1  ‐1.2  8.8  93.9 
1.90E+07 5.90E+06 
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2021 2.9 4.5 39,794 
Actin,  cytoplasmic  1 
Actin, cytoplasmic 1, N‐
terminally processed  
Actins are highly conserved proteins that are involved in 
various types of cell motility and are ubiquitously expressed 
in all eukaryotic cells. 
17  ‐75.6  5.3  41.7 
4.08E+06 1.18E+07 
Actin,  gamma‐enteric 
smooth muscle  
Actins are highly conserved proteins that are involved 
in various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 
13  ‐51.1  5.3  41.8 
Tropomyosin  alpha‐1 
chain  
Binds to actin filaments in muscle and non-muscle 
cells. Plays a central role, in association with the 
troponin complex, in the calcium dependent regulation 
of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with 
caldesmon. In non-muscle cells is implicated in 
stabilizing cytoskeleton actin filaments. 
9  ‐31.2  4.7  32.7 
beta‐actin‐like protein 2  Actins are highly conserved proteins that are involved 
in various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells 
6  ‐29.8  5.3  41.9 
2016 2.1 5.56 39,900 
Actin,  cytoplasmic  1 
Actin, cytoplasmic 1, N‐
terminally processed  
Actins are highly conserved proteins that are involved 
in various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 
23  ‐86.9  5.3  41.7 
1.89E+07 9.20E+06 
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Eukaryotic  translation 
initiation  factor  3 
subunit  I 
(eIF3i)(Eukaryotic 
translation  initiation 
factor  3  subunit  2)(eIF‐
3‐beta) 
Component of the eukaryotic translation initiation 
factor 3 (eIF-3) complex, which is required for several 
steps in the initiation of protein synthesis. The eIF-3 
complex associates with the 40S ribosome and 
facilitates the recruitment of eIF-1, eIF-1A, eIF-
2:GTP:methionyl-tRNAi and eIF-5 to form the 43S 
preinitiation complex (43S PIC). The eIF-3 complex 
stimulates mRNA recruitment to the 43S PIC and 
scanning of the mRNA for AUG recognition. The eIF-
3 complex is also required for disassembly and 
recycling of post-termination ribosomal complexes and 
subsequently prevents premature joining of the 40S and 
60S ribosomal subunits prior to initiation  
10  ‐35.8  5.3  19.4 
Na(+)/H(+)  exchange 
regulatory  cofactor 
NHE‐RF1 
Scaffold protein that connects plasma membrane 
proteins with members of the ezrin/moesin/radixin 
family and thereby helps to link them to the actin 
cytoskeleton and to regulate their surface expression. 
Necessary for recycling of internalized ADRB2. Was 
first known to play a role in the regulation of the 
activity and subcellular location of SLC9A3. Necessary 
for cAMP-mediated phosphorylation and inhibition of 
SLC9A3. May enhance Wnt signaling. May participate 
in HTR4 targeting to microvilli. Involved in the 
regulation of phosphate reabsorption in the renal 
proximal tubules 
6  ‐34.3  5.7  38.8 
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N‐acetyl‐D‐glucosamine 
kinase  (N‐
acetylglucosamine 
kinase)(EC 
2.7.1.59)(GlcNAc 
kinase)  
Converts endogenous N-acetylglucosamine (GlcNAc), 
a major component of complex carbohydrates, from 
lysosomal degradation or nutritional sources into 
GlcNAc 6-phosphate. Involved in the N-
glycolylneuraminic acid (Neu5Gc) degradation 
pathway. Also has ManNAc kinase activity. 
3  ‐18.1  5.6  37.2 
2212 2.2 7.18 35,193 
Voltage‐dependent 
anion‐selective 
channel  protein  2 
(VDAC‐2)(Outer 
mitochondrial 
membrane  protein 
porin 2)(B36‐VDAC)  
Forms a channel through the mitochondrial outer 
membrane that allows diffusion of small hydrophilic 
molecules. The channel adopts an open conformation 
at low or zero membrane potential and a closed 
conformation at potentials above 30-40 mV. The open 
state has a weak anion selectivity whereas the closed 
state is cation-selective  
17  ‐72.9  7.4  31.8 
7.26E+06 3.77E+06 
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2249 4.4 9.64 34,773 
Voltage‐dependent 
anion‐selective  channel 
protein 1  
Forms a channel through the mitochondrial outer 
membrane and also the plasma membrane. The channel 
at the outer mitochondrial membrane allows diffusion 
of small hydrophilic molecules; in the plasma 
membrane it is involved in cell volume regulation and 
apoptosis. It adopts an open conformation at low or 
zero membrane potential and a closed conformation at 
potentials above 30-40 mV. The open state has a weak 
anion selectivity whereas the closed state is cation-
selective. May participate in the formation of the 
permeability transition pore complex (PTPC) 
responsible for the release of mitochondrial products 
that triggers apoptosis 
10  ‐44.3  8.6  30.7 
4.41E+06 1.92E+07 
Hydroxyacyl‐coenzyme 
A  dehydrogenase, 
mitochondrial  
Plays an essential role in the mitochondrial beta-
oxidation of short chain fatty acids. Exerts it highest 
activity toward 3-hydroxybutyryl-CoA. Pathway: Lipid 
metabolism; fatty acid beta-oxidation 
4  ‐12.3  8.8  34.4 
D‐beta‐hydroxybutyrate 
dehydrogenase, 
mitochondrial Precursor 
(BDH)(EC  1.1.1.30)(3‐
hydroxybutyrate 
dehydrogenase)  
Catalytic activity: (R)-3-hydroxybutanoate + NAD+ = 
acetoacetate + NADH. 
3  ‐7.3  9  38.3 
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2045 3.3 7.49 38,983 
Glyceraldehyde‐3‐
phosphate 
dehydrogenase  
Has both glyceraldehyde-3-phosphate dehydrogenase 
and nitrosylase activities, thereby playing a role in 
glycolysis and nuclear functions, respectively. 
Glyceraldehyde-3-phosphate dehydrogenase is a key 
enzyme in glycolysis that catalyzes the first step of the 
pathway by converting D-glyceraldehyde 3-phosphate 
(G3P) into 3-phospho-D-glyceroyl phosphate. 
Modulates the organization and assembly of the 
cytoskeleton. Facilitates the CHP1-dependent 
microtubule and membrane associations through its 
ability to stimulate the binding of CHP1 to 
microtubules. Also participates in nuclear events 
including transcription, RNA transport, DNA 
replication and apoptosis. Nuclear functions are 
probably due to the nitrosylase activity that mediates 
cysteine S-nitrosylation of nuclear target proteins such 
as SIRT1, HDAC2 and PRKDC. Component of the 
GAIT (gamma interferon-activated inhibitor of 
translation) complex which mediates interferon-
gamma-induced transcript-selective translation 
inhibition in inflammation processes. Upon interferon-
gamma treatment assembles into the GAIT complex 
which binds to stem loop-containing GAIT elements in 
the 3'-UTR of diverse inflammatory mRNAs (such as 
ceruplasmin) and suppresses their translation.  
Pathway: carbohydrate degradation; Glycolysis 
28  ‐119  8.1  35.8 
2.90E+06 8.87E+05 
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Annexin A2   Calcium-regulated membrane-binding protein whose 
affinity for calcium is greatly enhanced by anionic 
phospholipids. It binds two calcium ions with high 
affinity. 
4  ‐27.4  7.5  38.9 
1146 3.3 7.45 65 
prelamin‐A/C  isoform 
C2 
Lamins are components of the nuclear lamina, a fibrous 
layer on the nucleoplasmic side of the inner nuclear 
membrane, which is thought to provide a framework 
for the nuclear envelope and may also interact with 
chromatin. Lamin A and C are present in equal 
amounts in the lamina of mammals. Plays an important 
role in nuclear assembly, chromatin organization, 
nuclear membrane and telomere dynamics.  Prelamin-
A/C can accelerate smooth muscle cell senescence. It 
acts to disrupt mitosis and induce DNA damage in 
vascular smooth muscle cells (VSMCs), leading to 
mitotic failure, genomic instability, and premature 
senescence 
37  ‐165  6.5  74.3 
6.29E+05 2.08E+06 
Stress‐induced‐
phosphoprotein 1  
Mediates the association of the molecular chaperones 
HSC70 and HSP90 (HSPCA and HSPCB). 
11  ‐62.9  6.4  62.5 
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heterogeneous  nuclear 
ribonucleoprotein  L 
isoform b  
This protein is a component of the heterogeneous 
nuclear ribonucleoprotein (hnRNP) complexes which 
provide the substrate for the processing events that pre-
mRNAs undergo before becoming functional, 
translatable mRNAs in the cytoplasm. Is associated 
with most nascent transcripts including those of the 
landmark giant loops of amphibian lampbrush 
chromosomes. Associates, together with APEX1, to the 
negative calcium responsive element (nCaRE) B2 of 
the APEX2 promoter (Homo sapiens (Human)). 
10  ‐38.2  7.9  64.3 
T‐complex  protein  1 
subunit zeta  
Protein which is transiently involved in the 
noncovalent folding, assembly and/or disassembly of 
other polypeptides or RNA molecules, including any 
transport and oligomerisation processes they may 
undergo, and the refolding and reassembly of protein 
and RNA molecules denatured by stress. Though 
involved in these processes, chaperones are not an 
integral part of these functioning molecules. Also used 
for metallochaperones, which function to provide a 
metal directly to target proteins while protecting this 
metal from scavengers. 
5  ‐31.7  6.6  58 
Catalase   Occurs in almost all aerobically respiring organisms 
and serves to protect cells from the toxic effects of 
hydrogen peroxide. Promotes growth of cells. 
5  ‐31.4  7.1  59.7 
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Electron  transfer 
flavoprotein‐
ubiquinone 
oxidoreductase, 
mitochondrial  
Accepts electrons from ETF and reduces ubiquinone  3  ‐14.6  7.3  68.1 
2400 2.5 8.85 31,500 
coiled‐coil‐helix‐coiled‐
coil‐helix  domain 
containing protein 3 
Required for maintenance of mitochondrial crista 
integrity and mitochondrial function. May act as a 
scaffolding protein that stabilizes protein complexes 
involved in crista architecture and protein import. Has 
also been shown to function as a transcription factor 
which binds to the BAG1 promoter and represses 
BAG1 transcription. 
11  ‐46.7  8.3  26.4 
2.55E+06 6.35E+06 
Heterogeneous  nuclear 
ribonucleoproteins 
A2/B1 (hnRNP A2/B1)  
nvolved with pre-mRNA processing. Forms complexes 
(ribonucleosomes) with at least 20 other different 
hnRNP and heterogeneous nuclear RNA in the nucleus. 
(Human) 
3  ‐14  9.1  37.3 
1976 3.5 4.14 41,109 
Tropomyosin beta chain  Binds to actin filaments in muscle and non-muscle 
cells. Plays a central role, in association with the 
troponin complex, in the calcium dependent regulation 
of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with 
caldesmon. In non-muscle cells is implicated in 
stabilizing cytoskeleton actin filaments. The non-
muscle isoform may have a role in agonist-mediated 
receptor internalization  
23  ‐81.9  4.5  28.6 
1.22E+07 3.44E+06 
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Tropomyosin  alpha‐1 
chain  
Binds to actin filaments in muscle and non-muscle 
cells. Plays a central role, in association with the 
troponin complex, in the calcium dependent regulation 
of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with 
caldesmon. In non-muscle cells is implicated in 
stabilizing cytoskeleton actin filaments. 
12  ‐48.8  4.7  32.7 
Calreticulin  Precursor 
(CRP55)(Calregulin)(HA
CBP)(Endoplasmic 
reticulum  resident 
protein 60)(ERp60) 
Calcium-binding chaperone that promotes folding, 
oligomeric assembly and quality control in the 
endoplasmic reticulum (ER) via the 
calreticulin/calnexin cycle. This lectin interacts 
transiently with almost all of the monoglucosylated 
glycoproteins that are synthesized in the ER. Interacts 
with the DNA-binding domain of NR3C1 and mediates 
its nuclear export. Involved in maternal gene 
expression regulation. May participate in oocyte 
maturation via the regulation of calcium homeostasis  
17  ‐39.2  4.3  48 
1950 2.1 5.89 41,582 
Serpin  B5  (Peptidase 
inhibitor  5)(PI‐
5)(Maspin) 
Tumor suppressor. It blocks the growth, invasion, and 
metastatic properties of mammary tumors. As it does 
not undergo the S (stressed) to R (relaxed) 
conformational transition characteristic of active 
serpins, it exhibits no serine protease inhibitory activity 
12  ‐77.1  5.7  42 
1.82E+06 8.67E+05 
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3'(2'),5'‐bisphosphate 
nucleotidase  1  (EC 
3.1.3.7)(Bisphosphate 
3'‐nucleotidase  1)(PAP‐
inositol‐1,4‐
phosphatase)(PIP)(scHA
L2 analogous 3)  
Converts  adenosine  3'‐phosphate  5'‐phosphosulfate 
(PAPS)  to  adenosine  5'‐phosphosulfate  (APS)  and 
3'(2')‐phosphoadenosine  5'‐  phosphate  (Bravo  et  al.) 
to AMP. Has 1000‐fold  lower activity towards  inositol 
1,4‐bisphosphate  (Ins(1,4)P2)  and  inositol  1,3,4‐
trisphosphate  (Ins(1,3,4)P3),  but  does  not  hydrolyze 
Ins1P, Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6. 
12  ‐57.1  5.6  29 
Elongation factor 2  Catalyzes  the GTP‐dependent  ribosomal  translocation 
step  during  translation  elongation.  During  this  step, 
the  ribosome  changes  from  the  pre‐translocational 
(PRE)  to  the post‐translocational    state  as  the  newly 
formed A‐site‐bound  peptidyl‐tRNA  and  P‐site‐bound 
deacylated  tRNA  move  to  the  P  and  E  sites, 
respectively. Catalyzes  the  coordinated movement of 
the  two  tRNA  molecules,  the  mRNA  and 
conformational changes in the ribosome. 
17  ‐56.7  6.4  95.2 
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2249 2.3 9.64 34,773 
Voltage‐dependent 
anion‐selective  channel 
protein 1  
Forms a channel through the mitochondrial outer 
membrane and also the plasma membrane. The channel 
at the outer mitochondrial membrane allows diffusion 
of small hydrophilic molecules; in the plasma 
membrane it is involved in cell volume regulation and 
apoptosis. It adopts an open conformation at low or 
zero membrane potential and a closed conformation at 
potentials above 30-40 mV. The open state has a weak 
anion selectivity whereas the closed state is cation-
selective. May participate in the formation of the 
permeability transition pore complex (PTPC) 
responsible for the release of mitochondrial products 
that triggers apoptosis 
33  ‐116 8.6  30.7 
4.41E+06 1.93E+06 
Hydroxyacyl‐coenzyme 
A  dehydrogenase, 
mitochondrial  
Plays an essential role in the mitochondrial beta-
oxidation of short chain fatty acids. Exerts it highest 
activity toward 3-hydroxybutyryl-CoA. Pathway: Lipid 
metabolism; fatty acid beta-oxidation 
4  ‐12 8.8  34.4 
D‐beta‐hydroxybutyrate 
dehydrogenase, 
mitochondrial 
Precursor  
Catalytic activity: (R)-3-hydroxybutanoate + NAD+ = 
acetoacetate + NADH. 
3  ‐7.3 9  38.3 
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2212 3.4 7.18 35,193 
Voltage‐dependent 
anion‐selective 
channel  protein  2 
(VDAC‐2)(Outer 
mitochondrial 
membrane  protein 
porin 2)(B36‐VDAC)  
Forms a channel through the mitochondrial outer 
membrane that allows diffusion of small hydrophilic 
molecules. The channel adopts an open conformation 
at low or zero membrane potential and a closed 
conformation at potentials above 30-40 mV. The open 
state has a weak anion selectivity whereas the closed 
state is cation-selective  
17  ‐72.9  7.4  31.8 
1.28E+07 3.77E+06 
3248 3.7 9.22 43,593 
3‐ketoacyl‐CoA thiolase, 
mitochondrial  
Pathway: Lipid metabolism; fatty acid metabolism. Abolishes 
BNIP3-mediated apoptosis and mitochondrial damage. 
(Human) 
4  ‐19.5  8.4  41.9 
2.43E+06 6.58E+05 
2279 3.7 7.53 34,221 
Electron  transfer 
flavoprotein  subunit 
alpha,  mitochondrial 
Precursor (Alpha‐ETF)  
The electron transfer flavoprotein serves as a specific 
electron acceptor for several dehydrogenases, including 
five acyl-CoA dehydrogenases, glutaryl-CoA and 
sarcosine dehydrogenase. It transfers the electrons to 
the main mitochondrial respiratory chain via ETF-
ubiquinone oxidoreductase (ETF dehydrogenase). 
6  ‐39.9  8.6  34.9 
8.58E+06 2.34E+06 
Heterogeneous  nuclear 
ribonucleoproteins 
A2/B1 (hnRNP A2/B1)  
Involved with pre-mRNA processing. Forms 
complexes (ribonucleosomes) with at least 20 other 
different hnRNP and heterogeneous nuclear RNA in 
the nucleus  
5  ‐23.9  9.1  37.3 
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Voltage‐dependent 
anion‐selective  channel 
protein  2  (VDAC‐
2)(Outer  mitochondrial 
membrane  protein 
porin 2)(B36‐VDAC) 
Forms a channel through the mitochondrial outer 
membrane that allows diffusion of small hydrophilic 
molecules. The channel adopts an open conformation 
at low or zero membrane potential and a closed 
conformation at potentials above 30-40 mV. The open 
state has a weak anion selectivity whereas the closed 
state is cation-selective 
3  ‐19.6  7.4  31.8 
3243 2.5 6.34 28,275 
Thioredoxin‐dependent 
peroxide  reductase, 
mitochondrial 
Precursor  (EC 
1.11.1.15)(Peroxiredoxi
n‐3)(PRX‐3)(PRx III)  
Involved in redox regulation of the cell. Protects 
radical-sensitive enzymes from oxidative damage by a 
radical-generating system. Acts synergistically with 
MAP3K13 to regulate the activation of NF-kappa-B in 
the cytosol. (Human) 
9  ‐15.7  7.1  28.3 
2.83E+06 1.12E+06 
1950 1.6 5.89 41,582 
Serpin  B5  (Peptidase 
inhibitor  5)(PI‐
5)(Maspin) 
Tumor suppressor. It blocks the growth, invasion, and 
metastatic properties of mammary tumors. As it does 
not undergo the S (stressed) to R (relaxed) 
conformational transition characteristic of active 
serpins, it exhibits no serine protease inhibitory activity 
12  ‐77.1  5.7  42 
1.76E+06 1.09E+06 
3'(2'),5'‐bisphosphate 
nucleotidase  1  (EC 
3.1.3.7)(Bisphosphate 
3'‐nucleotidase  1)(PAP‐
inositol‐1,4‐
phosphatase)(PIP)(scHA
L2 analogous 3)  
Converts  adenosine  3'‐phosphate  5'‐phosphosulfate 
(PAPS)  to  adenosine  5'‐phosphosulfate  (APS)  and 
3'(2')‐phosphoadenosine  5'‐  phosphate  (Bravo  et  al.) 
to AMP. Has 1000‐fold  lower activity towards  inositol 
1,4‐bisphosphate  (Ins(1,4)P2)  and  inositol  1,3,4‐
trisphosphate  (Ins(1,3,4)P3),  but  does  not  hydrolyze 
Ins1P, Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6. 
12  ‐57.1  5.6  29 
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Elongation factor 2  Catalyzes  the GTP‐dependent  ribosomal  translocation 
step  during  translation  elongation.  During  this  step, 
the  ribosome  changes  from  the  pre‐translocational 
(PRE)  to  the post‐translocational    state  as  the  newly 
formed A‐site‐bound  peptidyl‐tRNA  and  P‐site‐bound 
deacylated  tRNA  move  to  the  P  and  E  sites, 
respectively. Catalyzes  the  coordinated movement of 
the  two  tRNA  molecules,  the  mRNA  and 
conformational changes in the ribosome. 
17  ‐56.7  6.4  95.2 
  
2626 
  
  
1.8 
  
  
6.19 
  
  
27,015 
  
LDLR  chaperone  MESD 
Precursor  (Mesoderm 
development  candidate 
2)(Mesoderm 
development protein)  
Chaperone specifically assisting the folding of beta-
propeller/EGF modules within the family of low-
density lipoprotein receptors (LDLRs). Acts as a 
modulator of the Wnt pathway through chaperoning the 
coreceptors of the canonical Wnt pathway, LRP5 and 
LRP6, to the plasma membrane. Essential for 
specification of embryonic polarity and mesoderm 
induction. (Human) 
10  ‐46.6  5.5  25.2 
3.75E+06 2.05E+06 
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Average Normalised 
Volumes 
Mon 810 Mon Garst 
Growth factor receptor‐
bound protein 2  
Adapter protein that provides a critical link between 
cell surface growth factor receptors and the Ras 
signaling pathway. Isoform 2 does not bind to 
phosphorylated epidermal growth factor receptor  but 
inhibits EGF-induced transactivation of a RAS-
responsive element. Isoform 2 acts as a dominant 
negative protein over GRB2 and by suppressing 
proliferative signals, may trigger active programmed 
cell death. (human) 
9  ‐36.4  5.9  25.2 
Peroxiredoxin‐6  (EC 
1.11.1.15)(Antioxidant 
protein  2)(1‐Cys 
peroxiredoxin)(1‐Cys 
PRX) 
Involved in redox regulation of the cell. Can reduce 
H2O2 and short chain organic, fatty acid, and 
phospholipid hydroperoxides. May play a role in the 
regulation of phospholipid turnover as well as in 
protection against oxidative injury  
7  ‐33.4  5.6  24.8 
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2048 1.7 7.12 39,058 
Glyceraldehyde‐3‐
phosphate 
dehydrogenase  
Has both glyceraldehyde-3-phosphate dehydrogenase 
and nitrosylase activities, thereby playing a role in 
glycolysis and nuclear functions, respectively. 
Glyceraldehyde-3-phosphate dehydrogenase is a key 
enzyme in glycolysis that catalyzes the first step of the 
pathway by converting D-glyceraldehyde 3-phosphate 
(G3P) into 3-phospho-D-glyceroyl phosphate. 
Modulates the organization and assembly of the 
cytoskeleton. Facilitates the CHP1-dependent 
microtubule and membrane associations through its 
ability to stimulate the binding of CHP1 to 
microtubules. Also participates in nuclear events 
including transcription, RNA transport, DNA 
replication and apoptosis. Nuclear functions are 
probably due to the nitrosylase activity that mediates 
cysteine S-nitrosylation of nuclear target proteins such 
as SIRT1, HDAC2 and PRKDC. Component of the 
GAIT (gamma interferon-activated inhibitor of 
translation) complex which mediates interferon-
gamma-induced transcript-selective translation 
inhibition in inflammation processes. Upon interferon-
gamma treatment assembles into the GAIT complex 
which binds to stem loop-containing GAIT elements in 
the 3'-UTR of diverse inflammatory mRNAs (such as 
ceruplasmin) and suppresses their translation  
4  ‐26.1  8.1  35.8 
3.76E+06 2.23E+06 
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THO  complex  subunit 6 
homolog  (WD  repeat‐
containing protein 58)  
Component  of  the  THO  subcomplex  of  the  TREX 
complex.  The  TREX  complex  specifically  associates 
with spliced mRNA and not with unspliced pre‐mRNA. 
It  is  recruited  to  spliced  mRNAs  by  a  transcription‐
independent mechanism. Binds to mRNA upstream of 
the exon‐junction  complex  (EJC) and  is  recruited  in a 
splicing‐ and cap‐dependent manner  to a region near 
the 5' end of  the mRNA where  it  functions  in mRNA 
export.  The  recruitment  occurs  via  an  interaction 
between ALYREF/THOC4  and  the  cap‐binding protein 
NCBP1.  DDX39B  functions  as  a  bridge  between 
ALYREF/THOC4 and the THO complex 
3  ‐14.9  6.7  37.4 
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Mon 810 
Mon 
Conv 
Corn 
2883 7.1 8.89 21,929
Mesencephalic 
astrocyte‐derived 
neurotrophic  factor 
Precursor  (Protein 
ARMET)(Arginine‐rich 
protein) 
Selectively promotes the survival of dopaminergic 
neurons of the ventral mid-brain. Modulates 
GABAergic transmission to the dopaminergic neurons 
of the substantia nigra. Enhances spontaneous, as well 
as evoked, GABAergic inhibitory postsynaptic currents 
in dopaminergic neurons. Inhibits cell proliferation and 
endoplasmic reticulum (ER) stress-induced cell death. 
(Mouse)  
4  ‐18.3  8.5  20.4 
1.36E+06 9.70E+06
1950 2 5.89 41,582
Serpin  B5  (Peptidase 
inhibitor  5)(PI‐
5)(Maspin) 
Tumor suppressor. It blocks the growth, invasion, and 
metastatic properties of mammary tumors. As it does 
not undergo the S (stressed) to R (relaxed) 
conformational transition characteristic of active 
serpins, it exhibits no serine protease inhibitory activity 
12  ‐77.1  5.7  42 
1.76E+06 8.67E+053'(2'),5'‐bisphosphate nucleotidase  1  (EC 
3.1.3.7)(Bisphosphate 
3'‐nucleotidase  1)(PAP‐
inositol‐1,4‐
phosphatase)(PIP)(scHA
L2 analogous 3)  
Converts  adenosine  3'‐phosphate  5'‐phosphosulfate 
(PAPS)  to  adenosine  5'‐phosphosulfate  (APS)  and 
3'(2')‐phosphoadenosine  5'‐  phosphate  (Bravo  et  al.) 
to AMP. Has 1000‐fold  lower activity towards  inositol 
1,4‐bisphosphate  (Ins(1,4)P2)  and  inositol  1,3,4‐
trisphosphate  (Ins(1,3,4)P3),  but  does  not  hydrolyze 
Ins1P, Ins(3,4)P2, Ins(1,3,4,5)P4 or InsP6. 
12  ‐57.1  5.6  29 
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Elongation factor 2  Catalyzes  the GTP‐dependent  ribosomal  translocation 
step  during  translation  elongation.  During  this  step, 
the  ribosome  changes  from  the  pre‐translocational 
(PRE)  to  the  post‐translocational  state  as  the  newly 
formed A‐site‐bound  peptidyl‐tRNA  and  P‐site‐bound 
deacylated  tRNA  move  to  the  P  and  E  sites, 
respectively. Catalyzes  the  coordinated movement of 
the  two  tRNA  molecules,  the  mRNA  and 
conformational changes in the ribosome. 
17  ‐56.7  6.4  95.2 
2443 5.7 9.53 30,665 
Succinate 
dehydrogenase  iron‐
sulfur  subunit, 
mitochondrial Precursor 
(EC  1.3.5.1)(Iron‐sulfur 
subunit of complex II) 
Iron-sulfur protein  subunit of succinate dehydrogenase 
(SDH) that is involved in complex II of the 
mitochondrial electron transport chain and is 
responsible for transferring electrons from succinate to 
ubiquinone (coenzyme Q). Pathway: Carbohydrate 
metabolism; tricarboxylic acid cycle; fumarate from 
succinate (eukaryal route): step 1/1. (Human). 
23  ‐65.3  9  31.8 
2.64E+06 1.50E+07 
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Proteasome  subunit 
alpha  type‐7  (EC 
3.4.25.1)(Proteasome 
subunit RC6‐1)  
The proteasome is a multicatalytic proteinase complex 
which  is characterized by  its ability to cleave peptides 
with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving 
group at neutral or slightly basic pH. The proteasome 
has  an  ATP‐dependent  proteolytic  activity.  Plays  an 
important role in the regulation of cell proliferation or 
cell  cycle  control,  transcriptional  regulation,  immune 
and  stress  response,  cell  differentiation,  and 
apoptosis.  Interacts  with  some  important  proteins 
involved  in  transcription  factor  regulation,  cell  cycle 
transition,  viral  replication  and  even  tumor  initiation 
and progression.  Inhibits  the  transactivation  function 
of HIF‐1A under both normoxic and hypoxia‐mimicking 
conditions. The  interaction with EMAP2  increases  the 
proteasome‐mediated  HIF‐1A  degradation  under  the 
hypoxic  conditions.  Plays  a  role  in  hepatitis  C  virus 
internal  ribosome  entry  site‐mediated  translation. 
Mediates  nuclear  translocation  of  the  androgen 
receptor    and  thereby  enhances  androgen‐mediated 
transactivation.  Promotes  MAVS  degradation  and 
thereby  negatively  regulates  MAVS‐mediated  innate 
immune response (Human). 
14  ‐52.2  8.6  28.4 
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ATP  synthase  subunit 
alpha, mitochondrial  
Mitochondrial  membrane  ATP  synthase  (F1F0  ATP 
synthase or Complex V) produces ATP from ADP in the 
presence  of  a  proton  gradient  across  the membrane 
which is generated by electron transport complexes of 
the  respiratory  chain.  F‐type  ATPases  consist  of  two 
structural  domains,  F1  ‐  containing  the 
extramembraneous catalytic core, and F0 ‐ containing 
the membrane  proton  channel,  linked  together  by  a 
central  stalk  and  a  peripheral  stalk. During  catalysis, 
ATP synthesis  in the catalytic domain of F1  is coupled 
via a rotary mechanism of the central stalk subunits to 
proton  translocation.  Subunits  alpha  and  beta  form 
the  catalytic  core  in  F1. Rotation of  the  central  stalk 
against the surrounding alpha3beta3 subunits leads to 
hydrolysis of ATP  in  three  separate  catalytic  sites on 
the  beta  subunits.  Subunit  alpha  does  not  bear  the 
catalytic high‐affinity ATP‐binding sites (Human) 
6  ‐33.8  9.3  59.8 
Dihydrolipoyllysine‐
residue 
succinyltransferase 
component  of  2‐
oxoglutarate 
dehydrogenase 
complex, mitochondrial  
Pathway:  Amino‐acid  degradation;  L‐lysine 
degradation  via  saccharopine  pathway;  glutaryl‐CoA 
from  L‐lysine:  step  6/6.  The  2‐oxoglutarate 
dehydrogenase  complex  catalyzes  the  overall 
conversion of 2‐oxoglutarate to succinyl‐CoA and CO2. 
It  contains  multiple  copies  of  3  enzymatic 
components:  2‐oxoglutarate  dehydrogenase  (E1), 
dihydrolipoamide  succinyltransferase  (E2)  and 
lipoamide dehydrogenase (E3). 
4  ‐19  8.9  48.9 
2400 2.1 8.85 31,500
coiled‐coil‐helix‐coiled‐
coil‐helix  domain 
containing 3 
Required for maintenance of mitochondrial crista 
integrity and mitochondrial function. May act as a 
scaffolding protein that stabilizes protein complexes 
involved in crista architecture and protein import. Has 
also been shown to function as a transcription factor 
which binds to the BAG1 promoter and represses 
BAG1 transcription. 
11  ‐46.7  8.3  26.4 
2.95E+06 6.35E+06
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Heterogeneous  nuclear 
ribonucleoproteins 
A2/B1 (hnRNP A2/B1)  
Nvolved with pre-mRNA processing. Forms 
complexes (ribonucleosomes) with at least 20 other 
different hnRNP and heterogeneous nuclear RNA in 
the nucleus. (Human) 
3  ‐14  9.1  37.3 
2212 3.9 7.18 35,193
Voltage‐dependent 
anion‐selective  channel 
protein  2  (VDAC‐
2)(Outer  mitochondrial 
membrane  protein 
porin 2)(B36‐VDAC)  
Forms a channel through the mitochondrial outer 
membrane that allows diffusion of small hydrophilic 
molecules. The channel adopts an open conformation 
at low or zero membrane potential and a closed 
conformation at potentials above 30-40 mV. The open 
state has a weak anion selectivity whereas the closed 
state is cation-selective  
17  ‐72.9  7.4  31.8 
1.28E+07 3.32E+06
2004 4.8 9.42 40,215
Malate  dehydrogenase, 
mitochondrial  
Catalytic activity: (S)-malate + NAD+ = oxaloacetate + 
NADH. 
4  ‐21.6  8.9  35.7  1.27E+06 6.05E+06
1777 2.7 8.15 43,948
Phosphoglycerate 
kinase 1  
Catalytic activity: ATP + 3-phospho-D-glycerate = 
ADP + 3-phospho-D-glyceroyl phosphate. 
27  ‐129  8  44.5 
6.02E+06 1.63E+07
Creatine  kinase  U‐type, 
mitochondrial  
Reversibly catalyzes the transfer of phosphate between 
ATP and various phosphogens (e.g. creatine 
phosphate). Creatine kinase isoenzymes play a central 
role in energy transduction in tissues with large, 
fluctuating energy demands, such as skeletal muscle, 
heart, brain and spermatozoa. 
14  ‐70  8.6  46.9 
3‐ketoacyl‐CoA  thiolase, 
mitochondrial  
Abolishes BNIP3-mediated apoptosis and 
mitochondrial damage  
11  ‐67.3  8.4  41.9 
Cytochrome  b‐c1 
complex  subunit  2, 
mitochondrial Precursor 
(Ubiquinol‐cytochrome‐
c  reductase  complex 
core  protein  2)(Core 
protein  II)(Complex  III 
subunit 2) 
This is a component of the ubiquinol-cytochrome c 
reductase complex (complex III or cytochrome b-c1 
complex), which is part of the mitochondrial 
respiratory chain. The core protein 2 is required for the 
assembly of the complex. 
5  ‐34.4  9.2  48.4 
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1328 2.4 7.55 57,752
Succinyl‐CoA:3‐
ketoacid‐coenzyme  A 
transferase  1, 
mitochondrial Precursor 
(EC 2.8.3.5) 
Key enzyme for ketone body catabolism. Transfers the 
CoA moiety from succinate to acetoacetate. Formation 
of the enzyme-CoA intermediate proceeds via an 
unstable anhydride species formed between the 
carboxylate groups of the enzyme and substrate  
24  ‐122  8.9  48 
2.17E+06 8.89E+05
Dihydrolipoyl 
dehydrogenase, 
mitochondrial Precursor 
(EC 
1.8.1.4)(Dihydrolipoami
de dehydrogenase)  
Lipoamide dehydrogenase is a component of the 
glycine cleavage system as well as of the alpha-
ketoacid dehydrogenase complexes. Involved in the 
hyperactivation of spermatazoa during capacitation and 
in the spermatazoal acrosome reaction  
17  ‐100  8  54 
UDP‐glucose  6‐
dehydrogenase  (UDP‐
Glc 
dehydrogenase)(UDP‐
GlcDH)(UDPGDH)(EC 
1.1.1.22)  
Involved in the biosynthesis of glycosaminoglycans; 
hyaluronan, chondroitin sulfate, and heparan sulfate. 
13  ‐74.7  7.1  54.9 
UPF0027  protein 
C22orf28 homolog (p55) 
Catalytic subunit of the tRNA-splicing ligase complex 
that acts by directly joining spliced tRNA halves to 
mature-sized tRNAs by incorporating the precursor-
derived splice junction phosphate into the mature 
tRNA as a canonical 3',5'-phosphodiester. May act as a 
RNA ligase with broad substrate specificity, and may 
function toward other RNAs 
9  ‐58.3  6.8  55.2 
Methylmalonate‐
semialdehyde 
dehydrogenase  , 
mitochondrial  
Plays a role in valine and pyrimidine metabolism. 
Binds fatty acyl-CoA. 
9  ‐35.7  8.4  57.7 
Catalase   Occurs in almost all aerobically respiring organisms 
and serves to protect cells from the toxic effects of 
hydrogen peroxide. Promotes growth of cells. 
4  ‐24.6  7.1  59.7 
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Centrosomal  protein  of 
55 kDa. 
Plays a role in mitotic exit and cytokinesis. Not 
required for microtubule nucleation. Recruits 
PDCD6IP and TSG101 to midbody during cytokinesis  
4  ‐23.1  7.6  54 
60  kDa  heat  shock 
protein, mitochondrial  
Implicated in mitochondrial protein import and 
macromolecular assembly. May facilitate the correct 
folding of imported proteins. May also prevent 
misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under 
stress conditions in the mitochondrial matrix. 
4  ‐22.4  5.9  60.9 
2249 8.1 9.64 34,773
Voltage‐dependent 
anion‐selective  channel 
protein 1  
Forms a channel through the mitochondrial outer 
membrane and also the plasma membrane. The channel 
at the outer mitochondrial membrane allows diffusion 
of small hydrophilic molecules; in the plasma 
membrane it is involved in cell volume regulation and 
apoptosis. It adopts an open conformation at low or 
zero membrane potential and a closed conformation at 
potentials above 30-40 mV. The open state has a weak 
anion selectivity whereas the closed state is cation-
selective. May participate in the formation of the 
permeability transition pore complex (PTPC) 
responsible for the release of mitochondrial products 
that triggers apoptosis 
10  ‐44.3  8.6  30.7 
2.36E+06 1.92E+07
Hydroxyacyl‐coenzyme 
A  dehydrogenase, 
mitochondrial  
Plays an essential role in the mitochondrial beta-
oxidation of short chain fatty acids. Exerts it highest 
activity toward 3-hydroxybutyryl-CoA. Pathway: Lipid 
metabolism; fatty acid beta-oxidation 
4  ‐12.3  8.8  34.4 
D‐beta‐hydroxybutyrate 
dehydrogenase, 
mitochondrial Precursor 
(BDH)(EC  1.1.1.30)(3‐
hydroxybutyrate 
dehydrogenase)  
Catalytic activity: (R)-3-hydroxybutanoate + NAD+ = 
acetoacetate + NADH. 
3  ‐7.3  9  38.3 
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2045 4 7.49 38,983
Glyceraldehyde‐3‐
phosphate 
dehydrogenase  
Has both glyceraldehyde-3-phosphate dehydrogenase 
and nitrosylase activities, thereby playing a role in 
glycolysis and nuclear functions, respectively. 
Glyceraldehyde-3-phosphate dehydrogenase is a key 
enzyme in glycolysis that catalyzes the first step of the 
pathway by converting D-glyceraldehyde 3-phosphate 
(G3P) into 3-phospho-D-glyceroyl phosphate. 
Modulates the organization and assembly of the 
cytoskeleton. Facilitates the CHP1-dependent 
microtubule and membrane associations through its 
ability to stimulate the binding of CHP1 to 
microtubules. Also participates in nuclear events 
including transcription, RNA transport, DNA 
replication and apoptosis. Nuclear functions are 
probably due to the nitrosylase activity that mediates 
cysteine S-nitrosylation of nuclear target proteins such 
as SIRT1, HDAC2 and PRKDC. Component of the 
GAIT (gamma interferon-activated inhibitor of 
translation) complex which mediates interferon-
gamma-induced transcript-selective translation 
inhibition in inflammation processes. Upon interferon-
gamma treatment assembles into the GAIT complex 
which binds to stem loop-containing GAIT elements in 
the 3'-UTR of diverse inflammatory mRNAs (such as 
ceruplasmin) and suppresses their translation.  
Pathway: carbohydrate degradation; Glycolysis 
28  ‐119  8.1  35.8 
3.55E+06 8.87E+05 
Annexin A2   Calcium-regulated membrane-binding protein whose 
affinity for calcium is greatly enhanced by anionic 
phospholipids. It binds two calcium ions with high 
affinity. 
 
 
4  ‐27.4  7.5  38.9 
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Average Normalised 
Volumes 
Mon 810 Mon Gold 
2626 1.2 6.19 27,015 
LDLR  chaperone  MESD 
Precursor  (Mesoderm 
development  candidate 
2)(Mesoderm 
development protein)  
Chaperone specifically assisting the folding of beta-
propeller/EGF modules within the family of low-
density lipoprotein receptors (LDLRs). Acts as a 
modulator of the Wnt pathway through chaperoning the 
coreceptors of the canonical Wnt pathway, LRP5 and 
LRP6, to the plasma membrane. Essential for 
specification of embryonic polarity and mesoderm 
induction. (Human) 
10  ‐46.6  5.5  25.2 
3.75E+06 3.14E+06 
Growth factor receptor‐
bound protein 2  
Adapter protein that provides a critical link between 
cell surface growth factor receptors and the Ras 
signaling pathway. Isoform 2 does not bind to 
phosphorylated epidermal growth factor receptor  but 
inhibits EGF-induced transactivation of a RAS-
responsive element. Isoform 2 acts as a dominant 
negative protein over GRB2 and by suppressing 
proliferative signals, may trigger active programmed 
cell death. (human) 
9  ‐36.4  5.9  25.2 
Peroxiredoxin‐6  (EC 
1.11.1.15)(Antioxidant 
protein  2)(1‐Cys 
peroxiredoxin)(1‐Cys 
PRX) 
Involved in redox regulation of the cell. Can reduce 
H2O2 and short chain organic, fatty acid, and 
phospholipid hydroperoxides. May play a role in the 
regulation of phospholipid turnover as well as in 
protection against oxidative injury  
7  ‐33.4  5.6  24.8 
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Mon 
Conv 
Corn 
2249 11.6 9.64 34,773 
Voltage‐dependent 
anion‐selective 
channel protein 1  
Forms a channel through the mitochondrial outer 
membrane and also the plasma membrane. The channel 
at the outer mitochondrial membrane allows diffusion 
of small hydrophilic molecules; in the plasma 
membrane it is involved in cell volume regulation and 
apoptosis. It adopts an open conformation at low or zero 
membrane potential and a closed conformation at 
potentials above 30-40 mV. The open state has a weak 
anion selectivity whereas the closed state is cation-
selective. May participate in the formation of the 
permeability transition pore complex (PTPC) 
responsible for the release of mitochondrial products 
that triggers apoptosis 
10 ‐44.3 8.6 30.7
1.66E+06 1.92E+07 Hydroxyacyl‐
coenzyme  A 
dehydrogenase, 
mitochondrial  
Plays an essential role in the mitochondrial beta-
oxidation of short chain fatty acids. Exerts it highest 
activity toward 3-hydroxybutyryl-CoA. Pathway: Lipid 
metabolism; fatty acid beta-oxidation 
4 ‐12.3 8.8 34.4
D‐beta‐
hydroxybutyrate 
dehydrogenase, 
mitochondrial 
Precursor  (BDH)(EC 
1.1.1.30)(3‐
hydroxybutyrate 
dehydrogenase)  
Catalytic activity: (R)-3-hydroxybutanoate + NAD+ = 
acetoacetate + NADH. 
3 ‐7.3 9 38.3
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 Average Normalised 
Volumes 
Mon 
Garst 
Mon 
Conv 
Corn 
1257 2.6 8.06 61,099 
Catalase   Occurs in almost all aerobically respiring organisms 
and serves to protect cells from the toxic effects of 
hydrogen peroxide. Promotes growth of cells. 
34 ‐134 7.1 59.7
1.18E+06 3.02E+06 
Pyruvate  kinase 
isozymes M1/M2  
Glycolytic enzyme that catalyzes the transfer of a 
phosphoryl group from phosphoenolpyruvate (PEP) to 
ADP, generating ATP. Stimulates POU5F1-mediated 
transcriptional activation  
18 ‐110 7.1 57.7
Pyridine  nucleotide‐
disulfide 
oxidoreductase 
domain‐containing 
protein 2  
Probable oxidoreductase  4 ‐24.1 8.4 62.8
1777 2.9 8.15 43,948 
Phosphoglycerate 
kinase 1  
Catalytic activity: ATP + 3-phospho-D-glycerate = 
ADP + 3-phospho-D-glyceroyl phosphate. 
27 ‐129 8 44.5
5.54E+06 1.63E+07 
Creatine  kinase  U‐
type, mitochondrial  
Reversibly catalyzes the transfer of phosphate between 
ATP and various phosphogens (e.g. creatine 
phosphate). Creatine kinase isoenzymes play a central 
role in energy transduction in tissues with large, 
fluctuating energy demands, such as skeletal muscle, 
heart, brain and spermatozoa. 
14 ‐70 8.6 46.9
3‐ketoacyl‐CoA 
thiolase, 
mitochondrial  
Abolishes BNIP3-mediated apoptosis and 
mitochondrial damage  
11 ‐67.3 8.4 41.9
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Cytochrome  b‐c1 
complex  subunit  2, 
mitochondrial 
Precursor  (Ubiquinol‐
cytochrome‐c 
reductase  complex 
core  protein  2)(Core 
protein  II)(Complex 
III subunit 2) 
This is a component of the ubiquinol-cytochrome c 
reductase complex (complex III or cytochrome b-c1 
complex), which is part of the mitochondrial respiratory 
chain. The core protein 2 is required for the assembly of 
the complex. 
5 ‐34.4 9.2 48.4
2400 2.8 8.85 31,500 
coiled‐coil‐helix‐
coiled‐coil‐helix 
domain containing 3 
Required for maintenance of mitochondrial crista 
integrity and mitochondrial function. May act as a 
scaffolding protein that stabilizes protein complexes 
involved in crista architecture and protein import. Has 
also been shown to function as a transcription factor 
which binds to the BAG1 promoter and represses 
BAG1 transcription. 
11 ‐46.7 8.3 26.4
2.28E+06 6.35E+06 
Heterogeneous 
nuclear 
ribonucleoproteins 
A2/B1  (hnRNP 
A2/B1)  
nvolved with pre-mRNA processing. Forms complexes 
(ribonucleosomes) with at least 20 other different 
hnRNP and heterogeneous nuclear RNA in the nucleus. 
(Human) 
3 ‐14 9.1 37.3
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 Average Normalised 
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2883 5.4 8.89 21,929 
Mesencephalic 
astrocyte‐derived 
neurotrophic  factor 
Precursor  (Protein 
ARMET)(Arginine‐rich 
protein) 
Selectively promotes the survival of dopaminergic 
neurons of the ventral mid-brain. Modulates 
GABAergic transmission to the dopaminergic neurons 
of the substantia nigra. Enhances spontaneous, as well 
as evoked, GABAergic inhibitory postsynaptic currents 
in dopaminergic neurons. Inhibits cell proliferation and 
endoplasmic reticulum (ER) stress-induced cell death. 
(Mouse)  
4 ‐18.3 8.5 20.4
1.79E+06 9.70E+06 
2443 5.7 9.53 30,665 
Succinate 
dehydrogenase  iron‐
sulfur  subunit, 
mitochondrial 
Precursor  (EC 
1.3.5.1)(Iron‐sulfur 
subunit of complex II) 
Iron-sulfur protein  subunit of succinate dehydrogenase 
(SDH) that is involved in complex II of the 
mitochondrial electron transport chain and is 
responsible for transferring electrons from succinate to 
ubiquinone (coenzyme Q). Pathway: Carbohydrate 
metabolism; tricarboxylic acid cycle; fumarate from 
succinate (eukaryal route): step 1/1. (Human). 
23 ‐65.3 9 31.8
2.64E+06 1.50E+07 
  
 
232
S
p
o
t
 
N
o
.
 
F
o
l
d
 
E
x
p
e
r
i
m
e
n
t
a
l
 
p
I
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
W
 
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
r
I
 
l
o
g
(
e
)
 
T
h
e
o
r
i
t
i
c
a
l
 
p
I
 
T
h
e
o
r
i
t
i
c
a
l
 
M
W
 
(
K
i
l
o
D
a
l
t
o
n
s
)
 Average Normalised 
Volumes 
Mon 
Garst 
Mon 
Conv 
Corn 
Proteasome  subunit 
alpha  type‐7  (EC 
3.4.25.1)(Proteasome 
subunit RC6‐1)  
The proteasome is a multicatalytic proteinase complex 
which  is characterized by  its ability  to cleave peptides 
with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving 
group at neutral or  slightly basic pH. The proteasome 
has  an  ATP‐dependent  proteolytic  activity.  Plays  an 
important role  in the regulation of cell proliferation or 
cell  cycle  control,  transcriptional  regulation,  immune 
and stress response, cell differentiation, and apoptosis. 
Interacts  with  some  important  proteins  involved  in 
transcription  factor  regulation,  cell  cycle  transition, 
viral  replication  and  even  tumor  initiation  and 
progression.  Inhibits  the  transactivation  function  of 
HIF‐1A  under  both  normoxic  and  hypoxia‐mimicking 
conditions. The  interaction with EMAP2  increases  the 
proteasome‐mediated  HIF‐1A  degradation  under  the 
hypoxic  conditions.  Plays  a  role  in  hepatitis  C  virus 
internal  ribosome  entry  site‐mediated  translation. 
Mediates  nuclear  translocation  of  the  androgen 
receptor    and  thereby  enhances  androgen‐mediated 
transactivation.  Promotes  MAVS  degradation  and 
thereby  negatively  regulates  MAVS‐mediated  innate 
immune response (Human). 
14 ‐52.2 8.6 28.4
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ATP synthase subunit 
alpha, mitochondrial  
Mitochondrial  membrane  ATP  synthase  (F1F0  ATP 
synthase or Complex V) produces ATP from ADP in the 
presence  of  a  proton  gradient  across  the  membrane 
which is generated by electron transport complexes of 
the  respiratory  chain.  F‐type  ATPases  consist  of  two 
structural  domains,  F1  ‐  containing  the 
extramembraneous catalytic core, and F0  ‐ containing 
the  membrane  proton  channel,  linked  together  by  a 
central  stalk  and  a  peripheral  stalk.  During  catalysis, 
ATP synthesis  in  the catalytic domain of F1  is coupled 
via a rotary mechanism of the central stalk subunits to 
proton translocation. Subunits alpha and beta form the 
catalytic core in F1. Rotation of the central stalk against 
the  surrounding  alpha3beta3  subunits  leads  to 
hydrolysis  of  ATP  in  three  separate  catalytic  sites  on 
the  beta  subunits.  Subunit  alpha  does  not  bear  the 
catalytic high‐affinity ATP‐binding sites (Human) 
6 ‐33.8 9.3 59.8
Dihydrolipoyllysine‐
residue 
succinyltransferase 
component  of  2‐
oxoglutarate 
dehydrogenase 
complex, 
mitochondrial  
Pathway: Amino‐acid degradation; L‐lysine degradation 
via  saccharopine pathway;  glutaryl‐CoA  from  L‐lysine: 
step  6/6.  The  2‐oxoglutarate  dehydrogenase  complex 
catalyzes  the  overall  conversion  of  2‐oxoglutarate  to 
succinyl‐CoA and CO2.  It contains multiple copies of 3 
enzymatic components: 2‐oxoglutarate dehydrogenase 
(E1),  dihydrolipoamide  succinyltransferase  (E2)  and 
lipoamide dehydrogenase (E3). 
4 ‐19 8.9 48.9
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1444 1.5 7.43 54,604 
Dihydrolipoyl 
dehydrogenase, 
mitochondrial 
Precursor (EC 
1.8.1.4)(Dihydrolip
oamide 
dehydrogenase) 2 
Lipoamide dehydrogenase is a component of the 
glycine cleavage system as well as of the alpha-
ketoacid dehydrogenase complexes. Involved in the 
hyperactivation of spermatazoa during capacitation and 
in the spermatazoal acrosome reaction  
34 -153 8 54 
7.70E+06 4.97E+06 
Glutamate 
dehydrogenase 1, 
mitochondrial 
May be involved in learning and memory reactions by 
increasing the turnover of the excitatory 
neurotransmitter glutamate. 
24 -99 8.1 61.4 
Cytosol 
aminopeptidase (EC 
3.4.11.1)(Leucine 
aminopeptidase 
3)(LAP-3)(Leucyl 
aminopeptidase)(Pr
oline 
aminopeptidase)(EC 
3.4.11.5)(Prolyl 
aminopeptidase)  
Involved in the biosynthesis of glycosaminoglycans; 
hyaluronan, chondroitin sulfate, and heparan sulfate. 
8 -52 6.8 56.1 
Protein disulfide-
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 
7 -46 5.9 56.6 
annexin A11  Binds specifically to calcyclin in a calcium-dependent 
manner. Required for midbody formation and 
completion of the terminal phase of cytokinesis. 
(Human) 
6 -39 7.5 54.1 
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T-complex protein 1 
subunit beta (TCP-
1-beta)(CCT-beta)  
Molecular chaperone; assists the folding of proteins 
upon ATP hydrolysis. As part of the BBS/CCT 
complex may play a role in the assembly of BBSome, a 
complex involved in ciliogenesis regulating transports 
vesicles to the cilia. Known to play a role, in vitro, in 
the folding of actin and tubulin  
4 -24 6 57.4 
ATP synthase 
subunit alpha, 
mitochondrial  
Mitochondrial membrane ATP synthase (F1F0 ATP synthase 
or Complex V) produces ATP from ADP in the presence of a 
proton gradient across the membrane which is generated by 
electron transport complexes of the respiratory chain. F-type 
ATPases consist of two structural domains, F1 - containing 
the extramembraneous catalytic core, and F0 - containing the 
membrane proton channel, linked together by a central stalk 
and a peripheral stalk. During catalysis, ATP synthesis in the 
catalytic domain of F1 is coupled via a rotary mechanism of 
the central stalk subunits to proton translocation. Subunits 
alpha and beta form the catalytic core in F1. Rotation of the 
central stalk against the surrounding alpha3beta3 subunits 
leads to hydrolysis of ATP in three separate catalytic sites on 
the beta subunits. Subunit alpha does not bear the catalytic 
high-affinity ATP-binding sites  
4 -17 9.3 59.8 
UDP-glucose 6-
dehydrogenase 
(UDP-Glc 
dehydrogenase)(UD
P-
GlcDH)(UDPGDH)
(EC 1.1.1.22)  
Involved in the biosynthesis of glycosaminoglycans; 
hyaluronan, chondroitin sulfate, and heparan sulfate. 
3 -17 7.1 54.9 
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2883 7.2 8.89 21,929 
Mesencephalic 
astrocyte‐derived 
neurotrophic  factor 
Precursor  (Protein 
ARMET)(Arginine‐
rich protein) 
Selectively promotes the survival of dopaminergic 
neurons of the ventral mid-brain. Modulates 
GABAergic transmission to the dopaminergic neurons 
of the substantia nigra. Enhances spontaneous, as well 
as evoked, GABAergic inhibitory postsynaptic 
currents in dopaminergic neurons. Inhibits cell 
proliferation and endoplasmic reticulum (ER) stress-
induced cell death. (Mouse)  
4  ‐18.3  8.5  20.4  9.70E+06 1.35E+06 
2249 10 9.64 34,773 
Voltage‐dependent 
anion‐selective 
channel protein 1  
Forms a channel through the mitochondrial outer 
membrane and also the plasma membrane. The 
channel at the outer mitochondrial membrane allows 
diffusion of small hydrophilic molecules; in the 
plasma membrane it is involved in cell volume 
regulation and apoptosis. It adopts an open 
conformation at low or zero membrane potential and a 
closed conformation at potentials above 30-40 mV. 
The open state has a weak anion selectivity whereas 
the closed state is cation-selective. May participate in 
the formation of the permeability transition pore 
complex (PTPC) responsible for the release of 
mitochondrial products that triggers apoptosis 
10  ‐44.3  8.6  30.7 
1.50E+07 3.99E+06 
Hydroxyacyl‐
coenzyme  A 
dehydrogenase, 
mitochondrial  
Plays an essential role in the mitochondrial beta-
oxidation of short chain fatty acids. Exerts it highest 
activity toward 3-hydroxybutyryl-CoA. Pathway: 
Lipid metabolism; fatty acid beta-oxidation 
4  ‐12.3  8.8  34.4 
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D-beta-
hydroxybutyrate 
dehydrogenase, 
mitochondrial 
Precursor (BDH)(EC 
1.1.1.30)(3-
hydroxybutyrate 
dehydrogenase)  
Catalytic activity: (R)-3-hydroxybutanoate + NAD+ = 
acetoacetate + NADH. 
3  ‐7.3  9  38.3 
2443 3.8 9.53 30,665 
Succinate 
dehydrogenase 
iron‐sulfur  subunit, 
mitochondrial 
Precursor  (EC 
1.3.5.1)(Iron‐sulfur 
subunit  of  complex 
II) 
Iron-sulfur protein  subunit of succinate 
dehydrogenase (SDH) that is involved in complex II 
of the mitochondrial electron transport chain and is 
responsible for transferring electrons from succinate 
to ubiquinone (coenzyme Q). Pathway: Carbohydrate 
metabolism; tricarboxylic acid cycle; fumarate from 
succinate (eukaryal route): step 1/1. (Human). 
23  ‐65.3  9  31.8  1.50E+07 3.99E+06 
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Proteasome  subunit 
alpha  type‐7  (EC 
3.4.25.1)(Proteasom
e subunit RC6‐1)  
The  proteasome  is  a  multicatalytic  proteinase 
complex which is characterized by its ability to cleave 
peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to 
the  leaving group at neutral or slightly basic pH. The 
proteasome  has  an  ATP‐dependent  proteolytic 
activity. Plays an  important  role  in  the  regulation of 
cell proliferation or cell cycle control,  transcriptional 
regulation,  immune  and  stress  response,  cell 
differentiation,  and  apoptosis.  Interacts  with  some 
important  proteins  involved  in  transcription  factor 
regulation,  cell  cycle  transition,  viral  replication  and 
even  tumor  initiation  and  progression.  Inhibits  the 
transactivation  function  of  HIF‐1A  under  both 
normoxic  and  hypoxia‐mimicking  conditions.  The 
interaction  with  EMAP2  increases  the  proteasome‐
mediated  HIF‐1A  degradation  under  the  hypoxic 
conditions.  Plays  a  role  in  hepatitis  C  virus  internal 
ribosome  entry  site‐mediated  translation.  Mediates 
nuclear  translocation of  the androgen  receptor   and 
thereby  enhances  androgen‐mediated 
transactivation.  Promotes  MAVS  degradation  and 
thereby negatively  regulates MAVS‐mediated  innate 
immune response (Human). 
14  ‐52.2  8.6  28.4 
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ATP  synthase 
subunit  alpha, 
mitochondrial  
Mitochondrial  membrane  ATP  synthase  (F1F0  ATP 
synthase  or  Complex  V)  produces  ATP  from  ADP  in 
the  presence  of  a  proton  gradient  across  the 
membrane which  is generated by electron  transport 
complexes  of  the  respiratory  chain.  F‐type  ATPases 
consist of two structural domains, F1 ‐ containing the 
extramembraneous catalytic core, and F0 ‐ containing 
the membrane proton channel,  linked  together by a 
central  stalk and a peripheral  stalk. During catalysis, 
ATP synthesis in the catalytic domain of F1 is coupled 
via a  rotary mechanism of  the central stalk subunits 
to  proton  translocation.  Subunits  alpha  and  beta 
form the catalytic core  in F1. Rotation of the central 
stalk  against  the  surrounding  alpha3beta3  subunits 
leads to hydrolysis of ATP  in three separate catalytic 
sites  on  the  beta  subunits.  Subunit  alpha  does  not 
bear  the  catalytic  high‐affinity  ATP‐binding  sites 
(Human) 
6  ‐33.8  9.3  59.8 
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Dihydrolipoyllysine‐
residue 
succinyltransferase 
component  of  2‐
oxoglutarate 
dehydrogenase 
complex, 
mitochondrial  
Pathway:  Amino‐acid  degradation;  L‐lysine 
degradation  via  saccharopine  pathway;  glutaryl‐CoA 
from  L‐lysine:  step  6/6.  The  2‐oxoglutarate 
dehydrogenase  complex  catalyzes  the  overall 
conversion  of  2‐oxoglutarate  to  succinyl‐CoA  and 
CO2.  It  contains  multiple  copies  of  3  enzymatic 
components:  2‐oxoglutarate  dehydrogenase  (E1), 
dihydrolipoamide  succinyltransferase  (E2)  and 
lipoamide dehydrogenase (E3). 
4  ‐19  8.9  48.9 
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1950 2.23E-04 2.1 5.89/41.582 
Serpin  B5  (Peptidase 
inhibitor 5)(PI‐5)(Maspin) 
Tumor suppressor. 
It blocks the 
growth, invasion, 
and metastatic 
properties of 
mammary tumors. 
As it does not 
undergo the S 
(stressed) to R 
(relaxed) 
conformational 
transition 
characteristic of 
active serpins, it 
exhibits no serine 
protease inhibitory 
activity  
12 ‐77  5.7/42 
1.82E+06 1.76E+06 1.09E+06 8.67E+05 1.26E+06 
3'(2'),5'‐bisphosphate 
nucleotidase  1  (EC 
3.1.3.7)(Bisphosphate  3'‐
nucleotidase  1)(PAP‐
inositol‐1,4‐
phosphatase)(PIP)(scHAL2 
analogous 3)  
Converts  adenosine 
3'‐phosphate  5'‐
phosphosulfate 
(PAPS) to adenosine 
5'‐phosphosulfate 
(APS)  and  3'(2')‐
phosphoadenosine 
5'‐  phosphate 
(Bravo  et  al.)  to 
12 ‐57  5.6/29 
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AMP. Has 1000‐fold 
lower  activity 
towards  inositol 
1,4‐bisphosphate 
(Ins(1,4)P2)  and 
inositol  1,3,4‐
trisphosphate 
(Ins(1,3,4)P3),  but 
does  not  hydrolyze 
Ins1P,  Ins(3,4)P2, 
Ins(1,3,4,5)P4  or 
InsP6. 
Elongation factor 2  Catalyzes  the  GTP‐
dependent 
ribosomal 
translocation  step 
during  translation 
elongation.  During 
this  step,  the 
ribosome  changes 
from  the  pre‐
translocational 
(PRE)  to  the  post‐
translocational  
state  as  the  newly 
17 ‐57  6.4/95.2 
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formed  A‐site‐
bound  peptidyl‐
tRNA  and  P‐site‐
bound  deacylated 
tRNA move to the P 
and  E  sites, 
respectively. 
Catalyzes  the 
coordinated 
movement  of  the 
two  tRNA 
molecules,  the 
mRNA  and 
conformational 
changes  in  the 
ribosome. 
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2045 2.45E-04 4 7.49/38.983 
Glyceraldehyde‐3‐
phosphate dehydrogenase 
Has both 
glyceraldehyde-3-
phosphate 
dehydrogenase and 
nitrosylase 
activities, thereby 
playing a role in 
glycolysis and 
nuclear functions, 
respectively. 
Glyceraldehyde-3-
phosphate 
dehydrogenase is a 
key enzyme in 
glycolysis that 
catalyzes the first 
step of the pathway 
by converting D-
glyceraldehyde 3-
phosphate (G3P) 
into 3-phospho-D-
glyceroyl 
phosphate. 
Modulates the 
organization and 
assembly of the 
cytoskeleton. 
28 ‐119  8.1/35.8 
2.90E+06 3.55E+06 2.00E+06 8.87E+05 1.35E+06 
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Facilitates the 
CHP1-dependent 
microtubule and 
membrane 
associations through 
its ability to 
stimulate the 
binding of CHP1 to 
microtubules. Also 
participates in 
nuclear events 
including 
transcription, RNA 
transport, DNA 
replication and 
apoptosis. Nuclear 
functions are 
probably due to the 
nitrosylase activity 
that mediates 
cysteine S-
nitrosylation of 
nuclear target 
proteins such as 
SIRT1, HDAC2 and 
PRKDC. 
Component of the 
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GAIT (gamma 
interferon-activated 
inhibitor of 
translation) 
complex which 
mediates interferon-
gamma-induced 
transcript-selective 
translation 
inhibition in 
inflammation 
processes. Upon 
interferon-gamma 
treatment assembles 
into the GAIT 
complex which 
binds to stem loop-
containing GAIT 
elements in the 3'-
UTR of diverse 
inflammatory 
mRNAs (such as 
ceruplasmin) and 
suppresses their 
translation.  
Pathway: 
carbohydrate 
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degradation; 
Glycolysis 
Annexin A2  Calcium-regulated 
membrane-binding 
protein whose 
affinity for calcium 
is greatly enhanced 
by anionic 
phospholipids. It 
binds two calcium 
ions with high 
4  ‐27  7.5/38.9 
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affinity. 
2212 7.30E-07 3.9 7.18/35.102 
Voltage‐dependent  anion‐
selective  channel  protein 
2  (VDAC‐2)(Outer 
mitochondrial  membrane 
protein  porin  2)(B36‐
VDAC)  
Forms a channel 
through the 
mitochondrial outer 
membrane that 
allows diffusion of 
small hydrophilic 
molecules. The 
channel adopts an 
open conformation 
at low or zero 
membrane potential 
and a closed 
conformation at 
potentials above 30-
40 mV. The open 
state has a weak 
anion selectivity 
whereas the closed 
state is cation-
selective  
17 ‐73  7.4/31.8 
7.26E+06 1.28E+07 3.77E+06 3.32E+06 4.81E+06 
  
 
249
S
p
o
t
 
N
o
.
 
A
n
o
v
a
 
(
p
)
 
 
F
o
l
d
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
I
p
/
M
W
 
(
M
W
 
i
n
 
K
i
l
o
D
a
l
t
o
n
s
)
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
rI log(e) 
T
h
e
o
r
i
t
i
c
a
l
 
I
p
/
M
W
 
(
M
W
 
i
n
 
K
i
l
o
D
a
l
t
o
n
s
)
 
Average Normalised Volumes  
Mcert Mon 810 Mon Garst 
Mon 
Conv 
Corn 
Mon 
Gold 
2249 6.68E-06 11.6 9.65/34.686 
Voltage‐dependent  anion‐
selective  channel  protein 
1  
Forms a channel 
through the 
mitochondrial outer 
membrane and also 
the plasma 
membrane. The 
channel at the outer 
mitochondrial 
membrane allows 
diffusion of small 
hydrophilic 
molecules; in the 
plasma membrane it 
is involved in cell 
volume regulation 
and apoptosis. It 
adopts an open 
conformation at low 
or zero membrane 
potential and a 
closed conformation 
at potentials above 
30-40 mV. The 
open state has a 
weak anion 
selectivity whereas 
the closed state is 
10 ‐44  8.6/30.7 
4.41E+06 2.36E+06 1.66E+06 1.92E+07 1.93E+06 
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cation-selective. 
May participate in 
the formation of the 
permeability 
transition pore 
complex (PTPC) 
responsible for the 
release of 
mitochondrial 
products that 
triggers apoptosis 
Hydroxyacyl‐coenzyme  A 
dehydrogenase, 
mitochondrial  
Plays an essential 
role in the 
mitochondrial beta-
oxidation of short 
chain fatty acids. 
Exerts it highest 
activity toward 3-
hydroxybutyryl-
CoA. Pathway: 
Lipid metabolism; 
fatty acid beta-
oxidation 
4  ‐12  8.8/34.4 
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D-beta-hydroxybutyrate 
dehydrogenase, 
mitochondrial Precursor 
(BDH)(EC 1.1.1.30)(3-
hydroxybutyrate 
dehydrogenase)  
Catalytic activity: 
(R)-3-
hydroxybutanoate + 
NAD+ = 
acetoacetate + 
NADH. 
3  ‐7.3  9/38.3 
2306 0.001 1.7 4.32/33.852 
Tropomyosin  alpha‐3 
chain  
Binds to actin 
filaments in muscle 
and non-muscle 
cells. Plays a central 
role, in association 
with the troponin 
complex, in the 
calcium dependent 
regulation of 
vertebrate striated 
muscle contraction. 
Smooth muscle 
contraction is 
regulated by 
interaction with 
caldesmon. In non-
muscle cells is 
implicated in 
stabilizing 
cytoskeleton actin 
filaments. 
63 ‐170  4.7/29 
5.65E+07 3.25E+07 3.42E+07 4.30E+07 3.49E+07 
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2400 0.002 2.8 8.85/31.443 
coiled‐coil‐helix‐coiled‐
coil‐helix  domain 
containing 3 
Required for 
maintenance of 
mitochondrial crista 
integrity and 
mitochondrial 
function. May act as 
a scaffolding 
protein that 
stabilizes protein 
complexes involved 
in crista architecture 
and protein import. 
Has also been 
shown to function 
as a transcription 
factor which binds 
to the BAG1 
promoter and 
represses BAG1 
transcription. 
11 ‐47  8.3/26.4 
2.55E+06 2.95E+06 2.28E+06 6.35E+06 3.31E+06 
Heterogeneous  nuclear 
ribonucleoproteins  A2/B1 
(hnRNP A2/B1)  
nvolved with pre-
mRNA processing. 
Forms complexes 
(ribonucleosomes) 
with at least 20 
other different 
hnRNP and 
3  ‐14  9.1/37.3 
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heterogeneous 
nuclear RNA in the 
nucleus. (Human) 
2443 3.84E-04 5.7 9.53/30.665 
Succinate  dehydrogenase 
iron‐sulfur  subunit, 
mitochondrial  Precursor 
(EC  1.3.5.1)(Iron‐sulfur 
subunit of complex II) 
Iron-sulfur protein  
subunit of succinate 
dehydrogenase 
(SDH) that is 
involved in 
complex II of the 
mitochondrial 
electron transport 
chain and is 
responsible for 
transferring 
electrons from 
succinate to 
ubiquinone 
(coenzyme Q). 
Pathway: 
Carbohydrate 
metabolism; 
tricarboxylic acid 
cycle; fumarate 
from succinate 
23 ‐65  9/31.8 
1.16E+07 2.81E+06 2.64E+06 1.50E+07 3.99E+06 
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(eukaryal route): 
step 1/1. (Human). 
Proteasome subunit alpha 
type‐7  (EC 
3.4.25.1)(Proteasome 
subunit RC6‐1)  
The  proteasome  is 
a  multicatalytic 
proteinase  complex 
which  is 
characterized by  its 
ability  to  cleave 
peptides  with  Arg, 
Phe,  Tyr,  Leu,  and 
Glu adjacent  to  the 
leaving  group  at 
neutral  or  slightly 
basic  pH.  The 
proteasome  has  an 
ATP‐dependent 
proteolytic  activity. 
Plays  an  important 
role  in  the 
regulation  of  cell 
proliferation  or  cell 
cycle  control, 
transcriptional 
regulation,  immune 
and  stress 
14 ‐52  8.6/28.4 
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response,  cell 
differentiation,  and 
apoptosis.  Interacts 
with  some 
important  proteins 
involved  in 
transcription  factor 
regulation,  cell 
cycle  transition, 
viral replication and 
even  tumor 
initiation  and 
progression. 
Inhibits  the 
transactivation 
function  of  HIF‐1A 
under  both 
normoxic  and 
hypoxia‐mimicking 
conditions.  The 
interaction  with 
EMAP2  increases 
the  proteasome‐
mediated  HIF‐1A 
degradation  under 
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the  hypoxic 
conditions.  Plays  a 
role  in  hepatitis  C 
virus  internal 
ribosome  entry 
site‐mediated 
translation. 
Mediates  nuclear 
translocation of the 
androgen  receptor  
and  thereby 
enhances 
androgen‐mediated 
transactivation. 
Promotes  MAVS 
degradation  and 
thereby  negatively 
regulates  MAVS‐
mediated  innate 
immune  response 
(Human). 
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ATP  synthase  subunit 
alpha, mitochondrial  
Mitochondrial 
membrane  ATP 
synthase  (F1F0 ATP 
synthase  or 
Complex  V) 
produces  ATP  from 
ADP  in  the 
presence  of  a 
proton  gradient 
across  the 
membrane which  is 
generated  by 
electron  transport 
complexes  of  the 
respiratory chain. F‐
type  ATPases 
consist  of  two 
structural  domains, 
F1  ‐  containing  the 
extramembraneous 
catalytic  core,  and 
F0  ‐  containing  the 
membrane  proton 
channel,  linked 
together  by  a 
6  ‐34  9.3/59.8 
  
 
258
S
p
o
t
 
N
o
.
 
A
n
o
v
a
 
(
p
)
 
 
F
o
l
d
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
I
p
/
M
W
 
(
M
W
 
i
n
 
K
i
l
o
D
a
l
t
o
n
s
)
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
rI log(e) 
T
h
e
o
r
i
t
i
c
a
l
 
I
p
/
M
W
 
(
M
W
 
i
n
 
K
i
l
o
D
a
l
t
o
n
s
)
 
Average Normalised Volumes  
Mcert Mon 810 Mon Garst 
Mon 
Conv 
Corn 
Mon 
Gold 
central  stalk  and  a 
peripheral  stalk. 
During  catalysis, 
ATP synthesis in the 
catalytic  domain  of 
F1  is  coupled  via  a 
rotary  mechanism 
of  the  central  stalk 
subunits  to  proton 
translocation. 
Subunits  alpha  and 
beta  form  the 
catalytic core  in F1. 
Rotation  of  the 
central stalk against 
the  surrounding 
alpha3beta3 
subunits  leads  to 
hydrolysis of ATP  in 
three  separate 
catalytic  sites  on 
the  beta  subunits. 
Subunit  alpha  does 
not  bear  the 
catalytic  high‐
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affinity  ATP‐binding 
sites (Human) 
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Dihydrolipoyllysine‐
residue 
succinyltransferase 
component  of  2‐
oxoglutarate 
dehydrogenase  complex, 
mitochondrial  
Pathway:  Amino‐
acid degradation; L‐
lysine  degradation 
via  saccharopine 
pathway;  glutaryl‐
CoA  from  L‐lysine: 
step  6/6.  The  2‐
oxoglutarate 
dehydrogenase 
complex  catalyzes 
the  overall 
conversion  of  2‐
oxoglutarate  to 
succinyl‐CoA  and 
CO2.  It  contains 
multiple copies of 3 
enzymatic 
components:  2‐
oxoglutarate 
dehydrogenase 
(E1), 
dihydrolipoamide 
succinyltransferase 
(E2)  and  lipoamide 
dehydrogenase 
4  ‐19  8.9/48.9 
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(E3).
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2511 2.34E-04 3.2 6.09/29.372 
PAX  interacting  (with 
transcription‐activation 
domain) protein 1  
Involved in DNA 
damage response and 
in transcriptional 
regulation through 
histone 
methyltransferase 
(HMT) complexes. 
Plays a role in early 
development. In DNA 
damage response is 
required for cell 
survival after ionizing 
radiation. In vitro 
shown to be involved 
in the homologous 
recombination 
mechanism for the 
repair of double-
strand breaks (DSBs). 
Its localization to 
DNA damage foci 
requires RNF8 and 
UBE2N. Recruits 
TP53BP1 to DNA 
damage foci and, at 
least in particular 
repair processes, 
effective DNA 
damage response 
appears to require the 
1  ‐1.2  8.8/93.9 
1.90E+07 1.33E+07 1.69E+07 5.90E+06 1.42E+07 
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association with 
TP53BP1 
phosphorylated by 
ATM at 'Ser-25'. 
Together with 
TP53BP1 regulates 
ATM association. 
Recruits PAGR1 to 
sites of DNA damage 
and the 
PAGR1:PAXIP1 
complex is required 
for cell survival in 
response to DNA 
damage; the function 
is probbaly 
independent of MLL-
containing histone 
methyltransferase 
(HMT) complexes. 
Promotes 
ubiquitination of 
PCNA following UV 
irradiation and may 
regulate recruitment 
of polymerase eta and 
RAD51 to chromatin 
after DNA damage. 
Proposed to be 
involved in 
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transcriptional 
regulation by linking 
MLL-containing 
histone 
methyltransferase 
(HMT) complexes to 
gene promoters by 
interacting with 
promoter-bound 
transcription factors 
such as PAX2. 
Associates with gene 
promoters that are 
known to be regulated 
by MLL2. During 
immunoglobulin class 
switching in activated 
B-cells is involved in 
trimethylation of 
histone H3 at 'Lys-4' 
and in transcription 
initiation of 
downstream switch 
regions at the 
immunoglobulin 
heavy-chain  locus; 
this function appears 
to involve the 
recruitment of MLL-
containing HMT 
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complexes. (Human) 
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2626 4.58E-04 2.4 6.18/26.990 
LDLR  chaperone  MESD 
Precursor  (Mesoderm 
development  candidate 
2)(Mesoderm 
development protein)  
Chaperone 
specifically 
assisting the folding 
of beta-
propeller/EGF 
modules within the 
family of low-
density lipoprotein 
receptors (LDLRs). 
Acts as a modulator 
of the Wnt pathway 
through 
chaperoning the 
coreceptors of the 
canonical Wnt 
pathway, LRP5 and 
LRP6, to the plasma 
membrane. 
Essential for 
specification of 
embryonic polarity 
and mesoderm 
induction. (Human) 
10 ‐47  5.5/25.2 
3.62E+06 3.75E+06 2.05E+06 1.55E+06 3.14E+06 
Growth  factor  receptor‐
bound protein 2  
Adapter protein that 
provides a critical 
link between cell 
surface growth 
9  ‐36  5.9/25.2 
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factor receptors and 
the Ras signaling 
pathway. Isoform 2 
does not bind to 
phosphorylated 
epidermal growth 
factor receptor  but 
inhibits EGF-
induced 
transactivation of a 
RAS-responsive 
element. Isoform 2 
acts as a dominant 
negative protein 
over GRB2 and by 
suppressing 
proliferative 
signals, may trigger 
active programmed 
cell death. (human) 
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Peroxiredoxin‐6  (EC 
1.11.1.15)(Antioxidant 
protein  2)(1‐Cys 
peroxiredoxin)(1‐Cys PRX) 
Involved in redox 
regulation of the 
cell. Can reduce 
H2O2 and short 
chain organic, fatty 
acid, and 
phospholipid 
hydroperoxides. 
May play a role in 
the regulation of 
phospholipid 
turnover as well as 
in protection against 
oxidative injury  
7  ‐33  5.6/24.8 
2883 1.82E-06 7.2 8.89/21.919 
Mesencephalic  astrocyte‐
derived  neurotrophic 
factor  Precursor  (Protein 
ARMET)(Arginine‐rich 
protein) 
Selectively 
promotes the 
survival of 
dopaminergic 
neurons of the 
ventral mid-brain. 
Modulates 
GABAergic 
transmission to the 
dopaminergic 
neurons of the 
substantia nigra. 
Enhances 
4  ‐18  8.5/20.4 
1.41E+06 1.36E+06 1.79E+06 9.70E+06 1.35E+06 
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spontaneous, as 
well as evoked, 
GABAergic 
inhibitory 
postsynaptic 
currents in 
dopaminergic 
neurons. Inhibits 
cell proliferation 
and endoplasmic 
reticulum (ER) 
stress-induced cell 
death. (Mouse)  
3243 0.002 2.6 6.33/28.246 
Thioredoxin‐dependent 
peroxide  reductase, 
mitochondrial  Precursor 
(EC 
1.11.1.15)(Peroxiredoxin‐
3)(PRX‐3)(PRx III)  
Involved in redox 
regulation of the 
cell. Protects 
radical-sensitive 
enzymes from 
oxidative damage 
by a radical-
generating system. 
Acts synergistically 
with MAP3K13 to 
regulate the 
activation of NF-
kappa-B in the 
cytosol. (Human) 
9  ‐16  7.1/28.3 
2.86E+06 2.83E+06 1.12E+06 1.13E+06 1.64E+06 
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3258 9.31E-04 1.6 4.35/32.615 
Tropomyosin  alpha‐1 
chain  (Tropomyosin‐
1)(Alpha‐tropomyosin)  
Binds to actin 
filaments in 
muscle and non-
muscle cells. 
Plays a central 
role, in 
association with 
the troponin 
complex, in the 
calcium 
dependent 
regulation of 
vertebrate striated 
muscle 
contraction. 
Smooth muscle 
contraction is 
regulated by 
interaction with 
caldesmon. In 
non-muscle cells 
is implicated in 
stabilizing 
cytoskeleton actin 
51 ‐109  4.7/28.5 
2.22E+07 1.36E+07 1.35E+07 1.89E+07 1.42E+07 
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filaments.  
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Appendix 28: Identification of differentially expressed proteins from the epithelial cells of the small intestine of rats fed different maize based diets for 28-Day. 
The data represent two way comparisons as follows (Mcert vs Mon Garst, Mcert vs Mon Conv Corn, Mcert vs Mon Gold, Mon810 vs Mon Garst, Mon810 vs Mon Conv Corn, Mon 
Garst vs Mon Conv Corn, Mon810 vs Mon Gold, Mon Conv Corn vs Mon Gold) and five way comparisons. 
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3190 2.8 8.55 40,202
NADH  dehydrogenase 
(ubiquinone)  1  beta 
subcomplex, 10 
Accessory subunit of the mitochondrial membrane 
respiratory chain NADH dehydrogenase (Complex I), 
that is believed not to be involved in catalysis. 
Complex I functions in the transfer of electrons from 
NADH to the respiratory chain. The immediate 
electron acceptor for the enzyme is believed to be 
ubiquinone 
36  ‐113  7.6  20.8 
3.94E+06 1.42E+06 
Peroxiredoxin‐1  (EC 
1.11.1.15)(Thioredoxin 
peroxidase 
2)(Thioredoxin‐
dependent  peroxide 
reductase  2)(Heme‐
binding  23  kDa 
protein)(HBP23)  
Involved in redox regulation of the cell. Reduces 
peroxides with reducing equivalents provided through 
the thioredoxin system but not from glutaredoxin. 
May play an important role in eliminating peroxides 
generated during metabolism. Might participate in the 
signaling cascades of growth factors and tumor 
necrosis factor-alpha by regulating the intracellular 
concentrations of H2O2. Reduces an intramolecular 
disulfide bond in GDPD5 that gates the ability to 
GDPD5 to drive postmitotic motor neuron 
differentiation 
3  ‐16.8  8.3  22.1 
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Isocitrate 
dehydrogenase 
subunit  alpha, 
mitochondrial 
Precursor  (EC 
1.1.1.41)(Isocitric 
dehydrogenase 
subunit 
alpha)(NAD(+)‐specific 
ICDH subunit alpha) 
catalytic activity: Isocitrate + NAD+ = 2-oxoglutarate 
+ CO2 + NADH. 
3  ‐10.4  6.5  39.6 
3123 3.1 8.56 41,617
NADH  dehydrogenase 
(ubiquinone)  1  beta 
subcomplex, 10 
Accessory subunit of the mitochondrial membrane 
respiratory chain NADH dehydrogenase (Complex I), 
that is believed not to be involved in catalysis. 
Complex I functions in the transfer of electrons from 
NADH to the respiratory chain. The immediate 
electron acceptor for the enzyme is believed to be 
ubiquinone 
10  ‐70.1  7.6  20.8  1.50E+06 4.65E+06 
3320 2.9 8.77 36,807
NADH  dehydrogenase 
(ubiquinone)  1  beta 
subcomplex, 9  
 Accessory subunit of the mitochondrial membrane 
respiratory chain NADH dehydrogenase (Complex I), 
that is believed to be not involved in catalysis. 
Complex I functions in the transfer of electrons from 
NADH to the respiratory chain. The immediate 
electron acceptor for the enzyme is believed to be 
ubiquinone 
1  ‐4.5  8.2  21.9  3.77E+06 1.32E+06 
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Mcert 
Mon 
Conv 
Corn 
2550 1.6 5.7 56,979
Ornithine 
aminotransferase, 
mitochondrial 
Precursor  (EC 
2.6.1.13)(Ornithine‐‐
oxo‐acid 
aminotransferase)  
catalytic  activity:  L‐ornithine  +  a  2‐oxo  acid  =  L‐
glutamate 5‐semialdehyde + an L‐amino acid. 
1  ‐2.6  6.5  48.3 
2.76E+06 1.71E+06 
heterogeneous 
nuclear 
ribonucleoprotein U  
Component of the CRD-mediated complex that 
promotes MYC mRNA stabilization. Binds to pre-
mRNA. Has high affinity for scaffold-attached region 
(Otaka et al.) DNA. Binds to double- and single-
stranded DNA and RNA. 
1  ‐2.6  5.9  87.7 
3506 3.1 4.69 32,253 
Actin,  cytoplasmic  1 
Actin,  cytoplasmic  1, 
N‐terminally 
processed  
Actins are highly conserved proteins that are involved 
in various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 4  ‐27.6  5.3  41.7 
1.52E+06 4.68E+06 
Actin,  gamma‐enteric 
smooth muscle  
Actins are highly conserved proteins that are involved 
in various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 
4  ‐26.4  5.3  41.8 
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2762 2.4 7.5 50,171
Protein MEMO1  May control cell migration by relaying extracellular 
chemotactic signals to the microtubule cytoskeleton. 
Mediator of ERBB2 signaling. The MEMO1-RHOA-
DIAPH1 signaling pathway plays an important role in 
ERBB2-dependent stabilization of microtubules at 
the cell cortex. It controls the localization of APC and 
CLASP2 to the cell membrane, via the regulation of 
GSK3B activity. In turn, membrane-bound APC 
allows the localization of the MACF1 to the cell 
membrane, which is required for microtubule capture 
and stabilization. Is required for breast carcinoma cell 
migration. 
3  ‐8.6  6.4  32.1 
2.81E+06 1.18E+06 
40S  ribosomal protein 
S3  
Ribosomal protein S3 (rpS3) is a component of the 
40S ribosomal subunit and is involved in translation. 2  ‐6  9.7  26.7 
3305 2.3 5.07 37,180
chromobox homolog 3  Seems to be involved in transcriptional silencing in 
heterochromatin-like complexes. Recognizes and 
binds histone H3 tails methylated at 'Lys-9', leading 
to epigenetic repression. May contribute to the 
association of the heterochromatin with the inner 
nuclear membrane through its interaction with lamin 
B receptor (LBR). Involved in the formation of 
functional kinetochore through interaction with 
MIS12 complex proteins. 
2  ‐9.4  5.2  20.8  2.62E+06 6.06E+06 
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2912 3.5 8.12 45,065 
Electron  transfer 
flavoprotein  subunit 
beta (Beta‐ETF)  
The electron transfer flavoprotein serves as a specific 
electron acceptor for several dehydrogenases, 
including five acyl-CoA dehydrogenases, glutaryl-
CoA and sarcosine dehydrogenase. It transfers the 
electrons to the main mitochondrial respiratory chain 
via ETF-ubiquinone oxidoreductase (ETF 
dehydrogenase) 
66  ‐149  7.6  27.7 
5.13E+06 1.48E+06 
Proteasome  subunit 
alpha  type‐4  (EC 
3.4.25.1)(Proteasome 
component C9) 
The  proteasome  is  a  multicatalytic  proteinase 
complex which is characterized by its ability to cleave 
peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to 
the leaving group at neutral or slightly basic pH. The 
proteasome  has  an  ATP‐dependent  proteolytic 
activity. 
12  ‐49.3  7.6  29.5 
Adenylate  kinase  2, 
mitochondrial  (AK 
2)(EC  2.7.4.3)(ATP‐
AMP 
transphosphorylase 
2)  
Catalyzes  the  reversible  transfer  of  the  terminal 
phosphate  group  between  ATP  and  AMP.  Plays  an 
important role  in cellular energy homeostasis and  in 
adenine  nucleotide  metabolism.  Adenylate  kinase 
activity  is  critical  for  regulation  of  the  phosphate 
utilization  and  the  AMP  de  novo  biosynthesis 
pathways. Plays a key role in hematopoiesis  
12  ‐44.6  7  25.5 
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Calcyclin‐binding 
protein  
May  be  involved  in  calcium‐dependent 
ubiquitination  and  subsequent  proteasomal 
degradation of  target proteins. Probably serves as a 
molecular  bridge  in  ubiquitin  E3  complexes. 
Participates in the ubiquitin‐mediated degradation of 
beta‐catenin (CTNNB1) 
10  ‐34  7.6  26.5 
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Volumes  
Mcert Mon Gold 
2149 2.5 7.09 66,200 
Protein 
disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 
4  ‐20.3  5.9  56.6  1.33E+06 5.32E+05 
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Average Normalised 
Volumes  
Mcert Mon Gold 
3305 2.7 5.07 37,180 
chromobox 
homolog 3  
Seems to be involved in transcriptional silencing in 
heterochromatin-like complexes. Recognizes and binds 
histone H3 tails methylated at 'Lys-9', leading to epigenetic 
repression. May contribute to the association of the 
heterochromatin with the inner nuclear membrane through 
its interaction with lamin B receptor (LBR). Involved in 
the formation of functional kinetochore through interaction 
with MIS12 complex proteins. 
2  ‐9.4  5.2  20.8  2.62E+06 7.05E+06 
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Mon 810 
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Conv 
Corn 
3123 3.4 8.56 41,617 
NADH 
dehydrogenase 
(ubiquinone)  1 
beta  subcomplex, 
10 
 Accessory subunit of the mitochondrial membrane 
respiratory chain NADH dehydrogenase (Complex I), 
that is believed not to be involved in catalysis. Complex I 
functions in the transfer of electrons from NADH to the 
respiratory chain. The immediate electron acceptor for 
the enzyme is believed to be ubiquinone 
10  ‐70.1  7.6  20.8  1.35E+06 4.65E+06 
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Mon 810 
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Corn 
3506 5.1 4.7 32,253 
Actin, cytoplasmic 
1  Actin, 
cytoplasmic  1,  N‐
terminally 
processed  
Actins are highly conserved proteins that are involved in 
various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 4  ‐27.6  5.3  41.7 
9.19E+05 4.68E+06 
Actin,  gamma‐
enteric  smooth 
muscle  
Actins are highly conserved proteins that are involved in 
various types of cell motility and are ubiquitously 
expressed in all eukaryotic cells. 
4  ‐26.4  5.3  41.8 
3320 3.2 8.77 36,807 
NADH 
dehydrogenase 
(ubiquinone)  1 
beta  subcomplex, 
9  
 Accessory subunit of the mitochondrial membrane 
respiratory chain NADH dehydrogenase (Complex I), 
that is believed to be not involved in catalysis. Complex I 
functions in the transfer of electrons from NADH to the 
respiratory chain. The immediate electron acceptor for 
the enzyme is believed to be ubiquinone 
1  ‐4.5  8.2  21.9  4.29E+06 1.32E+06 
1485 3.1 6.92 73,807 
Lamin‐A   Lamins are components of the nuclear lamina, a fibrous 
layer on the nucleoplasmic side of the inner nuclear 
membrane, which is thought to provide a framework for 
the nuclear envelope and may also interact with 
chromatin. 
22  ‐110  6.5  74.3 
5.72E+05 1.83E+05 
Stress‐induced‐
phosphoprotein  1 
(STI1) 
(Hsc70/Hsp90‐
organizing 
protein)(Guertler 
et al.) 
Mediates the association of the molecular chaperones 
HSC70 and HSP90 (HSPCA and HSPCB). 
3  ‐14.2  6.4  62.5 
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Average Normalised 
Volumes  
Mon 810 
Mon 
Conv 
Corn 
2550 1.5 5.7 56,979 
Ornithine 
aminotransferase, 
mitochondrial 
Precursor  (EC 
2.6.1.13)  
catalytic activity: L‐ornithine + a 2‐oxo acid = L‐glutamate 
5‐semialdehyde + an L‐amino acid. 
1  ‐2.6  6.5  48.3 
2.53E+06 1.71E+06 
heterogeneous 
nuclear 
ribonucleoprotein 
U  
Component of the CRD-mediated complex that promotes 
MYC mRNA stabilization. Binds to pre-mRNA. Has 
high affinity for scaffold-attached region (Otaka et al.) 
DNA. Binds to double- and single-stranded DNA and 
RNA. 
1  ‐2.6  5.9  87.7 
2222 3.3 9.2 64,993 
3‐ketoacyl‐CoA 
thiolase, 
mitochondrial  
Abolishes BNIP3-mediated apoptosis and mitochondrial 
damage  14  ‐63.5  8.4  41.9 
2.63E+06 8.07E+05 Isocitrate 
dehydrogenase  , 
mitochondrial  
Plays a role in intermediary metabolism and energy 
production. It may tightly associate or interact with the 
pyruvate dehydrogenase complex 
6  ‐23.1  8.9  50.9 
3190 2.5 8.6 40,202 
NADH 
dehydrogenase 
(ubiquinone)  1 
beta  subcomplex, 
10 
Accessory subunit of the mitochondrial membrane 
respiratory chain NADH dehydrogenase (Complex I), 
that is believed not to be involved in catalysis. Complex I 
functions in the transfer of electrons from NADH to the 
respiratory chain. The immediate electron acceptor for 
the enzyme is believed to be ubiquinone 
36  ‐113  7.6  20.8  3.52E+06 1.42E+06 
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Average Normalised 
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Corn 
Peroxiredoxin‐1 
(EC 
1.11.1.15)(Thiore
doxin  peroxidase 
2)(Thioredoxin‐
dependent 
peroxide 
reductase 
2)(Heme‐binding 
23  kDa 
protein)(HBP23)  
Involved in redox regulation of the cell. Reduces 
peroxides with reducing equivalents provided through the 
thioredoxin system but not from glutaredoxin. May play 
an important role in eliminating peroxides generated 
during metabolism. Might participate in the signaling 
cascades of growth factors and tumor necrosis factor-
alpha by regulating the intracellular concentrations of 
H2O2. Reduces an intramolecular disulfide bond in 
GDPD5 that gates the ability to GDPD5 to drive 
postmitotic motor neuron differentiation 
3  ‐16.8  8.3  22.1 
Isocitrate 
dehydrogenase 
subunit  alpha, 
mitochondrial 
Precursor  (EC 
1.1.1.41)(Isocitric 
dehydrogenase 
subunit 
alpha)(NAD(+)‐
specific  ICDH 
subunit alpha) 
catalytic activity: Isocitrate + NAD+ = 2-oxoglutarate + 
CO2 + NADH. 
3  ‐10.4  6.5  39.6 
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Average Normalised 
Volumes  
Mon 810 
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Corn 
2179 2.5 6.49 66,200 
Ornithine 
aminotransferase, 
mitochondrial 
Precursor  (EC 
2.6.1.13)(Ornithine‐
‐oxo‐acid 
aminotransferase)  
catalytic activity: L-ornithine + a 2-oxo acid = L-
glutamate 5-semialdehyde + an L-amino acid. 
5  ‐22.2  6.5  48.3  9.67E+05 3.91E+05 
1707 1.9 7.15 66,200 
Protein  disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 
71  ‐192  5.9  56.6 
3.34E+06 1.73E+06 
Tyrosyl‐tRNA 
synthetase, 
cytoplasmic  (EC 
6.1.1.1)(Tyrosyl‐‐
tRNA 
ligase)(TyrRS)  
Catalyzes the attachment of tyrosine to tRNA(Tyr) in a 
two-step reaction: tyrosine is first activated by ATP to 
form Tyr-AMP and then transferred to the acceptor end 
of tRNA(Tyr) 
7  ‐35  8.6  63 
Dihydrolipoyl 
dehydrogenase, 
mitochondrial 
Precursor  (EC 
1.8.1.4)(Dihydroli
poamide 
dehydrogenase)  
Lipoamide dehydrogenase is a component of the glycine 
cleavage system as well as of the alpha-ketoacid 
dehydrogenase complexes. Involved in the 
hyperactivation of spermatazoa during capacitation and in 
the spermatazoal acrosome reaction  
4  ‐25.2  8  54 
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Average Normalised 
Volumes  
Mon 810 
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Conv 
Corn 
3255 1.5 8.77 38,762 
Superoxide 
dismutase  , 
mitochondrial 
Precursor  (EC 
1.15.1.1)  
Destroys superoxide anion radicals which are normally 
produced within the cells and which are toxic to 
biological systems. 5  ‐30  9  24.7  6.78E+06 9.84E+06 
2232 1.8 8.72 64,735 
Phosphoglycerate 
kinase 1  
Catalytic activity: ATP + 3-phospho-D-glycerate = ADP 
+ 3-phospho-D-glyceroyl phosphate. 39  ‐152  8  44.5 
8.40E+06 4.73E+06 
Cytochrome  b‐c1 
complex  subunit 
2,  mitochondrial 
Precursor 
(Ubiquinol‐
cytochrome‐c 
reductase 
complex  core 
protein  2)(Core 
protein II) 
This  is  a  component  of  the  ubiquinol‐cytochrome  c 
reductase  complex  (complex  III  or  cytochrome  b‐c1 
complex), which  is part of the mitochondrial respiratory 
chain. The core protein 2 is required for the assembly of 
the complex.  8  ‐52.6  9.2  48.4 
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Average Normalised 
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Mon 810 
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Conv 
Corn 
2442 1.6  6.7 30,665 
Alcohol 
dehydrogenase 
(EC 
1.1.1.2)(Aldehyde 
reductase)(Aldo‐
keto  reductase 
family  1  member 
A1)(3‐DG‐
reducing enzyme) 
Catalyzes  the NADPH‐dependent  reduction of  a  variety 
of  aromatic  and  aliphatic  aldehydes  to  their 
corresponding  alcohols.  Catalyzes  the  reduction  of 
mevaldate  to mevalonic  acid  and  of  glyceraldehyde  to 
glycerol. Has broad  substrate  specificity. Plays a  role  in 
the  activation  of  procarcinogens,  such  as  polycyclic 
aromatic  hydrocarbon  trans‐dihydrodiols,  and  in  the 
metabolism of various  xenobiotics and drugs. Catalyzes 
the  NADPH‐dependent  reduction  of  3‐deoxyglucosone 
(3‐DG). 
33  ‐85.4  6.8  36.5 
4.43E+06  3.56E+06 Cytosol 
aminopeptidase 
(EC 
3.4.11.1)(Leucine 
aminopeptidase 
3)(LAP‐3)(Leucyl 
aminopeptidase)(
Proline 
aminopeptidase)(
EC 
3.4.11.5)(Prolyl 
aminopeptidase)  
Presumably  involved  in  the  processing  and  regular 
turnover of  intracellular proteins. Catalyzes the removal 
of  unsubstituted  N‐terminal  amino  acids  from  various 
peptides 
6  ‐40.7  6.8  56.1 
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Volumes  
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2893 3.1 6.27 45,776 
Lactotransferrin; 
Lactoferrin;  EC 
3.4.21. 
Transferrins are iron binding transport proteins which can bind 
two Fe3+ ions in association with the binding of an anion, 
usually bicarbonate.Lactotransferrin has antimicrobial activity 
which depends on the extracellular cation 
concentration.Lactoferroxins A, B and C have opioid antagonist 
activity. Lactoferroxin A shows preference for mu-receptors, 
while lactoferroxin B and C have somewhat higher degrees of 
preference for kappa-receptors than for mu-receptors.The 
lactotransferrin transferrin-like domain 1 functions as a serine 
protease of the peptidase S60 family that cuts arginine rich 
regions. This function contributes to the antimicrobial 
activity.Isoform DeltaLf: transcription factor with 
antiproliferative properties and inducing cell cycle arrest. Binds 
to DeltaLf response element found in the SKP1, BAX, DCPS, 
and SELH promoters.  
21  ‐147  8.5  78.1 
1.15E+06 3.54E+06 
T‐complex 
protein  1 
subunit  beta 
(TCP‐1‐
beta)(CCT‐beta)  
Molecular chaperone; assists the folding of proteins upon 
ATP hydrolysis. As part of the BBS/CCT complex may 
play a role in the assembly of BBSome, a complex 
involved in ciliogenesis regulating transports vesicles to 
the cilia. Known to play a role, in vitro, in the folding of 
actin and tubulin 
3  ‐11.7  6  57.4 
2209 1.6 7.22 65,424 
Gelsolin 
Precursor (Actin‐
depolymerizing 
factor)(ADF)(Bre
vin)  
Calcium-regulated, actin-modulating protein that binds to 
the plus (or barbed) ends of actin monomers or filaments, 
preventing monomer exchange (end-blocking or 
capping). It can promote the assembly of monomers into 
filaments (nucleation) as well as sever filaments already 
formed. Plays a role in ciliogenesis 
12  ‐55.7  5.9  86.2  2.73E+06 1.70E+06 
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Average Normalised 
Volumes  
Mon 810 Mon Garst 
Isocitrate 
dehydrogenase 
cytoplasmic  
catalise the reactiom: Isocitrate + NADP+ = 2-
oxoglutarate + CO2 + NADPH. 7  ‐24.2  6.5  46.7 
1485 2.4 6.92 73,807 
Lamin‐A   Lamins are components of the nuclear lamina, a fibrous 
layer on the nucleoplasmic side of the inner nuclear 
membrane, which is thought to provide a framework for 
the nuclear envelope and may also interact with 
chromatin. 
22  ‐110  6.5  74.3 
5.72E+05 2.35E+05 
Stress‐induced‐
phosphoprotein 
1  (STI1) 
(Hsc70/Hsp90‐
organizing 
protein)(Guertle
r et al.) 
Mediates the association of the molecular chaperones 
HSC70 and HSP90 (HSPCA and HSPCB). 
3  ‐14.2  6.4  62.5 
1960 2.2 6.53 66,200 
Alpha‐enolase 
(EC  4.2.1.11)(2‐
phospho‐D‐
glycerate  hydro‐
lyase)(Non‐
neural 
enolase)(Enolase 
1)  
Multifunctional enzyme that, as well as its role in 
glycolysis, plays a part in various processes such as 
growth control, hypoxia tolerance and allergic responses. 
May also function in the intravascular and pericellular 
fibrinolytic system due to its ability to serve as a receptor 
and activator of plasminogen on the cell surface of 
several cell-types such as leukocytes and neurons. 
Stimulates immunoglobulin production. 
32  ‐149  6.2  47.1  8.88E+06 4.11E+06 
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Volumes  
Mon 810 Mon Garst 
60  kDa  heat 
shock  protein, 
mitochondrial  
Implicated in mitochondrial protein import and 
macromolecular assembly. May facilitate the correct 
folding of imported proteins. May also prevent 
misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress 
conditions in the mitochondrial matrix. 
6  ‐29.7  5.9  60.9 
Protein 
disulfide‐
isomerase A3 
Catalyzes the rearrangement of -S-S- bonds in proteins. 
3  ‐14.3  5.9  56.6 
1972 2.6 6.86 66,200 
Protein 
disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 
2  ‐6.9  5.9  56.6  1.80E+06 6.86E+05 
2965 1.9 5.85 44,112 
6‐
phosphoglucono
lactonase 
(6PGL)(EC 
3.1.1.31)  
Hydrolysis of 6-phosphogluconolactone to 6-
phosphogluconate  
5  ‐28.5  6.4  30.8  2.52E+06 4.68E+06 
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DNA‐directed 
RNA 
polymerases I, II, 
and  III  subunit 
RPABC1  (RNA 
polymerases I, II, 
and  III  subunit 
ABC1)(DNA‐
directed  RNA 
polymerase  II 
subunit E) 
DNA-dependent RNA polymerase catalyzes the 
transcription of DNA into RNA using the four 
ribonucleoside triphosphates as substrates. Common 
component of RNA polymerases I, II and III which 
synthesize ribosomal RNA precursors, mRNA precursors 
and many functional non-coding RNAs, and small RNAs, 
such as 5S rRNA and tRNAs, respectively. Pol II is the 
central component of the basal RNA polymerase II 
transcription machinery. Pols are composed of mobile 
elements that move relative to each other. In Pol II, 
POLR2E/RPB5 is part of the lower jaw surrounding the 
central large cleft and thought to grab the incoming DNA 
template. Seems to be the major component in this 
process  
5  ‐24.5  5.7  24.6 
2912 3.8 8.12 31,042 
Electron transfer 
flavoprotein 
subunit  beta 
(Beta‐ETF)  
The electron transfer flavoprotein serves as a specific 
electron acceptor for several dehydrogenases, including 
five acyl-CoA dehydrogenases, glutaryl-CoA and 
sarcosine dehydrogenase. It transfers the electrons to the 
main mitochondrial respiratory chain via ETF-ubiquinone 
oxidoreductase (ETF dehydrogenase) 
66  ‐149  7.6  27.7 
5.58E+06 1.48E+06 Proteasome 
subunit  alpha 
type‐4  (EC 
3.4.25.1)(Protea
some 
component C9) 
The  proteasome  is  a multicatalytic  proteinase  complex 
which  is  characterized  by  its  ability  to  cleave  peptides 
with Arg, Phe, Tyr, Leu, and Glu adjacent to the  leaving 
group at neutral or slightly basic pH. The proteasome has 
an ATP‐dependent proteolytic activity. 
12  ‐49.3  7.6  29.5 
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Adenylate kinase 
2,  mitochondrial 
(AK  2)(EC 
2.7.4.3)(ATP‐
AMP 
transphosphoryl
ase 2)  
Catalyzes  the  reversible  transfer  of  the  terminal 
phosphate  group  between  ATP  and  AMP.  Plays  an 
important  role  in  cellular  energy  homeostasis  and  in 
adenine  nucleotide  metabolism.  Adenylate  kinase 
activity  is  critical  for  regulation  of  the  phosphate 
utilization and the AMP de novo biosynthesis pathways. 
Plays a key role in hematopoiesis  
12  ‐44.6  7  25.5 
Calcyclin‐binding 
protein  
May  be  involved  in  calcium‐dependent  ubiquitination 
and  subsequent  proteasomal  degradation  of  target 
proteins.  Probably  serves  as  a  molecular  bridge  in 
ubiquitin  E3  complexes.  Participates  in  the  ubiquitin‐
mediated degradation of beta‐catenin (CTNNB1) 
10  ‐34  7.6  26.5 
4082 2 9.09 57,000 
Malate 
dehydrogenase, 
mitochondrial 
Catalytic activity: (S)-malate + NAD+ = oxaloacetate + 
NADH. 23  ‐125  8.9  35.7  5.19E+06 2.65E+06 
  
 
290
S
p
o
t
 
N
o
.
 
F
o
l
d
 
E
x
p
e
r
i
m
e
n
t
a
l
 
p
I
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
W
 
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
rI log(e) 
T
h
e
o
r
i
t
i
c
a
l
 
p
I
 
T
h
e
o
r
i
t
i
c
a
l
 
M
W
 
(
K
i
l
o
D
a
l
t
o
n
s
)
 
Average Normalised 
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Glyceraldehyde‐
3‐phosphate 
dehydrogenase  
Has  both  glyceraldehyde‐3‐phosphate  dehydrogenase 
and  nitrosylase  activities,  thereby  playing  a  role  in 
glycolysis  and  nuclear  functions,  respectively. 
Glyceraldehyde‐3‐phosphate  dehydrogenase  is  a  key 
enzyme  in glycolysis  that  catalyzes  the  first  step of  the 
pathway  by  converting  D‐glyceraldehyde  3‐phosphate 
(G3P) into 3‐phospho‐D‐glyceroyl phosphate. Modulates 
the  organization  and  assembly  of  the  cytoskeleton. 
Facilitates  the  CHP1‐dependent  microtubule  and 
membrane  associations  through  its  ability  to  stimulate 
the binding of CHP1 to microtubules. Also participates in 
nuclear  events  including  transcription,  RNA  transport, 
DNA  replication  and  apoptosis.  Nuclear  functions  are 
probably  due  to  the  nitrosylase  activity  that  mediates 
cysteine  S‐nitrosylation  of  nuclear  target  proteins  such 
as  SIRT1,  HDAC2  and  PRKDC.  Component  of  the  GAIT 
(gamma  interferon‐activated  inhibitor  of  translation) 
complex  which  mediates  interferon‐gamma‐induced 
transcript‐selective translation inhibition in inflammation 
processes. Upon interferon‐gamma treatment assembles 
into  the  GAIT  complex  which  binds  to  stem  loop‐
containing  GAIT  elements  in  the  3'‐UTR  of  diverse 
inflammatory  mRNAs  (such  as  ceruplasmin)  and 
suppresses their translation  
15  ‐64.1  8.1  35.8 
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Heterogeneous 
nuclear 
ribonucleoprotei
n A3 (hnRNP A3) 
Plays  a  role  in  cytoplasmic  trafficking of RNA. Binds  to 
the cis‐acting response element, A2RE. May be  involved 
in pre‐mRNA splicing.  5  ‐26.1  8.5  37.1 
4101  1.7  7.21  44,497 
Isocitrate 
dehydrogenase 
cytoplasmic  
catalytic activity:  Isocitrate + NADP+ = 2‐oxoglutarate + 
CO2 + NADPH.  24  ‐108  6.5  46.7 
2.59E+06  1.50E+06 
Acyl‐coenzyme A 
thioesterase  2, 
mitochondrial  
Acyl‐CoA  thioesterases  are  a  group  of  enzymes  that 
catalyze the hydrolysis of acyl‐CoAs to the free fatty acid 
and  coenzyme  A  (CoASH),  providing  the  potential  to 
regulate intracellular levels of acyl‐CoAs, free fatty acids 
and CoASH. Most active on substrates with chain lengths 
ranging from C14‐C20. 
9  ‐64.7  8.2  49.6 
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2232 2.3 8.72 64,735 
Phosphoglycerate 
kinase 1  
Catalytic activity: ATP + 3-phospho-D-glycerate = ADP 
+ 3-phospho-D-glyceroyl phosphate. 39  ‐152  8  44.5 
8.40E+06 3.73E+06 
Cytochrome  b‐c1 
complex  subunit  2, 
mitochondrial 
Precursor 
(Ubiquinol‐
cytochrome‐c 
reductase  complex 
core protein 2)(Core 
protein II) 
This  is  a  component  of  the  ubiquinol‐cytochrome  c 
reductase  complex  (complex  III  or  cytochrome  b‐c1 
complex), which is part of the mitochondrial respiratory 
chain. The core protein 2 is required for the assembly of 
the complex.  8  ‐53  9.2  48.4 
2149 2.7 7.09 66,200 
Protein  disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 
4  ‐20  5.9  56.6  1.44E+06 5.32E+05 
1564 1.8 6.99 67,644 
Stress‐induced‐
phosphoprotein  1 
(STI1)(Hsc70/Hsp90‐
organizing protein) 
Mediates  the association of  the molecular  chaperones 
HSC70 and HSP90 (HSPCA and HSPCB).   40  ‐131  6.4  62.5 
5.44E+06 3.09E+06 Lamin‐A   Lamins are components of the nuclear lamina, a fibrous 
layer on the nucleoplasmic side of the inner nuclear 
membrane, which is thought to provide a framework for 
the nuclear envelope and may also interact with 
chromatin. 
32  ‐125  6.5  74.3 
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Mon 810 Mon Gold 
1485 2.4 6.92 73,807 
Lamin‐A   Lamins are components of the nuclear lamina, a fibrous 
layer on the nucleoplasmic side of the inner nuclear 
membrane, which is thought to provide a framework for 
the nuclear envelope and may also interact with 
chromatin. 
22  ‐110  6.5  74.3 
5.72E+05 2.40E+05 
Stress‐induced‐
phosphoprotein  1 
(STI1) 
(Hsc70/Hsp90‐
organizing 
protein)(Guertler  et 
al.) 
Mediates the association of the molecular chaperones 
HSC70 and HSP90 (HSPCA and HSPCB). 
3  ‐14  6.4  62.5 
3305 2.8 5.07 37,180 
chromobox 
homolog 3  
Seems to be involved in transcriptional silencing in 
heterochromatin-like complexes. Recognizes and binds 
histone H3 tails methylated at 'Lys-9', leading to 
epigenetic repression. May contribute to the association 
of the heterochromatin with the inner nuclear membrane 
through its interaction with lamin B receptor (LBR). 
Involved in the formation of functional kinetochore 
through interaction with MIS12 complex proteins. 
2  ‐9.4  5.2  20.8  2.51E+06 7.05E+06 
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Average Normalised 
Volumes  
Mon Conv 
Corn 
Mon 
Garst 
1972 2.5 6.86 66,200 Protein  disulfide‐isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 2  ‐6.9  5.9  56.6  1.73E+06 6.86E+05 
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2149 2.7 7.09 66,200 
Protein  disulfide‐
isomerase A3  
Catalyzes the rearrangement of -S-S- bonds in proteins. 4  ‐20  5.9  56.6  1.45E+06 5.32E+05 
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Average Normalised Volumes  
Mcert Mon 810 
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Conv 
Corn 
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Garst 
Mon 
Gold 
2912 7.67E-05 3.8 8.12/31.042 
Electron  transfer 
flavoprotein 
subunit beta (Beta‐
ETF)  
The electron 
transfer 
flavoprotein 
serves as a 
specific electron 
acceptor for 
several 
dehydrogenases, 
including five 
acyl-CoA 
dehydrogenases, 
glutaryl-CoA and 
sarcosine 
dehydrogenase. It 
transfers the 
electrons to the 
main 
mitochondrial 
respiratory chain 
via ETF-
ubiquinone 
oxidoreductase 
(ETF 
dehydrogenase) 
66 ‐149  7.6/27.7 
5.13E+06 5.58E+06 3.33E+06 1.48E+06 3.60E+06 
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Mcert Mon 810 
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Conv 
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Mon 
Garst 
Mon 
Gold 
Proteasome 
subunit  alpha 
type‐4  (EC 
3.4.25.1)(Proteaso
me component C9) 
The proteasome is 
a  multicatalytic 
proteinase 
complex  which  is 
characterized  by 
its ability to cleave 
peptides with Arg, 
Phe, Tyr,  Leu, and 
Glu  adjacent  to 
the  leaving  group 
at  neutral  or 
slightly  basic  pH. 
The  proteasome 
has  an  ATP‐
dependent 
proteolytic 
activity. 
12 ‐49.3  7.6/29.5 
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Average Normalised Volumes  
Mcert Mon 810 
Mon 
Conv 
Corn 
Mon 
Garst 
Mon 
Gold 
Adenylate  kinase 
2,  mitochondrial 
(AK  2)(EC 
2.7.4.3)(ATP‐AMP 
transphosphorylas
e 2)  
Catalyzes  the 
reversible  transfer 
of  the  terminal 
phosphate  group 
between  ATP  and 
AMP.  Plays  an 
important  role  in 
cellular  energy 
homeostasis  and 
in  adenine 
nucleotide 
metabolism. 
Adenylate  kinase 
activity  is  critical 
for  regulation  of 
the  phosphate 
utilization and  the 
AMP  de  novo 
biosynthesis 
pathways.  Plays  a 
key  role  in 
hematopoiesis  
12 ‐44.6  7/25.5 
  
 
298
S
p
o
t
 
N
o
.
 
A
n
o
v
a
 
(
p
)
 
 
F
o
l
d
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
I
p
/
M
W
 
(
M
W
 
K
i
l
o
 
i
n
 
D
a
l
t
o
n
s
)
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
F
u
n
c
t
i
o
n
 
rI log(e) 
T
h
e
o
r
i
t
i
c
a
l
 
I
p
/
M
W
 
(
M
W
 
i
n
 
K
i
l
o
D
a
l
t
o
n
s
)
 
Average Normalised Volumes  
Mcert Mon 810 
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Mon 
Garst 
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Gold 
Calcyclin‐binding 
protein  
May  be  involved 
in  calcium‐
dependent 
ubiquitination and 
subsequent 
proteasomal 
degradation  of 
target  proteins. 
Probably serves as 
a molecular bridge 
in  ubiquitin  E3 
complexes. 
Participates  in  the 
ubiquitin‐
mediated 
degradation  of 
beta‐catenin 
(CTNNB1) 
10 ‐34  7.6/26.5 
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1485 3.10E-05 3.1 6.91/72.759 
Lamin‐A  Lamins are 
components of the 
nuclear lamina, a 
fibrous layer on 
the nucleoplasmic 
side of the inner 
nuclear 
membrane, which 
is thought to 
provide a 
framework for the 
nuclear envelope 
and may also 
interact with 
chromatin. 
22 ‐110  6.5/74.3 
3.32E+05 5.72E+05 1.83E+05 2.35E+05 2.40E+05 
Stress‐induced‐
phosphoprotein  1 
(STI1) 
(Hsc70/Hsp90‐
organizing protein) 
Mediates the 
association of the 
molecular 
chaperones 
HSC70 and 
HSP90 (HSPCA 
and HSPCB). 
3  ‐14.2  6.4/62.5 
log(e): the base-10 log of the expectation that any particular protein assignment was made at random (E-value). 
rl: the number of unique peptide sequences associated with this protein assignment. 
pI: isoelectric point for the intact gene product. 
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Appendices to chapter 5 
 
 
 
 
 
Appendix 29: 2DE of the proteome of the primary epithelial-like cells from the small
intestine of rats exposed to Bt maize extract. Protein spots from this gel were
compared to those from comparator gels where intestinal primary epithelial-like cells
were exposed to non-Bt maize extract. 
Differentially expressed protein spots were identified by Progenesis SameSpot
software. Protein spots that were picked for subsequent identification by LC-MS/MS
were 1627, 1687, 2204, 2547, 2601, and 2882 (as indicated on the proteome map). 
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Appendix 30: 2DE of the proteome of HCT116 cell line exposed to Bt maize extract. Protein spots from 
this gel were compared to those from comparator gels where intestinal primary epithelial-like cells were 
exposed to Bt maize extract. 
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots 
that were picked for subsequent identification by LC-MS/MS were 814, 914, 1561, 1650, 1615, 1043, 
3634, 1706, 1891, 1954, 2098, 2170, 2262, 2370, 2393, 2401, 2550, 2547, 2590, 2597, 3657, 2648, 2786, 
2817, 2987, 3653, 3137, 3391, 3436, and 3524 (as indicated on the proteome map). 
 
 
 
Appendix 31: 2DE of the proteome of the primary epithelial-like cells from the small intestine of rats 
exposed to non-Bt maize extract. Protein spots from this gel were compared to those from comparator 
gels where HCT116 cell line was exposed to non-Bt maize extract. 
Differentially expressed protein spots were identified by Progenesis SameSpot software. Protein spots 
that were picked for subsequent identification by LC-MS/MS were 914, 1687, 1895, 2370, 2600, 3663, 
2817, 2877, 3667, 3120, 3360, and 3309 (as indicated on the proteome map). 
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Appendix 32: Identification of differentially expressed proteins from the primary epithelial cells of the small intestine of rats and from HCT116 cell line exposed to Bt and non-Bt 
maize extracts. 
The data represent two way comparisons as follows (HCT116 Bt vs IECs Bt, IECs Bt vs IECs non-Bt, HCT116 non-Bt vs IECs non-Bt). 
Spots were ranked by p-value (from low to high). 
S
p
o
t
 
N
o
.
 
 
F
o
l
d
 
 
E
x
p
e
r
i
m
e
n
t
a
l
 
p
I
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
W
 
P
r
o
t
e
i
n
 
D
e
s
c
r
i
p
t
i
o
n
 
 
F
u
n
c
t
i
o
n
 
r
I
 
l
o
g
(
e
)
 
T
h
e
o
r
i
t
i
c
a
l
 
p
I
 
T
h
e
o
r
i
t
i
c
a
l
 
M
W
 
(
K
i
l
o
D
a
l
t
o
n
s
)
 
A
v
e
r
a
g
e
 
N
o
r
m
a
l
i
s
e
d
 
V
o
l
u
m
e
s
 
 
HCT Bt IEC Bt 
2393 1.8 6.43 40,646 
Elongation factor 2   Catalyzes the GTP-dependent ribosomal translocation step during 
translation elongation. During this step, the ribosome changes from 
the pre-translocational (PRE) to the post-translocational  state as the 
newly formed A-site-bound peptidyl-tRNA and P-site-bound 
deacylated tRNA move to the P and E sites, respectively. Catalyzes 
the coordinated movement of the two tRNA molecules, the mRNA 
and conformational changes in the ribosome. Biological process: 
Protein biosynthesis 
32 -112 6.4 95.2 
7.87E+06 4.40E+06 inner membrane protein, 
mitochondrial 
involved in the maintenance of an internal steady state of calcium ions 
within the cytoplasm of a cell or between mitochondria and their 
surroundings 
8 -25.3 5.6 87.1 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
3 -17.3 5.9 73.7 
2597 1.6 5.8 37,634 
Actin, cytoplasmic 1 Actin, 
cytoplasmic 1, N-terminally 
processed  
Actins are highly conserved proteins that are involved in various types 
of cell motility and are ubiquitously expressed in all eukaryotic cells. 
12 -62.3 5.3 41.7 
4.36E+06 6.97E+06 
814 3.2 5 98,898 
filamin-A  Promotes orthogonal branching of actin filaments and links actin 
filaments to membrane glycoproteins. Anchors various 
transmembrane proteins to the actin cytoskeleton and serves as a 
scaffold for a wide range of cytoplasmic signaling proteins. Interaction 
with FLNA may allow neuroblast migration from the ventricular zone 
into the cortical plate. Tethers cell surface-localized furin, modulates 
its rate of internalization and directs its intracellular trafficking. 
Involved in ciliogenesis.  
33 -168 5.7 281.1 
1.27E+06 4.03E+06 
Myosin-9  Cellular myosin that appears to play a role in cytokinesis, cell shape, 
and specialized functions such as secretion and capping. 
20 -115 5.5 226.3 
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HCT Bt IEC Bt 
Fibronectin Precursor (FN)  Fibronectins bind cell surfaces and various compounds including 
collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in 
cell adhesion, cell motility, opsonization, wound healing, and 
maintenance of cell shape. Anastellin binds fibronectin and induces 
fibril formation. This fibronectin polymer, named superfibronectin, 
exhibits enhanced adhesive properties. Both anastellin and 
superfibronectin inhibit tumor growth, angiogenesis and metastasis. 
Anastellin activates p38 MAPK and inhibits lysophospholipid 
signaling 
5 -32.7 5.4 272.3 
Vinculin (Metavinculin)  Actin filament (F-actin)-binding protein involved in cell-matrix 
adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin 
expression and potentiates mechanosensing by the E-cadherin 
complex. May also play important roles in cell morphology and 
locomotion  
4 -28.4 5.8 116.5 
Spectrin alpha chain, brain Fodrin, which seems to be involved in secretion, interacts with 
calmodulin in a calcium-dependent manner and is thus candidate for 
the calcium-dependent movement of the cytoskeleton at the membrane 
3 -17.3 5.2 285.3 
78 kDa glucose-regulated 
protein  
Probably plays a role in facilitating the assembly of multimeric protein 
complexes inside the ER. 
3 -15.6 5.1 72.3 
filamin, beta  Connects cell membrane constituents to the actin cytoskeleton. May 
promote orthogonal branching of actin filaments and links actin 
filaments to membrane glycoproteins. Anchors various 
transmembrane proteins to the actin cytoskeleton. Interaction with 
FLNA may allow neuroblast migration from the ventricular zone into 
the cortical plate. Various interactions and localizations of isoforms 
affect myotube morphology and myogenesis. Isoform 6 accelerates 
muscle differentiation in vitro.  
3 -14.3 5.4 277.7 
integrin alpha V Gene The alpha-V integrins are receptors for vitronectin, cytotactin, 
fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, 
osteopontin, osteomodulin, prothrombin, thrombospondin and vWF. 
They recognize the sequence R-G-D in a wide array of ligands. In case 
of HIV-1 infection, the interaction with extracellular viral Tat protein 
seems to enhance angiogenesis in Kaposi's sarcoma lesions.  
4 -13.6 5.4 108.9 
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HCT Bt IEC Bt 
2547 4.4 5.13 38,583 
Heat shock protein HSP 90-
beta (Heat shock 84 kDa)(HSP 
84)(HSP84) 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function  
24 -73.2 5 83.2 
4.16E+05 1.82E+06 
Heat shock protein HSP 90-
alpha  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function 
9 -39.9 4.9 84.8 
L-lactate dehydrogenase B 
chain  
Catalytic activity: (S)-lactate + NAD+ = pyruvate + NADH. Pathway: 
Fermentation; pyruvate fermentation to lactate; (S)-lactate from 
pyruvate: step 1/1. Biological process: Glycolysis 
5 -38.6 5.7 36.6 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9)(Peptide-
binding protein 74)(PBP74) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
7 -30.7 5.9 73.7 
Pyruvate kinase isozymes 
M1/M2 
Glycolytic enzyme that catalyzes the transfer of a phosphoryl group 
from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates 
POU5F1-mediated transcriptional activation. Pathway: Carbohydrate 
degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: 
step 5/5 
4 -24.3 6.6 57.8 
Lamin-B1 Lamins are components of the nuclear lamina, a fibrous layer on the 
nucleoplasmic side of the inner nuclear membrane, which is thought to 
provide a framework for the nuclear envelope and may also interact 
with chromatin  
4 -24.2 5.1 66.6 
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HCT Bt IEC Bt 
S-adenosylmethionine 
synthetase isoform type-2 
(AdoMet synthetase 2)  
Catalyzes the formation of S-adenosylmethionine from methionine 
and ATP. Pathway: Amino-acid biosynthesis; S-adenosyl-L-
methionine biosynthesis; S-adenosyl-L-methionine from L-
methionine: step 1/1 
5 -17.4 5.7 42.7 
Nuclear migration protein nudC 
(Nuclear distribution protein C 
homolog) 
Plays a role in neurogenesis and neuronal migration. Necessary for 
correct formation of mitotic spindles and chromosome separation 
during mitosis 
3 -17.2 5.3 38.4 
Endoplasmin Precursor (Heat 
shock protein 90 kDa beta 
member 1)(94 kDa glucose-
regulated protein)(GRP-94)  
Molecular chaperone that functions in the processing and transport of 
secreted proteins. When associated with CNPY3, required for proper 
folding of Toll-like receptors. Functions in endoplasmic reticulum 
associated degradation (ERAD). Has ATPase activity  
3 -16.3 4.7 92.7 
Moesin  Probably involved in connections of major cytoskeletal structures to 
the plasma membrane. 
3 -15.8 6.1 67.6 
Tubulin beta-5 chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
3 -10.6 4.8 49.6 
T-complex protein 1 subunit 
epsilon (TCP-1-epsilon)(CCT-
epsilon)  
Molecular chaperone; assists the folding of proteins upon ATP 
hydrolysis. As part of the BBS/CCT complex may play a role in the 
assembly of BBSome, a complex involved in ciliogenesis regulating 
transports vesicles to the cilia. Known to play a role, in vitro, in the 
folding of actin and tubulin 
4 -9.5 5.5 59.5 
Aldose reductase  Catalyzes the NADPH-dependent reduction of a wide variety of 
carbonyl-containing compounds to their corresponding alcohols with a 
broad range of catalytic efficiencies. 
6 -8.7 6.3 35.8 
aldo-keto reductase family 1, 
member B8 
Biological process: oxidation-reduction process 5 -8.2 7.1 36.1 
3634 3 5.33 63,881 
Plectin-1  Interlinks intermediate filaments with microtubules and 
microfilaments and anchors intermediate filaments to desmosomes or 
hemidesmosomes. May be involved not only in the cross-linking and 
stabilization of cytoskeletal intermediate filaments network, but also 
in the regulation of their dynamics. 
12 -80.3 5.6 521.7 
7.73E+05 2.30E+06 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated protein) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
17 -65 5.9 73.7 
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HCT Bt IEC Bt 
60 kDa heat shock protein, 
mitochondrial  
Implicated in mitochondrial protein import and macromolecular 
assembly. May facilitate the correct folding of imported proteins. May 
also prevent misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix. 
6 -41.1 5.9 60.9 
1561 1.9 5.46 72,629 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
71 -236 5.9 73.7 
4.04E+06 7.52E+06 
78 kDa glucose-regulated 
protein  
Probably plays a role in facilitating the assembly of multimeric protein 
complexes inside the ER. 
8 -52.3 5.1 72.3 
prelamin-A/C isoform C2  Lamins are components of the nuclear lamina, a fibrous layer on the 
nucleoplasmic side of the inner nuclear membrane, which is thought to 
provide a framework for the nuclear envelope and may also interact 
with chromatin. Lamin A and C are present in equal amounts in the 
lamina of mammals. Plays an important role in nuclear assembly, 
chromatin organization, nuclear membrane and telomere dynamics. 
Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to 
disrupt mitosis and induce DNA damage in vascular smooth muscle 
cells (VSMCs), leading to mitotic failure, genomic instability, and 
premature senescence.  
4 -23.8 6.5 74.3 
Lactotransferrin; Lactoferrin Transferrins are iron binding transport proteins which can bind two 
Fe3+ ions in association with the binding of an anion, usually 
bicarbonate. Lactotransferrin has antimicrobial activity which depends 
on the extracellular cation concentration. Lactoferroxins A, B and C 
have opioid antagonist activity. Lactoferroxin A shows preference for 
mu-receptors, while lactoferroxin B and C have somewhat higher 
degrees of preference for kappa-receptors than for mu-receptors. The 
lactotransferrin transferrin-like domain 1 functions as a serine protease 
of the peptidase S60 family that cuts arginine rich regions. This 
function contributes to the antimicrobial activity.  
3 -7.6 8.5 78.1 
3653 2.3 6.34 27,447 
Pyruvate kinase isozymes 
M1/M2  
Glycolytic enzyme that catalyzes the transfer of a phosphoryl group 
from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates 
POU5F1-mediated transcriptional activation 
5 -33.4 6.6 57.8 
2.78E+06 6.27E+06 
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HCT Bt IEC Bt 
Proteasome subunit alpha type-
6  
The proteasome is a multicatalytic proteinase complex which is 
characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, 
and Glu adjacent to the leaving group at neutral or slightly basic pH. 
The proteasome has an ATP-dependent proteolytic activity. 
4 -18.2 6.3 27.4 
Annexin A2  Calcium-regulated membrane-binding protein whose affinity for 
calcium is greatly enhanced by anionic phospholipids. It binds two 
calcium ions with high affinity. 
4 -17.9 7.5 38.9 
1891 2.5 5.05 54,196 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. Involved with LARP6 in the stabilization of type I 
collagen mRNAs for CO1A1 and CO1A2  
16 -86.2 5.1 53.7 
2.71E+06 6.73E+06 
ATP synthase subunit beta, 
mitochondrial  
Mitochondrial membrane ATP synthase (F1F0 ATP synthase or 
Complex V) produces ATP from ADP in the presence of a proton 
gradient across the membrane which is generated by electron transport 
complexes of the respiratory chain. F-type ATPases consist of two 
structural domains, F1 - containing the extramembraneous catalytic 
core, and F0 - containing the membrane proton channel, linked 
together by a central stalk and a peripheral stalk. During catalysis, 
ATP synthesis in the catalytic domain of F1 is coupled via a rotary 
mechanism of the central stalk subunits to proton translocation. 
Subunits alpha and beta form the catalytic core in F1. Rotation of the 
central stalk against the surrounding alpha3beta3 subunits leads to 
hydrolysis of ATP in three separate catalytic sites on the beta subunits. 
8 -56.8 5.1 56.3 
2262 2.2 5.55 42,710 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. Involved with LARP6 in the stabilization of type I 
collagen mRNAs for CO1A1 and CO1A2  
20 -102 5.1 53.7 
9.03E+05 2.02E+06 60 kDa heat shock protein, 
mitochondrial 
Implicated in mitochondrial protein import and macromolecular 
assembly. May facilitate the correct folding of imported proteins. May 
also prevent misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix. 
12 -82.2 5.9 60.9 
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HCT Bt IEC Bt 
Heat shock protein HSP 90-
beta (Heat shock 84 kDa)(HSP 
84) 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function 
8 -49.5 5 83.2 
Heat shock protein HSP 90-
alpha  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function  
6 -39.7 4.9 84.8 
tubulin, alpha 1B (Tuba1b), 
mRNA  
Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
3 -19.8 4.9 50.2 
Nuclear migration protein nudC 
(Nuclear distribution protein C 
homolog)(c15)  
Plays a role in neurogenesis and neuronal migration. Necessary for 
correct formation of mitotic spindles and chromosome separation 
during mitosis 
4 -17.7 5.3 38.4 
Pyruvate kinase isozymes 
M1/M2 
Glycolytic enzyme that catalyzes the transfer of a phosphoryl group 
from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates 
POU5F1-mediated transcriptional activation. Pathway: Carbohydrate 
degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: 
step 5/5 
3 -11.8 6.6 57.8 
1615 2.2 5.24 67,203 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
24 -87.3 5.9 73.7 
6.69E+05 1.49E+06 
78 kDa glucose-regulated 
protein 
Probably plays a role in facilitating the assembly of multimeric protein 
complexes inside the ER. 
4 -25.9 5.1 72.3 
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HCT Bt IEC Bt 
2401 1.8 7.76 40,564 
Transketolase (UniProtKB) Catalyzes the transfer of a two-carbon ketol group from a ketose donor 
to an aldose acceptor, via a covalent intermediate with the cofactor 
thiamine pyrophosphate 
9 -41.9 7.5 71.1 
2.35E+06 1.28E+06 
Elongation factor 2 Catalyzes the GTP-dependent ribosomal translocation step during 
translation elongation. During this step, the ribosome changes from 
the pre-translocational (PRE) to the post-translocational  state as the 
newly formed A-site-bound peptidyl-tRNA and P-site-bound 
deacylated tRNA move to the P and E sites, respectively. Catalyzes 
the coordinated movement of the two tRNA molecules, the mRNA 
and conformational changes in the ribosome. Biological process: 
Protein biosynthesis 
5 -28.3 6.4 95.2 
3436 1.4 6 14,785 
Non-POU domain-containing 
octamer-binding protein  
DNA- and RNA binding protein, involved in several nuclear 
processes. Binds the conventional octamer sequence in double 
stranded DNA. Also binds single-stranded DNA and RNA at a site 
independent of the duplex site. Involved in pre-mRNA splicing, 
probably as a heterodimer with SFPQ. Interacts with U5 snRNA, 
probably by binding to a purine-rich sequence located on the 3' side of 
U5 snRNA stem 1b. The SFPQ-NONO heteromer associated with 
MATR3 may play a role in nuclear retention of defective RNAs. The 
SFPQ-NONO heteromer may be involved in DNA unwinding by 
modulating the function of topoisomerase I/TOP1. The SFPQ-NONO 
heteromer may be involved in DNA nonhomologous end joining 
(NHEJ) required for double-strand break repair and V(D)J 
recombination and may stabilize paired DNA ends. In vitro, the 
complex strongly stimulates DNA end joining, binds directly to the 
DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5  
dimer to establish a functional preligation complex. NONO is 
involved in transcriptional regulation. The SFPQ-NONO-NR5A1 
complex binds to the CYP17 promoter and regulates basal and cAMP-
dependent transcriptional avtivity. NONO binds to an enhancer 
element in long terminal repeats of endogenous intracisternal A 
particles (IAPs) and activates transcription. Together with PSPC1, 
required for the formation of nuclear paraspeckles. 
7 -29.8 9 54.9 
7.70E+06 5.64E+06 
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HCT Bt IEC Bt 
ErbB3-binding protein 1  May play a role in a ERBB3-regulated signal transduction pathway. 
Seems be involved in growth regulation. Acts a corepressor of the 
androgen receptor  and is regulated by the ERBB3 ligand neuregulin-
1/heregulin (HRG). Inhibits transcription of some E2F1-regulated 
promoters, probably by recruiting histone acetylase (HAT) activity. 
Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, 
several rRNA precursors and probably U3 small nucleolar RNA. May 
be involved in regulation of intermediate and late steps of rRNA 
processing. May be involved in ribosome assembly. Mediates cap-
independent translation of specific viral IRESs (internal ribosomal 
entry site) 
4 -11.4 6.4 43.6 
914 2.7 5.48 92,918 
Heat shock protein HSP 90-
alpha 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function 
9 -73.1 4.9 84.8 
2.52E+05 6.84E+05 
Heat shock protein HSP 90-
beta 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function  
9 -57.1 5 83.2 
Vinculin (Metavinculin)  Actin filament (F-actin)-binding protein involved in cell-matrix 
adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin 
expression and potentiates mechanosensing by the E-cadherin 
complex. May also play important roles in cell morphology and 
locomotion  
7 -56.2 5.8 116.5 
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HCT Bt IEC Bt 
1954 2.3 6.56 49,964 Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
59 -156 5.9 73.7 
6.12E+06 2.71E+06 
3391 1.9 5.1 15,950 
Ezrin  Probably involved in connections of major cytoskeletal structures to 
the plasma membrane. In epithelial cells, required for the formation of 
microvilli and membrane ruffles on the apical pole. Along with 
PLEKHG6, required for normal macropinocytosis 
7 -41.6 5.8 69.3 
2.79E+06 5.21E+06 
Nucleolin-like protein  Molecular function: nuclic acid binding and nucleotide binding 9 -30.8 5.3 61.7 
T-complex protein 1 subunit 
alpha 
Molecular chaperone; assists the folding of proteins upon ATP 
hydrolysis. As part of the BBS/CCT complex may play a role in the 
assembly of BBSome, a complex involved in ciliogenesis regulating 
transports vesicles to the cilia. Known to play a role, in vitro, in the 
folding of actin and tubulin  
5 -30.4 5.9 60.3 
Heat shock protein HSP 90-
beta  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function  
5 -28.3 5 83.2 
40S ribosomal protein SA  Required for the assembly and/or stability of the 40S ribosomal 
subunit. Required for the processing of the 20S rRNA-precursor to 
mature 18S rRNA in a late step of the maturation of 40S ribosomal 
subunits. Also functions as a cell surface receptor for laminin. Plays a 
role in cell adhesion to the basement membrane and in the consequent 
activation of signaling transduction pathways. May play a role in cell 
fate determination and tissue morphogenesis. Also acts as a receptor 
for several other ligands, including the pathogenic prion protein, 
viruses, and bacteria. Acts as a PPP1R16B-dependent substrate of 
PPP1CA  
5 -21.7 4.8 32.8 
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HCT Bt IEC Bt 
Eukaryotic translation initiation 
factor 3 subunit I (eIF3i) 
Component of the eukaryotic translation initiation factor 3 (eIF-3) 
complex, which is required for several steps in the initiation of protein 
synthesis. The eIF-3 complex associates with the 40S ribosome and 
facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-
tRNAi and eIF-5 to form the 43S preinitiation complex (43S PIC). 
The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and 
scanning of the mRNA for AUG recognition. The eIF-3 complex is 
also required for disassembly and recycling of post-termination 
ribosomal complexes and subsequently prevents premature joining of 
the 40S and 60S ribosomal subunits prior to initiation.  
3 -9.2 5.3 19.4 
1043 2 7.5 87,256 Lactotransferrin 
Transferrins are iron binding transport proteins which can bind two 
Fe3+ ions in association with the binding of an anion, usually 
bicarbonate. Lactotransferrin has antimicrobial activity which depends 
on the extracellular cation concentration. Lactoferroxins A, B and C 
have opioid antagonist activity. Lactoferroxin A shows preference for 
mu-receptors, while lactoferroxin B and C have somewhat higher 
degrees of preference for kappa-receptors than for mu-receptors. The 
lactotransferrin transferrin-like domain 1 functions as a serine protease 
of the peptidase S60 family that cuts arginine rich regions. This 
function contributes to the antimicrobial activity.  
3 -18.2 8.5 78.1 2.12E+06 1.09E+06 
3137 1.4 6.24 21,626 
Annexin A1  Calcium/phospholipid-binding protein which promotes membrane 
fusion and is involved in exocytosis. This protein regulates 
phospholipase A2 activity. It seems to bind from two to four calcium 
ions with high affinity. 
14 -41.2 7 38.8 
1.90E+06 2.69E+06 
Ras-related protein Rab-11B  GTPase that modulates endosomal trafficking. Acts as a major 
regulator of membrane delivery during cytokinesis  
4 -25.6 5.6 24.5 
NADH dehydrogenase 
flavoprotein 2, mitochondrial  
Core subunit of the mitochondrial membrane respiratory chain NADH 
dehydrogenase (Complex I) that is believed to belong to the minimal 
assembly required for catalysis. Complex I functions in the transfer of 
electrons from NADH to the respiratory chain. The immediate 
electron acceptor for the enzyme is believed to be ubiquinone  
5 -22.9 6.2 27.4 
2170 1.6 4.36 43,576 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. Involved with LARP6 in the stabilization of type I 
41 -127 5.1 53.7 
2.77E+06 4.40E+06 
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HCT Bt IEC Bt 
collagen mRNAs for CO1A1 and CO1A2  
Heat shock protein HSP 90-
beta (Heat shock 84 kDa) 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function 
9 -61.5 5 83.2 
beta-actin-like protein 2  Actins are highly conserved proteins that are involved in various types 
of cell motility and are ubiquitously expressed in all eukaryotic cells  
3 -19.9 5.3 41.9 
2817 1.4 5.8 33,218 
Protein disulfide-isomerase A3 Catalytic activity: Catalyzes the rearrangement of -S-S- bonds in 
proteins. 
20 -61.6 5.9 56.6 
5.64E+06 7.98E+06 
Serine-threonine kinase 
receptor-associated protein  
The SMN complex plays an essential role in spliceosomal snRNP 
assembly in the cytoplasm and is required for pre-mRNA splicing in 
the nucleus. STRAP may play a role in the cellular distribution of the 
SMN complex. Negatively regulates TGF-beta signaling but positively 
regulates the PDPK1 kinase activity by enhancing its 
autophosphorylation and by significantly reducing the association of 
PDPK1 with 14-3-3 protein. Biological process: mRNA processing 
and mRNA splicing 
5 -32.8 5 38.4 
14-3-3 protein epsilon (14-3-
3E)(Mitochondrial import 
stimulation factor L subunit) 
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
5 -24.3 4.6 29.2 
Chloride intracellular channel 
protein 1  
Can insert into membranes and form chloride ion channels. Channel 
activity depends on the pH. Membrane insertion seems to be redox-
regulated and may occur only under oxydizing conditions 
5 -18 5.1 27 
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HCT Bt IEC Bt 
2550 1.7 5.58 38,542 
Tubulin beta-5 chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
27 -106 4.8 49.6 
5.72E+06 9.78E+06 
Tubulin beta-2C chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain 
30 -94.6 4.8 49.8 
60S acidic ribosomal protein P0 
(60S ribosomal protein L10E) 
Ribosomal protein P0 is the functional equivalent of E.coli protein 
L10. 
7 -38 5.9 34.2 
Pyruvate dehydrogenase E1 
component subunit beta, 
mitochondrial Precursor  
The pyruvate dehydrogenase complex catalyzes the overall conversion 
of pyruvate to acetyl-CoA and CO2, and thereby links the glycolytic 
pathway to the tricarboxylic cycle. Biological process: Glucose 
metabolism 
7 -29.6 6.2 39 
L-lactate dehydrogenase B 
chain  
catalytic activity: (S)-lactate + NAD+ = pyruvate + NADH. Pathway: 
Fermentation; pyruvate fermentation to lactate; (S)-lactate from 
pyruvate: step 1/1.  Biological process: Glycolysis  
4 -25.6 5.7 36.6 
Aldose reductase (EC 
1.1.1.21)(Aldehyde reductase)  
Catalyzes the NADPH-dependent reduction of a wide variety of 
carbonyl-containing compounds to their corresponding alcohols with a 
broad range of catalytic efficiencies. 
4 -9 6.3 35.8 
2590 1.5 5.26 37,799 
Heat shock protein HSP 90-
alpha 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various 
co-chaperones that modulate its substrate recognition, ATPase cycle 
and chaperone function. Biological process: Stress response  
28 -88.6 4.9 84.8 
6.04E+06 9.34E+06 Tubulin beta-5 chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. Biological process: protein 
polymerization  
8 -34.4 4.8 49.6 
S-adenosylmethionine 
synthetase isoform type-2 
(AdoMet synthetase 2) 
Catalyzes the formation of S-adenosylmethionine from methionine 
and ATP. Pathway:Amino-acid biosynthesis; S-adenosyl-L-
methionine biosynthesis; S-adenosyl-L-methionine from L-
methionine: step 1/1.
 
10 -33.5 5.7 42.7 
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HCT Bt IEC Bt 
Tubulin beta-2C chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain  
5 -26.6 4.8 49.8 
2648 2.8 7.05 36,520 
Elongation factor 2  Catalyzes the GTP-dependent ribosomal translocation step during 
translation elongation. During this step, the ribosome changes from 
the pre-translocational (PRE) to the post-translocational  state as the 
newly formed A-site-bound peptidyl-tRNA and P-site-bound 
deacylated tRNA move to the P and E sites, respectively. Catalyzes 
the coordinated movement of the two tRNA molecules, the mRNA 
and conformational changes in the ribosome. 
43 -128 6.4 95.2 
9.14E+06 3.24E+06 
2987 2.5 5.54 29,186 
Pyruvate kinase isozymes 
M1/M2 
Glycolytic enzyme that catalyzes the transfer of a phosphoryl group 
from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates 
POU5F1-mediated transcriptional activation  
11 -61.3 6.6 57.8 
1.89E+06 4.70E+06 
Annexin A1  Calcium/phospholipid-binding protein which promotes membrane 
fusion and is involved in exocytosis. This protein regulates 
phospholipase A2 activity. It seems to bind from two to four calcium 
ions with high affinity. 
14 -49.6 7 38.8 
Alpha-enolase (EC 4.2.1.11) Multifunctional enzyme that, as well as its role in glycolysis, plays a 
part in various processes such as growth control, hypoxia tolerance 
and allergic responses. May also function in the intravascular and 
pericellular fibrinolytic system due to its ability to serve as a receptor 
and activator of plasminogen on the cell surface of several cell-types 
such as leukocytes and neurons. Stimulates immunoglobulin 
production. 
6 -29.9 6.2 47.1 
Chloride intracellular channel 
protein 1  
Can insert into membranes and form chloride ion channels. Channel 
activity depends on the pH. Membrane insertion seems to be redox-
regulated and may occur only under oxydizing conditions  
6 -23.8 5.1 27 
14-3-3 protein zeta/delta 
(Protein kinase C inhibitor 
protein 1) 
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
4 -17.7 4.7 27.8 
Peroxiredoxin-4  Probably involved in redox regulation of the cell. Regulates the 
activation of NF-kappa-B in the cytosol by a modulation of I-kappa-B-
alpha phosphorylation 
3 -7.8 5.7 29.3 
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HCT Bt IEC Bt 
2098 2.6 7.35 44,484 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated protein) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
3 -17.1 5.9 73.7 
3.55E+06 1.36E+06 
Lactotransferrin Transferrins are iron binding transport proteins which can bind two 
Fe3+ ions in association with the binding of an anion, usually 
bicarbonate. Lactotransferrin has antimicrobial activity which depends 
on the extracellular cation concentration. Lactoferroxins A, B and C 
have opioid antagonist activity. Lactoferroxin A shows preference for 
mu-receptors, while lactoferroxin B and C have somewhat higher 
degrees of preference for kappa-receptors than for mu-receptors. The 
lactotransferrin transferrin-like domain 1 functions as a serine protease 
of the peptidase S60 family that cuts arginine rich regions. This 
function contributes to the antimicrobial activity.  
3 -16.6 8.5 78.1 
3657 3.2 8.21 37,716 
aldolase A-like 1  Plays a key role in glycolysis and gluconeogenesis. In addition, may 
also function as scaffolding protein  
10 -38.8 7.1 39.9 
2.44E+06 7.85E+06 Malate dehydrogenase, 
mitochondrial  
catalytic activity: (S)-malate + NAD+ = oxaloacetate + NADH. 3 -16.8 8.9 35.7 
2786 2.2 4.48 33,961 
Tropomyosin alpha-3 chain  Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
58 -187 4.7 29 
1.84E+07 4.12E+07 
Tropomyosin alpha-3 chain 
(Tropomyosin-3) 
Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
48 -139 4.7 33.1 
Tropomyosin alpha-3 chain  Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
36 -111 4.7 32.8 
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HCT Bt IEC Bt 
Tropomyosin alpha-4 chain  Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
Binds calcium. 
46 -101 4.7 28.5 
Tropomyosin alpha-1 chain  Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
27 -76.6 4.7 32.7 
2370 1.5 6.01 41,224 
Elongation factor 2 Catalyzes the GTP-dependent ribosomal translocation step during 
translation elongation. During this step, the ribosome changes from 
the pre-translocational (PRE) to the post-translocational  state as the 
newly formed A-site-bound peptidyl-tRNA and P-site-bound 
deacylated tRNA move to the P and E sites, respectively. Catalyzes 
the coordinated movement of the two tRNA molecules, the mRNA 
and conformational changes in the ribosome. Biological process: 
Protein biosynthesis 
69 -189 6.4 95.2 
1.06E+07 7.27E+06 
60 kDa heat shock protein, 
mitochondrial  
Implicated in mitochondrial protein import and macromolecular 
assembly. May facilitate the correct folding of imported proteins. May 
also prevent misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix. 
3 -17.5 5.9 60.9 
Moesin  Probably involved in connections of major cytoskeletal structures to 
the plasma membrane. 
3 -16.5 6.1 67.6 
1650 2 4.82 65,915 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. 
15 -86.6 5.1 53.7 
2.69E+06 1.32E+06 
78 kDa glucose-regulated 
protein  
Probably plays a role in facilitating the assembly of multimeric protein 
complexes inside the ER. 
5 -30.3 5.1 72.3 
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HCT Bt IEC Bt 
Protein disulfide-isomerase  This multifunctional protein catalyzes the formation, breakage and 
rearrangement of disulfide bonds. At the cell surface, seems to act as a 
reductase that cleaves disulfide bonds of proteins attached to the cell. 
May therefore cause structural modifications of exofacial proteins. 
Inside the cell, seems to form/rearrange disulfide bonds of nascent 
proteins. At high concentrations, functions as a chaperone that inhibits 
aggregation of misfolded proteins. At low concentrations, facilitates 
aggregation (anti-chaperone activity). May be involved with other 
chaperones in the structural modification of the TG precursor in 
hormone biogenesis. Also acts a structural subunit of various enzymes 
such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer 
protein MTTP. Catalyzes the rearrangement of -S-S- bonds in 
proteins. 
4 -21.6 4.8 56.9 
1706 2.9 6.32 62,985 
Protein disulfide-isomerase A3  Catalyzes the rearrangement of -S-S- bonds in proteins. 36 -141 5.9 56.6 
2.01E+06 5.80E+06 
Lactotransferrin Transferrins are iron binding transport proteins which can bind two 
Fe3+ ions in association with the binding of an anion, usually 
bicarbonate. Lactotransferrin has antimicrobial activity which depends 
on the extracellular cation concentration. Lactoferroxins A, B and C 
have opioid antagonist activity. Lactoferroxin A shows preference for 
mu-receptors, while lactoferroxin B and C have somewhat higher 
degrees of preference for kappa-receptors than for mu-receptors. The 
lactotransferrin transferrin-like domain 1 functions as a serine protease 
of the peptidase S60 family that cuts arginine rich regions. This 
function contributes to the antimicrobial activity.  
5 -26.2 8.5 78.1 
tubulin, alpha 1B (Tuba1b) Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
4 -17.2 4.9 50.2 
3524 1.9 6.83 6,534 Peroxiredoxin-1; EC 1.11.1.15 
Involved in redox regulation of the cell. Reduces peroxides with 
reducing equivalents provided through the thioredoxin system but not 
from glutaredoxin. May play an important role in eliminating 
peroxides generated during metabolism. Might participate in the 
signaling cascades of growth factors and tumor necrosis factor-alpha 
by regulating the intracellular concentrations of H2O2. Reduces an 
intramolecular disulfide bond in GDPD5 that gates the ability to 
GDPD5 to drive postmitotic motor neuron differentiation  
24 -62.8 8.3 22.1 5.12E+06 2.69E+06 
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HCT non-
Bt 
IEC non-
Bt 
2600 1.3 4.95 37,592 
Lamin-B1  Lamins are components of the nuclear lamina, a fibrous layer on the 
nucleoplasmic side of the inner nuclear membrane, which is thought to 
provide a framework for the nuclear envelope and may also interact 
with chromatin  
6 -36.7 5.1 66.6 
5.94E+06 4.51E+06 
S-adenosylmethionine 
synthetase isoform type-2 
(AdoMet synthetase 2)(EC 
2.5.1.6) 
Catalyzes the formation of S-adenosylmethionine from methionine 
and ATP. Pathway: Amino-acid biosynthesis; S-adenosyl-L-
methionine biosynthesis; S-adenosyl-L-methionine from L-
methionine: step 1/1. 
4 -23.6 5.7 42.7 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
8 -23.5 5.9 73.7 
heat shock protein 4 like  Biological process: Stress response.  Molecular function: ATP binding 3 -16.8 5.5 94.2 
Aldose reductase  Catalyzes the NADPH-dependent reduction of a wide variety of 
carbonyl-containing compounds to their corresponding alcohols with a 
broad range of catalytic efficiencies. 
3 -9.3 6.3 35.8 
2877 1.9 4.78 31,743 
Heat shock protein HSP 90-
beta (Heat shock 84 kDa) 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various co-
chaperones that modulate its substrate recognition, ATPase cycle and 
chaperone function 
7 -55.6 5 83.2 
2.66E+06 1.37E+06 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
23 -52 5.9 73.7 
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14-3-3 protein gamma  Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
4 -25.8 4.8 28.3 
Tubulin beta-5 chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
4 -19.1 4.8 49.6 
Tubulin beta-2C chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain  
4 -15.1 4.8 49.8 
3309 1.8 6.55 18,177 
Peroxiredoxin-1; EC 1.11.1.15; 
Natural killer cell-enhancing 
factor A 
Involved in redox regulation of the cell. Reduces peroxides with 
reducing equivalents provided through the thioredoxin system but not 
from glutaredoxin. May play an important role in eliminating 
peroxides generated during metabolism. Might participate in the 
signaling cascades of growth factors and tumor necrosis factor-alpha 
by regulating the intracellular concentrations of H2O2. Reduces an 
intramolecular disulfide bond in GDPD5 that gates the ability to 
GDPD5 to drive postmitotic motor neuron differentiation 
66 -109 8.3 22.1 
1.32E+07 7.28E+06 
Peroxiredoxin-1 (EC 
1.11.1.15)(Thioredoxin 
peroxidase 2) 
Involved in redox regulation of the cell. Reduces peroxides with 
reducing equivalents provided through the thioredoxin system but not 
from glutaredoxin. May play an important role in eliminating 
peroxides generated during metabolism. Might participate in the 
signaling cascades of growth factors and tumor necrosis factor-alpha 
by regulating the intracellular concentrations of H2O2. Reduces an 
intramolecular disulfide bond in GDPD5 that gates the ability to 
GDPD5 to drive postmitotic motor neuron differentiation 
57 -98 8.3 22.1 
Peroxiredoxin-4  Probably involved in redox regulation of the cell. Regulates the 
activation of NF-kappa-B in the cytosol by a modulation of I-kappa-B-
alpha phosphorylation 
8 -15.4 5.7 29.3 
14-3-3 protein zeta/delta 
(Protein kinase C inhibitor 
protein 1) 
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
4 -14.1 4.7 27.8 
914 1.9 5.48 92,918 
Heat shock protein HSP 90-
alpha  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various co-
chaperones that modulate its substrate recognition, ATPase cycle and 
chaperone function 
9 -73.1 4.9 84.8 
1.74E+05 3.31E+05 
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Heat shock protein HSP 90-
beta (Heat shock 84 kDa) 
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various co-
chaperones that modulate its substrate recognition, ATPase cycle and 
chaperone function  
9 -57.1 5 83.2 
3663 1.7 4.55 36,189 
Tropomyosin alpha-1 chain 
(Tropomyosin-1)(Alpha-
tropomyosin)  
Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
11
6 
-227 4.7 32.8 
9.83E+06 1.72E+07 
Tropomyosin alpha-3 chain 
(Tropomyosin-3)(Gamma-
tropomyosin) 
Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
61 -117 4.7 33.1 
Tropomyosin alpha-1 chain Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
67 -114 4.7 28.5 
3667 1.9 5.58 23,692 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L1 
Ubiquitin-protein hydrolase involved both in the processing of 
ubiquitin precursors and of ubiquitinated proteins. This enzyme is a 
thiol protease that recognizes and hydrolyzes a peptide bond at the C-
terminal glycine of ubiquitin. Also binds to free monoubiquitin and 
may prevent its degradation in lysosomes. The homodimer may have 
ATP-independent ubiquitin ligase activity  
19 -45.3 5.1 24.8 
4.83E+06 9.30E+06 
14-3-3 protein zeta/delta 
(Protein kinase C inhibitor 
protein 1)(KCIP-
1)(Mitochondrial import 
stimulation factor S1 subunit)  
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
4 -24.3 4.7 27.8 
Ras-related protein Rab-11B GTPase that modulates endosomal trafficking. Acts as a major 
regulator of membrane delivery during cytokinesis  
3 -18.3 5.6 24.5 
Tropomyosin beta chain  Binds to actin filaments in muscle and non-muscle cells. Plays a 
central role, in association with the troponin complex, in the calcium 
dependent regulation of vertebrate striated muscle contraction. Smooth 
muscle contraction is regulated by interaction with caldesmon. In non-
muscle cells is implicated in stabilizing cytoskeleton actin filaments. 
The non-muscle isoform may have a role in agonist-mediated receptor 
internalization 
4 -3.6 4.5 28.6 
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2817 1.4 5.8 33,218 
Protein disulfide-isomerase A3  Catalytic activity: Catalyzes the rearrangement of -S-S- bonds in 
proteins. 
20 -61.6 5.9 56.6 
5.53E+06 7.60E+06 
prelamin-A/C isoform C2  Lamins are components of the nuclear lamina, a fibrous layer on the 
nucleoplasmic side of the inner nuclear membrane, which is thought to 
provide a framework for the nuclear envelope and may also interact 
with chromatin. Lamin A and C are present in equal amounts in the 
lamina of mammals. Plays an important role in nuclear assembly, 
chromatin organization, nuclear membrane and telomere dynamics. 
Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to 
disrupt mitosis and induce DNA damage in vascular smooth muscle 
cells (VSMCs), leading to mitotic failure, genomic instability, and 
premature senescence 
8 -48.2 6.5 74.3 
Serine-threonine kinase 
receptor-associated protein  
The SMN complex plays an essential role in spliceosomal snRNP 
assembly in the cytoplasm and is required for pre-mRNA splicing in 
the nucleus. STRAP may play a role in the cellular distribution of the 
SMN complex. Negatively regulates TGF-beta signaling but positively 
regulates the PDPK1 kinase activity by enhancing its 
autophosphorylation and by significantly reducing the association of 
PDPK1 with 14-3-3 protein. Biological process: mRNA processing 
and mRNA splicing 
5 -32.8 5 38.4 
14-3-3 protein epsilon (14-3-
3E)(Mitochondrial import 
stimulation factor L 
subunit)(MSF L) 
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
5 -24.3 4.6 29.2 
14-3-3 protein zeta/delta 
(Protein kinase C inhibitor 
protein 1)(KCIP-
1)(Mitochondrial import 
stimulation factor S1 subunit)  
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
5 -23 4.7 27.8 
Chloride intracellular channel 
protein 1  
Can insert into membranes and form chloride ion channels. Channel 
activity depends on the pH. Membrane insertion seems to be redox-
regulated and may occur only under oxydizing conditions 
5 -18 5.1 27 
Nucleolin-like protein  Molecular function: nuclic acid binding and nucleotide binding 4 -17.7 5.3 61.7 
1895 2.3 5.21 54,033 
ATP synthase subunit beta, 
mitochondrial  
Mitochondrial membrane ATP synthase (F1F0 ATP synthase or 
Complex V) produces ATP from ADP in the presence of a proton 
gradient across the membrane which is generated by electron transport 
complexes of the respiratory chain. F-type ATPases consist of two 
structural domains, F1 - containing the extramembraneous catalytic 
core, and F0 - containing the membrane proton channel, linked 
together by a central stalk and a peripheral stalk. During catalysis, 
ATP synthesis in the catalytic domain of F1 is coupled via a rotary 
19 -72.6 5.1 56.3 
1.59E+06 3.59E+06 
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mechanism of the central stalk subunits to proton translocation. 
Subunits alpha and beta form the catalytic core in F1. Rotation of the 
central stalk against the surrounding alpha3beta3 subunits leads to 
hydrolysis of ATP in three separate catalytic sites on the beta subunits. 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. Involved with LARP6 in the stabilization of type I 
collagen mRNAs for CO1A1 and CO1A2  
4 -22.6 5.1 53.7 
3120 1.2 5.3 22,508 
60 kDa heat shock protein, 
mitochondrial  
Implicated in mitochondrial protein import and macromolecular 
assembly. May facilitate the correct folding of imported proteins. May 
also prevent misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix. 
13 -61.4 5.9 60.9 
8.25E+06 1.00E+07 Ubiquitin carboxyl-terminal hydrolase isozyme L1  
Ubiquitin-protein hydrolase involved both in the processing of 
ubiquitin precursors and of ubiquitinated proteins. This enzyme is a 
thiol protease that recognizes and hydrolyzes a peptide bond at the C-
terminal glycine of ubiquitin. Also binds to free monoubiquitin and 
may prevent its degradation in lysosomes. The homodimer may have 
ATP-independent ubiquitin ligase activity  
4 -20 5.1 24.8 
Nucleolin-like protein  Molecular function: nuclic acid binding and nucleotide binding 3 -15.4 5.3 61.7 
3360 1.6 4.38 16,884 
Tubulin beta-5 chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
2 -10.7 4.8 49.6 
7.95E+06 4.83E+06 
2370 1.5 6.01 41,224 
Elongation factor 2  Catalyzes the GTP-dependent ribosomal translocation step during 
translation elongation. During this step, the ribosome changes from the 
pre-translocational (PRE) to the post-translocational  state as the 
newly formed A-site-bound peptidyl-tRNA and P-site-bound 
deacylated tRNA move to the P and E sites, respectively. Catalyzes 
the coordinated movement of the two tRNA molecules, the mRNA 
and conformational changes in the ribosome. Biological process: 
Protein biosynthesis 
69 -189 6.4 95.2 
1.07E+07 7.27E+06 
60 kDa heat shock protein, 
mitochondrial  
Implicated in mitochondrial protein import and macromolecular 
assembly. May facilitate the correct folding of imported proteins. May 
also prevent misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix. 
3 -17.5 5.9 60.9 
Moesin  Probably involved in connections of major cytoskeletal structures to 
the plasma membrane. 
3 -16.5 6.1 67.6 
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1687 1.8 4.93 64,125 
Protein disulfide-isomerase  This multifunctional protein catalyzes the formation, breakage and 
rearrangement of disulfide bonds. At the cell surface, seems to act as a 
reductase that cleaves disulfide bonds of proteins attached to the cell. 
May therefore cause structural modifications of exofacial proteins. 
Inside the cell, seems to form/rearrange disulfide bonds of nascent 
proteins. At high concentrations, functions as a chaperone that inhibits 
aggregation of misfolded proteins. At low concentrations, facilitates 
aggregation (anti-chaperone activity). May be involved with other 
chaperones in the structural modification of the TG precursor in 
hormone biogenesis. Also acts a structural subunit of various enzymes 
such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer 
protein MTTP. Catalyzes the rearrangement of -S-S- bonds in 
proteins. 
36 -129 4.8 56.9 
2.06E+06 3.61E+06 
78 kDa glucose-regulated 
protein  
Probably plays a role in facilitating the assembly of multimeric protein 
complexes inside the ER. 
10 -65.5 5.1 72.3 
Heat shock-related 70 kDa 
protein 2 (Heat shock protein 
70.2)(Testis-specific heat 
shock protein-related)  
In cooperation with other chaperones, Hsp70s stabilize preexistent 
proteins against aggregation and mediate the folding of newly 
translated polypeptides in the cytosol as well as within organelles. 
These chaperones participate in all these processes through their 
ability to recognize nonnative conformations of other proteins. They 
bind extended peptide segments with a net hydrophobic character 
exposed by polypeptides during translation and membrane 
translocation, or following stress-induced damage. 
5 -34.9 5.5 69.6 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. Involved with LARP6 in the stabilization of type I 
collagen mRNAs for CO1A1 and CO1A2  
6 -32.9 5.1 53.7 
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IEC Bt IEC non-
Bt 
2547 3.7 5.13 38,583 
Heat shock protein HSP 90-
beta (Heat shock 84 kDa)(HSP 
84)(HSP84)  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various co-
chaperones that modulate its substrate recognition, ATPase cycle and 
chaperone function  
24 -73.2 5 83.2 
1.82E+06 4.86E+05 
Heat shock protein HSP 90-
alpha  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various co-
chaperones that modulate its substrate recognition, ATPase cycle and 
chaperone function 
9 -39.9 4.9 84.8 
L-lactate dehydrogenase B 
chain  
Catalytic activity: (S)-lactate + NAD+ = pyruvate + NADH. Pathway: 
Fermentation; pyruvate fermentation to lactate; (S)-lactate from 
pyruvate: step 1/1. Biological process: Glycolysis 
5 -38.6 5.7 36.6 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9)(Peptide-
binding protein 
74)(PBP74)(mtHSP70) 
(Mortalin)  
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
7 -30.7 5.9 73.7 
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IEC Bt IEC non-
Bt 
Pyruvate kinase isozymes 
M1/M2 
Glycolytic enzyme that catalyzes the transfer of a phosphoryl group 
from phosphoenolpyruvate (PEP) to ADP, generating ATP. Stimulates 
POU5F1-mediated transcriptional activation. Pathway: Carbohydrate 
degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: 
step 5/5 
4 -24.3 6.6 57.8 
Lamin-B1  Lamins are components of the nuclear lamina, a fibrous layer on the 
nucleoplasmic side of the inner nuclear membrane, which is thought to 
provide a framework for the nuclear envelope and may also interact 
with chromatin  
4 -24.2 5.1 66.6 
S-adenosylmethionine 
synthetase isoform type-2 
(AdoMet synthetase 2)(EC 
2.5.1.6) 
Catalyzes the formation of S-adenosylmethionine from methionine 
and ATP. Pathway: Amino-acid biosynthesis; S-adenosyl-L-
methionine biosynthesis; S-adenosyl-L-methionine from L-
methionine: step 1/1 
5 -17.4 5.7 42.7 
Nuclear migration protein 
nudC (Nuclear distribution 
protein C homolog)(c15) 
Plays a role in neurogenesis and neuronal migration. Necessary for 
correct formation of mitotic spindles and chromosome separation 
during mitosis 
3 -17.2 5.3 38.4 
Endoplasmin Precursor (Heat 
shock protein 90 kDa beta 
member 1)(94 kDa glucose-
regulated protein)(GRP-94)  
Molecular chaperone that functions in the processing and transport of 
secreted proteins. When associated with CNPY3, required for proper 
folding of Toll-like receptors. Functions in endoplasmic reticulum 
associated degradation (ERAD). Has ATPase activity  
3 -16.3 4.7 92.7 
Moesin  Probably involved in connections of major cytoskeletal structures to 
the plasma membrane. 
3 -15.8 6.1 67.6 
Tubulin beta-5 chain  Tubulin is the major constituent of microtubules. It binds two moles of 
GTP, one at an exchangeable site on the beta chain and one at a non-
exchangeable site on the alpha chain. 
3 -10.6 4.8 49.6 
T-complex protein 1 subunit 
epsilon (TCP-1-epsilon)(CCT-
epsilon)  
Molecular chaperone; assists the folding of proteins upon ATP 
hydrolysis. As part of the BBS/CCT complex may play a role in the 
assembly of BBSome, a complex involved in ciliogenesis regulating 
transports vesicles to the cilia. Known to play a role, in vitro, in the 
folding of actin and tubulin 
4 -9.5 5.5 59.5 
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IEC Bt IEC non-
Bt 
Aldose reductase (EC 
1.1.1.21)(Aldehyde reductase)  
Catalyzes the NADPH-dependent reduction of a wide variety of 
carbonyl-containing compounds to their corresponding alcohols with a 
broad range of catalytic efficiencies. 
6 -8.7 6.3 35.8 
aldo-keto reductase family 1, 
member B8 
Biological process: oxidation-reduction process 5 -8.2 7.1 36.1 
1627 2.1 5.72 66,495 
60 kDa heat shock protein, 
mitochondrial  
Implicated in mitochondrial protein import and macromolecular 
assembly. May facilitate the correct folding of imported proteins. May 
also prevent misfolding and promote the refolding and proper 
assembly of unfolded polypeptides generated under stress conditions 
in the mitochondrial matrix. 
21 -113 5.9 60.9 
3.81E+06 1.81E+06 
Stress-70 protein, 
mitochondrial Precursor (75 
kDa glucose-regulated 
protein)(GRP-75)(Heat shock 
70 kDa protein 9)(Peptide-
binding protein 
74)(PBP74)(mtHSP70)(Mortali
n) 
Implicated in the control of cell proliferation and cellular aging. May 
also act as a chaperone. 
16 -74.5 5.9 73.7 
T-complex protein 1 subunit 
epsilon (TCP-1-epsilon)(CCT-
epsilon)  
Molecular chaperone; assists the folding of proteins upon ATP 
hydrolysis. As part of the BBS/CCT complex may play a role in the 
assembly of BBSome, a complex involved in ciliogenesis regulating 
transports vesicles to the cilia. Known to play a role, in vitro, in the 
folding of actin and tubulin 
20 -56.5 5.5 59.5 
inner membrane protein, 
mitochondrial 
Interacts with OPA1, preferentially with the soluble OPA1 form. 
Component of the MINOS/MitOS complex, that includes IMMT, 
HSPA9 and CHCHD3 and associates with mitochondrial outer 
membrane proteins SAMM50, MTX1 and MTX2. Interacts with 
CHCHD6; the interaction is direct  
4 -17.3 5.6 87.1 
2601 2.3 5.64 37,592 
Actin, cytoplasmic 1 Actin, 
cytoplasmic 1 
Actins are highly conserved proteins that are involved in various types 
of cell motility and are ubiquitously expressed in all eukaryotic cells. 
20 -70.3 5.3 41.7 
6.29E+06 2.79E+06 Nucleolin-like protein  Molecular function: nuclic acid binding and nucleotide binding 7 -25.4 5.3 61.7 
Moesin Probably involved in connections of major cytoskeletal structures to 
the plasma membrane. 
5 -23.4 6.1 67.6 
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IEC Bt IEC non-
Bt 
Transitional endoplasmic 
reticulum ATPase  
Necessary for the fragmentation of Golgi stacks during mitosis and for 
their reassembly after mitosis. Involved in the formation of the 
transitional endoplasmic reticulum . The transfer of membranes from 
the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm 
transition vesicles which derive from part-rough, part-smooth 
transitional elements of the endoplasmic reticulum . Vesicle budding 
from the tER is an ATP-dependent process. The ternary complex 
containing UFD1L, VCP and NPLOC4 binds ubiquitinated proteins 
and is necessary for the export of misfolded proteins from the ER to 
the cytoplasm, where they are degraded by the proteasome. The 
NPLOC4-UFD1L-VCP complex regulates spindle disassembly at the 
end of mitosis and is necessary for the formation of a closed nuclear 
envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A. 
Also involved in DNA damage response: recruited to double-strand 
breaks (DSBs) sites in a RNF8- and RNF168-dependent manner and 
promotes the recruitment of TP53BP1 at DNA damage sites. Recruited 
to stalled replication forks by SPRTN: may act by mediating 
extraction of DNA polymerase eta (POLH) to prevent excessive 
translesion DNA synthesis and limit the incidence of mutations 
induced by DNA damage. Component of the VCP/p97-AMFR/gp78 
complex that participates in the final step of the sterol-mediated 
ubiquitination and endoplasmic reticulum-associated degradation 
(ERAD) of HMGCR. 
3 -19.6 5.1 89.3 
Heat shock protein HSP 90-
beta (Heat shock 84 kDa)(HSP 
84)(HSP84)  
Molecular chaperone that promotes the maturation, structural 
maintenance and proper regulation of specific target proteins involved 
for instance in cell cycle control and signal transduction. Undergoes a 
functional cycle that is linked to its ATPase activity. This cycle 
probably induces conformational changes in the client proteins, 
thereby causing their activation. Interacts dynamically with various co-
chaperones that modulate its substrate recognition, ATPase cycle and 
chaperone function  
3 -18.2 5 83.2 
1687 2.2 4.93 64,125 
Protein disulfide-isomerase  This multifunctional protein catalyzes the formation, breakage and 
rearrangement of disulfide bonds. At the cell surface, seems to act as a 
reductase that cleaves disulfide bonds of proteins attached to the cell. 
May therefore cause structural modifications of exofacial proteins. 
Inside the cell, seems to form/rearrange disulfide bonds of nascent 
36 -129 4.8 56.9 
1.62E+06 3.61E+06 
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IEC Bt IEC non-
Bt 
proteins. At high concentrations, functions as a chaperone that inhibits 
aggregation of misfolded proteins. At low concentrations, facilitates 
aggregation (anti-chaperone activity). May be involved with other 
chaperones in the structural modification of the TG precursor in 
hormone biogenesis. Also acts a structural subunit of various enzymes 
such as prolyl 4-hydroxylase and microsomal triacylglycerol transfer 
protein MTTP. Catalyzes the rearrangement of -S-S- bonds in 
proteins. 
78 kDa glucose-regulated 
protein  
Probably plays a role in facilitating the assembly of multimeric protein 
complexes inside the ER. 
10 -65.5 5.1 72.3 
Heat shock-related 70 kDa 
protein 2 (Heat shock protein 
70.2)(Testis-specific heat 
shock protein-related)  
In cooperation with other chaperones, Hsp70s stabilize preexistent 
proteins against aggregation and mediate the folding of newly 
translated polypeptides in the cytosol as well as within organelles. 
These chaperones participate in all these processes through their 
ability to recognize nonnative conformations of other proteins. They 
bind extended peptide segments with a net hydrophobic character 
exposed by polypeptides during translation and membrane 
translocation, or following stress-induced damage. 
5 -34.9 5.5 69.6 
Vimentin  Vimentins are class-III intermediate filaments found in various non-
epithelial cells, especially mesenchymal cells. Vimentin is attached to 
the nucleus, endoplasmic reticulum, and mitochondria, either laterally 
or terminally. Involved with LARP6 in the stabilization of type I 
collagen mRNAs for CO1A1 and CO1A2  
6 -32.9 5.1 53.7 
2204 1.9 7.56 43,287 
Annexin A2  Calcium-regulated membrane-binding protein whose affinity for 
calcium is greatly enhanced by anionic phospholipids. It binds two 
calcium ions with high affinity. 
3 -18 7.5 38.9 
6.20E+05 1.15E+06 
2882 1.4 5.01 31,609 
14-3-3 protein zeta/delta 
(Protein kinase C inhibitor 
protein 1)(KCIP-
1)(Mitochondrial import 
stimulation factor S1 subunit)  
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
14 -58.1 4.7 27.8 
2.41E+06 1.72E+06 14-3-3 protein gamma  Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. 
6 -43.2 4.8 28.3 
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IEC Bt IEC non-
Bt 
14-3-3 protein eta  Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. Negatively regulates the kinase 
activity of PDPK1  
6 -39.6 4.8 28.2 
14-3-3 protein theta (14-3-3 
protein tau)  
Adapter protein implicated in the regulation of a large spectrum of 
both general and specialized signaling pathways. Binds to a large 
number of partners, usually by recognition of a phosphoserine or 
phosphothreonine motif. Binding generally results in the modulation 
of the activity of the binding partner. Negatively regulates the kinase 
activity of PDPK1  
9 -39.2 4.7 27.8 
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structural molecule 
activity, 34, 22%
chaperones
, 31, 20%
Oxidoreductase
, 9, 6%
Antioxidant, 5, 3%
Protein disulfide isomerase 
activity, 4, 3%
Kinase
, 4, 3%
Initiation factor in Protein 
biosynthesis, 1, 1%
chloride channel regulator 
activity, 2, 1%
Transferase, 4, 3%
Response to stress                
, 1, 1%
Ribonucleoprotein, 3, 2%
Muscle protein, 9, 6%
Hydrolase, 6, 4%
translation elongation 
factor activity , 4, 3%
ATP binding, 6, 4%
calcium ion 
binding/Transfer
, Carrier protein, 
5, 3%
mitochondrial 
calcium ion 
homeostasis, 2, 
1%
Host 
cell 
recept
or for 
virus 
entry, 
1, 1%
ferric iron 
binding, 4, 
3%
nucleotide 
binding, 3, 2%
GTPase activity, 2, 1%
mRNA splicing, 1, 1%
protein kinase C 
inhibitor activity, 1, 
1%
Lyase, 2, 1%
protein domain specific 
binding, 5, 3% actin binding, 2, 1%
sodium channel 
regulator activity, 1, 
1%
Appendix 33: Functional classifications of differentially expressed intestinal epithelial cells proteins (IECs and
HCT116). 
A total of 152 proteins were identified and these proteins fall within 27 major functional categories. 9 (6%)
contain oxidoreductase activity, 31 (20%) are chaperones, 4 (3%) contained transferase activity, 34 (22%)
contained structural molecule activity and 3 (2%) are ribonucleoproteins. 
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Appendix 34: Functional classification of the identified protein spots when comparing IE cells and 
HCT116 cell line. 
Molecular 
function 
number of 
proteins name of protein Spot No. Groups 
structural 
molecule activity 
1 Fibronectin Precursor (FN)  814 HCT116 Bt vs IECs Bt 
2 Actin, cytoplasmic 1 Actin, cytoplasmic 1 2597, 2601 HCT116 Bt vs IECs Bt, IECs Bt vs IECs non-Bt 
1 filamin-A  814 HCT116 Bt vs IECs Bt 
2 Vinculin (Metavinculin)  814, 914 HCT116 Bt vs IECs Bt 
1 filamin, beta  814 HCT116 Bt vs IECs Bt 
1 prelamin-A/C isoform C2  1561 HCT116 Bt vs IECs Bt 
2 Lamin-B1 2547, 2600 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt  
2 Nuclear migration protein nudC  2547, 2262 HCT116 Bt vs IECs Bt,  IECs Bt vs IECs non-Bt 
5 Tubulin beta-5 chain  
2547, 2550, 
2590, 2877, 
3360 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt  
1 tubulin, alpha 1B (Tuba1b) 1706 HCT116 Bt vs IECs Bt 
3 Tubulin beta-2C chain  2550, 2590, 2877 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
3 Moesin  2547, 2370, 2601 
HCT116 Bt vs IECs Bt, IECs 
Bt vs IECs non-Bt 
1 Plectin-1  3634 HCT116 Bt vs IECs Bt 
1 tubulin, alpha 1B (Tuba1b), mRNA  2262 HCT116 Bt vs IECs Bt 
1 Ezrin  3391 HCT116 Bt vs IECs Bt 
6 Vimentin  
1891, 2262, 
2170, 1650, 
1895, 1687 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt 
1 Myosin-9  814 HCT116 Bt vs IECs Bt 
chaperones 
1 Endoplasmin Precursor (Heat shock protein 90 kDa beta member 1) 2547 
HCT116 Bt vs IECs Bt, IECs 
Bt vs IECs non-Bt 
7 Heat shock protein HSP 90-beta  
2547, 2262, 
914, 3391, 
2170, 2877, 
2601 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt 
4 Heat shock protein HSP 90-alpha  2547, 2262, 914, 2590 
HCT116 Bt vs IECs Bt,  
IECs Bt vs IECs non-Bt 
2 T-complex protein 1 subunit epsilon  2547, 1627 HCT116 Bt vs IECs Bt, IECs Bt vs IECs non-Bt 
1 T-complex protein 1 subunit alpha 3391 HCT116 Bt vs IECs Bt 
Appendices 
333 
 
5 60 kDa heat shock protein, mitochondrial  
3634, 2262, 
2370,3120, 
1627 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt 
1 Heat shock-related 70 kDa protein 2 1687 IECs Bt vs IECs non-Bt 
10 Stress-70 protein, mitochondrial Precursor  
2393, 2547, 
3634, 1561, 
1615, 1954, 
2098, 2600, 
2877, 1627 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt 
Oxidoreductase 
1 L-lactate dehydrogenase B chain  2547 HCT116 Bt vs IECs Bt,  IECs Bt vs IECs non-Bt 
1 aldo-keto reductase family 1, member B8 2547 HCT116 Bt vs IECs Bt,  IECs Bt vs IECs non-Bt 
1 NADH dehydrogenase flavoprotein 2, mitochondrial  3137 HCT116 Bt vs IECs Bt 
1 Pyruvate dehydrogenase E1 component subunit beta, mitochondrial Precursor  2550 HCT116 Bt vs IECs Bt 
1 L-lactate dehydrogenase B chain  2550 HCT116 Bt vs IECs Bt 
3 Aldose reductase  2547, 2550, 
2600 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt , IECs Bt vs IECs 
non-Bt 
1 Malate dehydrogenase, mitochondrial  3657 HCT116 Bt vs IECs Bt 
Antioxidant 
2 Peroxiredoxin-4  2987, 3309 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
3 Peroxiredoxin-1 3524, 3309 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
Protein disulfide 
isomerase activity 
2 Protein disulfide-isomerase A3 2817, 1706 HCT116 Bt vs IECs Bt 
2 Protein disulfide-isomerase  1650, 1687 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt , IECs Bt vs IECs 
non-Bt 
Kinase 4 Pyruvate kinase isozymes M1/M2 2547, 3653, 2262, 2987 
HCT116 Bt vs IECs Bt,  
IECs Bt vs IECs non-Bt 
Initiation factor in 
Protein 
biosynthesis 
1 Eukaryotic translation initiation factor 3 subunit I (eIF3i) 3391 HCT116 Bt vs IECs Bt 
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chloride channel 
activity 2 Chloride intracellular channel protein 1  2817, 2987 HCT116 Bt vs IECs Bt 
Transferase 
3 S-adenosylmethionine synthetase isoform type-2  
2547, 2590, 
2600 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt  
1 Transketolase  2401 HCT116 Bt vs IECs Bt 
Response to 
stress             1 heat shock protein 4 like  2600 
HCT116 non-Bt vs IECs 
non-Bt 
Ribonucleoprotei
n 
1 40S ribosomal protein SA  3391 HCT116 Bt vs IECs Bt 
1 60S acidic ribosomal protein P0  2550 HCT116 Bt vs IECs Bt 
1 ErbB3-binding protein 1  3436 HCT116 Bt vs IECs Bt 
Muscle protein 
1 Tropomyosin alpha-4 chain  2786 HCT116 Bt vs IECs Bt 
3 Tropomyosin alpha-1 chain  2786, 3663 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
1 Tropomyosin beta chain  3667  HCT116 non-Bt vs IECs non-Bt  
4 Tropomyosin alpha-3 chain  2786, 3663 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
Hydrolase 
1 Proteasome subunit alpha type-6  3653 HCT116 Bt vs IECs Bt 
1 Transitional endoplasmic reticulum ATPase  2601 IECs Bt vs IECs non-Bt 
2 Ubiquitin carboxyl-terminal hydrolase isozyme L1 3667, 3120 
 HCT116 non-Bt vs IECs 
non-Bt  
2 ATP synthase subunit beta, mitochondrial  1891, 1895 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
translation 
elongation factor 
activity  
4 Elongation factor 2  2393, 2401, 2648, 2370 HCT116 Bt vs IECs Bt 
ATP binding 
5 78 kDa glucose-regulated protein  
814, 1561, 
1615, 1650, 
1687 
HCT116 Bt vs IECs Bt, IECs 
Bt vs IECs non-Bt, IECs Bt 
vs IECs non-Bt 
1 beta-actin-like protein 2  2170 HCT116 Bt vs IECs Bt 
calcium ion 
binding 
1 Spectrin alpha chain, brain 814 HCT116 Bt vs IECs Bt 
2 Annexin A1  3137, 2987 HCT116 Bt vs IECs Bt 
2 Annexin A2  3653, 2204 HCT116 Bt vs IECs Bt, IECs Bt vs IECs non-Bt 
mitochondrial 
calcium ion 
homeostasis 
2 inner membrane protein, mitochondrial 2393, 1627 HCT116 Bt vs IECs Bt, IECs Bt vs IECs non-Bt 
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Host cell receptor 
for virus entry 1 integrin alpha V Gene 814 HCT116 Bt vs IECs Bt 
ferric iron 
binding 4 Lactotransferrin 
1561, 1043, 
2098, 1706 HCT116 Bt vs IECs Bt 
nucleotide 
binding 
1 Non-POU domain-containing octamer-binding protein  3436 HCT116 Bt vs IECs Bt 
2 Nucleolin-like protein  3120, 2601 
HCT116 non-Bt vs IECs 
non-Bt , IECs Bt vs IECs 
non-Bt 
GTPase activity 2 Ras-related protein Rab-11B  3137, 3667 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt  
mRNA splicing 1 Serine-threonine kinase receptor-associated protein  2817 HCT116 Bt vs IECs Bt 
protein kinase C 
inhibitor activity 1 14-3-3 protein epsilon  2817 HCT116 Bt vs IECs Bt 
Lyase 
1 Alpha-enolase  2987 HCT116 Bt vs IECs Bt 
1 aldolase A-like 1  3657 HCT116 Bt vs IECs Bt 
protein domain 
specific binding 
4 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) 
2987, 3309, 
3667, 2882 
HCT116 Bt vs IECs Bt,  
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt  
1 14-3-3 protein theta  2882 IECs Bt vs IECs non-Bt 
actin binding 2 14-3-3 protein gamma  2877, 2882 
HCT116 non-Bt vs IECs 
non-Bt, IECs Bt vs IECs 
non-Bt 
sodium channel 
regulator activity 1 14-3-3 protein eta  2882 IECs Bt vs IECs non-Bt 
